mp:V3.0.0 testgegevens afhandelen voorschrift addendum: verschil tussen versies

Uit informatiestandaarden
Ga naar: navigatie, zoeken
(Nieuwe pagina aangemaakt met ' __NUMBEREDHEADINGS__ {{DISPLAYTITLE:Sturen afhandeling medicatievoorschrift 9.2.0: addendum inhoudelijke gegevens kwalificatie}} =Addenda voor inhoudelijke gegeve...')
 
 
(12 tussenliggende versies door 5 gebruikers niet weergegeven)
Regel 1: Regel 1:
  
 
__NUMBEREDHEADINGS__
 
__NUMBEREDHEADINGS__
−
{{DISPLAYTITLE:Sturen afhandeling medicatievoorschrift 9.2.0: addendum inhoudelijke gegevens kwalificatie}}
+
{{DISPLAYTITLE:Sturen afhandeling medicatievoorschrift MP9 3.0: addendum inhoudelijke gegevens}}
  
 
=Addenda voor inhoudelijke gegevens=
 
=Addenda voor inhoudelijke gegevens=
Regel 10: Regel 10:
 
{| class="wikitable"
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
−
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id|| MVE id
+
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|1.1|| Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum en einddatum|| MBH_300_start_eind-tav|| MBH_300_start_eind_TA-tav|| MBH_300_start_eind_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|1.1|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ einddatum).|| Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum en einddatum|| MBH_200_start_eind|| MBH_200_start_eind_TA|| MBH_200_start_eind_MVE
+
|1.2a|| Afhandelen medicatievoorschrift met een toediedingsafspraak gebruiksperiode ingangsdatum en duur (weken)|| MBH_300_start_duur-tav|| MBH_300_start_duur_TA-tav|| MBH_300_start_duur_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|1.2a|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur).|| Afhandelen medicatievoorschrift met een toediedingsafspraak gebruiksperiode ingangsdatum en duur (weken)|| MBH_200_start_duur|| MBH_200_start_duur_TA|| MBH_200_start_duur_MVE
+
|1.2b|| Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum en duur (dagen)|| MBH_300_start_duur2-tav|| MBH_300_start_duur2_TA-tav|| MBH_300_start_duur2_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|1.2b|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur).|| Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum en duur (dagen)|| MBH_200_start_duur2|| MBH_200_start_duur2_TA|| MBH_200_start_duur2_MVE
+
|1.3|| Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum (chronische medicatie)|| MBH_300_chronisch-tav|| MBH_300_chronisch_TA-tav|| MBH_300_chronisch_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|1.3|| || Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum (chronische medicatie)|| MBH_200_chronisch|| MBH_200_chronisch_TA|| MBH_200_chronisch_MVE
+
|1.4|| <div>Extra MVE&nbsp;</div><div>LET OP: MVE met TA uit scenario 1.3 (20 dagen later)</div>|| MBH_300_chronisch-tav|| MBH_300_chronisch_TA-tav|| MBH_300_chronisch_MVE_extraMVEbestaandeTA-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|1.4|| Maak screenshot(s) waaruit blijkt dat het extra MVE gemaakt wordt/behoort bij de eerdere TA.|| <div>Extra MVE&nbsp;</div><div>LET OP: MVE met TA uit scenario 1.3 (20 dagen later)</div>|| MBH_200_chronisch|| MBH_200_chronisch_TA|| MBH_200_chronisch_MVE_extraMVEbestaandeTA
+
|1.5|| Afhandeling medicatievoorschrift met eenheid 'dosis/stuks'|| MBH_300_dosis_stuks-tav|| MBH_300_dosis_stuks_TA-tav|| MBH_300_dosis_stuks_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|1.5|| || Afhandeling medicatievoorschrift met eenheid 'dosis/stuks'|| MBH_200_dosis_stuks|| MBH_200_dosis_stuks_TA|| MBH_200_dosis_stuks_MVE
+
|1.6|| <div>Afhandeling medicatievoorschrift met onzekerheidscriterium</div>|| MBH_300_start_criterium-tav|| MBH_300_start_criterium_TA-tav|| MBH_300_start_criterium_MVE-tav
 
|}
 
|}
 
<section end=overview-AVS-1 />
 
<section end=overview-AVS-1 />
Regel 29: Regel 31:
 
{| class="wikitable"
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
−
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id|| MVE id
+
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|2.1|| Maak screenshot(s) waaruit blijkt dat een 'aanvullende instructie' ingevoerd kan worden (als vrije tekst en/of uit keuze lijstje)|| Aanvullende instructie (TA)|| MBH_200_aanvullendeinstructie|| MBH_200_aanvullendeinstructie_TA|| MBH_200_aanvullendeinstructie_MVE
+
|2.1|| Aanvullende instructie (TA)|| MBH_300_aanvullendeinstructie-tav|| MBH_300_aanvullendeinstructie_TA-tav|| MBH_300_aanvullendeinstructie_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|2.2|| Maak screenshot(s) waaruit blijkt dat bij zowel de TA als MVE een 'toelichting' ingevoerd kan worden|| Toelichting (TA), toelichting (MVE)|| MBH_200_toelichting|| MBH_200_toelichting_TA|| MBH_200_toelichting_MVE
+
|2.2|| Toelichting (TA), toelichting (MVE)|| MBH_300_toelichting-tav|| MBH_300_toelichting_TA-tav|| MBH_300_toelichting_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|2.3|| Maak screenshot(s) van de melding/waarschuwing indien de reden van voorschrijven niet wordt ingevuld.|| Reden van voorschrijven (TA)|| MBH_200_redenvanvoorschrijven|| MBH_200_redenvanvoorschrijven_TA|| MBH_200_redenvanvoorschrijven_MVE
+
|2.3|| Reden van voorschrijven (TA)|| MBH_300_redenvanvoorschrijven-tav|| MBH_300_redenvanvoorschrijven_TA-tav|| MBH_300_redenvanvoorschrijven_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|2.5|| Maak screenshot(s) waarop de lijst met concepten voor 'aanvullende informatie' (TA) en 'aanvullende wensen' (MVE) zichtbaar zijn|| Aanvullende informatie (MA), aanvullende wensen (VV)|| MBH_200_aanvullendeinformatiewensen|| MBH_200_aanvullendeinformatiewensen_TA|| MBH_200_aanvullendeinformatiewensen_MVE
+
|2.4|| Aanvullende informatie (MA), aanvullende wensen (VV)|| MBH_300_aanvullendeinformatiewensen-tav|| MBH_300_aanvullendeinformatiewensen_TA-tav|| MBH_300_aanvullendeinformatiewensen_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|2.6|| Maak screenshot(s) waarop toedieningsweg keuze zichtbaar is|| Toedieningsweg (TA)|| MBH_200_Toedieningsweg|| MBH_200_Toedieningsweg_TA|| MBH_200_Toedieningsweg_MVE
+
|2.5|| Toedieningsweg (TA)|| MBH_300_Toedieningsweg-tav|| MBH_300_Toedieningsweg_TA-tav|| MBH_300_Toedieningsweg_MVE-tav
 
|}
 
|}
 
<section end=overview-AVS-2 />
 
<section end=overview-AVS-2 />
Regel 46: Regel 48:
 
{| class="wikitable"
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
−
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id|| MVE id
+
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|3.1a|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Benodigd voor scenario 3.1b</span></div><div>&nbsp;</div>|| MBH_300_stoppen-tav|| MBH_300_stoppen_TA_start-tav|| MBH_300_stoppen_MVE-tav
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|3.1b|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Stop-toedieningsafspraak, met reden staken</span></div><div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;"><span style="color: #ff0000; background-color: #ffffff;">LET OP: stoppen toedieningsafspraak van scenario 3.1a</span></span></div>|| MBH_300_stoppen-tav|| MBH_300_stoppen_TA_staken-tav||
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|3.2a|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Benodigd voor scenario 3.2b</span></div>|| MBH_300_wijzigen_verhoging-tav|| MBH_300_wijzigen_verhoging_TA_start-tav|| MBH_300_wijzigen_verhoging_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|3.1a|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Benodigd voor scenario 3.1b</span></div><div>&nbsp;</div>|| MBH_200_stoppen|| MBH_200_stoppen_TA_start|| MBH_200_stoppen_MVE
+
|3.2b|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Wijziging toedieningsafspraak, verhoging wijziging (stop-ta + nieuwe ta) met MVE</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: wijziging toedieningsafspraak van scenario 3.2a</span></div>|| MBH_300_wijzigen_verhoging-tav|| MBH_300_wijzigen_verhoging_TA_wijzigingmetMVE-tav<br>MBH_300_wijzigen_verhoging_TA_techstaken-tav|| MBH_300_wijzigen_verhoging_MVE_extra-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|3.1b|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Stop-toedieningsafspraak, met reden staken</span></div><div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;"><span style="color: #ff0000; background-color: #ffffff;">LET OP: stoppen toedieningsafspraak van scenario 3.1a</span></span></div>|| MBH_200_stoppen|| MBH_200_stoppen_TA_staken||  
+
|3.3a|| <div><span style="font-family: sans-serif;"><span style="font-size: 14px; background-color: #ffffff;">Benodigd voor scenario 3.3b</span></span></div>|| MBH_300_wijzigen_verlaging-tav|| MBH_300_wijzigen_verlaging_TA_start-tav|| MBH_300_wijzigen_verlaging_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|3.2a|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Benodigd voor scenario 3.2b</span></div>|| MBH_200_wijzigen_verhoging|| MBH_200_wijzigen_verhoging_TA_start|| MBH_200_wijzigen_verhoging_MVE
+
|3.3b|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Wijziging toedieningsafspraak, met verlaging wijziging (stop-ta + nieuwe ta) zonder MVE</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: wijziging toedieningsafspraak van scenario 3.3a</span></div>|| MBH_300_wijzigen_verlaging-tav|| MBH_300_wijzigen_verlaging_TA_wijzigingzonderMVE-tav<br>MBH_300_wijzigen_verlaging_TA_techstaken-tav||  
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|3.2b|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Wijziging toedieningsafspraak, met reden wijziging (stop-ta + nieuwe ta) met MVE</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: wijziging toedieningsafspraak van scenario 3.2a</span></div>|| MBH_200_wijzigen_verhoging|| MBH_200_wijzigen_verhoging_TA_wijzigingmetMVE<br>MBH_200_wijzigen_verhoging_TA_techstaken|| MBH_200_wijzigen_verhoging_MVE_extra
+
|3.4a|| <div><span style="font-family: sans-serif;"><span style="font-size: 14px; background-color: #ffffff;">Benodigd voor scenario 3.4b</span></span></div>|| MBH_300_onderbreken-tav|| MBH_300_onderbreken_TA_start-tav|| MBH_300_onderbreken_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|3.3a|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div><span style="font-family: sans-serif;"><span style="font-size: 14px; background-color: #ffffff;">Benodigd voor scenario 3.3b</span></span></div>|| MBH_200_wijzigen_verlaging|| MBH_200_wijzigen_verlaging_TA_start|| MBH_200_wijzigen_verlaging_MVE
+
|3.4b|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Onderbreken toedieningsafspraak</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: onderbreking toedieningsafspraak van scenario 3.4a</span></div>|| MBH_300_onderbreken-tav|| MBH_300_onderbreken_TA_onderbreken-tav||  
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|3.3b|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Wijziging toedieningsafspraak, met reden wijziging (stop-ta + nieuwe ta) zonder MVE</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: wijziging toedieningsafspraak van scenario 3.3a</span></div>|| MBH_200_wijzigen_verlaging|| MBH_200_wijzigen_verlaging_TA_wijzigingzonderMVE<br>MBH_200_wijzigen_verlaging_TA_techstaken||  
+
|3.5a|| <div><span style="font-family: sans-serif;"><span style="font-size: 14px; background-color: #ffffff;">Benodigd voor scenario 3.5b</span></span></div>|| MBH_300_TAwijzigen-tav|| MBH_300_TAwijzigen_TA_start-tav|| MBH_300_TAwijzigen_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|3.4a|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div><span style="font-family: sans-serif;"><span style="font-size: 14px; background-color: #ffffff;">Benodigd voor scenario 3.4b</span></span></div>|| MBH_200_onderbreken|| MBH_200_onderbreken_TA_start|| MBH_200_onderbreken_MVE
+
|3.5b|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Wijziging toedieningsafspraak, met reden wijziging (stop-ta + nieuwe ta) en MVE</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: wijziging toedieningsafspraak van scenario 3.5a</span></div>|| MBH_300_TAwijzigen-tav|| MBH_300_TAwijzigen_TA_anderePRK-tav<br>MBH_300_TAwijzigen_TA_techstaken-tav|| MBH_300_TAwijzigen_MVE_anderePRK-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|3.4b|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Onderbreken toedieningsafspraak</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: onderbreking toedieningsafspraak van scenario 3.4a</span></div>|| MBH_200_onderbreken|| MBH_200_onderbreken_TA_onderbreken||  
+
|3.6a|| <div>Benodigd voor scenarioset 3.6b</div>|| MBH_300_annuleren-tav|| MBH_300_annuleren_TA_starten-tav|| MBH_300_annuleren_MVE_starten-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|3.5a|| <div>Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt</div>|| <div><span style="font-family: sans-serif;"><span style="font-size: 14px; background-color: #ffffff;">Benodigd voor scenario 3.5b</span></span></div>|| MBH_200_TAwijzigen|| MBH_200_TAwijzigen_TA_start|| MBH_200_TAwijzigen_MVE
+
|3.6b|| <div><br/><div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">annuleer-toedieningsafspraak</span></div><br/><div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;"><span style="color: #ff0000; background-color: #ffffff;">LET OP: annuleren medicatieafspraak van scenario 3.6a</span></span></div><br/></div>|| MBH_300_annuleren-tav|| MBH_300_annuleren_TA_geannuleerd-tav||  
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|3.5b|| <div>Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt</div>|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Wijziging toedieningsafspraak, met reden wijziging (stop-ta + nieuwe ta) en MVE</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: wijziging toedieningsafspraak van scenario 3.5a</span></div>|| MBH_200_TAwijzigen|| MBH_200_TAwijzigen_TA_anderePRK<br>MBH_200_TAwijzigen_TA_techstaken|| MBH_200_TAwijzigen_MVE_anderePRK
+
|3.8a|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Starten van parallelle TA voor GDS</span></div>|| MBH_300_stoppen_parallele_TA-tav|| MBH_300_stoppen_parallele_TA_TA_start_GDS-tav|| MBH_300_stoppen_parallele_TA_MVE_start_GDS-tav
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|3.8b|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Starten van parallelle TA voor zo nodig medicaties</span></div>|| MBH_300_stoppen_parallele_TA-tav|| MBH_300_stoppen_parallele_TA_TA_start_zonodig-tav|| MBH_300_stoppen_parallele_TA_MVE_start_zonodig-tav
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|3.8c|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Stoppen van zonodig TA</span></div><div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Let op: de stop-TA stopt de toedieningsafspraak van scenario 3.8b</span></div>|| MBH_300_stoppen_parallele_TA-tav|| MBH_300_stoppen_parallele_TA_TA_stop_zonodig-tav||
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|3.8d|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">starten van een nieuwe zonodig TA</span></div><div>&nbsp;</div>|| MBH_300_stoppen_parallele_TA-tav|| MBH_300_stoppen_parallele_TA_TA_start2_zonodig-tav|| MBH_300_stoppen_parallele_TA_MVE_start2_zonodig-tav
 
|}
 
|}
 
<section end=overview-AVS-3 />
 
<section end=overview-AVS-3 />
Regel 73: Regel 87:
 
{| class="wikitable"
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
−
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id|| MVE id
+
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.1|| || Variabele frequentie<br/>|| MBH_200_variabelefrequentie|| MBH_200_variabelefrequentie_TA|| MBH_200_variabelefrequentie_MVE
+
|6.1|| Variabele frequentie<br/>|| MBH_300_variabelefrequentie-tav|| MBH_300_variabelefrequentie_TA-tav|| MBH_300_variabelefrequentie_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.2|| || Interval|| MBH_200_interval|| MBH_200_interval_TA|| MBH_200_interval_MVE
+
|6.2|| Interval|| MBH_300_interval-tav|| MBH_300_interval_TA-tav|| MBH_300_interval_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.3|| || Variabele hoeveelheid (1)|| MBH_200_variabelehoeveelheid|| MBH_200_variabelehoeveelheid_TA|| MBH_200_variabelehoeveelheid_MVE
+
|6.3|| Variabele hoeveelheid (1)|| MBH_300_variabelehoeveelheid-tav|| MBH_300_variabelehoeveelheid_TA-tav|| MBH_300_variabelehoeveelheid_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.4|| || Zonder keerdosis|| MBH_200_zonderkeerdosis|| MBH_200_zonderkeerdosis_TA|| MBH_200_zonderkeerdosis_MVE
+
|6.4|| Zonder keerdosis|| MBH_300_zonderkeerdosis-tav|| MBH_300_zonderkeerdosis_TA-tav|| MBH_300_zonderkeerdosis_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.5|| || Bijzondere keerdosis|| MBH_200_bijzonderekeerdosis|| MBH_200_bijzonderekeerdosis_TA|| MBH_200_bijzonderekeerdosis_MVE
+
|6.5|| Bijzondere keerdosis|| MBH_300_bijzonderekeerdosis-tav|| MBH_300_bijzonderekeerdosis_TA-tav|| MBH_300_bijzonderekeerdosis_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.6|| || Variabele hoeveelheid (2)<br/>|| MBH_200_variabelehoeveelheid2|| MBH_200_variabelehoeveelheid2_TA|| MBH_200_variabelehoeveelheid2_MVE
+
|6.6|| Variabele hoeveelheid (2)<br/>|| MBH_300_variabelehoeveelheid2-tav|| MBH_300_variabelehoeveelheid2_TA-tav|| MBH_300_variabelehoeveelheid2_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.7a|| Maak screenshot(s) waarop zichtbaar is dat aangegeven kan worden of het tijdstip gekozen kan worden|| Tijdstippen|| MBH_200_tijdstippen_flexibel|| MBH_200_tijdstippen_flexibel_TA|| MBH_200_tijdstippen_flexibel_MVE
+
|6.7a|| Tijdstippen|| MBH_300_tijdstippen_flexibel-tav|| MBH_300_tijdstippen_flexibel_TA-tav|| MBH_300_tijdstippen_flexibel_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.7b|| Maak screenshot(s) waarop zichtbaar is dat aangegeven kan worden of het tijdstip gekozen kan worden|| Tijdstippen|| MBH_200_tijdstippen_niet_flexibel|| MBH_200_tijdstippen_niet_flexibel_TA|| MBH_200_tijdstippen_niet_flexibel_MVE
+
|6.7b|| Tijdstippen|| MBH_300_tijdstippen_niet_flexibel-tav|| MBH_300_tijdstippen_niet_flexibel_TA-tav|| MBH_300_tijdstippen_niet_flexibel_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.8|| Maak screenshot(s) waarop zichtbaar is dat weekdagen gekozen kunnen worden|| Weekdagen|| MBH_200_weekdagen|| MBH_200_weekdagen_TA|| MBH_200_weekdagen_MVE
+
|6.8|| Weekdagen|| MBH_300_weekdagen-tav|| MBH_300_weekdagen_TA-tav|| MBH_300_weekdagen_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.9|| Maak screenshot(s) waarop zichtbaar is dat dagdelen gekozen kunnen worden|| Dagdeel|| MBH_200_dagdeel|| MBH_200_dagdeel_TA|| MBH_200_dagdeel_MVE
+
|6.9|| Dagdeel|| MBH_300_dagdeel-tav|| MBH_300_dagdeel_TA-tav|| MBH_300_dagdeel_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.10|| Maak screenshot(s) waarop zichtbaar is dat een cyclisch schema ingevuld kan worden|| Cyclisch schema|| MBH_200_cyclischschema|| MBH_200_cyclischschema_TA|| MBH_200_cyclischschema_MVE
+
|6.10|| Cyclisch schema|| MBH_300_cyclischschema-tav|| MBH_300_cyclischschema_TA-tav|| MBH_300_cyclischschema_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.11|| Maak screenshot(s) waarop zichtbaar is dat een doseerschema (met doseerduur) ingevoerd kan worden|| Afbouw schema en doseerduur|| MBH_200_afbouwschema|| MBH_200_afbouwschema_TA|| MBH_200_afbouwschema_MVE
+
|6.11|| Afbouw schema en doseerduur|| MBH_300_afbouwschema-tav|| MBH_300_afbouwschema_TA-tav|| MBH_300_afbouwschema_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.12|| || Variabele hoeveelheid en maximum|| MBH_200_variabelehoeveelheidenmaximum|| MBH_200_variabelehoeveelheidenmaximum_TA|| MBH_200_variabelehoeveelheidenmaximum_MVE
+
|6.12|| Variabele hoeveelheid en maximum|| MBH_300_variabelehoeveelheidenmaximum-tav|| MBH_300_variabelehoeveelheidenmaximum_TA-tav|| MBH_300_variabelehoeveelheidenmaximum_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.13|| || Toedieningssnelheid|| MBH_200_toedieningssnelheid|| MBH_200_toedieningssnelheid_TA|| MBH_200_toedieningssnelheid_MVE
+
|6.13|| Toedieningssnelheid|| MBH_300_toedieningssnelheid-tav|| MBH_300_toedieningssnelheid_TA-tav|| MBH_300_toedieningssnelheid_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.14|| || Toedieningsduur|| MBH_200_toedieningsduur|| MBH_200_toedieningsduur_TA|| MBH_200_toedieningsduur_MVE
+
|6.14|| Toedieningsduur|| MBH_300_toedieningsduur-tav|| MBH_300_toedieningsduur_TA-tav|| MBH_300_toedieningsduur_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.15|| Maak screenshot(s) waarop de lijst met concepten voor 'zo nodig' zichtbaar zijn (incl. eventueel overige concepten of eigen invoer mogelijkheid)|| Zo nodig<br/>|| MBH_200_zonodig|| MBH_200_zonodig_TA|| MBH_200_zonodig_MVE
+
|6.15|| Zo nodig<br/>|| MBH_300_zonodig-tav|| MBH_300_zonodig_TA-tav|| MBH_300_zonodig_MVE-tav
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|6.17|| Dagdeel|| MBH_300_redundantefrequentie-tav|| MBH_300_redundantefrequentie_TA-tav|| MBH_300_redundantefrequentie_MVE-tav
 
|}
 
|}
 
<section end=overview-AVS-6 />
 
<section end=overview-AVS-6 />
Regel 112: Regel 128:
 
{| class="wikitable"
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
−
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id|| MVE id
+
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|7.1|| Maak screenshot(s) waarop zichtbaar is dat er ingrediënten ingevoerd/gekozen kunnen worden|| Alle ingrediënten|| MBH_200_magistraalalleingredienten|| MBH_200_magistraalalleingredienten_TA|| MBH_200_magistraalalleingredienten_MVE
+
|7.1|| Alle ingrediënten|| MBH_300_magistraalalleingredienten-tav|| MBH_300_magistraalalleingredienten_TA-tav|| MBH_300_magistraalalleingredienten_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|7.2|| Maak screenshot(s) waarop zichtbaar is dat er een ingrediënt ingevoerd/gekozen kan worden|| Actief ingrediënt|| MBH_200_magistraalactieveingredient|| MBH_200_magistraalactieveingredient_TA|| MBH_200_magistraalactieveingredient_MVE
+
|7.2|| Actief ingrediënt|| MBH_300_magistraalactieveingredient-tav|| MBH_300_magistraalactieveingredient_TA-tav|| MBH_300_magistraalactieveingredient_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|7.3|| Maak screenshot(s) waarop zichtbaar is dat het eigen artikel gekozen wordt <br/>|| 90 miljoen nummer|| MBH_200_magistraal90miljoennr|| MBH_200_magistraal90miljoennr_TA|| MBH_200_magistraal90miljoennr_MVE
+
|7.3|| 90 miljoen nummer|| MBH_300_magistraal90miljoennr-tav|| MBH_300_magistraal90miljoennr_TA-tav|| MBH_300_magistraal90miljoennr_MVE-tav
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|7.4|| <div>Vrije tekst product</div>|| MBH_300_vrijetekstproduct-tav|| MBH_300_vrijetekstproduct_TA-tav|| MBH_300_vrijetekstproduct_MVE-tav
 
|}
 
|}
 
<section end=overview-AVS-7 />
 
<section end=overview-AVS-7 />
Regel 125: Regel 143:
 
{| class="wikitable"
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
−
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id|| MVE id
+
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|8.1|| Maak screenshot(s) na het versturen van het voorschrift waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| Verstrekking onder andermans toedieningsafspraak|| MBH_200_VVandermansMA|| MBH_200_MVEandermansTA_TA|| MBH_200_MVEandermansTA_MVE
+
|8.1|| <div>Verstrekking onder andermans toedieningsafspraak</div>|| MBH_300_VVandermansMA-tav|| MBH_300_MVEandermansTA_TA-tav|| MBH_300_MVEandermansTA_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|8.2|| Maak screenshot(s) na het versturen van het voorschrift waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| Stoppen andermans toedieningsafspraak|| MBH_200_stakenandermansMA|| MBH_200_stakenandermansTA_TA2|| MBH_200_stakenandermansTA_andermansMVE
+
|8.2|| <div>Stoppen andermans toedieningsafspraak</div>|| MBH_300_stakenandermansMA-tav|| MBH_300_stakenandermansTA_TA2-tav|| MBH_300_stakenandermansTA_andermansMVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|8.3|| Maak screenshot(s) na het versturen van het voorschrift waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt <br/>|| Onderbreken andermans toedieningsafspraak|| MBH_200_onderbrekenandermansMA|| MBH_200_onderbrekenandermansTA_TA2|| MBH_200_onderbrekenandermansTA_andermansMVE
+
|8.3|| <div>Onderbreken andermans toedieningsafspraak</div>|| MBH_300_onderbrekenandermansMA-tav|| MBH_300_onderbrekenandermansTA_TA2-tav|| MBH_300_onderbrekenandermansTA_andermansMVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|8.4|| Maak screenshot(s) na het versturen van het voorschrift waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt <br/>|| Wijzigen andermans medicatieafspraak<br/>|| MBH_200_wijzigenandermansMA|| MBH_200_wijzigenandermansTA_TA_techstaken|| MBH_200_wijzigenandermansTA_andermansMVE
+
|8.4|| <div>Verstrekking onder andermans toedieningsafspraak</div>|| MBH_300_wijzigenandermansMA-tav|| MBH_300_wijzigenandermansTA_TA1-tav|| MBH_300_wijzigenandermansTA_andermansMVE-tav
 
|}
 
|}
 
<section end=overview-AVS-8 />
 
<section end=overview-AVS-8 />
Regel 140: Regel 158:
 
{| class="wikitable"
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
−
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id|| MVE id
+
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|9.1a|| Logistieke verbruiksperiode|| MBH_300_logistiekeverbruiksperiode_start_eind-tav|| MBH_300_logistiekeverbruiksperiode_start_eind_TA-tav|| MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tav
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|9.1b|| <div>GDS</div>|| MBH_300_distributievorm_GDS-tav|| MBH_300_distributievorm_GDS_TA-tav|| MBH_300_distributievorm_GDS_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|9.1a|| || Logistieke verbruiksperiode|| MBH_200_logistiekeverbruiksperiode_start_eind|| MBH_200_logistiekeverbruiksperiode_start_eind_TA|| MBH_200_logistiekeverbruiksperiode_start_eind_MVE
+
|9.1c|| <div>Logistieke verbruiksduur</div>|| MBH_300_logistiekeverbruiksperiode_duur_dagen-tav|| MBH_300_logistiekeverbruiksperiode_duur_dagen_TA-tav|| MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|9.1b|| || <div>GDS</div>|| MBH_200_logistiekeverbruiksperiode_eind|| MBH_200_logistiekeverbruiksperiode_eind_TA|| MBH_200_logistiekeverbruiksperiode_eind_MVE
+
|9.2a|| Herhalingen|| MBH_300_herhalingen-tav|| MBH_300_herhalingen_TA-tav|| MBH_300_herhalingen_MVE1-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|9.1c|| || <div>Logistieke verbruiksduur</div>|| MBH_200_logistiekeverbruiksperiode_duur_dagen|| MBH_200_logistiekeverbruiksperiode_duur_dagen_TA|| MBH_200_logistiekeverbruiksperiode_duur_dagen_MVE
+
|9.2b|| Herhalingen|| MBH_300_herhalingen-tav|| MBH_300_herhalingen_TA-tav|| MBH_300_herhalingen_MVE2-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|9.2|| Maak screenshot(s) waarin zichtbaar is dat het aantal herhalingen ingevuld kan worden <br/>|| Herhalingen|| MBH_200_herhalingen|| MBH_200_herhalingen_TA|| MBH_200_herhalingen_MVE
+
|9.2c|| Herhalingen|| MBH_300_herhalingen-tav|| MBH_300_herhalingen_TA-tav|| MBH_300_herhalingen_MVE3-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|9.3|| Maak screenshot(s) waarop zichtbaar is dat de afleverlocatie ingevuld kan worden <br/>|| <div>Afleverlocatie en Aanschrijfdatum</div>|| MBH_200_afleverlocatie|| MBH_200_afleverlocatie_TA|| MBH_200_afleverlocatie_MVE
+
|9.3|| <div>Afleverlocatie en Aanschrijfdatum</div>|| MBH_300_afleverlocatie-tav|| MBH_300_afleverlocatie_TA-tav|| MBH_300_afleverlocatie_MVE-tav
 
|}
 
|}
 
<section end=overview-AVS-9 />
 
<section end=overview-AVS-9 />
Regel 157: Regel 179:
 
{| class="wikitable"
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
−
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id|| MVE id
+
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|10.1|| || HPK geneesmiddel|| MBH_200_HPKvoorschrijven|| MBH_200_HPKvoorschrijven_TA|| MBH_200_HPKvoorschrijven_MVE
+
|10.1|| HPK geneesmiddel|| MBH_300_HPKvoorschrijven-tav|| MBH_300_HPKvoorschrijven_TA-tav|| MBH_300_HPKvoorschrijven_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|10.2|| || ZI-nr geneesmiddel<br/>|| MBH_200_ZINRvoorschrijven|| MBH_200_ZINRvoorschrijven_TA|| MBH_200_ZINRvoorschrijven_MVE
+
|10.2|| ZI-nr geneesmiddel<br/>|| MBH_300_ZINRvoorschrijven-tav|| MBH_300_ZINRvoorschrijven_TA-tav|| MBH_300_ZINRvoorschrijven_MVE-tav
 
|}
 
|}
 
<section end=overview-AVS-10 />
 
<section end=overview-AVS-10 />
Regel 168: Regel 190:
 
{| class="wikitable"
 
{| class="wikitable"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
|-style="background-color: #1F497D;; color: white; text-align:left;"
−
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id|| MVE id
+
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|11.1|| Maak screenshot(s) waarop zichtbaar is dat er verwezen kan worden naar extern doseerschema.|| <div>Afhandelen medicatievoorschrift met verwijzing naar extern doseerschema</div>|| MBH_200_wdsmtd1|| MBH_200_wdsmtd1_TA|| MBH_200_wdsmtd1_MVE
+
|11.1|| <div>Afhandelen medicatievoorschrift met verwijzing naar extern doseerschema</div>|| MBH_300_wdsmtd1-tav|| MBH_300_wdsmtd1_TA-tav|| MBH_300_wdsmtd1_MVE-tav
 
|}
 
|}
 
<section end=overview-AVS-11 />
 
<section end=overview-AVS-11 />
 +
=== Scenarioset 23===
 +
<section begin=overview-AVS-23 />
 +
{| class="wikitable"
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|23.1a|| <div><span class="xforms-group xforms-group-appearance-full xforms-visited" id="main-ui"><span class="xforms-group xforms-visited" id="xf-103"><span class="fr-accordion-lnf xforms-group xforms-visited" id="main-accordion≡fr-accordion-group"><span class="xforms-group xforms-visited" id="main-accordion≡xf-177⊙21"><span class="xforms-group xforms-group-appearance-full" id="main-ui"><span class="xforms-group" id="xf-103"><span class="fr-accordion-lnf xforms-group" id="main-accordion≡fr-accordion-group"><span class="xforms-group" id="main-accordion≡xf-177⊙16">TEST Scenarioset 23.1a afhandelen voorschrift voor afhandeling VMA t.b.v. 100% akkoord VMA met eerdere verstrekking​</span></span></span></span></span></span></span></span></div>|| MBH_300_VMA_geaccepteerd-tav|| MBH_300_VMA_geaccepteerd_TA_start-tav|| MBH_300_VMA_geaccepteerd_MVE-tav
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|23.1b|| <div><span class="xforms-group xforms-group-appearance-full xforms-visited" id="main-ui"><span class="xforms-group xforms-visited" id="xf-103"><span class="fr-accordion-lnf xforms-group xforms-visited" id="main-accordion≡fr-accordion-group"><span class="xforms-group xforms-visited" id="main-accordion≡xf-177⊙21"><span class="xforms-group xforms-group-appearance-full" id="main-ui"><span class="xforms-group" id="xf-103"><span class="fr-accordion-lnf xforms-group" id="main-accordion≡fr-accordion-group"><span class="xforms-group" id="main-accordion≡xf-177⊙16">TEST Scenarioset 23.1b afhandelen voorschrift na afhandeling VMA t.b.v. 100% akkoord VMA met eerdere verstrekking​</span></span></span></span></span></span></span></span></div>|| MBH_300_VMA_geaccepteerd-tav|| MBH_300_VMA_geaccepteerd_TA_techstop-tav<br>MBH_300_VMA_geaccepteerd_TA_naVMA-tav||
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|23.2|| <div><span class="xforms-group xforms-group-appearance-full xforms-visited" id="main-ui"><span class="xforms-group xforms-visited" id="xf-103"><span class="fr-accordion-lnf xforms-group xforms-visited" id="main-accordion≡fr-accordion-group"><span class="xforms-group xforms-visited" id="main-accordion≡xf-177⊙21"><span class="xforms-group xforms-group-appearance-full" id="main-ui"><span class="xforms-group" id="xf-103"><span class="fr-accordion-lnf xforms-group" id="main-accordion≡fr-accordion-group"><span class="xforms-group" id="main-accordion≡xf-177⊙16">TEST Scenarioset 23.2 afhandelen voorschrift t.b.v. Afwijzen VMA o.b.v. voorstel PRK</span></span></span></span></span></span></span></span></div>|| MBH_300_VMAafgewezen_PRK-tav|| MBH_300_VMAafgewezen_PRK_TA-tav|| MBH_300_VMAafgewezen_PRK_MVE-tav
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|23.3a|| <div><span class="xforms-group xforms-group-appearance-full xforms-visited" id="main-ui"><span class="xforms-group xforms-visited" id="xf-103"><span class="fr-accordion-lnf xforms-group xforms-visited" id="main-accordion≡fr-accordion-group"><span class="xforms-group xforms-visited" id="main-accordion≡xf-177⊙21"><span class="xforms-group xforms-group-appearance-full" id="main-ui"><span class="xforms-group" id="xf-103"><span class="fr-accordion-lnf xforms-group" id="main-accordion≡fr-accordion-group"><span class="xforms-group" id="main-accordion≡xf-177⊙16">TEST Scenarioset 23.3a afhandelen voorschrift voor afhandeling VMA t.b.v. Aanvullend middel VMA</span></span></span></span></span></span></span></span></div>|| MBH_300_VMAaanvullendmiddel-tav|| MBH_300_VMAaanvullendmiddel_TA_start-tav|| MBH_300_VMAaanvullendmiddel_MVE-tav
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|23.3b|| <div><span class="xforms-group xforms-group-appearance-full xforms-visited" id="main-ui"><span class="xforms-group xforms-visited" id="xf-103"><span class="fr-accordion-lnf xforms-group xforms-visited" id="main-accordion≡fr-accordion-group"><span class="xforms-group xforms-visited" id="main-accordion≡xf-177⊙21"><span class="xforms-group xforms-group-appearance-full" id="main-ui"><span class="xforms-group" id="xf-103"><span class="fr-accordion-lnf xforms-group" id="main-accordion≡fr-accordion-group"><span class="xforms-group" id="main-accordion≡xf-177⊙16">TEST Scenarioset 23.3b afhandelen voorschrift na afhandeling VMA t.b.v. Aanvullend middel VMA</span></span></span></span></span></span></span></span></div>|| MBH_300_VMAaanvullendmiddel-tav|| MBH_300_VMAaanvullendmiddel_techstopTA-tav<br>MBH_300_VMAaanvullendmiddel_TA_naVMA-tav||
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|23.4a|| <div><span class="xforms-group xforms-group-appearance-full xforms-visited" id="main-ui"><span class="xforms-group xforms-visited" id="xf-103"><span class="fr-accordion-lnf xforms-group xforms-visited" id="main-accordion≡fr-accordion-group"><span class="xforms-group xforms-visited" id="main-accordion≡xf-177⊙21"><span class="xforms-group xforms-group-appearance-full" id="main-ui"><span class="xforms-group" id="xf-103"><span class="fr-accordion-lnf xforms-group" id="main-accordion≡fr-accordion-group"><span class="xforms-group" id="main-accordion≡xf-177⊙16">TEST Scenarioset 23.4a afhandelen voorschrift voor akkoord VMA t.b.v. Vervangend middel VMA</span></span></span></span></span></span></span></span></div>|| MBH_300_VMAvervangend_voorschr-tav|| MBH_300_VMAvervangend_voorschr_TA_start-tav|| MBH_300_VMAvervangend_voorschr_MVE_start-tav
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|23.4b|| <div><span class="xforms-group xforms-group-appearance-full xforms-visited" id="main-ui"><span class="xforms-group xforms-visited" id="xf-103"><span class="fr-accordion-lnf xforms-group xforms-visited" id="main-accordion≡fr-accordion-group"><span class="xforms-group xforms-visited" id="main-accordion≡xf-177⊙21"><span class="xforms-group xforms-group-appearance-full" id="main-ui"><span class="xforms-group" id="xf-103"><span class="fr-accordion-lnf xforms-group" id="main-accordion≡fr-accordion-group"><span class="xforms-group" id="main-accordion≡xf-177⊙16">TEST Scenarioset 23.4b afhandelen voorschrift na akkoord VMA t.b.v. Vervangend middel VMA</span></span></span></span></span></span></span></span></div>|| MBH_300_VMAvervangend_voorschr-tav|| MBH_300_VMAvervangend_voorschr_stopTA-tav||
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|23.4c|| <div><span class="xforms-group xforms-group-appearance-full xforms-visited" id="main-ui"><span class="xforms-group xforms-visited" id="xf-103"><span class="fr-accordion-lnf xforms-group xforms-visited" id="main-accordion≡fr-accordion-group"><span class="xforms-group xforms-visited" id="main-accordion≡xf-177⊙21"><span class="xforms-group xforms-group-appearance-full" id="main-ui"><span class="xforms-group" id="xf-103"><span class="fr-accordion-lnf xforms-group" id="main-accordion≡fr-accordion-group"><span class="xforms-group" id="main-accordion≡xf-177⊙16">TEST Scenarioset 23.4c afhandelen voorschrift na akkoord VMA t.b.v. Vervangend middel VMA</span></span></span></span></span></span></span></span></div>|| MBH_300_VMAvervangendmiddel-tav|| MBH_300_VMAvervangendmiddel_TA_naVMA-tav||
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|23.5a|| <div><span class="xforms-group xforms-group-appearance-full xforms-visited" id="main-ui"><span class="xforms-group xforms-visited" id="xf-103"><span class="fr-accordion-lnf xforms-group xforms-visited" id="main-accordion≡fr-accordion-group"><span class="xforms-group xforms-visited" id="main-accordion≡xf-177⊙21"><span class="xforms-group xforms-group-appearance-full" id="main-ui"><span class="xforms-group" id="xf-103"><span class="fr-accordion-lnf xforms-group" id="main-accordion≡fr-accordion-group"><span class="xforms-group" id="main-accordion≡xf-177⊙16">TEST Scenarioset 23.5a afhandelen voorschrift t.b.v. 100% akkoord VVV met eerdere verstrekking</span></span></span></span></span></span></span></span></div>|| MBH_300_VVV_geaccepteerd-tav|| MBH_300_VVV_geaccepteerd_TA_start-tav|| MBH_300_VVV_geaccepteerd_MVE_start-tav
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|23.5b|| <div><span class="xforms-group xforms-group-appearance-full xforms-visited" id="main-ui"><span class="xforms-group xforms-visited" id="xf-103"><span class="fr-accordion-lnf xforms-group xforms-visited" id="main-accordion≡fr-accordion-group"><span class="xforms-group xforms-visited" id="main-accordion≡xf-177⊙21"><span class="xforms-group xforms-group-appearance-full" id="main-ui"><span class="xforms-group" id="xf-103"><span class="fr-accordion-lnf xforms-group" id="main-accordion≡fr-accordion-group"><span class="xforms-group" id="main-accordion≡xf-177⊙16">TEST Scenarioset 23.5b afhandelen voorschrift t.b.v. 100% akkoord VVV met eerdere verstrekking</span></span></span></span></span></span></span></span></div>|| MBH_300_VVV_geaccepteerd-tav|| MBH_300_VVV_geaccepteerd_TA_start-tav|| MBH_300_VVV_geaccepteerd_MVE_naVVV-tav
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|23.6|| <div><span class="xforms-group xforms-group-appearance-full xforms-visited" id="main-ui"><span class="xforms-group xforms-visited" id="xf-103"><span class="fr-accordion-lnf xforms-group xforms-visited" id="main-accordion≡fr-accordion-group"><span class="xforms-group xforms-visited" id="main-accordion≡xf-177⊙21"><span class="xforms-group xforms-group-appearance-full" id="main-ui"><span class="xforms-group" id="xf-103"><span class="fr-accordion-lnf xforms-group" id="main-accordion≡fr-accordion-group"><span class="xforms-group" id="main-accordion≡xf-177⊙16">TEST Scenarioset 23.6 afhandelen voorschrift t.b.v. gedeeltelijke overname VVV</span></span></span></span></span></span></span></span></div>|| MBH_300_VVV_wijziging-tav|| MBH_300_VVV_wijziging_TA-tav|| MBH_300_VVV_wijziging_MVE-tav
 +
|}
 +
<section end=overview-AVS-23 />
 
== Overzicht van scenario's voor ontvangend systeem ==
 
== Overzicht van scenario's voor ontvangend systeem ==
  
Regel 181: Regel 232:
 
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
 
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|1.1|| Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum en einddatum|| MBH_200_start_eind|| MBH_200_start_eind_TA|| MBH_200_start_eind_MVE
+
|1.1|| Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum en einddatum|| MBH_300_start_eind-tav|| MBH_300_start_eind_TA-tav|| MBH_300_start_eind_MVE-tav
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|1.2a|| Afhandelen medicatievoorschrift met een toediedingsafspraak gebruiksperiode ingangsdatum en duur (weken)|| MBH_300_start_duur-tav|| MBH_300_start_duur_TA-tav|| MBH_300_start_duur_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|1.2a|| Afhandelen medicatievoorschrift met een toediedingsafspraak gebruiksperiode ingangsdatum en duur (weken)|| MBH_200_start_duur|| MBH_200_start_duur_TA|| MBH_200_start_duur_MVE
+
|1.2b|| Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum en duur (dagen)|| MBH_300_start_duur2-tav|| MBH_300_start_duur2_TA-tav|| MBH_300_start_duur2_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|1.2b|| Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum en duur (dagen)|| MBH_200_start_duur2|| MBH_200_start_duur2_TA|| MBH_200_start_duur2_MVE
+
|1.3|| Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum (chronische medicatie)|| MBH_300_chronisch-tav|| MBH_300_chronisch_TA-tav|| MBH_300_chronisch_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|1.3|| Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum (chronische medicatie)|| MBH_200_chronisch|| MBH_200_chronisch_TA|| MBH_200_chronisch_MVE
+
|1.4|| <div>Extra MVE&nbsp;</div><div>LET OP: MVE met TA uit scenario 1.3 (20 dagen later)</div>|| MBH_300_chronisch-tav|| MBH_300_chronisch_TA-tav|| MBH_300_chronisch_MVE_extraMVEbestaandeTA-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|1.4|| <div>Extra MVE&nbsp;</div><div>LET OP: MVE met TA uit scenario 1.3 (20 dagen later)</div>|| MBH_200_chronisch|| MBH_200_chronisch_TA|| MBH_200_chronisch_MVE_extraMVEbestaandeTA
+
|1.5|| Afhandeling medicatievoorschrift met eenheid 'dosis/stuks'|| MBH_300_dosis_stuks-tav|| MBH_300_dosis_stuks_TA-tav|| MBH_300_dosis_stuks_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|1.5|| Afhandeling medicatievoorschrift met eenheid 'dosis/stuks'|| MBH_200_dosis_stuks|| MBH_200_dosis_stuks_TA|| MBH_200_dosis_stuks_MVE
+
|1.6|| <div>Afhandeling medicatievoorschrift met onzekerheidscriterium</div>|| MBH_300_start_criterium-tav|| MBH_300_start_criterium_TA-tav|| MBH_300_start_criterium_MVE-tav
 
|}
 
|}
 
<section end=overview-AVO-1 />
 
<section end=overview-AVO-1 />
Regel 200: Regel 253:
 
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
 
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|2.1|| Aanvullende instructie (TA)|| MBH_200_aanvullendeinstructie|| MBH_200_aanvullendeinstructie_TA|| MBH_200_aanvullendeinstructie_MVE
+
|2.1|| Aanvullende instructie (TA)|| MBH_300_aanvullendeinstructie-tav|| MBH_300_aanvullendeinstructie_TA-tav|| MBH_300_aanvullendeinstructie_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|2.2|| Toelichting (TA), toelichting (MVE)|| MBH_200_toelichting|| MBH_200_toelichting_TA|| MBH_200_toelichting_MVE
+
|2.2|| Toelichting (TA), toelichting (MVE)|| MBH_300_toelichting-tav|| MBH_300_toelichting_TA-tav|| MBH_300_toelichting_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|2.3|| Reden van voorschrijven (TA)|| MBH_200_redenvanvoorschrijven|| MBH_200_redenvanvoorschrijven_TA|| MBH_200_redenvanvoorschrijven_MVE
+
|2.3|| Reden van voorschrijven (TA)|| MBH_300_redenvanvoorschrijven-tav|| MBH_300_redenvanvoorschrijven_TA-tav|| MBH_300_redenvanvoorschrijven_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|2.5|| Aanvullende informatie (MA), aanvullende wensen (VV)|| MBH_200_aanvullendeinformatiewensen|| MBH_200_aanvullendeinformatiewensen_TA|| MBH_200_aanvullendeinformatiewensen_MVE
+
|2.4|| Aanvullende informatie (MA), aanvullende wensen (VV)|| MBH_300_aanvullendeinformatiewensen-tav|| MBH_300_aanvullendeinformatiewensen_TA-tav|| MBH_300_aanvullendeinformatiewensen_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|2.6|| Toedieningsweg (TA)|| MBH_200_Toedieningsweg|| MBH_200_Toedieningsweg_TA|| MBH_200_Toedieningsweg_MVE
+
|2.5|| Toedieningsweg (TA)|| MBH_300_Toedieningsweg-tav|| MBH_300_Toedieningsweg_TA-tav|| MBH_300_Toedieningsweg_MVE-tav
 
|}
 
|}
 
<section end=overview-AVO-2 />
 
<section end=overview-AVO-2 />
Regel 217: Regel 270:
 
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
 
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|3.1a|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Benodigd voor scenario 3.1b</span></div><div>&nbsp;</div>|| MBH_200_stoppen|| MBH_200_stoppen_TA_start|| MBH_200_stoppen_MVE
+
|3.1a|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Benodigd voor scenario 3.1b</span></div><div>&nbsp;</div>|| MBH_300_stoppen-tav|| MBH_300_stoppen_TA_start-tav|| MBH_300_stoppen_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|3.1b|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Stop-toedieningsafspraak, met reden staken</span></div><div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;"><span style="color: #ff0000; background-color: #ffffff;">LET OP: stoppen toedieningsafspraak van scenario 3.1a</span></span></div>|| MBH_200_stoppen|| MBH_200_stoppen_TA_staken||  
+
|3.1b|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Stop-toedieningsafspraak, met reden staken</span></div><div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;"><span style="color: #ff0000; background-color: #ffffff;">LET OP: stoppen toedieningsafspraak van scenario 3.1a</span></span></div>|| MBH_300_stoppen-tav|| MBH_300_stoppen_TA_staken-tav||  
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|3.2a|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Benodigd voor scenario 3.2b</span></div>|| MBH_200_wijzigen_verhoging|| MBH_200_wijzigen_verhoging_TA_start|| MBH_200_wijzigen_verhoging_MVE
+
|3.2a|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Benodigd voor scenario 3.2b</span></div>|| MBH_300_wijzigen_verhoging-tav|| MBH_300_wijzigen_verhoging_TA_start-tav|| MBH_300_wijzigen_verhoging_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|3.2b|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Wijziging toedieningsafspraak, met reden wijziging (stop-ta + nieuwe ta) met MVE</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: wijziging toedieningsafspraak van scenario 3.2a</span></div>|| MBH_200_wijzigen_verhoging|| MBH_200_wijzigen_verhoging_TA_wijzigingmetMVE<br>MBH_200_wijzigen_verhoging_TA_techstaken|| MBH_200_wijzigen_verhoging_MVE_extra
+
|3.2b|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Wijziging toedieningsafspraak, verhoging wijziging (stop-ta + nieuwe ta) met MVE</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: wijziging toedieningsafspraak van scenario 3.2a</span></div>|| MBH_300_wijzigen_verhoging-tav|| MBH_300_wijzigen_verhoging_TA_wijzigingmetMVE-tav<br>MBH_300_wijzigen_verhoging_TA_techstaken-tav|| MBH_300_wijzigen_verhoging_MVE_extra-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|3.3a|| <div><span style="font-family: sans-serif;"><span style="font-size: 14px; background-color: #ffffff;">Benodigd voor scenario 3.3b</span></span></div>|| MBH_200_wijzigen_verlaging|| MBH_200_wijzigen_verlaging_TA_start|| MBH_200_wijzigen_verlaging_MVE
+
|3.3a|| <div><span style="font-family: sans-serif;"><span style="font-size: 14px; background-color: #ffffff;">Benodigd voor scenario 3.3b</span></span></div>|| MBH_300_wijzigen_verlaging-tav|| MBH_300_wijzigen_verlaging_TA_start-tav|| MBH_300_wijzigen_verlaging_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|3.3b|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Wijziging toedieningsafspraak, met reden wijziging (stop-ta + nieuwe ta) zonder MVE</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: wijziging toedieningsafspraak van scenario 3.3a</span></div>|| MBH_200_wijzigen_verlaging|| MBH_200_wijzigen_verlaging_TA_wijzigingzonderMVE<br>MBH_200_wijzigen_verlaging_TA_techstaken||  
+
|3.3b|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Wijziging toedieningsafspraak, met verlaging wijziging (stop-ta + nieuwe ta) zonder MVE</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: wijziging toedieningsafspraak van scenario 3.3a</span></div>|| MBH_300_wijzigen_verlaging-tav|| MBH_300_wijzigen_verlaging_TA_wijzigingzonderMVE-tav<br>MBH_300_wijzigen_verlaging_TA_techstaken-tav||  
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|3.4a|| <div><span style="font-family: sans-serif;"><span style="font-size: 14px; background-color: #ffffff;">Benodigd voor scenario 3.4b</span></span></div>|| MBH_200_onderbreken|| MBH_200_onderbreken_TA_start|| MBH_200_onderbreken_MVE
+
|3.4a|| <div><span style="font-family: sans-serif;"><span style="font-size: 14px; background-color: #ffffff;">Benodigd voor scenario 3.4b</span></span></div>|| MBH_300_onderbreken-tav|| MBH_300_onderbreken_TA_start-tav|| MBH_300_onderbreken_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|3.4b|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Onderbreken toedieningsafspraak</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: onderbreking toedieningsafspraak van scenario 3.4a</span></div>|| MBH_200_onderbreken|| MBH_200_onderbreken_TA_onderbreken||  
+
|3.4b|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Onderbreken toedieningsafspraak</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: onderbreking toedieningsafspraak van scenario 3.4a</span></div>|| MBH_300_onderbreken-tav|| MBH_300_onderbreken_TA_onderbreken-tav||  
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|3.5a|| <div><span style="font-family: sans-serif;"><span style="font-size: 14px; background-color: #ffffff;">Benodigd voor scenario 3.5b</span></span></div>|| MBH_200_TAwijzigen|| MBH_200_TAwijzigen_TA_start|| MBH_200_TAwijzigen_MVE
+
|3.5a|| <div><span style="font-family: sans-serif;"><span style="font-size: 14px; background-color: #ffffff;">Benodigd voor scenario 3.5b</span></span></div>|| MBH_300_TAwijzigen-tav|| MBH_300_TAwijzigen_TA_start-tav|| MBH_300_TAwijzigen_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|3.5b|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Wijziging toedieningsafspraak, met reden wijziging (stop-ta + nieuwe ta) en MVE</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: wijziging toedieningsafspraak van scenario 3.5a</span></div>|| MBH_200_TAwijzigen|| MBH_200_TAwijzigen_TA_anderePRK<br>MBH_200_TAwijzigen_TA_techstaken|| MBH_200_TAwijzigen_MVE_anderePRK
+
|3.5b|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Wijziging toedieningsafspraak, met reden wijziging (stop-ta + nieuwe ta) en MVE</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: wijziging toedieningsafspraak van scenario 3.5a</span></div>|| MBH_300_TAwijzigen-tav|| MBH_300_TAwijzigen_TA_anderePRK-tav<br>MBH_300_TAwijzigen_TA_techstaken-tav|| MBH_300_TAwijzigen_MVE_anderePRK-tav
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|3.6a|| <div>Benodigd voor scenarioset 3.6b</div>|| MBH_300_annuleren-tav|| MBH_300_annuleren_TA_starten-tav|| MBH_300_annuleren_MVE_starten-tav
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|3.6b|| <div><br/><div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">annuleer-toedieningsafspraak</span></div><br/><div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;"><span style="color: #ff0000; background-color: #ffffff;">LET OP: annuleren medicatieafspraak van scenario 3.6a</span></span></div><br/></div>|| MBH_300_annuleren-tav|| MBH_300_annuleren_TA_geannuleerd-tav||
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|3.8a|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Starten van parallelle TA voor GDS</span></div>|| MBH_300_stoppen_parallele_TA-tav|| MBH_300_stoppen_parallele_TA_TA_start_GDS-tav|| MBH_300_stoppen_parallele_TA_MVE_start_GDS-tav
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|3.8b|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Starten van parallelle TA voor zo nodig medicaties</span></div>|| MBH_300_stoppen_parallele_TA-tav|| MBH_300_stoppen_parallele_TA_TA_start_zonodig-tav|| MBH_300_stoppen_parallele_TA_MVE_start_zonodig-tav
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|3.8c|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Stoppen van zonodig TA</span></div><div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Let op: de stop-TA stopt de toedieningsafspraak van scenario 3.8b</span></div>|| MBH_300_stoppen_parallele_TA-tav|| MBH_300_stoppen_parallele_TA_TA_stop_zonodig-tav||
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|3.8d|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">starten van een nieuwe zonodig TA</span></div><div>&nbsp;</div>|| MBH_300_stoppen_parallele_TA-tav|| MBH_300_stoppen_parallele_TA_TA_start2_zonodig-tav|| MBH_300_stoppen_parallele_TA_MVE_start2_zonodig-tav
 
|}
 
|}
 
<section end=overview-AVO-3 />
 
<section end=overview-AVO-3 />
Regel 244: Regel 309:
 
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
 
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.1|| Variabele frequentie<br/>|| MBH_200_variabelefrequentie|| MBH_200_variabelefrequentie_TA|| MBH_200_variabelefrequentie_MVE
+
|6.1|| Variabele frequentie<br/>|| MBH_300_variabelefrequentie-tav|| MBH_300_variabelefrequentie_TA-tav|| MBH_300_variabelefrequentie_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.2|| Interval|| MBH_200_interval|| MBH_200_interval_TA|| MBH_200_interval_MVE
+
|6.2|| Interval|| MBH_300_interval-tav|| MBH_300_interval_TA-tav|| MBH_300_interval_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.3|| Variabele hoeveelheid (1)|| MBH_200_variabelehoeveelheid|| MBH_200_variabelehoeveelheid_TA|| MBH_200_variabelehoeveelheid_MVE
+
|6.3|| Variabele hoeveelheid (1)|| MBH_300_variabelehoeveelheid-tav|| MBH_300_variabelehoeveelheid_TA-tav|| MBH_300_variabelehoeveelheid_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.4|| Zonder keerdosis|| MBH_200_zonderkeerdosis|| MBH_200_zonderkeerdosis_TA|| MBH_200_zonderkeerdosis_MVE
+
|6.4|| Zonder keerdosis|| MBH_300_zonderkeerdosis-tav|| MBH_300_zonderkeerdosis_TA-tav|| MBH_300_zonderkeerdosis_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.5|| Bijzondere keerdosis|| MBH_200_bijzonderekeerdosis|| MBH_200_bijzonderekeerdosis_TA|| MBH_200_bijzonderekeerdosis_MVE
+
|6.5|| Bijzondere keerdosis|| MBH_300_bijzonderekeerdosis-tav|| MBH_300_bijzonderekeerdosis_TA-tav|| MBH_300_bijzonderekeerdosis_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.6|| Variabele hoeveelheid (2)<br/>|| MBH_200_variabelehoeveelheid2|| MBH_200_variabelehoeveelheid2_TA|| MBH_200_variabelehoeveelheid2_MVE
+
|6.6|| Variabele hoeveelheid (2)<br/>|| MBH_300_variabelehoeveelheid2-tav|| MBH_300_variabelehoeveelheid2_TA-tav|| MBH_300_variabelehoeveelheid2_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.7a|| Tijdstippen|| MBH_200_tijdstippen_flexibel|| MBH_200_tijdstippen_flexibel_TA|| MBH_200_tijdstippen_flexibel_MVE
+
|6.7a|| Tijdstippen|| MBH_300_tijdstippen_flexibel-tav|| MBH_300_tijdstippen_flexibel_TA-tav|| MBH_300_tijdstippen_flexibel_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.7b|| Tijdstippen|| MBH_200_tijdstippen_niet_flexibel|| MBH_200_tijdstippen_niet_flexibel_TA|| MBH_200_tijdstippen_niet_flexibel_MVE
+
|6.7b|| Tijdstippen|| MBH_300_tijdstippen_niet_flexibel-tav|| MBH_300_tijdstippen_niet_flexibel_TA-tav|| MBH_300_tijdstippen_niet_flexibel_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.8|| Weekdagen|| MBH_200_weekdagen|| MBH_200_weekdagen_TA|| MBH_200_weekdagen_MVE
+
|6.8|| Weekdagen|| MBH_300_weekdagen-tav|| MBH_300_weekdagen_TA-tav|| MBH_300_weekdagen_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.9|| Dagdeel|| MBH_200_dagdeel|| MBH_200_dagdeel_TA|| MBH_200_dagdeel_MVE
+
|6.9|| Dagdeel|| MBH_300_dagdeel-tav|| MBH_300_dagdeel_TA-tav|| MBH_300_dagdeel_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.10|| Cyclisch schema|| MBH_200_cyclischschema|| MBH_200_cyclischschema_TA|| MBH_200_cyclischschema_MVE
+
|6.10|| Cyclisch schema|| MBH_300_cyclischschema-tav|| MBH_300_cyclischschema_TA-tav|| MBH_300_cyclischschema_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.11|| Afbouw schema en doseerduur|| MBH_200_afbouwschema|| MBH_200_afbouwschema_TA|| MBH_200_afbouwschema_MVE
+
|6.11|| Afbouw schema en doseerduur|| MBH_300_afbouwschema-tav|| MBH_300_afbouwschema_TA-tav|| MBH_300_afbouwschema_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.12|| Variabele hoeveelheid en maximum|| MBH_200_variabelehoeveelheidenmaximum|| MBH_200_variabelehoeveelheidenmaximum_TA|| MBH_200_variabelehoeveelheidenmaximum_MVE
+
|6.12|| Variabele hoeveelheid en maximum|| MBH_300_variabelehoeveelheidenmaximum-tav|| MBH_300_variabelehoeveelheidenmaximum_TA-tav|| MBH_300_variabelehoeveelheidenmaximum_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.13|| Toedieningssnelheid|| MBH_200_toedieningssnelheid|| MBH_200_toedieningssnelheid_TA|| MBH_200_toedieningssnelheid_MVE
+
|6.13|| Toedieningssnelheid|| MBH_300_toedieningssnelheid-tav|| MBH_300_toedieningssnelheid_TA-tav|| MBH_300_toedieningssnelheid_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.14|| Toedieningsduur|| MBH_200_toedieningsduur|| MBH_200_toedieningsduur_TA|| MBH_200_toedieningsduur_MVE
+
|6.14|| Toedieningsduur|| MBH_300_toedieningsduur-tav|| MBH_300_toedieningsduur_TA-tav|| MBH_300_toedieningsduur_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|6.15|| Zo nodig<br/>|| MBH_200_zonodig|| MBH_200_zonodig_TA|| MBH_200_zonodig_MVE
+
|6.15|| Zo nodig<br/>|| MBH_300_zonodig-tav|| MBH_300_zonodig_TA-tav|| MBH_300_zonodig_MVE-tav
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|6.17|| Dagdeel|| MBH_300_redundantefrequentie-tav|| MBH_300_redundantefrequentie_TA-tav|| MBH_300_redundantefrequentie_MVE-tav
 
|}
 
|}
 
<section end=overview-AVO-6 />
 
<section end=overview-AVO-6 />
Regel 283: Regel 350:
 
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
 
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|7.1|| Alle ingrediënten|| MBH_200_magistraalalleingredienten|| MBH_200_magistraalalleingredienten_TA|| MBH_200_magistraalalleingredienten_MVE
+
|7.1|| Alle ingrediënten|| MBH_300_magistraalalleingredienten-tav|| MBH_300_magistraalalleingredienten_TA-tav|| MBH_300_magistraalalleingredienten_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|7.2|| Actief ingrediënt|| MBH_200_magistraalactieveingredient|| MBH_200_magistraalactieveingredient_TA|| MBH_200_magistraalactieveingredient_MVE
+
|7.2|| Actief ingrediënt|| MBH_300_magistraalactieveingredient-tav|| MBH_300_magistraalactieveingredient_TA-tav|| MBH_300_magistraalactieveingredient_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|7.3|| 90 miljoen nummer|| MBH_200_magistraal90miljoennr|| MBH_200_magistraal90miljoennr_TA|| MBH_200_magistraal90miljoennr_MVE
+
|7.3|| 90 miljoen nummer|| MBH_300_magistraal90miljoennr-tav|| MBH_300_magistraal90miljoennr_TA-tav|| MBH_300_magistraal90miljoennr_MVE-tav
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|7.4|| <div>Vrije tekst product</div>|| MBH_300_vrijetekstproduct-tav|| MBH_300_vrijetekstproduct_TA-tav|| MBH_300_vrijetekstproduct_MVE-tav
 
|}
 
|}
 
<section end=overview-AVO-7 />
 
<section end=overview-AVO-7 />
Regel 296: Regel 365:
 
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
 
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|8.1|| Verstrekking onder andermans toedieningsafspraak|| MBH_200_VVandermansMA|| MBH_200_MVEandermansTA_TA|| MBH_200_MVEandermansTA_MVE
+
|8.1|| <div>Verstrekking onder andermans toedieningsafspraak</div>|| MBH_300_VVandermansMA-tav|| MBH_300_MVEandermansTA_TA-tav|| MBH_300_MVEandermansTA_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|8.2|| Stoppen andermans toedieningsafspraak|| MBH_200_stakenandermansMA|| MBH_200_stakenandermansTA_TA2|| MBH_200_stakenandermansTA_andermansMVE
+
|8.2|| <div>Stoppen andermans toedieningsafspraak</div>|| MBH_300_stakenandermansMA-tav|| MBH_300_stakenandermansTA_TA2-tav|| MBH_300_stakenandermansTA_andermansMVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|8.3|| Onderbreken andermans toedieningsafspraak|| MBH_200_onderbrekenandermansMA|| MBH_200_onderbrekenandermansTA_TA2|| MBH_200_onderbrekenandermansTA_andermansMVE
+
|8.3|| <div>Onderbreken andermans toedieningsafspraak</div>|| MBH_300_onderbrekenandermansMA-tav|| MBH_300_onderbrekenandermansTA_TA2-tav|| MBH_300_onderbrekenandermansTA_andermansMVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|8.4|| Wijzigen andermans medicatieafspraak<br/>|| MBH_200_wijzigenandermansMA|| MBH_200_wijzigenandermansTA_TA_techstaken|| MBH_200_wijzigenandermansTA_andermansMVE
+
|8.4|| <div>Verstrekking onder andermans toedieningsafspraak</div>|| MBH_300_wijzigenandermansMA-tav|| MBH_300_wijzigenandermansTA_TA1-tav|| MBH_300_wijzigenandermansTA_andermansMVE-tav
 
|}
 
|}
 
<section end=overview-AVO-8 />
 
<section end=overview-AVO-8 />
Regel 311: Regel 380:
 
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
 
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|9.1a|| Logistieke verbruiksperiode|| MBH_200_logistiekeverbruiksperiode_start_eind|| MBH_200_logistiekeverbruiksperiode_start_eind_TA|| MBH_200_logistiekeverbruiksperiode_start_eind_MVE
+
|9.1a|| Logistieke verbruiksperiode|| MBH_300_logistiekeverbruiksperiode_start_eind-tav|| MBH_300_logistiekeverbruiksperiode_start_eind_TA-tav|| MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|9.1b|| <div>GDS</div>|| MBH_200_logistiekeverbruiksperiode_eind|| MBH_200_logistiekeverbruiksperiode_eind_TA|| MBH_200_logistiekeverbruiksperiode_eind_MVE
+
|9.1b|| <div>GDS</div>|| MBH_300_distributievorm_GDS-tav|| MBH_300_distributievorm_GDS_TA-tav|| MBH_300_distributievorm_GDS_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|9.1c|| <div>Logistieke verbruiksduur</div>|| MBH_200_logistiekeverbruiksperiode_duur_dagen|| MBH_200_logistiekeverbruiksperiode_duur_dagen_TA|| MBH_200_logistiekeverbruiksperiode_duur_dagen_MVE
+
|9.1c|| <div>Logistieke verbruiksduur</div>|| MBH_300_logistiekeverbruiksperiode_duur_dagen-tav|| MBH_300_logistiekeverbruiksperiode_duur_dagen_TA-tav|| MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|9.2|| Herhalingen|| MBH_200_herhalingen|| MBH_200_herhalingen_TA|| MBH_200_herhalingen_MVE
+
|9.2a|| Herhalingen|| MBH_300_herhalingen-tav|| MBH_300_herhalingen_TA-tav|| MBH_300_herhalingen_MVE1-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|9.3|| <div>Afleverlocatie en Aanschrijfdatum</div>|| MBH_200_afleverlocatie|| MBH_200_afleverlocatie_TA|| MBH_200_afleverlocatie_MVE
+
|9.2b|| Herhalingen|| MBH_300_herhalingen-tav|| MBH_300_herhalingen_TA-tav|| MBH_300_herhalingen_MVE2-tav
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|9.2c|| Herhalingen|| MBH_300_herhalingen-tav|| MBH_300_herhalingen_TA-tav|| MBH_300_herhalingen_MVE3-tav
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|9.3|| <div>Afleverlocatie en Aanschrijfdatum</div>|| MBH_300_afleverlocatie-tav|| MBH_300_afleverlocatie_TA-tav|| MBH_300_afleverlocatie_MVE-tav
 
|}
 
|}
 
<section end=overview-AVO-9 />
 
<section end=overview-AVO-9 />
Regel 328: Regel 401:
 
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
 
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|10.1|| HPK geneesmiddel|| MBH_200_HPKvoorschrijven|| MBH_200_HPKvoorschrijven_TA|| MBH_200_HPKvoorschrijven_MVE
+
|10.1|| HPK geneesmiddel|| MBH_300_HPKvoorschrijven-tav|| MBH_300_HPKvoorschrijven_TA-tav|| MBH_300_HPKvoorschrijven_MVE-tav
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|10.2|| ZI-nr geneesmiddel<br/>|| MBH_200_ZINRvoorschrijven|| MBH_200_ZINRvoorschrijven_TA|| MBH_200_ZINRvoorschrijven_MVE
+
|10.2|| ZI-nr geneesmiddel<br/>|| MBH_300_ZINRvoorschrijven-tav|| MBH_300_ZINRvoorschrijven_TA-tav|| MBH_300_ZINRvoorschrijven_MVE-tav
 
|}
 
|}
 
<section end=overview-AVO-10 />
 
<section end=overview-AVO-10 />
Regel 339: Regel 412:
 
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
 
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
 
|-style="vertical-align:top;|style="background-color: white;"
 
|-style="vertical-align:top;|style="background-color: white;"
−
|11.1|| <div>Afhandelen medicatievoorschrift met verwijzing naar extern doseerschema</div>|| MBH_200_wdsmtd1|| MBH_200_wdsmtd1_TA|| MBH_200_wdsmtd1_MVE
+
|11.1|| <div>Afhandelen medicatievoorschrift met verwijzing naar extern doseerschema</div>|| MBH_300_wdsmtd1-tav|| MBH_300_wdsmtd1_TA-tav|| MBH_300_wdsmtd1_MVE-tav
 
|}
 
|}
 
<section end=overview-AVO-11 />
 
<section end=overview-AVO-11 />
−
== TEST Scenarioset 1 ingangsdatum einddatum==
+
=== Scenarioset 23===
−
<section begin=av-mp-va-tst-1-1-ingangsdatum-einddatum-v20 /><section begin=patient-av-mp-va-tst-1-1-ingangsdatum-einddatum-v20 />
+
<section begin=overview-AVO-23 />
−
{| class="wikitable" width="85%"
+
{| class="wikitable"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
+
|-style="background-color: #1F497D;; color: white; text-align:left;"
−
|-style="background-color: #1F497D;; color: white; text-align:left;"  
+
| Scenario|| Beschrijving|| MBH id|| TA id|| MVE id
−
|colspan="4" width="25%"| Gegevenselement
+
|-style="vertical-align:top;|style="background-color: white;"
−
|| Waarde
+
|23.1a|| <div><span class="xforms-group xforms-group-appearance-full xforms-visited" id="main-ui"><span class="xforms-group xforms-visited" id="xf-103"><span class="fr-accordion-lnf xforms-group xforms-visited" id="main-accordion≡fr-accordion-group"><span class="xforms-group xforms-visited" id="main-accordion≡xf-177⊙21"><span class="xforms-group xforms-group-appearance-full" id="main-ui"><span class="xforms-group" id="xf-103"><span class="fr-accordion-lnf xforms-group" id="main-accordion≡fr-accordion-group"><span class="xforms-group" id="main-accordion≡xf-177⊙16">TEST Scenarioset 23.1a afhandelen voorschrift voor afhandeling VMA t.b.v. 100% akkoord VMA met eerdere verstrekking​</span></span></span></span></span></span></span></span></div>|| MBH_300_VMA_geaccepteerd-tav|| MBH_300_VMA_geaccepteerd_TA_start-tav|| MBH_300_VMA_geaccepteerd_MVE-tav
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|23.1b|| <div><span class="xforms-group xforms-group-appearance-full xforms-visited" id="main-ui"><span class="xforms-group xforms-visited" id="xf-103"><span class="fr-accordion-lnf xforms-group xforms-visited" id="main-accordion≡fr-accordion-group"><span class="xforms-group xforms-visited" id="main-accordion≡xf-177⊙21"><span class="xforms-group xforms-group-appearance-full" id="main-ui"><span class="xforms-group" id="xf-103"><span class="fr-accordion-lnf xforms-group" id="main-accordion≡fr-accordion-group"><span class="xforms-group" id="main-accordion≡xf-177⊙16">TEST Scenarioset 23.1b afhandelen voorschrift na afhandeling VMA t.b.v. 100% akkoord VMA met eerdere verstrekking​</span></span></span></span></span></span></span></span></div>|| MBH_300_VMA_geaccepteerd-tav|| MBH_300_VMA_geaccepteerd_TA_techstop-tav<br>MBH_300_VMA_geaccepteerd_TA_naVMA-tav||
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|23.2|| <div><span class="xforms-group xforms-group-appearance-full xforms-visited" id="main-ui"><span class="xforms-group xforms-visited" id="xf-103"><span class="fr-accordion-lnf xforms-group xforms-visited" id="main-accordion≡fr-accordion-group"><span class="xforms-group xforms-visited" id="main-accordion≡xf-177⊙21"><span class="xforms-group xforms-group-appearance-full" id="main-ui"><span class="xforms-group" id="xf-103"><span class="fr-accordion-lnf xforms-group" id="main-accordion≡fr-accordion-group"><span class="xforms-group" id="main-accordion≡xf-177⊙16">TEST Scenarioset 23.2 afhandelen voorschrift t.b.v. Afwijzen VMA o.b.v. voorstel PRK</span></span></span></span></span></span></span></span></div>|| MBH_300_VMAafgewezen_PRK-tav|| MBH_300_VMAafgewezen_PRK_TA-tav|| MBH_300_VMAafgewezen_PRK_MVE-tav
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|23.3a|| <div><span class="xforms-group xforms-group-appearance-full xforms-visited" id="main-ui"><span class="xforms-group xforms-visited" id="xf-103"><span class="fr-accordion-lnf xforms-group xforms-visited" id="main-accordion≡fr-accordion-group"><span class="xforms-group xforms-visited" id="main-accordion≡xf-177⊙21"><span class="xforms-group xforms-group-appearance-full" id="main-ui"><span class="xforms-group" id="xf-103"><span class="fr-accordion-lnf xforms-group" id="main-accordion≡fr-accordion-group"><span class="xforms-group" id="main-accordion≡xf-177⊙16">TEST Scenarioset 23.3a afhandelen voorschrift voor afhandeling VMA t.b.v. Aanvullend middel VMA</span></span></span></span></span></span></span></span></div>|| MBH_300_VMAaanvullendmiddel-tav|| MBH_300_VMAaanvullendmiddel_TA_start-tav|| MBH_300_VMAaanvullendmiddel_MVE-tav
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|23.3b|| <div><span class="xforms-group xforms-group-appearance-full xforms-visited" id="main-ui"><span class="xforms-group xforms-visited" id="xf-103"><span class="fr-accordion-lnf xforms-group xforms-visited" id="main-accordion≡fr-accordion-group"><span class="xforms-group xforms-visited" id="main-accordion≡xf-177⊙21"><span class="xforms-group xforms-group-appearance-full" id="main-ui"><span class="xforms-group" id="xf-103"><span class="fr-accordion-lnf xforms-group" id="main-accordion≡fr-accordion-group"><span class="xforms-group" id="main-accordion≡xf-177⊙16">TEST Scenarioset 23.3b afhandelen voorschrift na afhandeling VMA t.b.v. Aanvullend middel VMA</span></span></span></span></span></span></span></span></div>|| MBH_300_VMAaanvullendmiddel-tav|| MBH_300_VMAaanvullendmiddel_techstopTA-tav<br>MBH_300_VMAaanvullendmiddel_TA_naVMA-tav||
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|23.4a|| <div><span class="xforms-group xforms-group-appearance-full xforms-visited" id="main-ui"><span class="xforms-group xforms-visited" id="xf-103"><span class="fr-accordion-lnf xforms-group xforms-visited" id="main-accordion≡fr-accordion-group"><span class="xforms-group xforms-visited" id="main-accordion≡xf-177⊙21"><span class="xforms-group xforms-group-appearance-full" id="main-ui"><span class="xforms-group" id="xf-103"><span class="fr-accordion-lnf xforms-group" id="main-accordion≡fr-accordion-group"><span class="xforms-group" id="main-accordion≡xf-177⊙16">TEST Scenarioset 23.4a afhandelen voorschrift voor akkoord VMA t.b.v. Vervangend middel VMA</span></span></span></span></span></span></span></span></div>|| MBH_300_VMAvervangend_voorschr-tav|| MBH_300_VMAvervangend_voorschr_TA_start-tav|| MBH_300_VMAvervangend_voorschr_MVE_start-tav
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|23.4b|| <div><span class="xforms-group xforms-group-appearance-full xforms-visited" id="main-ui"><span class="xforms-group xforms-visited" id="xf-103"><span class="fr-accordion-lnf xforms-group xforms-visited" id="main-accordion≡fr-accordion-group"><span class="xforms-group xforms-visited" id="main-accordion≡xf-177⊙21"><span class="xforms-group xforms-group-appearance-full" id="main-ui"><span class="xforms-group" id="xf-103"><span class="fr-accordion-lnf xforms-group" id="main-accordion≡fr-accordion-group"><span class="xforms-group" id="main-accordion≡xf-177⊙16">TEST Scenarioset 23.4b afhandelen voorschrift na akkoord VMA t.b.v. Vervangend middel VMA</span></span></span></span></span></span></span></span></div>|| MBH_300_VMAvervangend_voorschr-tav|| MBH_300_VMAvervangend_voorschr_stopTA-tav||
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|23.4c|| <div><span class="xforms-group xforms-group-appearance-full xforms-visited" id="main-ui"><span class="xforms-group xforms-visited" id="xf-103"><span class="fr-accordion-lnf xforms-group xforms-visited" id="main-accordion≡fr-accordion-group"><span class="xforms-group xforms-visited" id="main-accordion≡xf-177⊙21"><span class="xforms-group xforms-group-appearance-full" id="main-ui"><span class="xforms-group" id="xf-103"><span class="fr-accordion-lnf xforms-group" id="main-accordion≡fr-accordion-group"><span class="xforms-group" id="main-accordion≡xf-177⊙16">TEST Scenarioset 23.4c afhandelen voorschrift na akkoord VMA t.b.v. Vervangend middel VMA</span></span></span></span></span></span></span></span></div>|| MBH_300_VMAvervangendmiddel-tav|| MBH_300_VMAvervangendmiddel_TA_naVMA-tav||
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|23.5a|| <div><span class="xforms-group xforms-group-appearance-full xforms-visited" id="main-ui"><span class="xforms-group xforms-visited" id="xf-103"><span class="fr-accordion-lnf xforms-group xforms-visited" id="main-accordion≡fr-accordion-group"><span class="xforms-group xforms-visited" id="main-accordion≡xf-177⊙21"><span class="xforms-group xforms-group-appearance-full" id="main-ui"><span class="xforms-group" id="xf-103"><span class="fr-accordion-lnf xforms-group" id="main-accordion≡fr-accordion-group"><span class="xforms-group" id="main-accordion≡xf-177⊙16">TEST Scenarioset 23.5a afhandelen voorschrift t.b.v. 100% akkoord VVV met eerdere verstrekking</span></span></span></span></span></span></span></span></div>|| MBH_300_VVV_geaccepteerd-tav|| MBH_300_VVV_geaccepteerd_TA_start-tav|| MBH_300_VVV_geaccepteerd_MVE_start-tav
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|23.5b|| <div><span class="xforms-group xforms-group-appearance-full xforms-visited" id="main-ui"><span class="xforms-group xforms-visited" id="xf-103"><span class="fr-accordion-lnf xforms-group xforms-visited" id="main-accordion≡fr-accordion-group"><span class="xforms-group xforms-visited" id="main-accordion≡xf-177⊙21"><span class="xforms-group xforms-group-appearance-full" id="main-ui"><span class="xforms-group" id="xf-103"><span class="fr-accordion-lnf xforms-group" id="main-accordion≡fr-accordion-group"><span class="xforms-group" id="main-accordion≡xf-177⊙16">TEST Scenarioset 23.5b afhandelen voorschrift t.b.v. 100% akkoord VVV met eerdere verstrekking</span></span></span></span></span></span></span></span></div>|| MBH_300_VVV_geaccepteerd-tav|| MBH_300_VVV_geaccepteerd_TA_start-tav|| MBH_300_VVV_geaccepteerd_MVE_naVVV-tav
 +
|-style="vertical-align:top;|style="background-color: white;"
 +
|23.6|| <div><span class="xforms-group xforms-group-appearance-full xforms-visited" id="main-ui"><span class="xforms-group xforms-visited" id="xf-103"><span class="fr-accordion-lnf xforms-group xforms-visited" id="main-accordion≡fr-accordion-group"><span class="xforms-group xforms-visited" id="main-accordion≡xf-177⊙21"><span class="xforms-group xforms-group-appearance-full" id="main-ui"><span class="xforms-group" id="xf-103"><span class="fr-accordion-lnf xforms-group" id="main-accordion≡fr-accordion-group"><span class="xforms-group" id="main-accordion≡xf-177⊙16">TEST Scenarioset 23.6 afhandelen voorschrift t.b.v. gedeeltelijke overname VVV</span></span></span></span></span></span></span></span></div>|| MBH_300_VVV_wijziging-tav|| MBH_300_VVV_wijziging_TA-tav|| MBH_300_VVV_wijziging_MVE-tav
 +
|}
 +
<section end=overview-AVO-23 />
 +
== TEST Scenarioset 1 ingangsdatum einddatum==
 +
<section begin=av-mp-va-tst-1-1-ingangsdatum-einddatum-v30 /><section begin=patient-av-mp-va-tst-1-1-ingangsdatum-einddatum-v30 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 +
|colspan="4" width="25%"| Gegevenselement
 +
|| Waarde
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
Regel 359: Regel 461:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 375: Regel 477:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-1-1-ingangsdatum-einddatum-v20 /><section begin=mbhs-av-mp-va-tst-1-1-ingangsdatum-einddatum-v20 />
+
|}<section end=patient-av-mp-va-tst-1-1-ingangsdatum-einddatum-v30 /><section begin=mbhs-av-mp-va-tst-1-1-ingangsdatum-einddatum-v30 />
−
==== Scenario 1.1 - MBH_200_start_eind====
+
==== Scenario 1.1 - MBH_300_start_eind-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_start_eind_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_start_eind_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 387: Regel 489:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_start_eind_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_start_eind_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
 
|style="background-color: white;"|T om 12:20 uur
 
|style="background-color: white;"|T om 12:20 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
Regel 408: Regel 510:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|METOCLOPRAMIDE HCL ACCORD TABLET 10MG (code = '2115468' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
Regel 424: Regel 526:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, tot en met T + 5 dagen, 1 maal per dag 1 stuk, Oraal
+
|style="background-color: white;"|1 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
Regel 432: Regel 534:
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_start_eind_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_start_eind-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_start_eind_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_start_eind_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 450: Regel 552:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_start_eind_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_start_eind_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
 
|style="background-color: white;"|T om 12:20 uur
 
|style="background-color: white;"|T om 12:20 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
Regel 460: Regel 562:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
 
|style="background-color: white;"|5 stuks
 
|style="background-color: white;"|5 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|METOCLOPRAMIDE HCL ACCORD TABLET 10MG (code = '2115468' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
Regel 474: Regel 576:
 
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK')
 
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_start_eind_VV
+
|style="background-color: white;"|MBH_300_start_eind_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_start_eind-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 488: Regel 590:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-1-1-ingangsdatum-einddatum-v20 /><section end=av-mp-va-tst-1-1-ingangsdatum-einddatum-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-1-1-ingangsdatum-einddatum-v30 /><section end=av-mp-va-tst-1-1-ingangsdatum-einddatum-v30 />
 
== TEST Scenarioset 1 ingangsdatum en duur (weken)==
 
== TEST Scenarioset 1 ingangsdatum en duur (weken)==
−
<section begin=av-mp-va-tst-1-2a-ingangsdatum-duur-weken-v20 /><section begin=patient-av-mp-va-tst-1-2a-ingangsdatum-duur-weken-v20 />
+
<section begin=av-mp-va-tst-1-2a-ingangsdatum-duur-weken-v30 /><section begin=patient-av-mp-va-tst-1-2a-ingangsdatum-duur-weken-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 515: Regel 620:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 531: Regel 636:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-1-2a-ingangsdatum-duur-weken-v20 /><section begin=mbhs-av-mp-va-tst-1-2a-ingangsdatum-duur-weken-v20 />
+
|}<section end=patient-av-mp-va-tst-1-2a-ingangsdatum-duur-weken-v30 /><section begin=mbhs-av-mp-va-tst-1-2a-ingangsdatum-duur-weken-v30 />
−
==== Scenario 1.2a - MBH_200_start_duur====
+
==== Scenario 1.2a - MBH_300_start_duur-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_start_duur_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_start_duur_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 543: Regel 648:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_start_duur_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_start_duur_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
 
|style="background-color: white;"|T om 12:30 uur
 
|style="background-color: white;"|T om 12:30 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
Regel 564: Regel 669:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
Regel 580: Regel 685:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, gedurende 3 weken, 1 maal per dag 1 stuk, oraal
+
|style="background-color: white;"|1 maal per dag 1 stuk, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
Regel 588: Regel 693:
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_start_duur_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_start_duur-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_start_duur_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_start_duur_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 606: Regel 711:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_start_duur_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_start_duur_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
 
|style="background-color: white;"|T om 12:30 uur
 
|style="background-color: white;"|T om 12:30 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
Regel 616: Regel 721:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
 
|style="background-color: white;"|21 stuks
 
|style="background-color: white;"|21 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
Regel 630: Regel 735:
 
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK')
 
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_start_duur_VV
+
|style="background-color: white;"|MBH_300_start_duur_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_start_duur-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 644: Regel 749:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-1-2a-ingangsdatum-duur-weken-v20 /><section end=av-mp-va-tst-1-2a-ingangsdatum-duur-weken-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-1-2a-ingangsdatum-duur-weken-v30 /><section end=av-mp-va-tst-1-2a-ingangsdatum-duur-weken-v30 />
 
== TEST Scenarioset 1 ingangsdatum duur (dagen)==
 
== TEST Scenarioset 1 ingangsdatum duur (dagen)==
−
<section begin=av-mp-va-tst-1-2b-ingangsdatum-duur-dagen-v20 /><section begin=patient-av-mp-va-tst-1-2b-ingangsdatum-duur-dagen-v20 />
+
<section begin=av-mp-va-tst-1-2b-ingangsdatum-duur-dagen-v30 /><section begin=patient-av-mp-va-tst-1-2b-ingangsdatum-duur-dagen-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 671: Regel 779:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 687: Regel 795:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-1-2b-ingangsdatum-duur-dagen-v20 /><section begin=mbhs-av-mp-va-tst-1-2b-ingangsdatum-duur-dagen-v20 />
+
|}<section end=patient-av-mp-va-tst-1-2b-ingangsdatum-duur-dagen-v30 /><section begin=mbhs-av-mp-va-tst-1-2b-ingangsdatum-duur-dagen-v30 />
−
==== Scenario 1.2b - MBH_200_start_duur2====
+
==== Scenario 1.2b - MBH_300_start_duur2-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_start_duur2_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_start_duur2_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 699: Regel 807:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_start_duur2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_start_duur2_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
 
|style="background-color: white;"|T om 12:30 uur
 
|style="background-color: white;"|T om 12:30 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
Regel 720: Regel 828:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
Regel 736: Regel 844:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, gedurende 28 dagen, 1 maal per dag 1 stuk, oraal
+
|style="background-color: white;"|1 maal per dag 1 stuk, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
Regel 744: Regel 852:
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_start_duur2_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_start_duur2-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_start_duur2_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_start_duur2_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 762: Regel 870:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_start_duur2_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_start_duur2_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
 
|style="background-color: white;"|T om 12:30 uur
 
|style="background-color: white;"|T om 12:30 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
Regel 772: Regel 880:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
 
|style="background-color: white;"|28 stuks
 
|style="background-color: white;"|28 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
Regel 786: Regel 894:
 
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK')
 
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_start_duur2_VV
+
|style="background-color: white;"|MBH_300_start_duur2_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_start_duur2-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 800: Regel 908:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-1-2b-ingangsdatum-duur-dagen-v20 /><section end=av-mp-va-tst-1-2b-ingangsdatum-duur-dagen-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-1-2b-ingangsdatum-duur-dagen-v30 /><section end=av-mp-va-tst-1-2b-ingangsdatum-duur-dagen-v30 />
 
== TEST Scenarioset 1 chronische medicatie==
 
== TEST Scenarioset 1 chronische medicatie==
−
<section begin=av-mp-va-tst-1-3-chronische-medicatie-v20 /><section begin=patient-av-mp-va-tst-1-3-chronische-medicatie-v20 />
+
<section begin=av-mp-va-tst-1-3-chronische-medicatie-v30 /><section begin=patient-av-mp-va-tst-1-3-chronische-medicatie-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 827: Regel 938:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 843: Regel 954:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-1-3-chronische-medicatie-v20 /><section begin=mbhs-av-mp-va-tst-1-3-chronische-medicatie-v20 />
+
|}<section end=patient-av-mp-va-tst-1-3-chronische-medicatie-v30 /><section begin=mbhs-av-mp-va-tst-1-3-chronische-medicatie-v30 />
−
==== Scenario 1.3 - MBH_200_chronisch====
+
==== Scenario 1.3 - MBH_300_chronisch-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_chronisch_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_chronisch_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 855: Regel 966:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_chronisch_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_chronisch_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
 
|style="background-color: white;"|T om 12:32 uur
 
|style="background-color: white;"|T om 12:32 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
Regel 873: Regel 984:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
Regel 889: Regel 1.000:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, 1 maal per dag 1 stuk, oraal
+
|style="background-color: white;"|1 maal per dag 1 stuk, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
Regel 897: Regel 1.008:
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_chronisch_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_chronisch-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_chronisch_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_chronisch_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 915: Regel 1.026:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_chronisch_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_chronisch_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
 
|style="background-color: white;"|T om 12:32 uur
 
|style="background-color: white;"|T om 12:32 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
Regel 925: Regel 1.036:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
 
|style="background-color: white;"|21 stuks
 
|style="background-color: white;"|21 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
Regel 939: Regel 1.050:
 
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
 
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_chronisch_VV
+
|style="background-color: white;"|MBH_300_chronisch_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_chronisch-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 953: Regel 1.064:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-1-3-chronische-medicatie-v20 /><section end=av-mp-va-tst-1-3-chronische-medicatie-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-1-3-chronische-medicatie-v30 /><section end=av-mp-va-tst-1-3-chronische-medicatie-v30 />
 
== TEST Scenarioset 1 extra VV onder bestaande MA==
 
== TEST Scenarioset 1 extra VV onder bestaande MA==
−
<section begin=av-mp-va-tst-1-4-extra-mve-v20 /><section begin=patient-av-mp-va-tst-1-4-extra-mve-v20 />
+
<section begin=av-mp-va-tst-1-4-extra-mve-v30 /><section begin=patient-av-mp-va-tst-1-4-extra-mve-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 980: Regel 1.094:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 996: Regel 1.110:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-1-4-extra-mve-v20 /><section begin=mbhs-av-mp-va-tst-1-4-extra-mve-v20 />
+
|}<section end=patient-av-mp-va-tst-1-4-extra-mve-v30 /><section begin=mbhs-av-mp-va-tst-1-4-extra-mve-v30 />
−
==== Scenario 1.4 - MBH_200_chronisch====
+
==== Scenario 1.4 - MBH_300_chronisch-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_chronisch_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_chronisch_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 1.008: Regel 1.122:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_chronisch_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_chronisch_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
 
|style="background-color: white;"|T - 20 dagen om 12:32 uur
 
|style="background-color: white;"|T - 20 dagen om 12:32 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
Regel 1.026: Regel 1.140:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
Regel 1.042: Regel 1.156:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T - 20 dagen, 1 maal per dag 1 stuk, oraal
+
|style="background-color: white;"|1 maal per dag 1 stuk, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
Regel 1.050: Regel 1.164:
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_chronisch_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_chronisch-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_chronisch_MVE_extraMVEbestaandeTA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_chronisch_MVE_extraMVEbestaandeTA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 1.068: Regel 1.182:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_chronisch_MVE_extraMVEbestaandeTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_chronisch_MVE_extraMVEbestaandeTA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
 
|style="background-color: white;"|T om 12:35 uur
 
|style="background-color: white;"|T om 12:35 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
Regel 1.078: Regel 1.192:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
 
|style="background-color: white;"|90 stuks
 
|style="background-color: white;"|90 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
Regel 1.092: Regel 1.206:
 
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
 
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_chronisch_VV_extraVVbestaandeMA
+
|style="background-color: white;"|MBH_300_chronisch_VV_extraVVbestaandeMA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_chronisch-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 1.106: Regel 1.220:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-1-4-extra-mve-v20 /><section end=av-mp-va-tst-1-4-extra-mve-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-1-4-extra-mve-v30 /><section end=av-mp-va-tst-1-4-extra-mve-v30 />
 
== TEST Scenarioset 1 met eenheid 'dosis/stuks'==
 
== TEST Scenarioset 1 met eenheid 'dosis/stuks'==
−
<section begin=av-mp-va-tst-1-5-eenheid-dosis-stuks-v20 /><section begin=patient-av-mp-va-tst-1-5-eenheid-dosis-stuks-v20 />
+
<section begin=av-mp-va-tst-1-5-eenheid-dosis-stuks-v30 /><section begin=patient-av-mp-va-tst-1-5-eenheid-dosis-stuks-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 1.133: Regel 1.250:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 1.149: Regel 1.266:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-1-5-eenheid-dosis-stuks-v20 /><section begin=mbhs-av-mp-va-tst-1-5-eenheid-dosis-stuks-v20 />
+
|}<section end=patient-av-mp-va-tst-1-5-eenheid-dosis-stuks-v30 /><section begin=mbhs-av-mp-va-tst-1-5-eenheid-dosis-stuks-v30 />
−
==== Scenario 1.5 - MBH_200_dosis_stuks====
+
==== Scenario 1.5 - MBH_300_dosis_stuks-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_dosis_stuks_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_dosis_stuks_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 1.161: Regel 1.278:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_dosis_stuks_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_dosis_stuks_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
 
|style="background-color: white;"|T om 12:35 uur
 
|style="background-color: white;"|T om 12:35 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
Regel 1.182: Regel 1.299:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
Regel 1.198: Regel 1.315:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, tot en met T + 29 dagen, 2 maal per dag 1 dosis, inhalatie
+
|style="background-color: white;"|2 maal per dag 1 dosis, inhalatie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
Regel 1.206: Regel 1.323:
 
|style="background-color: white;"|2 maal per dag 1 dosis
 
|style="background-color: white;"|2 maal per dag 1 dosis
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_dosis_stuks_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_dosis_stuks-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_dosis_stuks_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_dosis_stuks_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 1.224: Regel 1.341:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_dosis_stuks_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_dosis_stuks_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
 
|style="background-color: white;"|T om 12:35 uur
 
|style="background-color: white;"|T om 12:35 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
Regel 1.234: Regel 1.351:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
 
|style="background-color: white;"|1 stuk
 
|style="background-color: white;"|1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
Regel 1.248: Regel 1.365:
 
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK')
 
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_dosis_stuks_VV
+
|style="background-color: white;"|MBH_300_dosis_stuks_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_dosis_stuks-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 1.262: Regel 1.379:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-1-5-eenheid-dosis-stuks-v20 /><section end=av-mp-va-tst-1-5-eenheid-dosis-stuks-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 2 Aanvullende instructie==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-2-1-aanvullendeinstructie-v20 /><section begin=patient-av-mp-va-tst-2-1-aanvullendeinstructie-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-1-5-eenheid-dosis-stuks-v30 /><section end=av-mp-va-tst-1-5-eenheid-dosis-stuks-v30 />
 +
== TEST Scenarioset 1 met onzekerheidscriterium==
 +
<section begin=av-mp-va-tst-1-6-ingangsdatum-criterium-v30 /><section begin=patient-av-mp-va-tst-1-6-ingangsdatum-criterium-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 1.289: Regel 1.409:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 1.296: Regel 1.416:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Coenen
+
|style="background-color: white;"|XXX_Brugge
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900420 [BSN]
+
|style="background-color: white;"|999900419 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|17 okt 1963
+
|style="background-color: white;"|16 okt 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-2-1-aanvullendeinstructie-v20 /><section begin=mbhs-av-mp-va-tst-2-1-aanvullendeinstructie-v20 />
+
|}<section end=patient-av-mp-va-tst-1-6-ingangsdatum-criterium-v30 /><section begin=mbhs-av-mp-va-tst-1-6-ingangsdatum-criterium-v30 />
−
==== Scenario 2.1 - MBH_200_aanvullendeinstructie====
+
==== Scenario 1.6 - MBH_300_start_criterium-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_aanvullendeinstructie_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_start_criterium_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 1.317: Regel 1.437:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_aanvullendeinstructie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_start_criterium_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 09:00 uur
+
|style="background-color: white;"|T om 12:20 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 12 maanden''
+
|style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, gedurende 3 dagen (3 dagen voor operatie starten)''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|colspan="2"|Ingangsdatum
−
|style="background-color: white;"|T
+
|style="background-color: white;"|T + 1 dag
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Einddatum
+
|colspan="2"|Gebruiksduur
−
|style="background-color: white;"|T + 12 maanden
+
|style="background-color: white;"|3 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 1.338: Regel 1.458:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|CHLOORHEXIDINE DIGLUCONAAT CREME 1% (code = '1189921' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|CHLOORHEXIDINE CREME 10MG/G (code = '10138' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|CHLOORHEXIDINE CREME 10MG/G (code = '26603' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="5"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, tot en met T + 12 maanden, 1 maal per dag 1 stuk, Bij het eten innemen, Oraal
+
|style="background-color: white;"|1 maal per dag, cutaan
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Aanvullende instructie
 
−
|style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Bij het eten innemen
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|1 maal per dag 1 stuk
+
|style="background-color: white;"|1 maal per dag
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_aanvullendeinstructie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_start_criterium_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_start_criterium-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_aanvullendeinstructie_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_start_criterium_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 1.383: Regel 1.500:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_aanvullendeinstructie_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_start_criterium_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 09:00 uur
+
|style="background-color: white;"|T om 12:20 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 1.393: Regel 1.510:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|180 stuks
+
|style="background-color: white;"|30 gram
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|CHLOORHEXIDINE DIGLUCONAAT CREME 1% (code = '1189921' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|CHLOORHEXIDINE CREME 10MG/G (code = '10138' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|CHLOORHEXIDINE CREME 10MG/G (code = '26603' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_aanvullendeinstructie_VV
+
|style="background-color: white;"|MBH_300_start_criterium_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_start_criterium-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 1.421: Regel 1.538:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-2-1-aanvullendeinstructie-v20 /><section end=av-mp-va-tst-2-1-aanvullendeinstructie-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 2 Toelichting==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-2-2-toelichting-v20 /><section begin=patient-av-mp-va-tst-2-2-toelichting-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-1-6-ingangsdatum-criterium-v30 /><section end=av-mp-va-tst-1-6-ingangsdatum-criterium-v30 />
 +
== TEST Scenarioset 2 Aanvullende instructie==
 +
<section begin=av-mp-va-tst-2-1-aanvullendeinstructie-v30 /><section begin=patient-av-mp-va-tst-2-1-aanvullendeinstructie-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 1.448: Regel 1.568:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 1.464: Regel 1.584:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-2-2-toelichting-v20 /><section begin=mbhs-av-mp-va-tst-2-2-toelichting-v20 />
+
|}<section end=patient-av-mp-va-tst-2-1-aanvullendeinstructie-v30 /><section begin=mbhs-av-mp-va-tst-2-1-aanvullendeinstructie-v30 />
−
==== Scenario 2.2 - MBH_200_toelichting====
+
==== Scenario 2.1 - MBH_300_aanvullendeinstructie-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_toelichting_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_aanvullendeinstructie_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 1.476: Regel 1.596:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_toelichting_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_aanvullendeinstructie_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 09:02 uur
+
|style="background-color: white;"|T om 09:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 12 maanden''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="2"|
+
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T
 
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T + 12 maanden
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 1.494: Regel 1.617:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="4"|
+
|rowspan="5"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, 1 maal per dag 1 stuk, Oraal
+
|style="background-color: white;"|1 maal per dag 1 stuk, Bij het eten innemen, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|AanvullendeInstructie
 +
|style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Bij het eten innemen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|style="background-color: white;"|1 maal per dag 1 stuk
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Toelichting
 
−
|style="background-color: white;"|In overleg met specialist
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_aanvullendeinstructie_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_aanvullendeinstructie-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_toelichting_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_aanvullendeinstructie_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 1.539: Regel 1.662:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_toelichting_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_aanvullendeinstructie_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 09:02 uur
+
|style="background-color: white;"|T om 09:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 1.549: Regel 1.672:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|30 stuks
+
|style="background-color: white;"|180 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK')
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Toelichting
 
−
|style="background-color: white;"|Extra verstrekkingsverzoek omdat patient medicatie is kwijtgeraakt
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_toelichting_VV
+
|style="background-color: white;"|MBH_300_aanvullendeinstructie_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_aanvullendeinstructie-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 1.580: Regel 1.700:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-2-2-toelichting-v20 /><section end=av-mp-va-tst-2-2-toelichting-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 2 Reden van voorschrijven==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-2-3-redenvanvoorschrijven-v20 /><section begin=patient-av-mp-va-tst-2-3-redenvanvoorschrijven-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-2-1-aanvullendeinstructie-v30 /><section end=av-mp-va-tst-2-1-aanvullendeinstructie-v30 />
 +
== TEST Scenarioset 2 Toelichting==
 +
<section begin=av-mp-va-tst-2-2-toelichting-v30 /><section begin=patient-av-mp-va-tst-2-2-toelichting-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 1.607: Regel 1.730:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 1.623: Regel 1.746:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-2-3-redenvanvoorschrijven-v20 /><section begin=mbhs-av-mp-va-tst-2-3-redenvanvoorschrijven-v20 />
+
|}<section end=patient-av-mp-va-tst-2-2-toelichting-v30 /><section begin=mbhs-av-mp-va-tst-2-2-toelichting-v30 />
−
==== Scenario 2.3 - MBH_200_redenvanvoorschrijven====
+
==== Scenario 2.2 - MBH_300_toelichting-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_redenvanvoorschrijven_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_toelichting_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 1.635: Regel 1.758:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_redenvanvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_toelichting_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 09:05 uur
+
|style="background-color: white;"|T om 09:02 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 27 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T
 
|style="background-color: white;"|T
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Einddatum
 
−
|style="background-color: white;"|T + 27 dagen
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 1.656: Regel 1.776:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|METHOTREXAAT PCH TABLET 2,5MG (code = '1421778' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
Regel 1.672: Regel 1.792:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, tot en met T + 27 dagen, 1 maal per week 5 stuks, Oraal
+
|style="background-color: white;"|1 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
Regel 1.678: Regel 1.798:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|1 maal per week 5 stuks
+
|style="background-color: white;"|1 maal per dag 1 stuk
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Toelichting
 +
|style="background-color: white;"|In overleg met specialist
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_redenvanvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_toelichting_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_toelichting-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_redenvanvoorschrijven_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_toelichting_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 1.698: Regel 1.821:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_redenvanvoorschrijven_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_toelichting_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 09:05 uur
+
|style="background-color: white;"|T om 09:02 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 1.708: Regel 1.831:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|20 stuks
+
|style="background-color: white;"|30 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|METHOTREXAAT PCH TABLET 2,5MG (code = '1421778' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Toelichting
 +
|style="background-color: white;"|Extra verstrekkingsverzoek omdat patient medicatie is kwijtgeraakt
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_redenvanvoorschrijven_VV
+
|style="background-color: white;"|MBH_300_toelichting_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_toelichting-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 1.736: Regel 1.862:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-2-3-redenvanvoorschrijven-v20 /><section end=av-mp-va-tst-2-3-redenvanvoorschrijven-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 2 Aanvullende informatie==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-2-4-aanvullendeinformatie-v20 /><section begin=patient-av-mp-va-tst-2-4-aanvullendeinformatie-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-2-2-toelichting-v30 /><section end=av-mp-va-tst-2-2-toelichting-v30 />
 +
== TEST Scenarioset 2 Reden van voorschrijven==
 +
<section begin=av-mp-va-tst-2-3-redenvanvoorschrijven-v30 /><section begin=patient-av-mp-va-tst-2-3-redenvanvoorschrijven-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 1.763: Regel 1.892:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 1.779: Regel 1.908:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-2-4-aanvullendeinformatie-v20 /><section begin=mbhs-av-mp-va-tst-2-4-aanvullendeinformatie-v20 />
+
|}<section end=patient-av-mp-va-tst-2-3-redenvanvoorschrijven-v30 /><section begin=mbhs-av-mp-va-tst-2-3-redenvanvoorschrijven-v30 />
−
==== Scenario 2.5 - MBH_200_aanvullendeinformatiewensen====
+
==== Scenario 2.3 - MBH_300_redenvanvoorschrijven-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_aanvullendeinformatiewensen_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_redenvanvoorschrijven_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 1.791: Regel 1.920:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_aanvullendeinformatiewensen_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_redenvanvoorschrijven_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T - 5 dagen om 09:06 uur
+
|style="background-color: white;"|T om 09:05 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T + 5 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 27 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|colspan="2"|Ingangsdatum
−
|style="background-color: white;"|T - 4 dagen
+
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|colspan="2"|Einddatum
−
|style="background-color: white;"|T + 5 dagen
+
|style="background-color: white;"|T + 27 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 1.812: Regel 1.941:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|METHOTREXAAT PCH TABLET 2,5MG (code = '1421778' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
Regel 1.828: Regel 1.957:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T - 4 dagen, tot en met T + 5 dagen, 3 maal per dag 1 stuk, Oraal
+
|style="background-color: white;"|1 maal per week 5 stuks, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
Regel 1.834: Regel 1.963:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|3 maal per dag 1 stuk
+
|style="background-color: white;"|1 maal per week 5 stuks
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Toedieningsafspraak aanvullende informatie
 
−
|style="background-color: white;"|Bijwerking besproken
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_aanvullendeinformatiewensen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_redenvanvoorschrijven_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_redenvanvoorschrijven-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_aanvullendeinformatiewensen_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_redenvanvoorschrijven_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 1.857: Regel 1.983:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_aanvullendeinformatiewensen_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_redenvanvoorschrijven_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T - 5 dagen om 09:06 uur
+
|style="background-color: white;"|T om 09:05 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 1.867: Regel 1.993:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|30 stuks
+
|style="background-color: white;"|20 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|METHOTREXAAT PCH TABLET 2,5MG (code = '1421778' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_aanvullendeinformatiewensen_VV
+
|style="background-color: white;"|MBH_300_redenvanvoorschrijven_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_redenvanvoorschrijven-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 1.895: Regel 2.021:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-2-4-aanvullendeinformatie-v20 /><section end=av-mp-va-tst-2-4-aanvullendeinformatie-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 2 Toedieningsweg los==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-2-5-toedieningsweg-v20 /><section begin=patient-av-mp-va-tst-2-5-toedieningsweg-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-2-3-redenvanvoorschrijven-v30 /><section end=av-mp-va-tst-2-3-redenvanvoorschrijven-v30 />
 +
== TEST Scenarioset 2 Aanvullende informatie==
 +
<section begin=av-mp-va-tst-2-4-aanvullendeinformatie-v30 /><section begin=patient-av-mp-va-tst-2-4-aanvullendeinformatie-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 1.922: Regel 2.051:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 1.938: Regel 2.067:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-2-5-toedieningsweg-v20 /><section begin=mbhs-av-mp-va-tst-2-5-toedieningsweg-v20 />
+
|}<section end=patient-av-mp-va-tst-2-4-aanvullendeinformatie-v30 /><section begin=mbhs-av-mp-va-tst-2-4-aanvullendeinformatie-v30 />
−
==== Scenario 2.6 - MBH_200_Toedieningsweg====
+
==== Scenario 2.4 - MBH_300_aanvullendeinformatiewensen-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_Toedieningsweg_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_aanvullendeinformatiewensen_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 1.950: Regel 2.079:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_Toedieningsweg_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_aanvullendeinformatiewensen_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 09:15 uur
+
|style="background-color: white;"|T - 5 dagen om 09:06 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 7 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T + 5 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|colspan="2"|Ingangsdatum
−
|style="background-color: white;"|T
+
|style="background-color: white;"|T - 4 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|colspan="2"|Einddatum
−
|style="background-color: white;"|T + 7 dagen
+
|style="background-color: white;"|T + 5 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 1.971: Regel 2.100:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|SOFRADEX OORDRUPPELS (code = '644781' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="5"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, tot en met T + 7 dagen, 2 maal per dag 1 druppel, In het rechter oog, oculair
+
|style="background-color: white;"|elke dag om 19:00 1 stuk - let op, exacte toedientijd(en), Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
+
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Aanvullende instructie
 
−
|style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): In het rechter oog
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|2 maal per dag 1 druppel
+
|style="background-color: white;"|elke dag om 19:00 1 stuk - let op, exacte toedientijd(en)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak aanvullende informatie
+
|colspan="3"|Toelichting
−
|style="background-color: white;"|Gebruiksinstructie gegeven
+
|style="background-color: white;"|Bijwerking besproken
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_Toedieningsweg_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_aanvullendeinformatiewensen_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_Toedieningsweg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_aanvullendeinformatiewensen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_Toedieningsweg_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_aanvullendeinformatiewensen_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 2.019: Regel 2.145:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_Toedieningsweg_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_aanvullendeinformatiewensen_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 09:15 uur
+
|style="background-color: white;"|T - 5 dagen om 09:06 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 2.029: Regel 2.155:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|1 stuk
+
|style="background-color: white;"|40 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|SOFRADEX OORDRUPPELS (code = '644781' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MedicatieverstrekkingAanvullendeInformatie
 +
|style="background-color: white;"|Aantal bewust gewijzigd (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2052')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_Toedieningsweg_VV
+
|style="background-color: white;"|MBH_300_aanvullendeinformatiewensen_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_Toedieningsweg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_aanvullendeinformatiewensen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 2.057: Regel 2.186:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-2-5-toedieningsweg-v20 /><section end=av-mp-va-tst-2-5-toedieningsweg-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 3 (initieren scenario) Stoppen==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-3-1a-stoppen-v20 /><section begin=patient-av-mp-va-tst-3-1a-stoppen-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-2-4-aanvullendeinformatie-v30 /><section end=av-mp-va-tst-2-4-aanvullendeinformatie-v30 />
 +
== TEST Scenarioset 2 Toedieningsweg los==
 +
<section begin=av-mp-va-tst-2-5-toedieningsweg-v30 /><section begin=patient-av-mp-va-tst-2-5-toedieningsweg-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 2.078: Regel 2.210:
 
|colspan="5"|Naamgegevens
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="7"|
+
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|colspan="3"|Initialen
−
|style="background-color: white;"|J.
+
|style="background-color: white;"|C.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="2"|
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Voorvoegsels
 
−
|style="background-color: white;"|de
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Luzac
+
|style="background-color: white;"|XXX_Coenen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900778 [BSN]
+
|style="background-color: white;"|999900420 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|24 okt 1985
+
|style="background-color: white;"|17 okt 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-3-1a-stoppen-v20 /><section begin=mbhs-av-mp-va-tst-3-1a-stoppen-v20 />
+
|}<section end=patient-av-mp-va-tst-2-5-toedieningsweg-v30 /><section begin=mbhs-av-mp-va-tst-2-5-toedieningsweg-v30 />
−
==== Scenario 3.1a - MBH_200_stoppen====
+
==== Scenario 2.5 - MBH_300_Toedieningsweg-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_stoppen_TA_start
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_Toedieningsweg_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 2.115: Regel 2.244:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_stoppen_TA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_Toedieningsweg_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 09:00 uur
+
|style="background-color: white;"|T om 09:15 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 280 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 7 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
Regel 2.129: Regel 2.258:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|colspan="2"|Einddatum
−
|style="background-color: white;"|T + 280 dagen
+
|style="background-color: white;"|T + 7 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 2.136: Regel 2.265:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|SOFRADEX OORDRUPPELS (code = '644781' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="4"|
+
|rowspan="5"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, tot en met T + 280 dagen, 1 maal per dag 1 stuk, Oraal
+
|style="background-color: white;"|2 maal per dag 1 druppel, In het rechter oog, oculair
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|AanvullendeInstructie
 +
|style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): In het rechter oog
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|1 maal per dag 1 stuk
+
|style="background-color: white;"|2 maal per dag 1 druppel
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Toelichting
 +
|style="background-color: white;"|Gebruiksinstructie gegeven
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_stoppen_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_Toedieningsweg_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_stoppen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_Toedieningsweg-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_stoppen_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_Toedieningsweg_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 2.178: Regel 2.313:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_stoppen_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_Toedieningsweg_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 09:00 uur
+
|style="background-color: white;"|T om 09:15 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 2.188: Regel 2.323:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|180 stuks
+
|style="background-color: white;"|1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|SOFRADEX OORDRUPPELS (code = '644781' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_stoppen_VV
+
|style="background-color: white;"|MBH_300_Toedieningsweg_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_stoppen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_Toedieningsweg-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 2.216: Regel 2.351:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-3-1a-stoppen-v20 /><section end=av-mp-va-tst-3-1a-stoppen-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 3 Stoppen==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-3-1b-stoppen-v20 /><section begin=patient-av-mp-va-tst-3-1b-stoppen-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-2-5-toedieningsweg-v30 /><section end=av-mp-va-tst-2-5-toedieningsweg-v30 />
 +
== TEST Scenarioset 3 (initieren scenario) Stoppen==
 +
<section begin=av-mp-va-tst-3-1a-stoppen-v30 /><section begin=patient-av-mp-va-tst-3-1a-stoppen-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 2.239: Regel 2.377:
 
|rowspan="7"|
 
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Initialen
+
|colspan="3"|Voornamen
−
|style="background-color: white;"|J.
+
|style="background-color: white;"|C
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 2.250: Regel 2.388:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Voorvoegsels
 
|colspan="2"|Voorvoegsels
−
|style="background-color: white;"|de
+
|style="background-color: white;"|van de
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Luzac
+
|style="background-color: white;"|XXX_Voortman
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900778 [BSN]
+
|style="background-color: white;"|999908881 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|24 okt 1985
+
|style="background-color: white;"|18 sep 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-3-1b-stoppen-v20 /><section begin=mbhs-av-mp-va-tst-3-1b-stoppen-v20 />
+
|}<section end=patient-av-mp-va-tst-3-1a-stoppen-v30 /><section begin=mbhs-av-mp-va-tst-3-1a-stoppen-v30 />
−
==== Scenario 3.1b - MBH_200_stoppen====
+
==== Scenario 3.1a - MBH_300_stoppen-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_stoppen_TA_staken
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_stoppen_TA_start-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 2.274: Regel 2.412:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_stoppen_TA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_stoppen_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 19:00 uur
+
|style="background-color: white;"|T om 09:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 1 dag''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 280 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
Regel 2.288: Regel 2.426:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|colspan="2"|Einddatum
−
|style="background-color: white;"|T + 1 dag
+
|style="background-color: white;"|T + 280 dagen
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Toedieningsafspraak stop type
 
−
|style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT')
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 2.298: Regel 2.433:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
Regel 2.314: Regel 2.449:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, tot en met T + 1 dag, 1 maal per dag 1 stuk, Oraal, definitief gestopt
+
|style="background-color: white;"|1 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
Regel 2.322: Regel 2.457:
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_stoppen_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_stoppen_MA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_stoppen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_stoppen_MVE-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_stoppen_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MedicatieverstrekkingsDatumTijd
 +
|style="background-color: white;"|T om 09:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|VerstrekteHoeveelheid
 +
|style="background-color: white;"|180 stuks
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RelatieVerstrekkingsverzoek
 +
|style="background-color: white;"|MBH_300_stoppen_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_stoppen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_stoppen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 2.340: Regel 2.513:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_Jansen_en_Co" title="Intern ID = Apotheek_Jansen_en_Co">Zorgaanbieder Apotheek_Jansen_en_Co</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|ZorgaanbiederIdentificatienummer
 +
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|OrganisatieNaam
−
|style="background-color: white;"|99901111 (in identificerend systeem: URA)
+
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|Adresgegevens
−
|style="background-color: white;"|Apotheek Jansen en Co
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
−
|}<section end=mbhs-av-mp-va-tst-3-1b-stoppen-v20 /><section end=av-mp-va-tst-3-1b-stoppen-v20 />
+
|}<section end=mbhs-av-mp-va-tst-3-1a-stoppen-v30 /><section end=av-mp-va-tst-3-1a-stoppen-v30 />
−
== TEST Scenarioset 3 (initieren scenario) Wijzigen (verhoging)==
+
== TEST Scenarioset 3 Stoppen==
−
<section begin=av-mp-va-tst-3-2a-wijzigen-verhoging-v20 /><section begin=patient-av-mp-va-tst-3-2a-wijzigen-verhoging-v20 />
+
<section begin=av-mp-va-tst-3-1b-stoppen-v30 /><section begin=patient-av-mp-va-tst-3-1b-stoppen-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 2.363: Regel 2.539:
 
|rowspan="7"|
 
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Initialen
+
|colspan="3"|Voornamen
−
|style="background-color: white;"|J.
+
|style="background-color: white;"|C
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 2.374: Regel 2.550:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Voorvoegsels
 
|colspan="2"|Voorvoegsels
−
|style="background-color: white;"|de
+
|style="background-color: white;"|van de
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Luzac
+
|style="background-color: white;"|XXX_Voortman
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900778 [BSN]
+
|style="background-color: white;"|999908881 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|24 okt 1985
+
|style="background-color: white;"|18 sep 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-3-2a-wijzigen-verhoging-v20 /><section begin=mbhs-av-mp-va-tst-3-2a-wijzigen-verhoging-v20 />
+
|}<section end=patient-av-mp-va-tst-3-1b-stoppen-v30 /><section begin=mbhs-av-mp-va-tst-3-1b-stoppen-v30 />
−
==== Scenario 3.2a - MBH_200_wijzigen_verhoging====
+
==== Scenario 3.1b - MBH_300_stoppen-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_wijzigen_verhoging_TA_start
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_stoppen_TA_staken-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 2.398: Regel 2.574:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_wijzigen_verhoging_TA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_stoppen_TA_staken-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 09:02 uur
+
|style="background-color: white;"|T om 19:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T om 09:00 uur''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 1 dag''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="2"|
+
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|colspan="2"|Ingangsdatum
−
|style="background-color: white;"|T om 09:00 uur
+
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T + 1 dag
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|ToedieningsafspraakStopType
 +
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 2.416: Regel 2.598:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_JANSEN_EN_CO|Zorgaanbieder: APOTHEEK_JANSEN_EN_CO]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
Regel 2.432: Regel 2.614:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T om 09:00 uur, 1 maal per dag 1 stuk, Oraal
+
|style="background-color: white;"|1 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
Regel 2.440: Regel 2.622:
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_wijzigen_verhoging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_stoppen_MA_staken-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|MBH identificatie
 
−
|style="background-color: white;"|MBH_200_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
−
|}
 
−
{| class="wikitable" width="85%"
 
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_wijzigen_verhoging_MVE
 
−
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
−
|colspan="3" width="25%"| Gegevenselement
 
−
|| Waarde
 
−
 
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Identificatie
 
−
|style="background-color: white;"|MBH_200_wijzigen_verhoging_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Medicatieverstrekkings datum tijd
 
−
|style="background-color: white;"|T om 09:02 uur
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Verstrekker
+
|colspan="4"|RelatieToedieningsafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder
+
|colspan="2"|Identificatie
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|MBH_300_stoppen_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Verstrekte hoeveelheid
 
−
|style="background-color: white;"|30 stuks
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Geneesmiddel - primaire code
 
−
|style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK')
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Geneesmiddel - generiekere code
 
−
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Geneesmiddel - generiekere code
 
−
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Relatie verstrekkingsverzoek
 
−
|style="background-color: white;"|MBH_200_wijzigen_verhoging_VV
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_stoppen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 2.496: Regel 2.647:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_JANSEN_EN_CO" title="Intern ID = APOTHEEK_JANSEN_EN_CO">Zorgaanbieder APOTHEEK_JANSEN_EN_CO</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
−
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
+
|style="background-color: white;"|99901111 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
−
|style="background-color: white;"|Apotheek De Gulle Gaper
+
|style="background-color: white;"|Apotheek Jansen en Co
−
|}<section end=mbhs-av-mp-va-tst-3-2a-wijzigen-verhoging-v20 /><section end=av-mp-va-tst-3-2a-wijzigen-verhoging-v20 />
+
|}<section end=mbhs-av-mp-va-tst-3-1b-stoppen-v30 /><section end=av-mp-va-tst-3-1b-stoppen-v30 />
−
== TEST Scenarioset 3 Wijzigen (verhoging)==
+
== TEST Scenarioset 3 (initieren scenario) Wijzigen (verhoging)==
−
<section begin=av-mp-va-tst-3-2b-wijzigen-verhoging-v20 /><section begin=patient-av-mp-va-tst-3-2b-wijzigen-verhoging-v20 />
+
<section begin=av-mp-va-tst-3-2a-wijzigen-verhoging-v30 /><section begin=patient-av-mp-va-tst-3-2a-wijzigen-verhoging-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 2.519: Regel 2.670:
 
|rowspan="7"|
 
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Initialen
+
|colspan="3"|Voornamen
−
|style="background-color: white;"|J.
+
|style="background-color: white;"|C
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 2.530: Regel 2.681:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Voorvoegsels
 
|colspan="2"|Voorvoegsels
−
|style="background-color: white;"|de
+
|style="background-color: white;"|van de
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Luzac
+
|style="background-color: white;"|XXX_Voortman
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900778 [BSN]
+
|style="background-color: white;"|999908881 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|24 okt 1985
+
|style="background-color: white;"|18 sep 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-3-2b-wijzigen-verhoging-v20 /><section begin=mbhs-av-mp-va-tst-3-2b-wijzigen-verhoging-v20 />
+
|}<section end=patient-av-mp-va-tst-3-2a-wijzigen-verhoging-v30 /><section begin=mbhs-av-mp-va-tst-3-2a-wijzigen-verhoging-v30 />
−
==== Scenario 3.2b - MBH_200_wijzigen_verhoging====
+
==== Scenario 3.2a - MBH_300_wijzigen_verhoging-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_wijzigen_verhoging_TA_wijzigingmetMVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_wijzigen_verhoging_TA_start-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 2.554: Regel 2.705:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_wijzigen_verhoging_TA_wijzigingmetMVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_wijzigen_verhoging_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
 
|style="background-color: white;"|T om 09:02 uur
 
|style="background-color: white;"|T om 09:02 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
Regel 2.572: Regel 2.723:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
Regel 2.588: Regel 2.739:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T om 09:00 uur, 1 maal per dag 2 stuks, Oraal
+
|style="background-color: white;"|1 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
Regel 2.594: Regel 2.745:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|1 maal per dag 2 stuks
+
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_wijzigen_verhoging_MA_wijzigingmetVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_wijzigen_verhoging_MA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_wijzigen_verhoging-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_wijzigen_verhoging_TA_techstaken
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_wijzigen_verhoging_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 2.614: Regel 2.765:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_wijzigen_verhoging_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_wijzigen_verhoging_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
 
|style="background-color: white;"|T om 09:02 uur
 
|style="background-color: white;"|T om 09:02 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="3"|Gebruiksperiode
+
|colspan="4"|Verstrekker
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T om 09:00 uur''
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|rowspan="3"|
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Ingangsdatum
 
−
|style="background-color: white;"|T
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Einddatum
 
−
|style="background-color: white;"|T om 09:00 uur
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Toedieningsafspraak stop type
 
−
|style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT')
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="4"|Verstrekker
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|VerstrekteHoeveelheid
 +
|style="background-color: white;"|30 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
Regel 2.648: Regel 2.788:
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
 
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
 
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="4"|Gebruiksinstructie
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|rowspan="4"|
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Omschrijving
 
−
|style="background-color: white;"|Vanaf T, tot en met T om 09:00 uur, 1 maal per dag 1 stuk, Oraal, definitief gestopt
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Toedieningsweg
 
−
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Doseerinstructie
 
−
|style="background-color: white;"|1 maal per dag 1 stuk
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="4"|Relatie medicatieafspraak
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|rowspan="2"|
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Identificatie
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_wijzigen_verhoging_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_wijzigen_verhoging_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_wijzigen_verhoging-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 +
==== Bouwstenen ====
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_wijzigen_verhoging_MVE_extra
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
|| Waarde
  
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Identificatie
+
|rowspan="4"|
−
|style="background-color: white;"|MBH_200_wijzigen_verhoging_MVE_extra (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="2"|ZorgaanbiederIdentificatienummer
−
|style="background-color: white;"|T om 09:02 uur
+
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="4"|Verstrekker
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="2"|
+
|colspan="2"|OrganisatieNaam
 +
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder
+
|colspan="2"|Adresgegevens
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-3-2a-wijzigen-verhoging-v30 /><section end=av-mp-va-tst-3-2a-wijzigen-verhoging-v30 />
 +
== TEST Scenarioset 3 Wijzigen (verhoging)==
 +
<section begin=av-mp-va-tst-3-2b-wijzigen-verhoging-v30 /><section begin=patient-av-mp-va-tst-3-2b-wijzigen-verhoging-v30 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="4" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|rowspan="7"|
−
|style="background-color: white;"|60 stuks
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - primaire code
+
|colspan="3"|Voornamen
−
|style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|C
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - generiekere code
+
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="3"|Geneesmiddel - generiekere code
 
−
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Relatie verstrekkingsverzoek
 
−
|style="background-color: white;"|MBH_200_wijzigen_verhoging_VV_extra
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|MBH identificatie
 
−
|style="background-color: white;"|MBH_200_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
−
|}
 
−
==== Bouwstenen ====
 
−
{| class="wikitable" width="85%"
 
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 
−
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
−
|colspan="3" width="25%"| Gegevenselement
 
−
|| Waarde
 
−
 
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|rowspan="3"|
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Zorgaanbieder identificatienummer
 
−
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Organisatie naam
 
−
|style="background-color: white;"|Apotheek De Gulle Gaper
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="4"|<span id="Apotheek_Jansen_en_Co" title="Intern ID = Apotheek_Jansen_en_Co">Zorgaanbieder Apotheek_Jansen_en_Co</span>
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|rowspan="3"|
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Zorgaanbieder identificatienummer
 
−
|style="background-color: white;"|99901111 (in identificerend systeem: URA)
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Organisatie naam
 
−
|style="background-color: white;"|Apotheek Jansen en Co
 
−
|}<section end=mbhs-av-mp-va-tst-3-2b-wijzigen-verhoging-v20 /><section end=av-mp-va-tst-3-2b-wijzigen-verhoging-v20 />
 
−
== TEST Scenarioset 3 (initieren scenario) Wijzigen (verlaging)==
 
−
<section begin=av-mp-va-tst-3-3a-wijzigen-verlaging-v20 /><section begin=patient-av-mp-va-tst-3-3a-wijzigen-verlaging-v20 />
 
−
{| class="wikitable" width="85%"
 
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
−
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
−
|colspan="4" width="25%"| Gegevenselement
 
−
|| Waarde
 
−
 
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="5"|Naamgegevens
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|rowspan="7"|
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Initialen
 
−
|style="background-color: white;"|J.
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Naamgebruik
 
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
Regel 2.762: Regel 2.840:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Voorvoegsels
 
|colspan="2"|Voorvoegsels
−
|style="background-color: white;"|de
+
|style="background-color: white;"|van de
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Luzac
+
|style="background-color: white;"|XXX_Voortman
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900778 [BSN]
+
|style="background-color: white;"|999908881 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|24 okt 1985
+
|style="background-color: white;"|18 sep 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-3-3a-wijzigen-verlaging-v20 /><section begin=mbhs-av-mp-va-tst-3-3a-wijzigen-verlaging-v20 />
+
|}<section end=patient-av-mp-va-tst-3-2b-wijzigen-verhoging-v30 /><section begin=mbhs-av-mp-va-tst-3-2b-wijzigen-verhoging-v30 />
−
==== Scenario 3.3a - MBH_200_wijzigen_verlaging====
+
==== Scenario 3.2b - MBH_300_wijzigen_verhoging-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_wijzigen_verlaging_TA_start
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_wijzigen_verhoging_TA_wijzigingmetMVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 2.786: Regel 2.864:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_wijzigen_verlaging_TA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_wijzigen_verhoging_TA_wijzigingmetMVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 09:05 uur
+
|style="background-color: white;"|T om 09:02 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 27 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T om 09:00 uur''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|colspan="2"|Ingangsdatum
−
|style="background-color: white;"|T
+
|style="background-color: white;"|T om 09:00 uur
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="2"|Einddatum
+
|colspan="4"|Verstrekker
−
|style="background-color: white;"|T + 27 dagen
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
−
|colspan="4"|Verstrekker
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
Regel 2.823: Regel 2.898:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, tot en met T + 27 dagen, 1 maal per week 1 stuk, Oraal
+
|style="background-color: white;"|1 maal per dag 2 stuks, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
Regel 2.829: Regel 2.904:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|1 maal per week 1 stuk
+
|style="background-color: white;"|1 maal per dag 2 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_wijzigen_verlaging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_wijzigen_verhoging_MA_wijzigingmetVV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_wijzigen_verlaging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_wijzigen_verhoging-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_wijzigen_verlaging_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_wijzigen_verhoging_TA_techstaken-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 2.849: Regel 2.924:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_wijzigen_verlaging_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_wijzigen_verhoging_TA_techstaken-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 09:05 uur
+
|style="background-color: white;"|T om 09:02 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="3"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T om 09:00 uur''
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T om 09:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|ToedieningsafspraakStopType
 +
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 2.859: Regel 2.948:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_JANSEN_EN_CO|Zorgaanbieder: APOTHEEK_JANSEN_EN_CO]]
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Verstrekte hoeveelheid
 
−
|style="background-color: white;"|20 stuks
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|MBH_200_wijzigen_verlaging_VV
+
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|MBH identificatie
+
|rowspan="4"|
−
|style="background-color: white;"|MBH_200_wijzigen_verlaging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
−
|}
 
−
==== Bouwstenen ====
 
−
{| class="wikitable" width="85%"
 
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 
−
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
−
|colspan="3" width="25%"| Gegevenselement
 
−
|| Waarde
 
−
 
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|colspan="2"|Omschrijving
 +
|style="background-color: white;"|1 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
+
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|Apotheek De Gulle Gaper
+
|style="background-color: white;"|1 maal per dag 1 stuk
−
|}<section end=mbhs-av-mp-va-tst-3-3a-wijzigen-verlaging-v20 /><section end=av-mp-va-tst-3-3a-wijzigen-verlaging-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
== TEST Scenarioset 3 Wijzigen (verlaging)==
+
|colspan="4"|RelatieMedicatieafspraak
−
<section begin=av-mp-va-tst-3-3b-wijzigen-verlaging-v20 /><section begin=patient-av-mp-va-tst-3-3b-wijzigen-verlaging-v20 />
 
−
{| class="wikitable" width="85%"
 
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
−
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
−
|colspan="4" width="25%"| Gegevenselement
 
−
|| Waarde
 
−
 
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
−
|colspan="5"|Naamgegevens
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="7"|
+
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Initialen
+
|colspan="2"|Identificatie
−
|style="background-color: white;"|J.
+
|style="background-color: white;"|MBH_300_wijzigen_verhoging_MA_techstaken-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Naamgebruik
 
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Geslachtsnaam
+
|colspan="4"|RelatieToedieningsafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Voorvoegsels
+
|colspan="2"|Identificatie
−
|style="background-color: white;"|de
+
|style="background-color: white;"|MBH_300_wijzigen_verhoging_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Achternaam
+
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|XXX_Luzac
+
|style="background-color: white;"|MBH_300_wijzigen_verhoging-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|}
−
|colspan="4"|Identificatienummer
 
−
|style="background-color: white;"|999900778 [BSN]
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="4"|Geboortedatum
 
−
|style="background-color: white;"|24 okt 1985
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="4"|Geslacht
 
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
 
−
|}<section end=patient-av-mp-va-tst-3-3b-wijzigen-verlaging-v20 /><section begin=mbhs-av-mp-va-tst-3-3b-wijzigen-verlaging-v20 />
 
−
==== Scenario 3.3b - MBH_200_wijzigen_verlaging====
 
−
 
 
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_wijzigen_verlaging_TA_wijzigingzonderMVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_wijzigen_verhoging_MVE_extra-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 2.942: Regel 2.997:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_wijzigen_verlaging_TA_wijzigingzonderMVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_wijzigen_verhoging_MVE_extra-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 09:10 uur
+
|style="background-color: white;"|T om 09:02 uur
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="3"|Gebruiksperiode
 
−
|style="background-color: #E3E3E3;;"|''Vanaf T + 6 dagen, tot en met T + 14 dagen''
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|rowspan="3"|
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Ingangsdatum
 
−
|style="background-color: white;"|T + 6 dagen
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Einddatum
 
−
|style="background-color: white;"|T + 14 dagen
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 2.963: Regel 3.007:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|VerstrekteHoeveelheid
 +
|style="background-color: white;"|60 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="4"|Gebruiksinstructie
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="4"|
+
|colspan="3"|RelatieVerstrekkingsverzoek
 +
|style="background-color: white;"|MBH_300_wijzigen_verhoging_VV_extra-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Omschrijving
+
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|Vanaf T + 6 dagen, tot en met T + 14 dagen, 1 maal per week 1 stuk, Oraal
+
|style="background-color: white;"|MBH_300_wijzigen_verhoging-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
==== Bouwstenen ====
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|ZorgaanbiederIdentificatienummer
 +
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|OrganisatieNaam
 +
|style="background-color: white;"|Apotheek De Gulle Gaper
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|<span id="APOTHEEK_JANSEN_EN_CO" title="Intern ID = APOTHEEK_JANSEN_EN_CO">Zorgaanbieder APOTHEEK_JANSEN_EN_CO</span>
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|ZorgaanbiederIdentificatienummer
 +
|style="background-color: white;"|99901111 (in identificerend systeem: URA)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|OrganisatieNaam
 +
|style="background-color: white;"|Apotheek Jansen en Co
 +
|}<section end=mbhs-av-mp-va-tst-3-2b-wijzigen-verhoging-v30 /><section end=av-mp-va-tst-3-2b-wijzigen-verhoging-v30 />
 +
== TEST Scenarioset 3 (initieren scenario) Wijzigen (verlaging)==
 +
<section begin=av-mp-va-tst-3-3a-wijzigen-verlaging-v30 /><section begin=patient-av-mp-va-tst-3-3a-wijzigen-verlaging-v30 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="4" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Naamgegevens
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Toedieningsweg
+
|colspan="3"|Voornamen
−
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|C
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Doseerinstructie
+
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|1 maal per week 1 stuk
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|Geslachtsnaam
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="2"|
+
|colspan="2"|Voorvoegsels
 +
|style="background-color: white;"|van de
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Achternaam
 +
|style="background-color: white;"|XXX_Voortman
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Identificatienummer
 +
|style="background-color: white;"|999908881 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Identificatie
+
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|MBH_200_wijzigen_verlaging_MA_wijzigingzonderVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|18 sep 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|MBH identificatie
+
|colspan="4"|Geslacht
−
|style="background-color: white;"|MBH_200_wijzigen_verlaging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}
+
|}<section end=patient-av-mp-va-tst-3-3a-wijzigen-verlaging-v30 /><section begin=mbhs-av-mp-va-tst-3-3a-wijzigen-verlaging-v30 />
 +
==== Scenario 3.3a - MBH_300_wijzigen_verlaging-tav====
 +
 
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_wijzigen_verlaging_TA_techstaken
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_wijzigen_verlaging_TA_start-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 3.005: Regel 3.106:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_wijzigen_verlaging_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_wijzigen_verlaging_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 09:10 uur
+
|style="background-color: white;"|T om 09:05 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 6 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 27 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
Regel 3.019: Regel 3.120:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|colspan="2"|Einddatum
−
|style="background-color: white;"|T + 6 dagen
+
|style="background-color: white;"|T + 27 dagen
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Toedieningsafspraak stop type
 
−
|style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT')
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 3.029: Regel 3.127:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
Regel 3.045: Regel 3.143:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, tot en met T + 6 dagen, 2 maal per week 1 stuk, Oraal, definitief gestopt
+
|style="background-color: white;"|1 maal per week 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
+
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|2 maal per week 1 stuk
+
|style="background-color: white;"|1 maal per week 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_wijzigen_verlaging_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_wijzigen_verlaging_MA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_wijzigen_verlaging-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_wijzigen_verlaging_MVE-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_wijzigen_verlaging_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MedicatieverstrekkingsDatumTijd
 +
|style="background-color: white;"|T om 09:05 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|VerstrekteHoeveelheid
 +
|style="background-color: white;"|20 stuks
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RelatieVerstrekkingsverzoek
 +
|style="background-color: white;"|MBH_300_wijzigen_verlaging_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_wijzigen_verlaging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_wijzigen_verlaging-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 3.071: Regel 3.204:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_Jansen_en_Co" title="Intern ID = Apotheek_Jansen_en_Co">Zorgaanbieder Apotheek_Jansen_en_Co</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 +
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|OrganisatieNaam
−
|style="background-color: white;"|99901111 (in identificerend systeem: URA)
+
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|Adresgegevens
−
|style="background-color: white;"|Apotheek Jansen en Co
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
−
|}<section end=mbhs-av-mp-va-tst-3-3b-wijzigen-verlaging-v20 /><section end=av-mp-va-tst-3-3b-wijzigen-verlaging-v20 />
+
|}<section end=mbhs-av-mp-va-tst-3-3a-wijzigen-verlaging-v30 /><section end=av-mp-va-tst-3-3a-wijzigen-verlaging-v30 />
−
== TEST Scenarioset 3 (initieren scenario) Onderbreken ==
+
== TEST Scenarioset 3 Wijzigen (verlaging)==
−
<section begin=av-mp-va-tst-3-4a-onderbreken-v20 /><section begin=patient-av-mp-va-tst-3-4a-onderbreken-v20 />
+
<section begin=av-mp-va-tst-3-3b-wijzigen-verlaging-v30 /><section begin=patient-av-mp-va-tst-3-3b-wijzigen-verlaging-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 3.094: Regel 3.230:
 
|rowspan="7"|
 
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Initialen
+
|colspan="3"|Voornamen
−
|style="background-color: white;"|J.
+
|style="background-color: white;"|C
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 3.105: Regel 3.241:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Voorvoegsels
 
|colspan="2"|Voorvoegsels
−
|style="background-color: white;"|de
+
|style="background-color: white;"|van de
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Luzac
+
|style="background-color: white;"|XXX_Voortman
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900778 [BSN]
+
|style="background-color: white;"|999908881 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|24 okt 1985
+
|style="background-color: white;"|18 sep 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-3-4a-onderbreken-v20 /><section begin=mbhs-av-mp-va-tst-3-4a-onderbreken-v20 />
+
|}<section end=patient-av-mp-va-tst-3-3b-wijzigen-verlaging-v30 /><section begin=mbhs-av-mp-va-tst-3-3b-wijzigen-verlaging-v30 />
−
==== Scenario 3.4a - MBH_200_onderbreken====
+
==== Scenario 3.3b - MBH_300_wijzigen_verlaging-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_onderbreken_TA_start
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_wijzigen_verlaging_TA_wijzigingzonderMVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 3.129: Regel 3.265:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_onderbreken_TA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_wijzigen_verlaging_TA_wijzigingzonderMVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 09:06 uur
+
|style="background-color: white;"|T om 09:10 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 10 dagen om 15:00 uur''
+
|style="background-color: #E3E3E3;;"|''Vanaf T + 6 dagen, tot en met T + 14 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|colspan="2"|Ingangsdatum
−
|style="background-color: white;"|T
+
|style="background-color: white;"|T + 6 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|colspan="2"|Einddatum
−
|style="background-color: white;"|T + 10 dagen om 15:00 uur
+
|style="background-color: white;"|T + 14 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 3.150: Regel 3.286:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_JANSEN_EN_CO|Zorgaanbieder: APOTHEEK_JANSEN_EN_CO]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
Regel 3.166: Regel 3.302:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, tot en met T + 10 dagen om 15:00 uur, 3 maal per dag 1 stuk, Oraal
+
|style="background-color: white;"|1 maal per week 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
Regel 3.172: Regel 3.308:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|3 maal per dag 1 stuk
+
|style="background-color: white;"|1 maal per week 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_onderbreken_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_wijzigen_verlaging_MA_wijzigingzonderVV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_wijzigen_verlaging-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_onderbreken_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_wijzigen_verlaging_TA_techstaken-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 3.192: Regel 3.328:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_onderbreken_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_wijzigen_verlaging_TA_techstaken-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RegistratieDatumTijd
 +
|style="background-color: white;"|T om 09:10 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="3"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 6 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|rowspan="3"|
−
|style="background-color: white;"|T om 09:06 uur
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T + 6 dagen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|ToedieningsafspraakStopType
 +
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 3.202: Regel 3.352:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_JANSEN_EN_CO|Zorgaanbieder: APOTHEEK_JANSEN_EN_CO]]
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Verstrekte hoeveelheid
 
−
|style="background-color: white;"|30 stuks
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Gebruiksinstructie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Omschrijving
 +
|style="background-color: white;"|2 maal per week 1 stuk, Oraal
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Toedieningsweg
 +
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Doseerinstructie
 +
|style="background-color: white;"|2 maal per week 1 stuk
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|rowspan="2"|
−
|style="background-color: white;"|MBH_200_onderbreken_VV
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_wijzigen_verlaging_MA_techstaken-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieToedieningsafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_wijzigen_verlaging_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_wijzigen_verlaging-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 3.230: Regel 3.401:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_JANSEN_EN_CO" title="Intern ID = APOTHEEK_JANSEN_EN_CO">Zorgaanbieder APOTHEEK_JANSEN_EN_CO</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
−
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
+
|style="background-color: white;"|99901111 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
−
|style="background-color: white;"|Apotheek De Gulle Gaper
+
|style="background-color: white;"|Apotheek Jansen en Co
−
|}<section end=mbhs-av-mp-va-tst-3-4a-onderbreken-v20 /><section end=av-mp-va-tst-3-4a-onderbreken-v20 />
+
|}<section end=mbhs-av-mp-va-tst-3-3b-wijzigen-verlaging-v30 /><section end=av-mp-va-tst-3-3b-wijzigen-verlaging-v30 />
−
== TEST Scenarioset 3 Onderbreken ==
+
== TEST Scenarioset 3 (initieren scenario) Onderbreken ==
−
<section begin=av-mp-va-tst-3-4b-onderbreken-v20 /><section begin=patient-av-mp-va-tst-3-4b-onderbreken-v20 />
+
<section begin=av-mp-va-tst-3-4a-onderbreken-v30 /><section begin=patient-av-mp-va-tst-3-4a-onderbreken-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 3.253: Regel 3.424:
 
|rowspan="7"|
 
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Initialen
+
|colspan="3"|Voornamen
−
|style="background-color: white;"|J.
+
|style="background-color: white;"|C
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 3.264: Regel 3.435:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Voorvoegsels
 
|colspan="2"|Voorvoegsels
−
|style="background-color: white;"|de
+
|style="background-color: white;"|van de
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Luzac
+
|style="background-color: white;"|XXX_Voortman
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900778 [BSN]
+
|style="background-color: white;"|999908881 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|24 okt 1985
+
|style="background-color: white;"|18 sep 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-3-4b-onderbreken-v20 /><section begin=mbhs-av-mp-va-tst-3-4b-onderbreken-v20 />
+
|}<section end=patient-av-mp-va-tst-3-4a-onderbreken-v30 /><section begin=mbhs-av-mp-va-tst-3-4a-onderbreken-v30 />
−
==== Scenario 3.4b - MBH_200_onderbreken====
+
==== Scenario 3.4a - MBH_300_onderbreken-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_onderbreken_TA_onderbreken
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_onderbreken_TA_start-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 3.288: Regel 3.459:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_onderbreken_TA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_onderbreken_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 19:12 uur
+
|style="background-color: white;"|T om 09:06 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T om 15:00 uur''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 10 dagen om 15:00 uur''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
Regel 3.302: Regel 3.473:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|colspan="2"|Einddatum
−
|style="background-color: white;"|T om 15:00 uur
+
|style="background-color: white;"|T + 10 dagen om 15:00 uur
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Toedieningsafspraak stop type
 
−
|style="background-color: white;"|tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT')
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 3.312: Regel 3.480:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
Regel 3.321: Regel 3.489:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
Regel 3.328: Regel 3.496:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, tot en met T om 15:00 uur, 3 maal per dag 1 stuk, Oraal, tijdelijk gestopt
+
|style="background-color: white;"|3 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
+
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|3 maal per dag 1 stuk
 
|style="background-color: white;"|3 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_onderbreken_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_onderbreken_MA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_onderbreken-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_onderbreken_MVE-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_onderbreken_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MedicatieverstrekkingsDatumTijd
 +
|style="background-color: white;"|T om 09:06 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|VerstrekteHoeveelheid
 +
|style="background-color: white;"|30 stuks
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RelatieVerstrekkingsverzoek
 +
|style="background-color: white;"|MBH_300_onderbreken_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_onderbreken-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 3.354: Regel 3.560:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_Jansen_en_Co" title="Intern ID = Apotheek_Jansen_en_Co">Zorgaanbieder Apotheek_Jansen_en_Co</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 +
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|OrganisatieNaam
−
|style="background-color: white;"|99901111 (in identificerend systeem: URA)
+
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|Adresgegevens
−
|style="background-color: white;"|Apotheek Jansen en Co
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
−
|}<section end=mbhs-av-mp-va-tst-3-4b-onderbreken-v20 /><section end=av-mp-va-tst-3-4b-onderbreken-v20 />
+
|}<section end=mbhs-av-mp-va-tst-3-4a-onderbreken-v30 /><section end=av-mp-va-tst-3-4a-onderbreken-v30 />
−
== TEST Scenarioset 3 (initieren scenario) wijziging TA==
+
== TEST Scenarioset 3 Onderbreken ==
−
<section begin=av-mp-va-tst-3-5a-wijzigenTA-v20 /><section begin=patient-av-mp-va-tst-3-5a-wijzigenTA-v20 />
+
<section begin=av-mp-va-tst-3-4b-onderbreken-v30 /><section begin=patient-av-mp-va-tst-3-4b-onderbreken-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 3.377: Regel 3.586:
 
|rowspan="7"|
 
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Initialen
+
|colspan="3"|Voornamen
−
|style="background-color: white;"|J.
+
|style="background-color: white;"|C
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 3.388: Regel 3.597:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Voorvoegsels
 
|colspan="2"|Voorvoegsels
−
|style="background-color: white;"|de
+
|style="background-color: white;"|van de
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Luzac
+
|style="background-color: white;"|XXX_Voortman
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900778 [BSN]
+
|style="background-color: white;"|999908881 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|24 okt 1985
+
|style="background-color: white;"|18 sep 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-3-5a-wijzigenTA-v20 /><section begin=mbhs-av-mp-va-tst-3-5a-wijzigenTA-v20 />
+
|}<section end=patient-av-mp-va-tst-3-4b-onderbreken-v30 /><section begin=mbhs-av-mp-va-tst-3-4b-onderbreken-v30 />
−
==== Scenario 3.5a - MBH_200_TAwijzigen====
+
==== Scenario 3.4b - MBH_300_onderbreken-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_TAwijzigen_TA_start
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_onderbreken_TA_onderbreken-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 3.412: Regel 3.621:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_TAwijzigen_TA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_onderbreken_TA_onderbreken-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 12:30 uur
+
|style="background-color: white;"|T om 19:12 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, gedurende 28 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T om 15:00 uur''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
Regel 3.425: Regel 3.634:
 
|style="background-color: white;"|T
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Gebruiksduur
+
|colspan="2"|Einddatum
−
|style="background-color: white;"|28 dagen
+
|style="background-color: white;"|T om 15:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|ToedieningsafspraakStopType
 +
|style="background-color: white;"|onderbroken (code = '385655000' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 3.433: Regel 3.645:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_JANSEN_EN_CO|Zorgaanbieder: APOTHEEK_JANSEN_EN_CO]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
Regel 3.449: Regel 3.661:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, gedurende 28 dagen, 1 maal per dag 1 stuk, oraal
+
|style="background-color: white;"|3 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
+
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|1 maal per dag 1 stuk
+
|style="background-color: white;"|3 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_TAwijzigen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_onderbreken_MA_onderbreken-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|MBH identificatie
 
−
|style="background-color: white;"|MBH_200_TAwijzigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
−
|}
 
−
{| class="wikitable" width="85%"
 
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_TAwijzigen_MVE
 
−
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
−
|colspan="3" width="25%"| Gegevenselement
 
−
|| Waarde
 
−
 
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Identificatie
 
−
|style="background-color: white;"|MBH_200_TAwijzigen_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Medicatieverstrekkings datum tijd
 
−
|style="background-color: white;"|T om 12:30 uur
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Verstrekker
+
|colspan="4"|RelatieToedieningsafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder
+
|colspan="2"|Identificatie
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|MBH_300_onderbreken_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Verstrekte hoeveelheid
 
−
|style="background-color: white;"|10 stuks
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Geneesmiddel - primaire code
 
−
|style="background-color: white;"|PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK')
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Geneesmiddel - generiekere code
 
−
|style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK')
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Geneesmiddel - generiekere code
 
−
|style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK')
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Relatie verstrekkingsverzoek
 
−
|style="background-color: white;"|MBH_200_TAwijzigen_VV
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_TAwijzigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_onderbreken-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 3.513: Regel 3.694:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_JANSEN_EN_CO" title="Intern ID = APOTHEEK_JANSEN_EN_CO">Zorgaanbieder APOTHEEK_JANSEN_EN_CO</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
−
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
+
|style="background-color: white;"|99901111 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
−
|style="background-color: white;"|Apotheek De Gulle Gaper
+
|style="background-color: white;"|Apotheek Jansen en Co
−
|}<section end=mbhs-av-mp-va-tst-3-5a-wijzigenTA-v20 /><section end=av-mp-va-tst-3-5a-wijzigenTA-v20 />
+
|}<section end=mbhs-av-mp-va-tst-3-4b-onderbreken-v30 /><section end=av-mp-va-tst-3-4b-onderbreken-v30 />
−
== TEST Scenarioset 3 wijziging TA==
+
== TEST Scenarioset 3 (initieren scenario) wijziging TA==
−
<section begin=av-mp-va-tst-3-5b-wijzigenTA-v20 /><section begin=patient-av-mp-va-tst-3-5b-wijzigenTA-v20 />
+
<section begin=av-mp-va-tst-3-5a-wijzigenTA-v30 /><section begin=patient-av-mp-va-tst-3-5a-wijzigenTA-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 3.536: Regel 3.717:
 
|rowspan="7"|
 
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Initialen
+
|colspan="3"|Voornamen
−
|style="background-color: white;"|J.
+
|style="background-color: white;"|C
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 3.547: Regel 3.728:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Voorvoegsels
 
|colspan="2"|Voorvoegsels
−
|style="background-color: white;"|de
+
|style="background-color: white;"|van de
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Luzac
+
|style="background-color: white;"|XXX_Voortman
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900778 [BSN]
+
|style="background-color: white;"|999908881 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|24 okt 1985
+
|style="background-color: white;"|18 sep 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-3-5b-wijzigenTA-v20 /><section begin=mbhs-av-mp-va-tst-3-5b-wijzigenTA-v20 />
+
|}<section end=patient-av-mp-va-tst-3-5a-wijzigenTA-v30 /><section begin=mbhs-av-mp-va-tst-3-5a-wijzigenTA-v30 />
−
==== Scenario 3.5b - MBH_200_TAwijzigen====
+
==== Scenario 3.5a - MBH_300_TAwijzigen-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_TAwijzigen_TA_anderePRK
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_TAwijzigen_TA_start-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 3.571: Regel 3.752:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_TAwijzigen_TA_anderePRK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_TAwijzigen_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 12:35 uur
+
|style="background-color: white;"|T om 12:30 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, gedurende 18 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, gedurende 28 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
Regel 3.585: Regel 3.766:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Gebruiksduur
 
|colspan="2"|Gebruiksduur
−
|style="background-color: white;"|18 dagen
+
|style="background-color: white;"|28 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 3.592: Regel 3.773:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak reden wijzigen of staken
+
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|geneesmiddel niet voorradig (code = '182856006' in codeSystem 'SNOMED CT')
+
|style="background-color: white;"|PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - primaire code
+
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
Regel 3.608: Regel 3.789:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, gedurende 18 dagen, 2 maal per dag 1 stuk, oraal
+
|style="background-color: white;"|1 maal per dag 1 stuk, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
Regel 3.614: Regel 3.795:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|2 maal per dag 1 stuk
+
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_TAwijzigen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_TAwijzigen_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_TAwijzigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_TAwijzigen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_TAwijzigen_TA_techstaken
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_TAwijzigen_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 3.634: Regel 3.815:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_TAwijzigen_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_TAwijzigen_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
 
|style="background-color: white;"|T om 12:30 uur
 
|style="background-color: white;"|T om 12:30 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="3"|Gebruiksperiode
+
|colspan="4"|Verstrekker
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T''
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|rowspan="3"|
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Ingangsdatum
 
−
|style="background-color: white;"|T
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Einddatum
 
−
|style="background-color: white;"|T
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Toedieningsafspraak stop type
 
−
|style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT')
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="4"|Verstrekker
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|VerstrekteHoeveelheid
 +
|style="background-color: white;"|28 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
Regel 3.668: Regel 3.838:
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
 
|style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK')
 
|style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK')
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="4"|Gebruiksinstructie
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|rowspan="4"|
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Omschrijving
 
−
|style="background-color: white;"|Vanaf T, tot en met T, 1 maal per dag 1 stuk, Oraal, definitief gestopt
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Toedieningsweg
 
−
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Doseerinstructie
 
−
|style="background-color: white;"|1 maal per dag 1 stuk
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="4"|Relatie medicatieafspraak
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|rowspan="2"|
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Identificatie
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_TAwijzigen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_TAwijzigen_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_TAwijzigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_TAwijzigen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 +
==== Bouwstenen ====
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_TAwijzigen_MVE_anderePRK
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
|| Waarde
  
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Identificatie
+
|rowspan="4"|
−
|style="background-color: white;"|MBH_200_TAwijzigen_MVE_anderePRK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="2"|ZorgaanbiederIdentificatienummer
−
|style="background-color: white;"|T om 12:36 uur
+
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="4"|Verstrekker
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="2"|
+
|colspan="2"|OrganisatieNaam
 +
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder
+
|colspan="2"|Adresgegevens
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-3-5a-wijzigenTA-v30 /><section end=av-mp-va-tst-3-5a-wijzigenTA-v30 />
 +
== TEST Scenarioset 3 wijziging TA==
 +
<section begin=av-mp-va-tst-3-5b-wijzigenTA-v30 /><section begin=patient-av-mp-va-tst-3-5b-wijzigenTA-v30 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="4" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|rowspan="7"|
−
|style="background-color: white;"|28 stuks
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - primaire code
+
|colspan="3"|Voornamen
−
|style="background-color: white;"|PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|C
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - generiekere code
+
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="3"|Geneesmiddel - generiekere code
+
|colspan="4"|Geslachtsnaam
−
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK')
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Relatie verstrekkingsverzoek
 
−
|style="background-color: white;"|MBH_200_TAwijzigen_VV
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|MBH identificatie
 
−
|style="background-color: white;"|MBH_200_TAwijzigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
−
|}
 
−
==== Bouwstenen ====
 
−
{| class="wikitable" width="85%"
 
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 
−
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
−
|colspan="3" width="25%"| Gegevenselement
 
−
|| Waarde
 
−
 
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|Voorvoegsels
−
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
+
|style="background-color: white;"|van de
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Organisatie naam
 
−
|style="background-color: white;"|Apotheek De Gulle Gaper
 
−
|}<section end=mbhs-av-mp-va-tst-3-5b-wijzigenTA-v20 /><section end=av-mp-va-tst-3-5b-wijzigenTA-v20 />
 
−
== TEST Scenarioset 6 Variabele frequentie==
 
−
<section begin=av-mp-va-tst-6-1-variabele-frequentie-v20 /><section begin=patient-av-mp-va-tst-6-1-variabele-frequentie-v20 />
 
−
{| class="wikitable" width="85%"
 
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
−
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
−
|colspan="4" width="25%"| Gegevenselement
 
−
|| Waarde
 
−
 
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="5"|Naamgegevens
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|rowspan="6"|
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Initialen
 
−
|style="background-color: white;"|G.
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Naamgebruik
 
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="4"|Geslachtsnaam
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|rowspan="2"|
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Hemsbergen
+
|style="background-color: white;"|XXX_Voortman
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900602 [BSN]
+
|style="background-color: white;"|999908881 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|2 nov 1963
+
|style="background-color: white;"|18 sep 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-6-1-variabele-frequentie-v20 /><section begin=mbhs-av-mp-va-tst-6-1-variabele-frequentie-v20 />
+
|}<section end=patient-av-mp-va-tst-3-5b-wijzigenTA-v30 /><section begin=mbhs-av-mp-va-tst-3-5b-wijzigenTA-v30 />
−
==== Scenario 6.1 - MBH_200_variabelefrequentie====
+
==== Scenario 3.5b - MBH_300_TAwijzigen-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_variabelefrequentie_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_TAwijzigen_TA_anderePRK-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 3.793: Regel 3.914:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_variabelefrequentie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_TAwijzigen_TA_anderePRK-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 09:00 uur
+
|style="background-color: white;"|T om 12:35 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 16 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, gedurende 18 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
Regel 3.806: Regel 3.927:
 
|style="background-color: white;"|T
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Einddatum
+
|colspan="2"|Gebruiksduur
−
|style="background-color: white;"|T + 16 dagen
+
|style="background-color: white;"|18 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 3.814: Regel 3.935:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|ToedieningsafspraakRedenWijzigenOfStaken
 +
|style="background-color: white;"|geneesmiddel niet voorradig (code = '182856006' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK')
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="3"|Geneesmiddel - generiekere code
 
−
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK')
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
Regel 3.830: Regel 3.951:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, tot en met T + 16 dagen, 1 à 2 maal per dag 1 stuk, Oraal
+
|style="background-color: white;"|2 maal per dag 1 stuk, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|1 à 2 maal per dag 1 stuk
+
|style="background-color: white;"|2 maal per dag 1 stuk
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieMedicatieafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_TAwijzigen_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieToedieningsafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_variabelefrequentie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_TAwijzigen_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_TAwijzigen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_variabelefrequentie_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_TAwijzigen_TA_techstaken-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 3.856: Regel 3.984:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_variabelefrequentie_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_TAwijzigen_TA_techstaken-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 09:00 uur
+
|style="background-color: white;"|T om 12:30 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="3"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T''
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|ToedieningsafspraakStopType
 +
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 3.866: Regel 4.008:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Verstrekte hoeveelheid
 
−
|style="background-color: white;"|90 stuks
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Gebruiksinstructie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Omschrijving
 +
|style="background-color: white;"|1 maal per dag 1 stuk, Oraal
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Toedieningsweg
 +
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Doseerinstructie
 +
|style="background-color: white;"|1 maal per dag 1 stuk
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieMedicatieafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_TAwijzigen_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieToedieningsafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|rowspan="2"|
−
|style="background-color: white;"|MBH_200_variabelefrequentie_VV
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_TAwijzigen_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_TAwijzigen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
−
==== Bouwstenen ====
 
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_TAwijzigen_MVE_anderePRK-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_TAwijzigen_MVE_anderePRK-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MedicatieverstrekkingsDatumTijd
 +
|style="background-color: white;"|T om 12:36 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|VerstrekteHoeveelheid
 +
|style="background-color: white;"|28 stuks
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RelatieVerstrekkingsverzoek
 +
|style="background-color: white;"|MBH_300_TAwijzigen_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_TAwijzigen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
==== Bouwstenen ====
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 3.894: Regel 4.095:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
−
|style="background-color: white;"|Apotheek de Gulle Gaper
+
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-6-1-variabele-frequentie-v20 /><section end=av-mp-va-tst-6-1-variabele-frequentie-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 6 Interval==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-6-2-interval-v20 /><section begin=patient-av-mp-va-tst-6-2-interval-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-3-5b-wijzigenTA-v30 /><section end=av-mp-va-tst-3-5b-wijzigenTA-v30 />
 +
== TEST Scenarioset 3 (initieren scenario) annuleren==
 +
<section begin=av-mp-va-tst-3-6a-annuleren-v30 /><section begin=patient-av-mp-va-tst-3-6a-annuleren-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 3.915: Regel 4.119:
 
|colspan="5"|Naamgegevens
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="6"|
+
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Initialen
+
|colspan="3"|Voornamen
−
|style="background-color: white;"|G.
+
|style="background-color: white;"|C
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="2"|
+
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Voorvoegsels
 +
|style="background-color: white;"|van de
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Hemsbergen
+
|style="background-color: white;"|XXX_Voortman
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900602 [BSN]
+
|style="background-color: white;"|999908881 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|2 nov 1963
+
|style="background-color: white;"|18 sep 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-6-2-interval-v20 /><section begin=mbhs-av-mp-va-tst-6-2-interval-v20 />
+
|}<section end=patient-av-mp-va-tst-3-6a-annuleren-v30 /><section begin=mbhs-av-mp-va-tst-3-6a-annuleren-v30 />
−
==== Scenario 6.2 - MBH_200_interval====
+
==== Scenario 3.6a - MBH_300_annuleren-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_interval_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_annuleren_TA_starten-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 3.949: Regel 4.156:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_interval_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_annuleren_TA_starten-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 09:04 uur
+
|style="background-color: white;"|T om 14:10 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T''
+
|style="background-color: #E3E3E3;;"|''Vanaf T + 7 dagen, tot en met T + 49 dagen om 00:00 uur''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="2"|
+
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|colspan="2"|Ingangsdatum
−
|style="background-color: white;"|T
+
|style="background-color: white;"|T + 7 dagen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T + 49 dagen om 00:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 3.967: Regel 4.177:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|AMOXICILLINE DISPER SANDOZ TABLET 500MG (code = '802891' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|LARIAM TABLET 250MG (code = '602574' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|MEFLOQUINE TABLET 250MG (code = '25410' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|MEFLOQUINE TABLET 250MG (code = '66478' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
Regel 3.983: Regel 4.193:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, iedere 8 uur 1 stuk - let op, tijden exact aanhouden, Oraal
+
|style="background-color: white;"|1 maal per week 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|iedere 8 uur 1 stuk - let op, tijden exact aanhouden
+
|style="background-color: white;"|1 maal per week 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_interval_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_annuleren_MA_starten-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_annuleren-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_interval_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_annuleren_MVE_starten-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 4.009: Regel 4.219:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_interval_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_annuleren_MVE_starten-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 09:04 uur
+
|style="background-color: white;"|T om 14:10 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 4.019: Regel 4.229:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|90 stuks
+
|style="background-color: white;"|42 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|AMOXICILLINE DISPER SANDOZ TABLET 500MG (code = '802891' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|LARIAM TABLET 250MG (code = '602574' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|MEFLOQUINE TABLET 250MG (code = '25410' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|MEFLOQUINE TABLET 250MG (code = '66478' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_interval_VV
+
|style="background-color: white;"|MBH_300_annuleren_VV_starten-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_annuleren-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 4.047: Regel 4.257:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
−
|style="background-color: white;"|Apotheek de Gulle Gaper
+
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-6-2-interval-v20 /><section end=av-mp-va-tst-6-2-interval-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 6 Variabele hoeveelheid==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-6-3-variabele-hoeveelheid-v20 /><section begin=patient-av-mp-va-tst-6-3-variabele-hoeveelheid-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-3-6a-annuleren-v30 /><section end=av-mp-va-tst-3-6a-annuleren-v30 />
 +
== TEST Scenarioset 3 annuleren==
 +
<section begin=av-mp-va-tst-3-6b-annuleren-v30 /><section begin=patient-av-mp-va-tst-3-6b-annuleren-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 4.068: Regel 4.281:
 
|colspan="5"|Naamgegevens
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="6"|
+
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Initialen
+
|colspan="3"|Voornamen
−
|style="background-color: white;"|G.
+
|style="background-color: white;"|C
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="2"|
+
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Voorvoegsels
 +
|style="background-color: white;"|van de
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Hemsbergen
+
|style="background-color: white;"|XXX_Voortman
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900602 [BSN]
+
|style="background-color: white;"|999908881 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|2 nov 1963
+
|style="background-color: white;"|18 sep 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-6-3-variabele-hoeveelheid-v20 /><section begin=mbhs-av-mp-va-tst-6-3-variabele-hoeveelheid-v20 />
+
|}<section end=patient-av-mp-va-tst-3-6b-annuleren-v30 /><section begin=mbhs-av-mp-va-tst-3-6b-annuleren-v30 />
−
==== Scenario 6.3 - MBH_200_variabelehoeveelheid====
+
==== Scenario 3.6b - MBH_300_annuleren-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_variabelehoeveelheid_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_annuleren_TA_geannuleerd-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 4.102: Regel 4.318:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_variabelehoeveelheid_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_annuleren_TA_geannuleerd-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 09:10 uur
+
|style="background-color: white;"|T om 14:10 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T + 6 dagen, tot en met T + 6 dagen om 00:00 uur''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|colspan="2"|Ingangsdatum
−
|style="background-color: white;"|T
+
|style="background-color: white;"|T + 6 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|colspan="2"|Einddatum
−
|style="background-color: white;"|T + 28 dagen
+
|style="background-color: white;"|T + 6 dagen om 00:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|ToedieningsafspraakStopType
 +
|style="background-color: white;"|geannuleerd (code = '89925002' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 4.123: Regel 4.342:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|PARACETAMOL AURO TABLET 500MG (code = '1026291' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|LARIAM TABLET 250MG (code = '602574' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|MEFLOQUINE TABLET 250MG (code = '25410' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|MEFLOQUINE TABLET 250MG (code = '66478' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
Regel 4.139: Regel 4.358:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 3 maal per dag 1 à 2 stuks, oraal
+
|style="background-color: white;"|1 maal per week 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|3 maal per dag 1 à 2 stuks
+
|style="background-color: white;"|1 maal per week 1 stuk
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieMedicatieafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_annuleren_MA_geannuleerd-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieToedieningsafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_variabelehoeveelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_annuleren_TA_starten-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_annuleren-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 +
==== Bouwstenen ====
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_variabelehoeveelheid_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
|| Waarde
  
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Identificatie
 
−
|style="background-color: white;"|MBH_200_variabelehoeveelheid_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Medicatieverstrekkings datum tijd
 
−
|style="background-color: white;"|T om 09:10 uur
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Verstrekker
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="2"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder
+
|colspan="2"|ZorgaanbiederIdentificatienummer
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="2"|OrganisatieNaam
−
|style="background-color: white;"|100 stuks
+
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - primaire code
+
|colspan="2"|Adresgegevens
−
|style="background-color: white;"|PARACETAMOL AURO TABLET 500MG (code = '1026291' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|}<section end=mbhs-av-mp-va-tst-3-6b-annuleren-v30 /><section end=av-mp-va-tst-3-6b-annuleren-v30 />
−
|colspan="3"|Geneesmiddel - generiekere code
+
== TEST Scenarioset 3 (initieren GDS scenario) Stoppen parallelle TA==
−
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
+
<section begin=av-mp-va-tst-3-8a-Stoppen-parallelle-TA-v30 /><section begin=patient-av-mp-va-tst-3-8a-Stoppen-parallelle-TA-v30 />
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
{| class="wikitable" width="85%"
−
|colspan="3"|Geneesmiddel - generiekere code
 
−
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Relatie verstrekkingsverzoek
 
−
|style="background-color: white;"|MBH_200_variabelehoeveelheid_VV
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|MBH identificatie
 
−
|style="background-color: white;"|MBH_200_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
−
|}
 
−
==== Bouwstenen ====
 
−
{| class="wikitable" width="85%"
 
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 
−
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
−
|colspan="3" width="25%"| Gegevenselement
 
−
|| Waarde
 
−
 
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|rowspan="3"|
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Zorgaanbieder identificatienummer
 
−
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Organisatie naam
 
−
|style="background-color: white;"|Apotheek de Gulle Gaper
 
−
|}<section end=mbhs-av-mp-va-tst-6-3-variabele-hoeveelheid-v20 /><section end=av-mp-va-tst-6-3-variabele-hoeveelheid-v20 />
 
−
== TEST Scenarioset 6 Zonder keerdosis==
 
−
<section begin=av-mp-va-tst-6-4-zonder-keerdosis-v20 /><section begin=patient-av-mp-va-tst-6-4-zonder-keerdosis-v20 />
 
−
{| class="wikitable" width="85%"
 
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
Regel 4.224: Regel 4.415:
 
|colspan="5"|Naamgegevens
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="6"|
+
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Initialen
+
|colspan="3"|Voornamen
−
|style="background-color: white;"|G.
+
|style="background-color: white;"|C
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="2"|
+
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Voorvoegsels
 +
|style="background-color: white;"|van de
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Hemsbergen
+
|style="background-color: white;"|XXX_Voortman
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900602 [BSN]
+
|style="background-color: white;"|999908881 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|2 nov 1963
+
|style="background-color: white;"|18 sep 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-6-4-zonder-keerdosis-v20 /><section begin=mbhs-av-mp-va-tst-6-4-zonder-keerdosis-v20 />
+
|}<section end=patient-av-mp-va-tst-3-8a-Stoppen-parallelle-TA-v30 /><section begin=mbhs-av-mp-va-tst-3-8a-Stoppen-parallelle-TA-v30 />
−
==== Scenario 6.4 - MBH_200_zonderkeerdosis====
+
==== Scenario 3.8a - MBH_300_stoppen_parallele_TA-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_zonderkeerdosis_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_stoppen_parallele_TA_TA_start_GDS-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 4.258: Regel 4.452:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_zonderkeerdosis_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_stoppen_parallele_TA_TA_start_GDS-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 09:12 uur
+
|style="background-color: white;"|T om 10:15 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, gedurende 28 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
Regel 4.271: Regel 4.465:
 
|style="background-color: white;"|T
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Einddatum
+
|colspan="2"|Gebruiksduur
−
|style="background-color: white;"|T + 28 dagen
+
|style="background-color: white;"|28 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 4.279: Regel 4.473:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="5"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 3 maal per dag, aanbrengen, cutaan
+
|style="background-color: white;"|1 stuk 's ochtends, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Aanvullende instructie
 
−
|style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst')
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|3 maal per dag
+
|style="background-color: white;"|1 stuk 's ochtends
−
|-style="vertical-align:top; background-color: #E3E3E3;;"   
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="3"|Distributievorm
 +
|style="background-color: white;"|GDS (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.3.8')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 +
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_zonderkeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_stoppen_parallele_TA_MA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_stoppen_parallele_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_zonderkeerdosis_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_stoppen_parallele_TA_MVE_start_GDS-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 4.324: Regel 4.518:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_zonderkeerdosis_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_stoppen_parallele_TA_MVE_start_GDS-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 09:12 uur
+
|style="background-color: white;"|T om 10:05 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 4.334: Regel 4.528:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|1 stuk
+
|style="background-color: white;"|28 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|Distributievorm
−
|style="background-color: white;"|MBH_200_zonderkeerdosis_VV
+
|style="background-color: white;"|GDS (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.3.8')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RelatieVerstrekkingsverzoek
 +
|style="background-color: white;"|MBH_300_stoppen_parallele_TA_TA_start_GDS-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_stoppen_parallele_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 4.362: Regel 4.559:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
−
|style="background-color: white;"|Apotheek de Gulle Gaper
+
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-6-4-zonder-keerdosis-v20 /><section end=av-mp-va-tst-6-4-zonder-keerdosis-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 6 Bijzondere keerdosis==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-6-5-bijzondere-keerdosis-v20 /><section begin=patient-av-mp-va-tst-6-5-bijzondere-keerdosis-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-3-8a-Stoppen-parallelle-TA-v30 /><section end=av-mp-va-tst-3-8a-Stoppen-parallelle-TA-v30 />
 +
== TEST Scenarioset 3 (initieren zonodig scenario) Stoppen parallelle TA==
 +
<section begin=av-mp-va-tst-3-8b-Stoppen-parallelle-TA-v30 /><section begin=patient-av-mp-va-tst-3-8b-Stoppen-parallelle-TA-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 4.383: Regel 4.583:
 
|colspan="5"|Naamgegevens
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="6"|
+
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Initialen
+
|colspan="3"|Voornamen
−
|style="background-color: white;"|G.
+
|style="background-color: white;"|C
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="2"|
+
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Voorvoegsels
 +
|style="background-color: white;"|van de
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Hemsbergen
+
|style="background-color: white;"|XXX_Voortman
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900602 [BSN]
+
|style="background-color: white;"|999908881 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|2 nov 1963
+
|style="background-color: white;"|18 sep 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-6-5-bijzondere-keerdosis-v20 /><section begin=mbhs-av-mp-va-tst-6-5-bijzondere-keerdosis-v20 />
+
|}<section end=patient-av-mp-va-tst-3-8b-Stoppen-parallelle-TA-v30 /><section begin=mbhs-av-mp-va-tst-3-8b-Stoppen-parallelle-TA-v30 />
−
==== Scenario 6.5 - MBH_200_bijzonderekeerdosis====
+
==== Scenario 3.8b - MBH_300_stoppen_parallele_TA-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_bijzonderekeerdosis_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_stoppen_parallele_TA_TA_start_zonodig-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 4.417: Regel 4.620:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_bijzonderekeerdosis_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_stoppen_parallele_TA_TA_start_zonodig-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 09:15 uur
+
|style="background-color: white;"|T om 10:15 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, gedurende 28 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
Regel 4.430: Regel 4.633:
 
|style="background-color: white;"|T
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Einddatum
+
|colspan="2"|Gebruiksduur
−
|style="background-color: white;"|T + 28 dagen
+
|style="background-color: white;"|28 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 4.438: Regel 4.641:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|NAPROXEN APOTEX TABLET 500MG (code = '1137778' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
Regel 4.454: Regel 4.657:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 2 maal per dag 0.5 stuk, oraal
+
|style="background-color: white;"|Bij pijn 1 stuk 's avonds, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|2 maal per dag 0.5 stuk
+
|style="background-color: white;"|Bij pijn 1 stuk 's avonds
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_bijzonderekeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_stoppen_parallele_TA_MA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_stoppen_parallele_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_bijzonderekeerdosis_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_stoppen_parallele_TA_MVE_start_zonodig-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 4.480: Regel 4.683:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_bijzonderekeerdosis_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_stoppen_parallele_TA_MVE_start_zonodig-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 09:15 uur
+
|style="background-color: white;"|T om 10:15 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 4.490: Regel 4.693:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|30 stuks
+
|style="background-color: white;"|28 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|NAPROXEN APOTEX TABLET 500MG (code = '1137778' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_bijzonderekeerdosis_VV
+
|style="background-color: white;"|MBH_300_stoppen_parallele_TA_TA_start_zonodig-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_stoppen_parallele_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 4.518: Regel 4.721:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
−
|style="background-color: white;"|Apotheek de Gulle Gaper
+
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-6-5-bijzondere-keerdosis-v20 /><section end=av-mp-va-tst-6-5-bijzondere-keerdosis-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 6 Variabele hoeveelheid 2==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-6-6-variabele-hoeveelheid-2-v20 /><section begin=patient-av-mp-va-tst-6-6-variabele-hoeveelheid-2-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-3-8b-Stoppen-parallelle-TA-v30 /><section end=av-mp-va-tst-3-8b-Stoppen-parallelle-TA-v30 />
 +
== TEST Scenarioset 3 (stoppen zonodig scenario) Stoppen parallelle TA==
 +
<section begin=av-mp-va-tst-3-8c-Stoppen-parallelle-TA-v30 /><section begin=patient-av-mp-va-tst-3-8c-Stoppen-parallelle-TA-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 4.539: Regel 4.745:
 
|colspan="5"|Naamgegevens
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="6"|
+
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Initialen
+
|colspan="3"|Voornamen
−
|style="background-color: white;"|G.
+
|style="background-color: white;"|C
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="2"|
+
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Voorvoegsels
 +
|style="background-color: white;"|van de
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Hemsbergen
+
|style="background-color: white;"|XXX_Voortman
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900602 [BSN]
+
|style="background-color: white;"|999908881 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|2 nov 1963
+
|style="background-color: white;"|18 sep 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-6-6-variabele-hoeveelheid-2-v20 /><section begin=mbhs-av-mp-va-tst-6-6-variabele-hoeveelheid-2-v20 />
+
|}<section end=patient-av-mp-va-tst-3-8c-Stoppen-parallelle-TA-v30 /><section begin=mbhs-av-mp-va-tst-3-8c-Stoppen-parallelle-TA-v30 />
−
==== Scenario 6.6 - MBH_200_variabelehoeveelheid2====
+
==== Scenario 3.8c - MBH_300_stoppen_parallele_TA-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_variabelehoeveelheid2_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_stoppen_parallele_TA_TA_stop_zonodig-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 4.573: Regel 4.782:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_variabelehoeveelheid2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_stoppen_parallele_TA_TA_stop_zonodig-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 09:18 uur
+
|style="background-color: white;"|T om 10:05 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T - 4 dagen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 
|style="background-color: white;"|T
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Einddatum
+
|colspan="3"|ToedieningsafspraakStopType
−
|style="background-color: white;"|T + 28 dagen
+
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 4.594: Regel 4.806:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|ToedieningsafspraakRedenWijzigenOfStaken
 +
|style="background-color: white;"|medicatiebeleid veranderd (code = '112751000146109' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|WATERSTOFPEROXIDE 3% CONC VOOR MONDSP FNA MR (code = '261815' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72994' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="6"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 2 maal per dag 10 à 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen, OROMUCOSAAL
+
|style="background-color: white;"|Bij pijn 1 stuk 's avonds, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|OROMUCOSAAL (code = '34' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Aanvullende instructie
+
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst')
+
|style="background-color: white;"|Bij pijn 1 stuk 's avonds
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Aanvullende instructie
+
|rowspan="2"|
−
|style="background-color: white;"|mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst')
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Doseerinstructie
+
|colspan="2"|Identificatie
−
|style="background-color: white;"|2 maal per dag 10 à 15 ml
+
|style="background-color: white;"|MBH_300_stoppen_parallele_TA_MA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieToedieningsafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_variabelehoeveelheid2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_stoppen_parallele_TA_TA_start_zonodig-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_stoppen_parallele_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 +
==== Bouwstenen ====
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_variabelehoeveelheid2_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
|| Waarde
  
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Identificatie
 
−
|style="background-color: white;"|MBH_200_variabelehoeveelheid2_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Medicatieverstrekkings datum tijd
 
−
|style="background-color: white;"|T om 09:18 uur
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Verstrekker
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="2"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder
+
|colspan="2"|ZorgaanbiederIdentificatienummer
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="2"|OrganisatieNaam
−
|style="background-color: white;"|450 ml
+
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - primaire code
+
|colspan="2"|Adresgegevens
−
|style="background-color: white;"|WATERSTOFPEROXIDE 3% CONC VOOR MONDSP FNA MR (code = '261815' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|}<section end=mbhs-av-mp-va-tst-3-8c-Stoppen-parallelle-TA-v30 /><section end=av-mp-va-tst-3-8c-Stoppen-parallelle-TA-v30 />
−
|colspan="3"|Geneesmiddel - generiekere code
+
== TEST Scenarioset 3 (starten nieuw zonodig scenario) Stoppen parallelle TA==
−
|style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72994' in codeSystem 'G-Standaard PRK')
+
<section begin=av-mp-va-tst-3-8d-Stoppen-parallelle-TA-v30 /><section begin=patient-av-mp-va-tst-3-8d-Stoppen-parallelle-TA-v30 />
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
{| class="wikitable" width="85%"
−
|colspan="3"|Geneesmiddel - generiekere code
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
−
|style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK')
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Relatie verstrekkingsverzoek
 
−
|style="background-color: white;"|MBH_200_variabelehoeveelheid2_VV
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|MBH identificatie
 
−
|style="background-color: white;"|MBH_200_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
−
|}
 
−
==== Bouwstenen ====
 
−
{| class="wikitable" width="85%"
 
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 
−
|-style="background-color: #1F497D;; color: white; text-align:left;"
 
−
|colspan="3" width="25%"| Gegevenselement
 
−
|| Waarde
 
−
 
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|rowspan="3"|
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Zorgaanbieder identificatienummer
 
−
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Organisatie naam
 
−
|style="background-color: white;"|Apotheek de Gulle Gaper
 
−
|}<section end=mbhs-av-mp-va-tst-6-6-variabele-hoeveelheid-2-v20 /><section end=av-mp-va-tst-6-6-variabele-hoeveelheid-2-v20 />
 
−
== TEST Scenarioset 6 Tijdstippen flexibel==
 
−
<section begin=av-mp-va-tst-6-7a-tijdstippen-flexibel-v20 /><section begin=patient-av-mp-va-tst-6-7a-tijdstippen-flexibel-v20 />
 
−
{| class="wikitable" width="85%"
 
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="4" width="25%"| Gegevenselement
 
|colspan="4" width="25%"| Gegevenselement
Regel 4.701: Regel 4.882:
 
|colspan="5"|Naamgegevens
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="6"|
+
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Initialen
+
|colspan="3"|Voornamen
−
|style="background-color: white;"|G.
+
|style="background-color: white;"|C
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="2"|
+
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Voorvoegsels
 +
|style="background-color: white;"|van de
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Hemsbergen
+
|style="background-color: white;"|XXX_Voortman
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900602 [BSN]
+
|style="background-color: white;"|999908881 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|2 nov 1963
+
|style="background-color: white;"|18 sep 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-6-7a-tijdstippen-flexibel-v20 /><section begin=mbhs-av-mp-va-tst-6-7a-tijdstippen-flexibel-v20 />
+
|}<section end=patient-av-mp-va-tst-3-8d-Stoppen-parallelle-TA-v30 /><section begin=mbhs-av-mp-va-tst-3-8d-Stoppen-parallelle-TA-v30 />
−
==== Scenario 6.7a - MBH_200_tijdstippen_flexibel====
+
==== Scenario 3.8d - MBH_300_stoppen_parallele_TA-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_tijdstippen_flexibel_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_stoppen_parallele_TA_TA_start2_zonodig-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 4.735: Regel 4.919:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_tijdstippen_flexibel_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_stoppen_parallele_TA_TA_start2_zonodig-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 09:24 uur
+
|style="background-color: white;"|T om 10:05 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, gedurende 23 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
Regel 4.748: Regel 4.932:
 
|style="background-color: white;"|T
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Einddatum
+
|colspan="2"|Gebruiksduur
−
|style="background-color: white;"|T + 14 dagen
+
|style="background-color: white;"|23 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 4.756: Regel 4.940:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|ToedieningsafspraakRedenWijzigenOfStaken
 +
|style="background-color: white;"|geneesmiddel niet voorradig (code = '182856006' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
Regel 4.772: Regel 4.959:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, tot en met T + 14 dagen, elke dag om 08:00, 14:00 en 20:00 1 stuk, oraal
+
|style="background-color: white;"|Bij pijn 2 stuks 's avonds, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|elke dag om 08:00, 14:00 en 20:00 1 stuk
+
|style="background-color: white;"|Bij pijn 2 stuks 's avonds
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieMedicatieafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_stoppen_parallele_TA_MA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieToedieningsafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_tijdstippen_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_stoppen_parallele_TA_TA_start_zonodig-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_tijdstippen_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_stoppen_parallele_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_tijdstippen_flexibel_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_stoppen_parallele_TA_MVE_start2_zonodig-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 4.798: Regel 4.992:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_tijdstippen_flexibel_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_stoppen_parallele_TA_MVE_start2_zonodig-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 09:24 uur
+
|style="background-color: white;"|T om 10:05 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 4.808: Regel 5.002:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|45 stuks
+
|style="background-color: white;"|23 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_tijdstippen_flexibel_VV
+
|style="background-color: white;"|MBH_300_stoppen_parallele_TA_TA_start2_zonodig-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_tijdstippen_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_stoppen_parallele_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 4.836: Regel 5.030:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
−
|style="background-color: white;"|Apotheek de Gulle Gaper
+
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-6-7a-tijdstippen-flexibel-v20 /><section end=av-mp-va-tst-6-7a-tijdstippen-flexibel-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 6 Tijdstippen niet flexibel==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-6-7b-tijdstippen-niet-flexibe-v20 /><section begin=patient-av-mp-va-tst-6-7b-tijdstippen-niet-flexibe-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-3-8d-Stoppen-parallelle-TA-v30 /><section end=av-mp-va-tst-3-8d-Stoppen-parallelle-TA-v30 />
 +
== TEST Scenarioset 6 Variabele frequentie==
 +
<section begin=av-mp-va-tst-6-1-variabele-frequentie-v30 /><section begin=patient-av-mp-va-tst-6-1-variabele-frequentie-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 4.863: Regel 5.060:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 4.879: Regel 5.076:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-6-7b-tijdstippen-niet-flexibe-v20 /><section begin=mbhs-av-mp-va-tst-6-7b-tijdstippen-niet-flexibe-v20 />
+
|}<section end=patient-av-mp-va-tst-6-1-variabele-frequentie-v30 /><section begin=mbhs-av-mp-va-tst-6-1-variabele-frequentie-v30 />
−
==== Scenario 6.7b - MBH_200_tijdstippen_niet_flexibel====
+
==== Scenario 6.1 - MBH_300_variabelefrequentie-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_tijdstippen_niet_flexibel_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_variabelefrequentie_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 4.891: Regel 5.088:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_tijdstippen_niet_flexibel_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_variabelefrequentie_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 10:15 uur
+
|style="background-color: white;"|T om 09:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="3"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 16 dagen''
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T + 16 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 4.901: Regel 5.109:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
Regel 4.914: Regel 5.125:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, tijden exact aanhouden, oraal
+
|style="background-color: white;"|1 à 2 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
+
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, tijden exact aanhouden
+
|style="background-color: white;"|1 à 2 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_tijdstippen_niet_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_variabelefrequentie_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_tijdstippen_niet_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_variabelefrequentie-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_tijdstippen_niet_flexibel_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_variabelefrequentie_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 4.940: Regel 5.151:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_tijdstippen_niet_flexibel_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_variabelefrequentie_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 10:17 uur
+
|style="background-color: white;"|T om 09:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 4.950: Regel 5.161:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|24 stuks
+
|style="background-color: white;"|90 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_tijdstippen_niet_flexibel_VV
+
|style="background-color: white;"|MBH_300_variabelefrequentie_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_tijdstippen_niet_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_variabelefrequentie-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 4.978: Regel 5.189:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
−
|style="background-color: white;"|Apotheek de Gulle Gaper
+
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-6-7b-tijdstippen-niet-flexibe-v20 /><section end=av-mp-va-tst-6-7b-tijdstippen-niet-flexibe-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 6 Weekdagen==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-6-8-weekdagen-v20 /><section begin=patient-av-mp-va-tst-6-8-weekdagen-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-6-1-variabele-frequentie-v30 /><section end=av-mp-va-tst-6-1-variabele-frequentie-v30 />
 +
== TEST Scenarioset 6 Interval==
 +
<section begin=av-mp-va-tst-6-2-interval-v30 /><section begin=patient-av-mp-va-tst-6-2-interval-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 5.005: Regel 5.219:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 5.021: Regel 5.235:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-6-8-weekdagen-v20 /><section begin=mbhs-av-mp-va-tst-6-8-weekdagen-v20 />
+
|}<section end=patient-av-mp-va-tst-6-2-interval-v30 /><section begin=mbhs-av-mp-va-tst-6-2-interval-v30 />
−
==== Scenario 6.8 - MBH_200_weekdagen====
+
==== Scenario 6.2 - MBH_300_interval-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_weekdagen_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_interval_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 5.033: Regel 5.247:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_weekdagen_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_interval_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 09:25 uur
+
|style="background-color: white;"|T om 09:04 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 70 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T
 
|style="background-color: white;"|T
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Einddatum
 
−
|style="background-color: white;"|T + 70 dagen
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 5.054: Regel 5.265:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|ALDARA CREME 50MG/G IN SACHET (code = '1198521' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|AMOXICILLINE DISPER SANDOZ TABLET 500MG (code = '802891' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="6"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, tot en met T + 70 dagen, op maandag, woensdag en vrijdag, voor de nacht, aanbrengen, cutaan
+
|style="background-color: white;"|iedere 8 uur 1 stuk - gelijke tussenpozen aanhouden, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Aanvullende instructie
 
−
|style="background-color: white;"|voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst')
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Aanvullende instructie
 
−
|style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst')
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|op maandag, woensdag en vrijdag
+
|style="background-color: white;"|iedere 8 uur 1 stuk - gelijke tussenpozen aanhouden
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_weekdagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_interval_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_weekdagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_interval-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_weekdagen_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_interval_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 5.102: Regel 5.307:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_weekdagen_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_interval_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 09:25 uur
+
|style="background-color: white;"|T om 09:04 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 5.112: Regel 5.317:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|30 stuks
+
|style="background-color: white;"|90 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|ALDARA CREME 50MG/G IN SACHET (code = '1198521' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|AMOXICILLINE DISPER SANDOZ TABLET 500MG (code = '802891' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_weekdagen_VV
+
|style="background-color: white;"|MBH_300_interval_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_weekdagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_interval-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 5.140: Regel 5.345:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
−
|style="background-color: white;"|Apotheek de Gulle Gaper
+
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-6-8-weekdagen-v20 /><section end=av-mp-va-tst-6-8-weekdagen-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 6 Dagdeel==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-6-9-dagdeel-v20 /><section begin=patient-av-mp-va-tst-6-9-dagdeel-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-6-2-interval-v30 /><section end=av-mp-va-tst-6-2-interval-v30 />
 +
== TEST Scenarioset 6 Variabele hoeveelheid==
 +
<section begin=av-mp-va-tst-6-3-variabele-hoeveelheid-v30 /><section begin=patient-av-mp-va-tst-6-3-variabele-hoeveelheid-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 5.167: Regel 5.375:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 5.183: Regel 5.391:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-6-9-dagdeel-v20 /><section begin=mbhs-av-mp-va-tst-6-9-dagdeel-v20 />
+
|}<section end=patient-av-mp-va-tst-6-3-variabele-hoeveelheid-v30 /><section begin=mbhs-av-mp-va-tst-6-3-variabele-hoeveelheid-v30 />
−
==== Scenario 6.9 - MBH_200_dagdeel====
+
==== Scenario 6.3 - MBH_300_variabelehoeveelheid-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_dagdeel_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_variabelehoeveelheid_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 5.195: Regel 5.403:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_dagdeel_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_variabelehoeveelheid_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 09:27 uur
+
|style="background-color: white;"|T om 09:10 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="2"|
+
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T
 
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T + 28 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 5.213: Regel 5.424:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|INEGY TABLET 10/20MG (code = '1719785' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|PARACETAMOL AURO TABLET 500MG (code = '1026291' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
Regel 5.229: Regel 5.440:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, 1 stuk 's avonds, oraal
+
|style="background-color: white;"|3 maal per dag 1 à 2 stuks, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
Regel 5.235: Regel 5.446:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|1 stuk 's avonds
+
|style="background-color: white;"|3 maal per dag 1 à 2 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_dagdeel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_variabelehoeveelheid_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_dagdeel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_variabelehoeveelheid-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_dagdeel_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_variabelehoeveelheid_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 5.255: Regel 5.466:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_dagdeel_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_variabelehoeveelheid_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 09:27 uur
+
|style="background-color: white;"|T om 09:10 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 5.265: Regel 5.476:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|60 stuks
+
|style="background-color: white;"|100 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|INEGY TABLET 10/20MG (code = '1719785' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|PARACETAMOL AURO TABLET 500MG (code = '1026291' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_dagdeel_VV
+
|style="background-color: white;"|MBH_300_variabelehoeveelheid_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_dagdeel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_variabelehoeveelheid-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 5.293: Regel 5.504:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
−
|style="background-color: white;"|Apotheek de Gulle Gaper
+
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-6-9-dagdeel-v20 /><section end=av-mp-va-tst-6-9-dagdeel-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 6 Cyclisch schema==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-6-10-cyclisch-schema-v20 /><section begin=patient-av-mp-va-tst-6-10-cyclisch-schema-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-6-3-variabele-hoeveelheid-v30 /><section end=av-mp-va-tst-6-3-variabele-hoeveelheid-v30 />
 +
== TEST Scenarioset 6 Zonder keerdosis==
 +
<section begin=av-mp-va-tst-6-4-zonder-keerdosis-v30 /><section begin=patient-av-mp-va-tst-6-4-zonder-keerdosis-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 5.320: Regel 5.534:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 5.336: Regel 5.550:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-6-10-cyclisch-schema-v20 /><section begin=mbhs-av-mp-va-tst-6-10-cyclisch-schema-v20 />
+
|}<section end=patient-av-mp-va-tst-6-4-zonder-keerdosis-v30 /><section begin=mbhs-av-mp-va-tst-6-4-zonder-keerdosis-v30 />
−
==== Scenario 6.10 - MBH_200_cyclischschema====
+
==== Scenario 6.4 - MBH_300_zonderkeerdosis-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_cyclischschema_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_zonderkeerdosis_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 5.348: Regel 5.562:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_cyclischschema_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_zonderkeerdosis_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 09:33 uur
+
|style="background-color: white;"|T om 09:12 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="2"|
+
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T
 
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T + 28 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 5.366: Regel 5.583:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '226866' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '195758' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
Regel 5.379: Regel 5.599:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, cyclus van 28 dagen: steeds gedurende 21 dagen 1 maal per dag 1 stuk, oraal
+
|style="background-color: white;"|3 maal per dag, aanbrengen, cutaan
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|AanvullendeInstructie
 +
|style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|gedurende 21 dagen 1 maal per dag 1 stuk
+
|style="background-color: white;"|3 maal per dag
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Herhaalperiode cyclisch schema
 
−
|style="background-color: white;"|28 dagen
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_cyclischschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_zonderkeerdosis_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_cyclischschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_zonderkeerdosis-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_cyclischschema_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_zonderkeerdosis_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 5.408: Regel 5.628:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_cyclischschema_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_zonderkeerdosis_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 09:33 uur
+
|style="background-color: white;"|T om 09:12 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 5.418: Regel 5.638:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|126 stuks
+
|style="background-color: white;"|100 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|MARVELON TABLET (code = '416681' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '226866' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '195758' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_cyclischschema_VV
+
|style="background-color: white;"|MBH_300_zonderkeerdosis_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_cyclischschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_zonderkeerdosis-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 5.446: Regel 5.666:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
−
|style="background-color: white;"|Apotheek de Gulle Gaper
+
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-6-10-cyclisch-schema-v20 /><section end=av-mp-va-tst-6-10-cyclisch-schema-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 6 Afbouwschema==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-6-11-afbouwschema-v20 /><section begin=patient-av-mp-va-tst-6-11-afbouwschema-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-6-4-zonder-keerdosis-v30 /><section end=av-mp-va-tst-6-4-zonder-keerdosis-v30 />
 +
== TEST Scenarioset 6 Bijzondere keerdosis==
 +
<section begin=av-mp-va-tst-6-5-bijzondere-keerdosis-v30 /><section begin=patient-av-mp-va-tst-6-5-bijzondere-keerdosis-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 5.473: Regel 5.696:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 5.489: Regel 5.712:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-6-11-afbouwschema-v20 /><section begin=mbhs-av-mp-va-tst-6-11-afbouwschema-v20 />
+
|}<section end=patient-av-mp-va-tst-6-5-bijzondere-keerdosis-v30 /><section begin=mbhs-av-mp-va-tst-6-5-bijzondere-keerdosis-v30 />
−
==== Scenario 6.11 - MBH_200_afbouwschema====
+
==== Scenario 6.5 - MBH_300_bijzonderekeerdosis-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_afbouwschema_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_bijzonderekeerdosis_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 5.501: Regel 5.724:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_afbouwschema_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_bijzonderekeerdosis_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 09:40 uur
+
|style="background-color: white;"|T om 09:15 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 41 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
Regel 5.515: Regel 5.738:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|colspan="2"|Einddatum
−
|style="background-color: white;"|T + 41 dagen
+
|style="background-color: white;"|T + 28 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 5.522: Regel 5.745:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|AFFUSINE CREME 20MG/G (code = '2292556' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|NAPROXEN APOTEX TABLET 500MG (code = '1137778' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="6"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, tot en met T + 41 dagen, eerst gedurende 2 weken 1 maal per dag 3 gram, dan gedurende 3 weken 1 maal per dag 2 gram, dan gedurende 6 dagen 1 maal per dag 1 gram, cutaan
+
|style="background-color: white;"|2 maal per dag 0.5 stuk, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Doseerinstructie 1
+
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|eerst gedurende 2 weken 1 maal per dag 3 gram
+
|style="background-color: white;"|2 maal per dag 0.5 stuk
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Doseerinstructie 2
 
−
|style="background-color: white;"|dan gedurende 3 weken 1 maal per dag 2 gram
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Doseerinstructie 3
 
−
|style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag 1 gram
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_afbouwschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_bijzonderekeerdosis_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_afbouwschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_bijzonderekeerdosis-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_afbouwschema_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_bijzonderekeerdosis_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 5.570: Regel 5.787:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_afbouwschema_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_bijzonderekeerdosis_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 09:40 uur
+
|style="background-color: white;"|T om 09:15 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 5.580: Regel 5.797:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|90 gram
+
|style="background-color: white;"|30 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|AFFUSINE CREME 20MG/G (code = '2292556' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|NAPROXEN APOTEX TABLET 500MG (code = '1137778' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_afbouwschema_VV
+
|style="background-color: white;"|MBH_300_bijzonderekeerdosis_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_afbouwschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_bijzonderekeerdosis-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 5.608: Regel 5.825:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
−
|style="background-color: white;"|Apotheek de Gulle Gaper
+
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-6-11-afbouwschema-v20 /><section end=av-mp-va-tst-6-11-afbouwschema-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 6 Variabele hoeveelheid en maximum==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-6-12-variabele-hoeveelheid-en-maximum-v20 /><section begin=patient-av-mp-va-tst-6-12-variabele-hoeveelheid-en-maximum-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-6-5-bijzondere-keerdosis-v30 /><section end=av-mp-va-tst-6-5-bijzondere-keerdosis-v30 />
 +
== TEST Scenarioset 6 Variabele hoeveelheid 2==
 +
<section begin=av-mp-va-tst-6-6-variabele-hoeveelheid-2-v30 /><section begin=patient-av-mp-va-tst-6-6-variabele-hoeveelheid-2-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 5.635: Regel 5.855:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 5.651: Regel 5.871:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-6-12-variabele-hoeveelheid-en-maximum-v20 /><section begin=mbhs-av-mp-va-tst-6-12-variabele-hoeveelheid-en-maximum-v20 />
+
|}<section end=patient-av-mp-va-tst-6-6-variabele-hoeveelheid-2-v30 /><section begin=mbhs-av-mp-va-tst-6-6-variabele-hoeveelheid-2-v30 />
−
==== Scenario 6.12 - MBH_200_variabelehoeveelheidenmaximum====
+
==== Scenario 6.6 - MBH_300_variabelehoeveelheid2-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_variabelehoeveelheidenmaximum_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_variabelehoeveelheid2_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 5.663: Regel 5.883:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_variabelehoeveelheidenmaximum_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_variabelehoeveelheid2_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 09:45 uur
+
|style="background-color: white;"|T om 09:18 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 21 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
Regel 5.677: Regel 5.897:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|colspan="2"|Einddatum
−
|style="background-color: white;"|T + 21 dagen
+
|style="background-color: white;"|T + 28 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 5.684: Regel 5.904:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|CODEINEFOSFAAT PCH TABLET 10MG (code = '874965' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|WATERSTOFPEROXIDE 3% CONC VOOR MONDSP FNA MR (code = '261815' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72664' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="4"|
+
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, tot en met T + 21 dagen, Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag, oraal
+
|style="background-color: white;"|2 maal per dag 10 à 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen, OROMUCOSAAL
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|OROMUCOSAAL (code = '34' in codeSystem 'G-Standaard Toedieningswegen')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|AanvullendeInstructie
 +
|style="background-color: white;"|Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|AanvullendeInstructie
 +
|style="background-color: white;"|mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag
+
|style="background-color: white;"|2 maal per dag 10 à 15 ml
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_variabelehoeveelheidenmaximum_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_variabelehoeveelheid2_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_variabelehoeveelheidenmaximum (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_variabelehoeveelheid2-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_variabelehoeveelheidenmaximum_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_variabelehoeveelheid2_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 5.726: Regel 5.952:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_variabelehoeveelheidenmaximum_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_variabelehoeveelheid2_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 09:45 uur
+
|style="background-color: white;"|T om 09:18 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 5.736: Regel 5.962:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|120 stuks
+
|style="background-color: white;"|450 ml
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|CODEINEFOSFAAT PCH TABLET 10MG (code = '874965' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|WATERSTOFPEROXIDE 3% CONC VOOR MONDSP FNA MR (code = '261815' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72664' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_variabelehoeveelheidenmaximum_VV
+
|style="background-color: white;"|MBH_300_variabelehoeveelheid2_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_variabelehoeveelheidenmaximum (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_variabelehoeveelheid2-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 5.764: Regel 5.990:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
−
|style="background-color: white;"|Apotheek de Gulle Gaper
+
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-6-12-variabele-hoeveelheid-en-maximum-v20 /><section end=av-mp-va-tst-6-12-variabele-hoeveelheid-en-maximum-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 6 Toedieningssnelheid==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-6-13-toedieningssnelheid-v20 /><section begin=patient-av-mp-va-tst-6-13-toedieningssnelheid-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-6-6-variabele-hoeveelheid-2-v30 /><section end=av-mp-va-tst-6-6-variabele-hoeveelheid-2-v30 />
 +
== TEST Scenarioset 6 Tijdstippen flexibel==
 +
<section begin=av-mp-va-tst-6-7a-tijdstippen-flexibel-v30 /><section begin=patient-av-mp-va-tst-6-7a-tijdstippen-flexibel-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 5.791: Regel 6.020:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 5.807: Regel 6.036:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-6-13-toedieningssnelheid-v20 /><section begin=mbhs-av-mp-va-tst-6-13-toedieningssnelheid-v20 />
+
|}<section end=patient-av-mp-va-tst-6-7a-tijdstippen-flexibel-v30 /><section begin=mbhs-av-mp-va-tst-6-7a-tijdstippen-flexibel-v30 />
−
==== Scenario 6.13 - MBH_200_toedieningssnelheid====
+
==== Scenario 6.7a - MBH_300_tijdstippen_flexibel-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_toedieningssnelheid_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_tijdstippen_flexibel_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 5.819: Regel 6.048:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_toedieningssnelheid_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_tijdstippen_flexibel_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 09:47 uur
+
|style="background-color: white;"|T om 09:24 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 8 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
Regel 5.833: Regel 6.062:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|colspan="2"|Einddatum
−
|style="background-color: white;"|T + 8 dagen
+
|style="background-color: white;"|T + 14 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 5.840: Regel 6.069:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|MORFINEHYDROCHLORIDE 1ML= 5MG EPI CAS 100ML FNA MR (code = '779288' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
Regel 5.856: Regel 6.085:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, tot en met T + 8 dagen, toedieningssnelheid: maximaal 0.2 à 0.5 ml per uur, parenteraal
+
|style="background-color: white;"|elke dag om 08:00, 14:00 en 20:00 1 stuk, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|toedieningssnelheid: maximaal 0.2 à 0.5 ml per uur
+
|style="background-color: white;"|elke dag om 08:00, 14:00 en 20:00 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_toedieningssnelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_tijdstippen_flexibel_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_toedieningssnelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_tijdstippen_flexibel-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_toedieningssnelheid_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_tijdstippen_flexibel_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 5.882: Regel 6.111:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_toedieningssnelheid_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_tijdstippen_flexibel_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 09:47 uur
+
|style="background-color: white;"|T om 09:24 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 5.892: Regel 6.121:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|100 ml
+
|style="background-color: white;"|45 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|MORFINEHYDROCHLORIDE 1ML= 5MG EPI CAS 100ML FNA MR (code = '779288' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_toedieningssnelheid_VV
+
|style="background-color: white;"|MBH_300_tijdstippen_flexibel_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_toedieningssnelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_tijdstippen_flexibel-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 5.920: Regel 6.149:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
−
|style="background-color: white;"|Apotheek de Gulle Gaper
+
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-6-13-toedieningssnelheid-v20 /><section end=av-mp-va-tst-6-13-toedieningssnelheid-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 6 Toedieningsduur==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-6-14-toedieningsduur-v20 /><section begin=patient-av-mp-va-tst-6-14-toedieningsduur-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-6-7a-tijdstippen-flexibel-v30 /><section end=av-mp-va-tst-6-7a-tijdstippen-flexibel-v30 />
 +
== TEST Scenarioset 6 Tijdstippen niet flexibel==
 +
<section begin=av-mp-va-tst-6-7b-tijdstippen-niet-flexibel-v30 /><section begin=patient-av-mp-va-tst-6-7b-tijdstippen-niet-flexibel-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 5.947: Regel 6.179:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 5.963: Regel 6.195:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-6-14-toedieningsduur-v20 /><section begin=mbhs-av-mp-va-tst-6-14-toedieningsduur-v20 />
+
|}<section end=patient-av-mp-va-tst-6-7b-tijdstippen-niet-flexibel-v30 /><section begin=mbhs-av-mp-va-tst-6-7b-tijdstippen-niet-flexibel-v30 />
−
==== Scenario 6.14 - MBH_200_toedieningsduur====
+
==== Scenario 6.7b - MBH_300_tijdstippen_niet_flexibel-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_toedieningsduur_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_tijdstippen_niet_flexibel_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 5.975: Regel 6.207:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_toedieningsduur_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_tijdstippen_niet_flexibel_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 09:49 uur
+
|style="background-color: white;"|T om 10:15 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 7 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="2"|
+
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T
 
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T + 7 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 5.993: Regel 6.228:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG (code = '1013602' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '98477' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
Regel 6.009: Regel 6.244:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, 1 maal per dag 1 stuk gedurende 16 uur, transdermaal
+
|style="background-color: white;"|elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, exacte toedientijd(en), oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur
+
|style="background-color: white;"|elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, exacte toedientijd(en)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_toedieningsduur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_tijdstippen_niet_flexibel_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_toedieningsduur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_tijdstippen_niet_flexibel-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_toedieningsduur_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_tijdstippen_niet_flexibel_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 6.035: Regel 6.270:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_toedieningsduur_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_tijdstippen_niet_flexibel_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 09:49 uur
+
|style="background-color: white;"|T om 10:17 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 6.045: Regel 6.280:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|30 stuks
+
|style="background-color: white;"|24 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG (code = '1013602' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '98477' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_toedieningsduur_VV
+
|style="background-color: white;"|MBH_300_tijdstippen_niet_flexibel_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_toedieningsduur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_tijdstippen_niet_flexibel-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 6.073: Regel 6.308:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
−
|style="background-color: white;"|Apotheek de Gulle Gaper
+
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-6-14-toedieningsduur-v20 /><section end=av-mp-va-tst-6-14-toedieningsduur-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 6 Zo nodig==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-6-15-zonodig-v20 /><section begin=patient-av-mp-va-tst-6-15-zonodig-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-6-7b-tijdstippen-niet-flexibel-v30 /><section end=av-mp-va-tst-6-7b-tijdstippen-niet-flexibel-v30 />
 +
== TEST Scenarioset 6 Weekdagen==
 +
<section begin=av-mp-va-tst-6-8-weekdagen-v30 /><section begin=patient-av-mp-va-tst-6-8-weekdagen-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 6.100: Regel 6.338:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 6.116: Regel 6.354:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-6-15-zonodig-v20 /><section begin=mbhs-av-mp-va-tst-6-15-zonodig-v20 />
+
|}<section end=patient-av-mp-va-tst-6-8-weekdagen-v30 /><section begin=mbhs-av-mp-va-tst-6-8-weekdagen-v30 />
−
==== Scenario 6.15 - MBH_200_zonodig====
+
==== Scenario 6.8 - MBH_300_weekdagen-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_zonodig_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_weekdagen_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 6.128: Regel 6.366:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_zonodig_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_weekdagen_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 09:57 uur
+
|style="background-color: white;"|T om 09:25 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 27 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 70 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
Regel 6.142: Regel 6.380:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|colspan="2"|Einddatum
−
|style="background-color: white;"|T + 27 dagen
+
|style="background-color: white;"|T + 70 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 6.149: Regel 6.387:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|ALDARA CREME 50MG/G IN SACHET (code = '1198521' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|ACETYLSALICYLZUUR 100MG TAB (code = '3956' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="4"|
+
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, tot en met T + 27 dagen, Zo nodig 1 maal per dag 1 stuk, Oraal
+
|style="background-color: white;"|op maandag, woensdag en vrijdag, voor de nacht, aanbrengen, cutaan
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
+
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|AanvullendeInstructie
 +
|style="background-color: white;"|voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|AanvullendeInstructie
 +
|style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk
+
|style="background-color: white;"|op maandag, woensdag en vrijdag
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_zonodig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_weekdagen_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_weekdagen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_zonodig_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_weekdagen_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 6.191: Regel 6.435:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_zonodig_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_weekdagen_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 09:57 uur
+
|style="background-color: white;"|T om 09:25 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 6.201: Regel 6.445:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|14 stuks
+
|style="background-color: white;"|30 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|ALDARA CREME 50MG/G IN SACHET (code = '1198521' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|ACETYLSALICYLZUUR 100MG TAB (code = '3956' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_zonodig_VV
+
|style="background-color: white;"|MBH_300_weekdagen_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_weekdagen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 6.229: Regel 6.473:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
−
|style="background-color: white;"|Apotheek de Gulle Gaper
+
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-6-15-zonodig-v20 /><section end=av-mp-va-tst-6-15-zonodig-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 7 alle ingrediënten==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-7-1-alle-ingredienten-v20 /><section begin=patient-av-mp-va-tst-7-1-alle-ingredienten-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-6-8-weekdagen-v30 /><section end=av-mp-va-tst-6-8-weekdagen-v30 />
 +
== TEST Scenarioset 6 Dagdeel==
 +
<section begin=av-mp-va-tst-6-9-dagdeel-v30 /><section begin=patient-av-mp-va-tst-6-9-dagdeel-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 6.256: Regel 6.503:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 6.263: Regel 6.510:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Hess
+
|style="background-color: white;"|XXX_Hemsbergen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900614 [BSN]
+
|style="background-color: white;"|999900602 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|3 nov 1963
+
|style="background-color: white;"|2 nov 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-7-1-alle-ingredienten-v20 /><section begin=mbhs-av-mp-va-tst-7-1-alle-ingredienten-v20 />
+
|}<section end=patient-av-mp-va-tst-6-9-dagdeel-v30 /><section begin=mbhs-av-mp-va-tst-6-9-dagdeel-v30 />
−
==== Scenario 7.1 - MBH_200_magistraalalleingredienten====
+
==== Scenario 6.9 - MBH_300_dagdeel-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_200_magistraalalleingredienten_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_dagdeel_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
−
|colspan="4" width="25%"| Gegevenselement
+
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
|| Waarde
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="4"|Identificatie
+
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_magistraalalleingredienten_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_dagdeel_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="4"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 13:00 uur
+
|style="background-color: white;"|T om 09:27 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Gebruiksperiode
+
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 31 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Ingangsdatum
+
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T
 
|style="background-color: white;"|T
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Einddatum
 
−
|style="background-color: white;"|T + 31 dagen
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="5"|Verstrekker
+
|colspan="4"|Verstrekker
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Zorgaanbieder
+
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="5"|Geneesmiddel - Product specificatie
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="11"|
+
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|INEGY TABLET 10/20MG (code = '1719785' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Product naam
+
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr
+
|style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Omschrijving
+
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr          Regel: UREUM 10gr          Regel: EUCERINE MET WATER FAGRON ad 100gr
+
|style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Ingredient
+
|colspan="4"|Gebruiksinstructie
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|rowspan="3"|
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Ingredient code
 
−
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK')
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Sterkte
 
−
|style="background-color: white;"|  per 
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="4"|Ingredient
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|rowspan="3"|
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Ingredient code
 
−
|style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK')
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Sterkte
 
−
|style="background-color: white;"|  per 
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="5"|Gebruiksinstructie
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Omschrijving
+
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, tot en met T + 31 dagen, Zo nodig, cutaan
+
|style="background-color: white;"|1 stuk 's avonds, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsweg
+
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Doseerinstructie
+
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|Zo nodig
+
|style="background-color: white;"|1 stuk 's avonds
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="5"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Identificatie
+
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_magistraalalleingredienten_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_dagdeel_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="4"|MBH identificatie
+
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_dagdeel-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieverstrekking MBH_200_magistraalalleingredienten_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_dagdeel_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
−
|colspan="4" width="25%"| Gegevenselement
+
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
|| Waarde
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="4"|Identificatie
+
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_magistraalalleingredienten_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_dagdeel_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="4"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 13:00 uur
+
|style="background-color: white;"|T om 09:27 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="5"|Verstrekker
+
|colspan="4"|Verstrekker
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Zorgaanbieder
+
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="4"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|100 ml
+
|style="background-color: white;"|60 stuks
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="5"|Geneesmiddel - Product specificatie
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="11"|
+
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|INEGY TABLET 10/20MG (code = '1719785' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Product naam
+
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr
+
|style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Omschrijving
+
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr          Regel: UREUM 10gr          Regel: EUCERINE MET WATER FAGRON ad 100gr
+
|style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK')
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="4"|Ingredient
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|colspan="3"|RelatieVerstrekkingsverzoek
 +
|style="background-color: white;"|MBH_300_dagdeel_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Ingredient code
+
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|MBH_300_dagdeel-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Sterkte
 
−
|style="background-color: white;"|  per 
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="4"|Ingredient
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|rowspan="3"|
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Ingredient code
 
−
|style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK')
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Sterkte
 
−
|style="background-color: white;"|  per 
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="4"|Relatie verstrekkingsverzoek
 
−
|style="background-color: white;"|MBH_200_magistraalalleingredienten_VV
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="4"|MBH identificatie
 
−
|style="background-color: white;"|MBH_200_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 6.427: Regel 6.629:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-7-1-alle-ingredienten-v20 /><section end=av-mp-va-tst-7-1-alle-ingredienten-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 7 Actief ingrediënt==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-7-2-actief-ingredient-v20 /><section begin=patient-av-mp-va-tst-7-2-actief-ingredient-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-6-9-dagdeel-v30 /><section end=av-mp-va-tst-6-9-dagdeel-v30 />
 +
== TEST Scenarioset 6 Cyclisch schema==
 +
<section begin=av-mp-va-tst-6-10-cyclisch-schema-v30 /><section begin=patient-av-mp-va-tst-6-10-cyclisch-schema-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 6.454: Regel 6.659:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 6.461: Regel 6.666:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Hess
+
|style="background-color: white;"|XXX_Hemsbergen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900614 [BSN]
+
|style="background-color: white;"|999900602 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|3 nov 1963
+
|style="background-color: white;"|2 nov 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-7-2-actief-ingredient-v20 /><section begin=mbhs-av-mp-va-tst-7-2-actief-ingredient-v20 />
+
|}<section end=patient-av-mp-va-tst-6-10-cyclisch-schema-v30 /><section begin=mbhs-av-mp-va-tst-6-10-cyclisch-schema-v30 />
−
==== Scenario 7.2 - MBH_200_magistraalactieveingredient====
+
==== Scenario 6.10 - MBH_300_cyclischschema-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_200_magistraalactieveingredient_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_cyclischschema_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
−
|colspan="4" width="25%"| Gegevenselement
+
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
|| Waarde
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="4"|Identificatie
+
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_magistraalactieveingredient_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_cyclischschema_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="4"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 13:05 uur
+
|style="background-color: white;"|T om 09:33 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Gebruiksperiode
+
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, tot en met T + 70 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Ingangsdatum
+
|colspan="2"|Ingangsdatum
−
|style="background-color: white;"|T + 1 dag
+
|style="background-color: white;"|T
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Einddatum
 
−
|style="background-color: white;"|T + 70 dagen
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="5"|Verstrekker
+
|colspan="4"|Verstrekker
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Zorgaanbieder
+
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="5"|Geneesmiddel - Product specificatie
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="7"|
+
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|MARVELON TABLET (code = '416681' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Product naam
+
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA
+
|style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Omschrijving
+
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr
+
|style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Ingredient
+
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="5"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Ingredient code
+
|colspan="2"|Omschrijving
−
|style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|cyclus van 28 dagen: steeds gedurende 21 dagen 1 maal per dag 1 stuk, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Sterkte
+
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"| per 
+
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="5"|Gebruiksinstructie
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="4"|
+
|colspan="2"|Doseerinstructie
 +
|style="background-color: white;"|gedurende 21 dagen 1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Omschrijving
+
|colspan="2"|HerhaalperiodeCyclischSchema
−
|style="background-color: white;"|Vanaf T + 1 dag, tot en met T + 70 dagen, 1 maal per dag, cutaan
+
|style="background-color: white;"|28 dagen
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Toedieningsweg
 
−
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Doseerinstructie
 
−
|style="background-color: white;"|1 maal per dag
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="5"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Identificatie
+
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_magistraalactieveingredient_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_cyclischschema_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="4"|MBH identificatie
+
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_cyclischschema-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieverstrekking MBH_200_magistraalactieveingredient_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_cyclischschema_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
−
|colspan="4" width="25%"| Gegevenselement
+
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
|| Waarde
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="4"|Identificatie
+
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_magistraalactieveingredient_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_cyclischschema_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="4"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 13:05 uur
+
|style="background-color: white;"|T om 09:33 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="5"|Verstrekker
+
|colspan="4"|Verstrekker
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Zorgaanbieder
+
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="4"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|100 gram
+
|style="background-color: white;"|126 stuks
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="5"|Geneesmiddel - Product specificatie
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="7"|
+
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|MARVELON TABLET (code = '416681' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Product naam
+
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA
+
|style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Omschrijving
+
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr
+
|style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK')
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="4"|Ingredient
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|colspan="3"|RelatieVerstrekkingsverzoek
 +
|style="background-color: white;"|MBH_300_cyclischschema_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Ingredient code
+
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|MBH_300_cyclischschema-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Sterkte
 
−
|style="background-color: white;"|  per 
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="4"|Relatie verstrekkingsverzoek
 
−
|style="background-color: white;"|MBH_200_magistraalactieveingredient_VV
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="4"|MBH identificatie
 
−
|style="background-color: white;"|MBH_200_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 6.605: Regel 6.788:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-7-2-actief-ingredient-v20 /><section end=av-mp-va-tst-7-2-actief-ingredient-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 7 90 miljoennummer==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-7-3-90-miljoen-nr-v20 /><section begin=patient-av-mp-va-tst-7-3-90-miljoen-nr-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-6-10-cyclisch-schema-v30 /><section end=av-mp-va-tst-6-10-cyclisch-schema-v30 />
 +
== TEST Scenarioset 6 Afbouwschema==
 +
<section begin=av-mp-va-tst-6-11-afbouwschema-v30 /><section begin=patient-av-mp-va-tst-6-11-afbouwschema-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 6.632: Regel 6.818:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 6.639: Regel 6.825:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Hess
+
|style="background-color: white;"|XXX_Hemsbergen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900614 [BSN]
+
|style="background-color: white;"|999900602 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|3 nov 1963
+
|style="background-color: white;"|2 nov 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-7-3-90-miljoen-nr-v20 /><section begin=mbhs-av-mp-va-tst-7-3-90-miljoen-nr-v20 />
+
|}<section end=patient-av-mp-va-tst-6-11-afbouwschema-v30 /><section begin=mbhs-av-mp-va-tst-6-11-afbouwschema-v30 />
−
==== Scenario 7.3 - MBH_200_magistraal90miljoennr====
+
==== Scenario 6.11 - MBH_300_afbouwschema-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_200_magistraal90miljoennr_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_afbouwschema_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
−
|colspan="4" width="25%"| Gegevenselement
+
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
|| Waarde
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="4"|Identificatie
+
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_magistraal90miljoennr_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_afbouwschema_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="4"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 13:08 uur
+
|style="background-color: white;"|T om 09:40 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Gebruiksperiode
+
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 30 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 41 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Ingangsdatum
+
|colspan="2"|Ingangsdatum
 
|style="background-color: white;"|T
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Einddatum
+
|colspan="2"|Einddatum
−
|style="background-color: white;"|T + 30 dagen
+
|style="background-color: white;"|T + 41 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="5"|Verstrekker
+
|colspan="4"|Verstrekker
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Zorgaanbieder
+
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="5"|Geneesmiddel - Product specificatie
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="8"|
+
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|AFFUSINE CREME 20MG/G (code = '2292556' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Product code
+
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.9999.77.90000000.1.1111')
+
|style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Product naam
+
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr
+
|style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK')
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Omschrijving
 
−
|style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr          Regel: UREUM 10gr          Regel: EUCERINE MET WATER FAGRON ad 100gr
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Ingredient
+
|colspan="4"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Ingredient code
+
|colspan="2"|Omschrijving
−
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|eerst gedurende 2 weken 1 maal per dag 3 gram, dan gedurende 3 weken 1 maal per dag 2 gram, dan gedurende 6 dagen 1 maal per dag 1 gram, cutaan
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Sterkte
+
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"| per 
+
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="5"|Gebruiksinstructie
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="4"|
+
|colspan="2"|Doseerinstructie 1
 +
|style="background-color: white;"|eerst gedurende 2 weken 1 maal per dag 3 gram
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Omschrijving
+
|colspan="2"|Doseerinstructie 2
−
|style="background-color: white;"|Vanaf T, tot en met T + 30 dagen, 1 maal per dag, cutaan
+
|style="background-color: white;"|dan gedurende 3 weken 1 maal per dag 2 gram
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsweg
+
|colspan="2"|Doseerinstructie 3
−
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
+
|style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag 1 gram
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Doseerinstructie
 
−
|style="background-color: white;"|1 maal per dag
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="5"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Identificatie
+
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_magistraal90miljoennr_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_afbouwschema_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="4"|MBH identificatie
+
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_afbouwschema-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieverstrekking MBH_200_magistraal90miljoennr_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_afbouwschema_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
−
|colspan="4" width="25%"| Gegevenselement
+
|colspan="3" width="25%"| Gegevenselement
 
|| Waarde
 
|| Waarde
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="4"|Identificatie
+
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_magistraal90miljoennr_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_afbouwschema_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="4"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 13:08 uur
+
|style="background-color: white;"|T om 09:40 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="5"|Verstrekker
+
|colspan="4"|Verstrekker
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Zorgaanbieder
+
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="4"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|100 gram
+
|style="background-color: white;"|90 gram
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="5"|Geneesmiddel - Product specificatie
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="8"|
+
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|AFFUSINE CREME 20MG/G (code = '2292556' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Product code
+
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.9999.77.90000000.1.1111')
+
|style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Product naam
+
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr
+
|style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Omschrijving
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr          Regel: UREUM 10gr          Regel: EUCERINE MET WATER FAGRON ad 100gr
+
|style="background-color: white;"|MBH_300_afbouwschema_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
−
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 
−
|colspan="4"|Ingredient
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|colspan="3"|MBH identificatie
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
+
|style="background-color: white;"|MBH_300_afbouwschema-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
−
|colspan="2"|Ingredient code
 
−
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK')
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Sterkte
 
−
|style="background-color: white;"|  per 
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="4"|Relatie verstrekkingsverzoek
 
−
|style="background-color: white;"|MBH_200_magistraal90miljoennr_VV
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="4"|MBH identificatie
 
−
|style="background-color: white;"|MBH_200_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 6.789: Regel 6.953:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-7-3-90-miljoen-nr-v20 /><section end=av-mp-va-tst-7-3-90-miljoen-nr-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 8 VV onder andermans MA==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-8-1-mve-bij-vv-onder-andermans-ma-v20 /><section begin=patient-av-mp-va-tst-8-1-mve-bij-vv-onder-andermans-ma-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-6-11-afbouwschema-v30 /><section end=av-mp-va-tst-6-11-afbouwschema-v30 />
 +
== TEST Scenarioset 6 Variabele hoeveelheid en maximum==
 +
<section begin=av-mp-va-tst-6-12-variabele-hoeveelheid-en-maximum-v30 /><section begin=patient-av-mp-va-tst-6-12-variabele-hoeveelheid-en-maximum-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 6.810: Regel 6.977:
 
|colspan="5"|Naamgegevens
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="7"|
+
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|colspan="3"|Initialen
−
|style="background-color: white;"|L.
+
|style="background-color: white;"|G.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="2"|
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Voorvoegsels
 
−
|style="background-color: white;"|van
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Meijs
+
|style="background-color: white;"|XXX_Hemsbergen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900808 [BSN]
+
|style="background-color: white;"|999900602 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|26 okt 1985
+
|style="background-color: white;"|2 nov 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-8-1-mve-bij-vv-onder-andermans-ma-v20 /><section begin=mbhs-av-mp-va-tst-8-1-mve-bij-vv-onder-andermans-ma-v20 />
+
|}<section end=patient-av-mp-va-tst-6-12-variabele-hoeveelheid-en-maximum-v30 /><section begin=mbhs-av-mp-va-tst-6-12-variabele-hoeveelheid-en-maximum-v30 />
−
==== Scenario 8.1 - MBH_200_VVandermansMA====
+
==== Scenario 6.12 - MBH_300_variabelehoeveelheidenmaximum-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_MVEandermansTA_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_variabelehoeveelheidenmaximum_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 6.847: Regel 7.011:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_MVEandermansTA_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_variabelehoeveelheidenmaximum_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T - 14 dagen om 10:00 uur
+
|style="background-color: white;"|T om 09:45 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T + 6 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 21 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|colspan="2"|Ingangsdatum
−
|style="background-color: white;"|T - 14 dagen
+
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|colspan="2"|Einddatum
−
|style="background-color: white;"|T + 6 dagen
+
|style="background-color: white;"|T + 21 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 6.868: Regel 7.032:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|CODEINEFOSFAAT PCH TABLET 10MG (code = '874965' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
Regel 6.884: Regel 7.048:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T - 14 dagen, tot en met T + 6 dagen, 1 maal per dag 1 stuk, oraal
+
|style="background-color: white;"|Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
+
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|1 maal per dag 1 stuk
+
|style="background-color: white;"|Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_VVandermansMA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_variabelehoeveelheidenmaximum_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_VVandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_variabelehoeveelheidenmaximum-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_MVEandermansTA_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_variabelehoeveelheidenmaximum_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 6.910: Regel 7.074:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_MVEandermansTA_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_variabelehoeveelheidenmaximum_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 10:00 uur
+
|style="background-color: white;"|T om 09:45 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 6.920: Regel 7.084:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|6 stuks
+
|style="background-color: white;"|120 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|CODEINEFOSFAAT PCH TABLET 10MG (code = '874965' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_VVandermansMA_VV
+
|style="background-color: white;"|MBH_300_variabelehoeveelheidenmaximum_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_VVandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_variabelehoeveelheidenmaximum-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 6.948: Regel 7.112:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-8-1-mve-bij-vv-onder-andermans-ma-v20 /><section end=av-mp-va-tst-8-1-mve-bij-vv-onder-andermans-ma-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 8 Staken andermans MA==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-8-2-ta-bij-staken-andermans-ma-v20 /><section begin=patient-av-mp-va-tst-8-2-ta-bij-staken-andermans-ma-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-6-12-variabele-hoeveelheid-en-maximum-v30 /><section end=av-mp-va-tst-6-12-variabele-hoeveelheid-en-maximum-v30 />
 +
== TEST Scenarioset 6 Toedieningssnelheid==
 +
<section begin=av-mp-va-tst-6-13-toedieningssnelheid-v30 /><section begin=patient-av-mp-va-tst-6-13-toedieningssnelheid-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 6.969: Regel 7.136:
 
|colspan="5"|Naamgegevens
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="7"|
+
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|colspan="3"|Initialen
−
|style="background-color: white;"|L.
+
|style="background-color: white;"|G.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="2"|
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Voorvoegsels
 
−
|style="background-color: white;"|van
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Meijs
+
|style="background-color: white;"|XXX_Hemsbergen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900808 [BSN]
+
|style="background-color: white;"|999900602 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|26 okt 1985
+
|style="background-color: white;"|2 nov 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-8-2-ta-bij-staken-andermans-ma-v20 /><section begin=mbhs-av-mp-va-tst-8-2-ta-bij-staken-andermans-ma-v20 />
+
|}<section end=patient-av-mp-va-tst-6-13-toedieningssnelheid-v30 /><section begin=mbhs-av-mp-va-tst-6-13-toedieningssnelheid-v30 />
−
==== Scenario 8.2 - MBH_200_stakenandermansMA====
+
==== Scenario 6.13 - MBH_300_toedieningssnelheid-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_stakenandermansTA_TA2
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_toedieningssnelheid_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 7.006: Regel 7.170:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_stakenandermansTA_TA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_toedieningssnelheid_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 10:05 uur
+
|style="background-color: white;"|T om 09:47 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 8 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|colspan="2"|Ingangsdatum
−
|style="background-color: white;"|T - 5 dagen
+
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|colspan="2"|Einddatum
−
|style="background-color: white;"|T
+
|style="background-color: white;"|T + 8 dagen
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Toedieningsafspraak stop type
 
−
|style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT')
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 7.030: Regel 7.191:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|MORFINE HCL 3WATER INFVLST 5MG/ML CASS 100ML AHZ (code = '2554771' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
Regel 7.046: Regel 7.207:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T - 5 dagen, tot en met T, 1 maal per dag 1 stuk, Oraal, definitief gestopt
+
|style="background-color: white;"|toedieningssnelheid: 0.2 à 0.5 ml/h, Intraveneus
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
+
|style="background-color: white;"|Intraveneus (code = '5' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|1 maal per dag 1 stuk
+
|style="background-color: white;"|toedieningssnelheid: 0.2 à 0.5 ml/h
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_stakenandermansMA_MA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_toedieningssnelheid_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_stakenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_toedieningssnelheid-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_stakenandermansTA_andermansMVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_toedieningssnelheid_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 7.072: Regel 7.233:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_stakenandermansTA_andermansMVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_toedieningssnelheid_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T - 5 dagen om 09:45 uur
+
|style="background-color: white;"|T om 09:47 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 7.082: Regel 7.243:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|21 stuks
+
|style="background-color: white;"|100 ml
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|MORFINE HCL 3WATER INFVLST 5MG/ML CASS 100ML AHZ (code = '2554771' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_stakenandermansMA_andermansVV
+
|style="background-color: white;"|MBH_300_toedieningssnelheid_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_stakenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_toedieningssnelheid-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 7.110: Regel 7.271:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-8-2-ta-bij-staken-andermans-ma-v20 /><section end=av-mp-va-tst-8-2-ta-bij-staken-andermans-ma-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 8 Onderbreken andermans MA==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-8-3-ta-bij-onderbreken-andermans-ma-v20 /><section begin=patient-av-mp-va-tst-8-3-ta-bij-onderbreken-andermans-ma-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-6-13-toedieningssnelheid-v30 /><section end=av-mp-va-tst-6-13-toedieningssnelheid-v30 />
 +
== TEST Scenarioset 6 Toedieningsduur==
 +
<section begin=av-mp-va-tst-6-14-toedieningsduur-v30 /><section begin=patient-av-mp-va-tst-6-14-toedieningsduur-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 7.131: Regel 7.295:
 
|colspan="5"|Naamgegevens
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="7"|
+
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|colspan="3"|Initialen
−
|style="background-color: white;"|L.
+
|style="background-color: white;"|G.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="2"|
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Voorvoegsels
 
−
|style="background-color: white;"|van
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Meijs
+
|style="background-color: white;"|XXX_Hemsbergen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900808 [BSN]
+
|style="background-color: white;"|999900602 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|26 okt 1985
+
|style="background-color: white;"|2 nov 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-8-3-ta-bij-onderbreken-andermans-ma-v20 /><section begin=mbhs-av-mp-va-tst-8-3-ta-bij-onderbreken-andermans-ma-v20 />
+
|}<section end=patient-av-mp-va-tst-6-14-toedieningsduur-v30 /><section begin=mbhs-av-mp-va-tst-6-14-toedieningsduur-v30 />
−
==== Scenario 8.3 - MBH_200_onderbrekenandermansMA====
+
==== Scenario 6.14 - MBH_300_toedieningsduur-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_onderbrekenandermansTA_TA2
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_toedieningsduur_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 7.168: Regel 7.329:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_onderbrekenandermansTA_TA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_toedieningsduur_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 10:07 uur
+
|style="background-color: white;"|T om 09:49 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T''
+
|style="background-color: #E3E3E3;;"|''Vanaf T''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|colspan="2"|Ingangsdatum
−
|style="background-color: white;"|T - 60 dagen
 
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Einddatum
 
 
|style="background-color: white;"|T
 
|style="background-color: white;"|T
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Toedieningsafspraak stop type
 
−
|style="background-color: white;"|tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT')
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 7.192: Regel 7.347:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|APC APOTEX TABLET (code = '795097' in codeSystem 'G-Sandaard HPK')
+
|style="background-color: white;"|DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG (code = '1013602' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '228427' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '196738' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
Regel 7.208: Regel 7.363:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T - 60 dagen, tot en met T, 1 maal per dag 1 stuk, oraal, tijdelijk gestopt
+
|style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur, transdermaal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
+
|style="background-color: white;"|transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|1 maal per dag 1 stuk
+
|style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_onderbrekenandermansMA_MA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_toedieningsduur_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_onderbrekenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_toedieningsduur-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_onderbrekenandermansTA_andermansMVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_toedieningsduur_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 7.234: Regel 7.389:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_onderbrekenandermansTA_andermansMVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_toedieningsduur_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T - 60 dagen om 10:00 uur
+
|style="background-color: white;"|T om 09:49 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 7.244: Regel 7.399:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|90 stuks
+
|style="background-color: white;"|30 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|APC APOTEX TABLET (code = '795097' in codeSystem 'G-Sandaard HPK')
+
|style="background-color: white;"|DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG (code = '1013602' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '228427' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '196738' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_onderbrekenandermansMA_andermansVV
+
|style="background-color: white;"|MBH_300_toedieningsduur_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_onderbrekenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_toedieningsduur-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 7.272: Regel 7.427:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-8-3-ta-bij-onderbreken-andermans-ma-v20 /><section end=av-mp-va-tst-8-3-ta-bij-onderbreken-andermans-ma-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 8 Wijzigen andermans MA==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-8-4-ta-bij-wijzigen-andermans-ma-v20 /><section begin=patient-av-mp-va-tst-8-4-ta-bij-wijzigen-andermans-ma-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-6-14-toedieningsduur-v30 /><section end=av-mp-va-tst-6-14-toedieningsduur-v30 />
 +
== TEST Scenarioset 6 Zo nodig==
 +
<section begin=av-mp-va-tst-6-15-zonodig-v30 /><section begin=patient-av-mp-va-tst-6-15-zonodig-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 7.293: Regel 7.451:
 
|colspan="5"|Naamgegevens
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="7"|
+
|rowspan="6"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|colspan="3"|Initialen
−
|style="background-color: white;"|L.
+
|style="background-color: white;"|G.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="2"|
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="2"|Voorvoegsels
 
−
|style="background-color: white;"|van
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Meijs
+
|style="background-color: white;"|XXX_Hemsbergen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900808 [BSN]
+
|style="background-color: white;"|999900602 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|26 okt 1985
+
|style="background-color: white;"|2 nov 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-8-4-ta-bij-wijzigen-andermans-ma-v20 /><section begin=mbhs-av-mp-va-tst-8-4-ta-bij-wijzigen-andermans-ma-v20 />
+
|}<section end=patient-av-mp-va-tst-6-15-zonodig-v30 /><section begin=mbhs-av-mp-va-tst-6-15-zonodig-v30 />
−
==== Scenario 8.4 - MBH_200_wijzigenandermansMA====
+
==== Scenario 6.15 - MBH_300_zonodig-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_wijzigenandermansTA_TA_techstaken
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_zonodig_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 7.330: Regel 7.485:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_wijzigenandermansTA_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_zonodig_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 10:10 uur
+
|style="background-color: white;"|T om 09:57 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T - 7 dagen, tot en met T - 1 dag''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 27 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|colspan="2"|Ingangsdatum
−
|style="background-color: white;"|T - 7 dagen
+
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|colspan="2"|Einddatum
−
|style="background-color: white;"|T - 1 dag
+
|style="background-color: white;"|T + 27 dagen
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Toedieningsafspraak stop type
 
−
|style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT')
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 7.354: Regel 7.506:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|FUROSEMIDE MYLAN TABLET 40MG (code = '1529587' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
Regel 7.370: Regel 7.522:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T - 7 dagen, tot en met T - 1 dag, 1 maal per dag 2 stuks, oraal, definitief gestopt
+
|style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
+
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|1 maal per dag 2 stuks
+
|style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_wijzigenandermansMA_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_zonodig_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_wijzigenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_zonodig-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_wijzigenandermansTA_andermansMVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_zonodig_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 7.396: Regel 7.548:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_wijzigenandermansTA_andermansMVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_zonodig_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T - 7 dagen om 08:50 uur
+
|style="background-color: white;"|T om 09:57 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 7.406: Regel 7.558:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|42 stuks
+
|style="background-color: white;"|14 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|FUROSEMIDE MYLAN TABLET 40MG (code = '1529587' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_wijzigenandermansMA_andermansVV
+
|style="background-color: white;"|MBH_300_zonodig_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_wijzigenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_zonodig-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 7.434: Regel 7.586:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-8-4-ta-bij-wijzigen-andermans-ma-v20 /><section end=av-mp-va-tst-8-4-ta-bij-wijzigen-andermans-ma-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 9 Verbruiksperiode ==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-9-1a-verbruiksperiode-start-eind-v20 /><section begin=patient-av-mp-va-tst-9-1a-verbruiksperiode-start-eind-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-6-15-zonodig-v30 /><section end=av-mp-va-tst-6-15-zonodig-v30 />
 +
== TEST Scenarioset 6 Redundante frequentie==
 +
<section begin=av-mp-va-tst-6-17-redundante-frequentie-v30 /><section begin=patient-av-mp-va-tst-6-17-redundante-frequentie-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 7.458: Regel 7.613:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|colspan="3"|Initialen
−
|style="background-color: white;"|M.
+
|style="background-color: white;"|G.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 7.468: Regel 7.623:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Nederveen
+
|style="background-color: white;"|XXX_Hemsbergen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900833 [BSN]
+
|style="background-color: white;"|999900602 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|28 okt 1985
+
|style="background-color: white;"|2 nov 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-9-1a-verbruiksperiode-start-eind-v20 /><section begin=mbhs-av-mp-va-tst-9-1a-verbruiksperiode-start-eind-v20 />
+
|}<section end=patient-av-mp-va-tst-6-17-redundante-frequentie-v30 /><section begin=mbhs-av-mp-va-tst-6-17-redundante-frequentie-v30 />
−
==== Scenario 9.1a - MBH_200_logistiekeverbruiksperiode_start_eind====
+
==== Scenario 6.17 - MBH_300_redundantefrequentie-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_logistiekeverbruiksperiode_start_eind_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_redundantefrequentie_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 7.489: Regel 7.644:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_start_eind_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_redundantefrequentie_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 12:00 uur
+
|style="background-color: white;"|T om 09:45 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 12 maanden''
+
|style="background-color: #E3E3E3;;"|''Vanaf T om 09:45 uur, gedurende 14 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|colspan="2"|Ingangsdatum
−
|style="background-color: white;"|T
+
|style="background-color: white;"|T om 09:45 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Einddatum
+
|colspan="2"|Gebruiksduur
−
|style="background-color: white;"|T + 12 maanden
+
|style="background-color: white;"|14 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 7.510: Regel 7.665:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|PREDNISON AURO TABLET 5MG (code = '2033682' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|PREDNISON TABLET 5MG (code = '8311' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|PREDNISON TABLET 5MG (code = '23817' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
Regel 7.526: Regel 7.681:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, tot en met T + 12 maanden, 1 maal per dag 1 stuk, Oraal
+
|style="background-color: white;"|1 maal per dag om 10:00 1 stuk, Oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|1 maal per dag 1 stuk
+
|style="background-color: white;"|1 maal per dag om 10:00 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_redundantefrequentie_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_redundantefrequentie-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_logistiekeverbruiksperiode_start_eind_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_redundantefrequentie_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 7.552: Regel 7.707:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_start_eind_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_redundantefrequentie_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 12:00 uur
+
|style="background-color: white;"|T om 09:45 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 7.562: Regel 7.717:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|100 stuks
+
|style="background-color: white;"|14 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|PREDNISON AURO TABLET 5MG (code = '2033682' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|PREDNISON TABLET 5MG (code = '8311' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|PREDNISON TABLET 5MG (code = '23817' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_start_eind_VV
+
|style="background-color: white;"|MBH_300_redundantefrequentie_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_redundantefrequentie-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 7.590: Regel 7.745:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-9-1a-verbruiksperiode-start-eind-v20 /><section end=av-mp-va-tst-9-1a-verbruiksperiode-start-eind-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 9 GDS==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-9-1b-verbruiksperiode-einddatum-v20 /><section begin=patient-av-mp-va-tst-9-1b-verbruiksperiode-einddatum-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-6-17-redundante-frequentie-v30 /><section end=av-mp-va-tst-6-17-redundante-frequentie-v30 />
 +
== TEST Scenarioset 7 alle ingrediënten==
 +
<section begin=av-mp-va-tst-7-1-alle-ingredienten-v30 /><section begin=patient-av-mp-va-tst-7-1-alle-ingredienten-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 7.614: Regel 7.772:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|colspan="3"|Initialen
−
|style="background-color: white;"|M.
+
|style="background-color: white;"|G.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 7.624: Regel 7.782:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Nederveen
+
|style="background-color: white;"|XXX_Hess
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900833 [BSN]
+
|style="background-color: white;"|999900614 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|28 okt 1985
+
|style="background-color: white;"|3 nov 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-9-1b-verbruiksperiode-einddatum-v20 /><section begin=mbhs-av-mp-va-tst-9-1b-verbruiksperiode-einddatum-v20 />
+
|}<section end=patient-av-mp-va-tst-7-1-alle-ingredienten-v30 /><section begin=mbhs-av-mp-va-tst-7-1-alle-ingredienten-v30 />
−
==== Scenario 9.1b - MBH_200_logistiekeverbruiksperiode_eind====
+
==== Scenario 7.1 - MBH_300_magistraalalleingredienten-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_logistiekeverbruiksperiode_eind_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_magistraalalleingredienten_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
−
|colspan="3" width="25%"| Gegevenselement
+
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
|| Waarde
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Identificatie
+
|colspan="4"|Identificatie
−
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_eind_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_magistraalalleingredienten_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="4"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 12:01 uur
+
|style="background-color: white;"|T om 13:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="3"|Gebruiksperiode
+
|colspan="4"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 200 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 31 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Ingangsdatum
+
|colspan="3"|Ingangsdatum
 
|style="background-color: white;"|T
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Einddatum
+
|colspan="3"|Einddatum
−
|style="background-color: white;"|T + 200 dagen
+
|style="background-color: white;"|T + 31 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Verstrekker
+
|colspan="5"|Verstrekker
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder
+
|colspan="3"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Geneesmiddel - ProductSpecificatie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="11"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|ProductNaam
 +
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Omschrijving
 +
|style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr          Regel: UREUM 10gr          Regel: EUCERINE MET WATER FAGRON ad 100gr
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Ingredient
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|IngredientCode
 +
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Sterkte
 +
|style="background-color: white;"|10 gram per  100 gram
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Ingredient
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - primaire code
+
|rowspan="3"|
−
|style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK')
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - generiekere code
+
|colspan="2"|IngredientCode
−
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - generiekere code
+
|colspan="2"|Sterkte
−
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|90 gram per  100 gram
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Gebruiksinstructie
+
|colspan="5"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Omschrijving
+
|colspan="3"|Omschrijving
−
|style="background-color: white;"|Vanaf T, tot en met T + 200 dagen, 1 maal per dag 1 stuk, Oraal
+
|style="background-color: white;"|Zo nodig, cutaan
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Toedieningsweg
+
|colspan="3"|Toedieningsweg
−
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
+
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Doseerinstructie
+
|colspan="3"|Doseerinstructie
−
|style="background-color: white;"|1 maal per dag 1 stuk
+
|style="background-color: white;"|Zo nodig
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="5"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Identificatie
+
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_magistraalalleingredienten_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|MBH identificatie
+
|colspan="4"|MBH identificatie
−
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_magistraalalleingredienten-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_logistiekeverbruiksperiode_eind_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieverstrekking MBH_300_magistraalalleingredienten_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
−
|colspan="3" width="25%"| Gegevenselement
+
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
|| Waarde
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Identificatie
+
|colspan="4"|Identificatie
−
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_eind_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_magistraalalleingredienten_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="4"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 12:01 uur
+
|style="background-color: white;"|T om 13:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Verstrekker
+
|colspan="5"|Verstrekker
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder
+
|colspan="3"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|VerstrekteHoeveelheid
 +
|style="background-color: white;"|50 ml
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Geneesmiddel - ProductSpecificatie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="11"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|ProductNaam
 +
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Omschrijving
 +
|style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr          Regel: UREUM 10gr          Regel: EUCERINE MET WATER FAGRON ad 100gr
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Ingredient
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="2"|IngredientCode
−
|style="background-color: white;"|100 stuks
+
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - primaire code
+
|colspan="2"|Sterkte
−
|style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|10 gram per  100 gram
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Ingredient
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - generiekere code
+
|rowspan="3"|
−
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - generiekere code
+
|colspan="2"|IngredientCode
−
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Distributievorm
+
|colspan="2"|Sterkte
−
|style="background-color: white;"|GDS (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.3.8')
+
|style="background-color: white;"|90 gram per  100 gram
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="4"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_eind_VV
+
|style="background-color: white;"|MBH_300_magistraalalleingredienten_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|MBH identificatie
+
|colspan="4"|MBH identificatie
−
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_magistraalalleingredienten-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 7.749: Regel 7.946:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-9-1b-verbruiksperiode-einddatum-v20 /><section end=av-mp-va-tst-9-1b-verbruiksperiode-einddatum-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 9 verbruiksduur (dagen)==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-9-1c-verbruiksperiode-duur-v20 /><section begin=patient-av-mp-va-tst-9-1c-verbruiksperiode-duur-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-7-1-alle-ingredienten-v30 /><section end=av-mp-va-tst-7-1-alle-ingredienten-v30 />
 +
== TEST Scenarioset 7 Actief ingrediënt==
 +
<section begin=av-mp-va-tst-7-2-actief-ingredient-v30 /><section begin=patient-av-mp-va-tst-7-2-actief-ingredient-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 7.773: Regel 7.973:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|colspan="3"|Initialen
−
|style="background-color: white;"|M.
+
|style="background-color: white;"|G.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 7.783: Regel 7.983:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Nederveen
+
|style="background-color: white;"|XXX_Hess
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900833 [BSN]
+
|style="background-color: white;"|999900614 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|28 okt 1985
+
|style="background-color: white;"|3 nov 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-9-1c-verbruiksperiode-duur-v20 /><section begin=mbhs-av-mp-va-tst-9-1c-verbruiksperiode-duur-v20 />
+
|}<section end=patient-av-mp-va-tst-7-2-actief-ingredient-v30 /><section begin=mbhs-av-mp-va-tst-7-2-actief-ingredient-v30 />
−
==== Scenario 9.1c - MBH_200_logistiekeverbruiksperiode_duur_dagen====
+
==== Scenario 7.2 - MBH_300_magistraalactieveingredient-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_logistiekeverbruiksperiode_duur_dagen_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_magistraalactieveingredient_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
−
|colspan="3" width="25%"| Gegevenselement
+
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
|| Waarde
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Identificatie
+
|colspan="4"|Identificatie
−
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_duur_dagen_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_magistraalactieveingredient_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="4"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 12:02 uur
+
|style="background-color: white;"|T om 13:05 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="3"|Gebruiksperiode
+
|colspan="4"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 150 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, tot en met T + 70 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Ingangsdatum
+
|colspan="3"|Ingangsdatum
−
|style="background-color: white;"|T
+
|style="background-color: white;"|T + 1 dag
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Einddatum
+
|colspan="3"|Einddatum
−
|style="background-color: white;"|T + 150 dagen
+
|style="background-color: white;"|T + 70 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Verstrekker
+
|colspan="5"|Verstrekker
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder
+
|colspan="3"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Geneesmiddel - ProductSpecificatie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="7"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|ProductNaam
 +
|style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Omschrijving
 +
|style="background-color: white;"|Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Ingredient
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - primaire code
+
|rowspan="3"|
−
|style="background-color: white;"|PARACETAMOL PCH TABLET 500MG (code = '768901' in codeSystem 'G-Standaard HPK')
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - generiekere code
+
|colspan="2"|IngredientCode
−
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - generiekere code
+
|colspan="2"|Sterkte
−
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|80 gram per  100 gram
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Gebruiksinstructie
+
|colspan="5"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Omschrijving
+
|colspan="3"|Omschrijving
−
|style="background-color: white;"|Vanaf T, tot en met T + 150 dagen, 1 maal per dag 1 stuk, Oraal
+
|style="background-color: white;"|1 maal per dag, cutaan
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Toedieningsweg
+
|colspan="3"|Toedieningsweg
−
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
+
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Doseerinstructie
+
|colspan="3"|Doseerinstructie
−
|style="background-color: white;"|1 maal per dag 1 stuk
+
|style="background-color: white;"|1 maal per dag
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="5"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Identificatie
+
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_duur_dagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_magistraalactieveingredient_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|MBH identificatie
+
|colspan="4"|MBH identificatie
−
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_duur_dagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_magistraalactieveingredient-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_logistiekeverbruiksperiode_duur_dagen_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieverstrekking MBH_300_magistraalactieveingredient_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
−
|colspan="3" width="25%"| Gegevenselement
+
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
|| Waarde
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Identificatie
+
|colspan="4"|Identificatie
−
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_duur_dagen_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_magistraalactieveingredient_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="4"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 12:02 uur
+
|style="background-color: white;"|T om 13:05 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Verstrekker
+
|colspan="5"|Verstrekker
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder
+
|colspan="3"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|VerstrekteHoeveelheid
 +
|style="background-color: white;"|75 gram
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Geneesmiddel - ProductSpecificatie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|ProductNaam
−
|style="background-color: white;"|100 stuks
+
|style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verbruiksduur
+
|colspan="3"|Omschrijving
−
|style="background-color: white;"|50 dagen
+
|style="background-color: white;"|Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Ingredient
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - primaire code
+
|rowspan="3"|
−
|style="background-color: white;"|PARACETAMOL PCH TABLET 500MG (code = '768901' in codeSystem 'G-Standaard HPK')
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - generiekere code
+
|colspan="2"|IngredientCode
−
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - generiekere code
+
|colspan="2"|Sterkte
−
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|80 gram per  100 gram
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="4"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_duur_dagen_VV
+
|style="background-color: white;"|MBH_300_magistraalactieveingredient_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|MBH identificatie
+
|colspan="4"|MBH identificatie
−
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_duur_dagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_magistraalactieveingredient-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 7.908: Regel 8.127:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-9-1c-verbruiksperiode-duur-v20 /><section end=av-mp-va-tst-9-1c-verbruiksperiode-duur-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 9 Herhalingen==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-9-2-herhalingen-v20 /><section begin=patient-av-mp-va-tst-9-2-herhalingen-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-7-2-actief-ingredient-v30 /><section end=av-mp-va-tst-7-2-actief-ingredient-v30 />
 +
== TEST Scenarioset 7 90 miljoennummer==
 +
<section begin=av-mp-va-tst-7-3-90-miljoen-nr-v30 /><section begin=patient-av-mp-va-tst-7-3-90-miljoen-nr-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 7.932: Regel 8.154:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|colspan="3"|Initialen
−
|style="background-color: white;"|M.
+
|style="background-color: white;"|G.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 7.942: Regel 8.164:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Nederveen
+
|style="background-color: white;"|XXX_Hess
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900833 [BSN]
+
|style="background-color: white;"|999900614 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|28 okt 1985
+
|style="background-color: white;"|3 nov 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-9-2-herhalingen-v20 /><section begin=mbhs-av-mp-va-tst-9-2-herhalingen-v20 />
+
|}<section end=patient-av-mp-va-tst-7-3-90-miljoen-nr-v30 /><section begin=mbhs-av-mp-va-tst-7-3-90-miljoen-nr-v30 />
−
==== Scenario 9.2 - MBH_200_herhalingen====
+
==== Scenario 7.3 - MBH_300_magistraal90miljoennr-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_herhalingen_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_magistraal90miljoennr_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
−
|colspan="3" width="25%"| Gegevenselement
+
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
|| Waarde
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Identificatie
+
|colspan="4"|Identificatie
−
|style="background-color: white;"|MBH_200_herhalingen_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_magistraal90miljoennr_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="4"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 12:05 uur
+
|style="background-color: white;"|T om 13:08 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="3"|Gebruiksperiode
+
|colspan="4"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T''
+
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 30 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="2"|
+
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Ingangsdatum
+
|colspan="3"|Ingangsdatum
 
|style="background-color: white;"|T
 
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Einddatum
 +
|style="background-color: white;"|T + 30 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Verstrekker
+
|colspan="5"|Verstrekker
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder
+
|colspan="3"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Geneesmiddel - ProductSpecificatie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="8"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|ProductCode
 +
|style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.999.77.90000000.1.1111')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|ProductNaam
 +
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Omschrijving
 +
|style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr          Regel: UREUM 10gr          Regel: EUCERINE MET WATER FAGRON ad 100gr
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Ingredient
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - primaire code
+
|rowspan="3"|
−
|style="background-color: white;"|FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK')
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - generiekere code
+
|colspan="2"|IngredientCode
−
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - generiekere code
+
|colspan="2"|Sterkte
−
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|10 gram per  100 gram
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Gebruiksinstructie
+
|colspan="5"|Gebruiksinstructie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="4"|
 
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Omschrijving
+
|colspan="3"|Omschrijving
−
|style="background-color: white;"|Vanaf T, 1 maal per dag 1 stuk, Oraal
+
|style="background-color: white;"|1 maal per dag, cutaan
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Toedieningsweg
+
|colspan="3"|Toedieningsweg
−
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Doseerinstructie
+
|colspan="3"|Doseerinstructie
−
|style="background-color: white;"|1 maal per dag 1 stuk
+
|style="background-color: white;"|1 maal per dag
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="5"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Identificatie
+
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_herhalingen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_magistraal90miljoennr_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|MBH identificatie
+
|colspan="4"|MBH identificatie
−
|style="background-color: white;"|MBH_200_herhalingen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_magistraal90miljoennr-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_herhalingen_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieverstrekking MBH_300_magistraal90miljoennr_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
−
|colspan="3" width="25%"| Gegevenselement
+
|colspan="4" width="25%"| Gegevenselement
 
|| Waarde
 
|| Waarde
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Identificatie
+
|colspan="4"|Identificatie
−
|style="background-color: white;"|MBH_200_herhalingen_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_magistraal90miljoennr_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="4"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 12:05 uur
+
|style="background-color: white;"|T om 13:08 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Verstrekker
+
|colspan="5"|Verstrekker
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder
+
|colspan="3"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="4"|VerstrekteHoeveelheid
−
|style="background-color: white;"|30 stuks
+
|style="background-color: white;"|100 gram
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Geneesmiddel - ProductSpecificatie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - primaire code
+
|rowspan="8"|
−
|style="background-color: white;"|FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK')
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|ProductCode
 +
|style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.999.77.90000000.1.1111')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|ProductNaam
 +
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Omschrijving
 +
|style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr          Regel: UREUM 10gr          Regel: EUCERINE MET WATER FAGRON ad 100gr
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Ingredient
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - generiekere code
+
|colspan="2"|IngredientCode
−
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - generiekere code
+
|colspan="2"|Sterkte
−
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|10 gram per  100 gram
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="4"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_herhalingen_VV
+
|style="background-color: white;"|MBH_300_magistraal90miljoennr_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|MBH identificatie
+
|colspan="4"|MBH identificatie
−
|style="background-color: white;"|MBH_200_herhalingen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_magistraal90miljoennr-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 8.061: Regel 8.314:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-9-2-herhalingen-v20 /><section end=av-mp-va-tst-9-2-herhalingen-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 9 Afleverlocatie / Aanschrijfdatum==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-9-3-afleverlocatie-v20 /><section begin=patient-av-mp-va-tst-9-3-afleverlocatie-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-7-3-90-miljoen-nr-v30 /><section end=av-mp-va-tst-7-3-90-miljoen-nr-v30 />
 +
== TEST Scenarioset 7 vrije tekst product==
 +
<section begin=av-mp-va-tst-7-4-vrije-tekst-v30 /><section begin=patient-av-mp-va-tst-7-4-vrije-tekst-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 8.085: Regel 8.341:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Initialen
 
|colspan="3"|Initialen
−
|style="background-color: white;"|M.
+
|style="background-color: white;"|G.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
Regel 8.095: Regel 8.351:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Nederveen
+
|style="background-color: white;"|XXX_Hess
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900833 [BSN]
+
|style="background-color: white;"|999900614 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|28 okt 1985
+
|style="background-color: white;"|3 nov 1963
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-9-3-afleverlocatie-v20 /><section begin=mbhs-av-mp-va-tst-9-3-afleverlocatie-v20 />
+
|}<section end=patient-av-mp-va-tst-7-4-vrije-tekst-v30 /><section begin=mbhs-av-mp-va-tst-7-4-vrije-tekst-v30 />
−
==== Scenario 9.3 - MBH_200_afleverlocatie====
+
==== Scenario 7.4 - MBH_300_vrijetekstproduct-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_afleverlocatie_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_vrijetekstproduct_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 8.116: Regel 8.372:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_afleverlocatie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_vrijetekstproduct_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 12:07 uur
+
|style="background-color: white;"|T om 15:50 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, tot en met T + 10 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T - 1 dag, gedurende 12 weken''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|colspan="2"|Ingangsdatum
−
|style="background-color: white;"|T + 1 dag
+
|style="background-color: white;"|T - 1 dag
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Einddatum
+
|colspan="2"|Gebruiksduur
−
|style="background-color: white;"|T + 10 dagen
+
|style="background-color: white;"|12 weken
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 8.137: Regel 8.393:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Geneesmiddel - ProductSpecificatie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - primaire code
+
|rowspan="3"|
−
|style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK')
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - generiekere code
+
|colspan="2"|ProductNaam
−
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|Jemperli 500 mg/ 10 mL
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - generiekere code
+
|colspan="2"|Omschrijving
−
|style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|Titel: Jemperli (Dostarlimab-gxly) 500 mg/10 mL
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
Regel 8.153: Regel 8.410:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T + 1 dag, tot en met T + 10 dagen, 3 maal per dag 1 stuk, Oraal
+
|style="background-color: white;"|1 maal per 3 weken 1 stuk, Intraveneus
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|Intraveneus (code = '5' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|3 maal per dag 1 stuk
+
|style="background-color: white;"|1 maal per 3 weken 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_afleverlocatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_vrijetekstproduct_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_afleverlocatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_vrijetekstproduct-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_afleverlocatie_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_vrijetekstproduct_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 8.179: Regel 8.436:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_afleverlocatie_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_vrijetekstproduct_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 12:07 uur
+
|style="background-color: white;"|T om 15:50 uur
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Aanschrijf datum
 
−
|style="background-color: white;"|T om 11:07 uur
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 8.192: Regel 8.446:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|30 stuks
+
|style="background-color: white;"|4 stuks
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Geneesmiddel - ProductSpecificatie
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - primaire code
+
|rowspan="3"|
−
|style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK')
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - generiekere code
+
|colspan="2"|ProductNaam
−
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|Jemperli 500 mg/ 10 mL
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - generiekere code
+
|colspan="2"|Omschrijving
−
|style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|Titel: Jemperli (Dostarlimab-gxly) 500 mg/10 mL
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Afleverlocatie
 
−
|style="background-color: white;"|Dorpsrand 200,1256ZZ Ons Dorp
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_afleverlocatie_VV
+
|style="background-color: white;"|MBH_300_vrijetekstproduct_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_afleverlocatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_vrijetekstproduct-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 8.223: Regel 8.475:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-9-3-afleverlocatie-v20 /><section end=av-mp-va-tst-9-3-afleverlocatie-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 10 HPK geneesmiddel==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-10-1-hpk-geneesmiddel-v20 /><section begin=patient-av-mp-va-tst-10-1-hpk-geneesmiddel-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-7-4-vrije-tekst-v30 /><section end=av-mp-va-tst-7-4-vrije-tekst-v30 />
 +
== TEST Scenarioset 8 VV onder andermans MA==
 +
<section begin=av-mp-va-tst-8-1-VV-onder-andermans-MA-v30 /><section begin=patient-av-mp-va-tst-8-1-VV-onder-andermans-MA-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 8.244: Regel 8.499:
 
|colspan="5"|Naamgegevens
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="6"|
+
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Initialen
+
|colspan="3"|Voornamen
−
|style="background-color: white;"|M.
+
|style="background-color: white;"|L.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="2"|
+
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Voorvoegsels
 +
|style="background-color: white;"|van
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Niesing
+
|style="background-color: white;"|XXX_Meijs
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900845 [BSN]
+
|style="background-color: white;"|999900808 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|29 okt 1985
+
|style="background-color: white;"|26 okt 1985
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-10-1-hpk-geneesmiddel-v20 /><section begin=mbhs-av-mp-va-tst-10-1-hpk-geneesmiddel-v20 />
+
|}<section end=patient-av-mp-va-tst-8-1-VV-onder-andermans-MA-v30 /><section begin=mbhs-av-mp-va-tst-8-1-VV-onder-andermans-MA-v30 />
−
==== Scenario 10.1 - MBH_200_HPKvoorschrijven====
+
==== Scenario 8.1 - MBH_300_VVandermansMA-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_HPKvoorschrijven_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_MVEandermansTA_TA-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 8.278: Regel 8.536:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_HPKvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_MVEandermansTA_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 14:00 uur
+
|style="background-color: white;"|T - 14 dagen om 10:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 150 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T + 6 dagen''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|colspan="2"|Ingangsdatum
−
|style="background-color: white;"|T
+
|style="background-color: white;"|T - 14 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Einddatum
 
|colspan="2"|Einddatum
−
|style="background-color: white;"|T + 150 dagen
+
|style="background-color: white;"|T + 6 dagen
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 8.299: Regel 8.557:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|DICLOFENAC NATRIUM AUROBINDO RET TABLET MGA 100MG (code = '630608' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
Regel 8.315: Regel 8.573:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, tot en met T + 150 dagen, 1 maal per dag 1 stuk, Oraal
+
|style="background-color: white;"|1 maal per dag 1 stuk, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
+
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_HPKvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_VVandermansMA_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_VVandermansMA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_HPKvoorschrijven_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_MVEandermansTA_MVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 8.341: Regel 8.599:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_HPKvoorschrijven_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_MVEandermansTA_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 14:00 uur
+
|style="background-color: white;"|T om 10:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 8.351: Regel 8.609:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|150 stuks
+
|style="background-color: white;"|6 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|DICLOFENAC NATRIUM AUROBINDO RET TABLET MGA 100MG (code = '630608' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_HPKvoorschrijven_VV
+
|style="background-color: white;"|MBH_300_VVandermansMA_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_VVandermansMA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 8.379: Regel 8.637:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-10-1-hpk-geneesmiddel-v20 /><section end=av-mp-va-tst-10-1-hpk-geneesmiddel-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 10 ZI-nummer geneesmiddel==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-10-2-zi-nummer-geneesmiddel-v20 /><section begin=patient-av-mp-va-tst-10-2-zi-nummer-geneesmiddel-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-8-1-VV-onder-andermans-MA-v30 /><section end=av-mp-va-tst-8-1-VV-onder-andermans-MA-v30 />
 +
== TEST Scenarioset 8 Staken andermans MA==
 +
<section begin=av-mp-va-tst-8-2-staken-andermans-MA-v30 /><section begin=patient-av-mp-va-tst-8-2-staken-andermans-MA-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 8.400: Regel 8.661:
 
|colspan="5"|Naamgegevens
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="6"|
+
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Initialen
+
|colspan="3"|Voornamen
−
|style="background-color: white;"|M.
+
|style="background-color: white;"|L.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="2"|
+
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Voorvoegsels
 +
|style="background-color: white;"|van
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Niesing
+
|style="background-color: white;"|XXX_Meijs
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900845 [BSN]
+
|style="background-color: white;"|999900808 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|29 okt 1985
+
|style="background-color: white;"|26 okt 1985
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-10-2-zi-nummer-geneesmiddel-v20 /><section begin=mbhs-av-mp-va-tst-10-2-zi-nummer-geneesmiddel-v20 />
+
|}<section end=patient-av-mp-va-tst-8-2-staken-andermans-MA-v30 /><section begin=mbhs-av-mp-va-tst-8-2-staken-andermans-MA-v30 />
−
==== Scenario 10.2 - MBH_200_ZINRvoorschrijven====
+
==== Scenario 8.2 - MBH_300_stakenandermansMA-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_ZINRvoorschrijven_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_stakenandermansTA_TA2-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 8.434: Regel 8.698:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_ZINRvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_stakenandermansTA_TA2-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 14:05 uur
+
|style="background-color: white;"|T om 10:05 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 150 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="3"|
 
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T - 5 dagen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 
|style="background-color: white;"|T
 
|style="background-color: white;"|T
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Einddatum
+
|colspan="3"|ToedieningsafspraakStopType
−
|style="background-color: white;"|T + 150 dagen
+
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 8.455: Regel 8.722:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr')
+
|style="background-color: white;"|LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK')
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Geneesmiddel - generiekere code
 
−
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK')
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
Regel 8.474: Regel 8.738:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T, tot en met T + 150 dagen, 1 maal per dag 1 stuk, Oraal
+
|style="background-color: white;"|1 maal per dag 1 stuk, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
+
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Doseerinstructie
 
|colspan="2"|Doseerinstructie
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_ZINRvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_stakenandermansMA_MA2-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_stakenandermansMA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_ZINRvoorschrijven_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_stakenandermansTA_andermansMVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 8.500: Regel 8.764:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_ZINRvoorschrijven_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_stakenandermansTA_andermansMVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 14:05 uur
+
|style="background-color: white;"|T - 5 dagen om 09:45 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 8.510: Regel 8.774:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|150 stuks
+
|style="background-color: white;"|21 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr')
+
|style="background-color: white;"|LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Geneesmiddel - generiekere code
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|MBH_300_stakenandermansMA_andermansVV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
−
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
−
|colspan="3"|Relatie verstrekkingsverzoek
 
−
|style="background-color: white;"|MBH_200_ZINRvoorschrijven_VV
 
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_stakenandermansMA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 8.541: Regel 8.802:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-10-2-zi-nummer-geneesmiddel-v20 /><section end=av-mp-va-tst-10-2-zi-nummer-geneesmiddel-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
== TEST Scenarioset 11 extern doseerschema==
+
|colspan="2"|Adresgegevens
−
<section begin=av-mp-va-tst-11-1-externdoseerschema-v20 /><section begin=patient-av-mp-va-tst-11-1-externdoseerschema-v20 />
+
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-8-2-staken-andermans-MA-v30 /><section end=av-mp-va-tst-8-2-staken-andermans-MA-v30 />
 +
== TEST Scenarioset 8 Onderbreken andermans MA==
 +
<section begin=av-mp-va-tst-8-3-onderbreken-andermans-MA-v30 /><section begin=patient-av-mp-va-tst-8-3-onderbreken-andermans-MA-v30 />
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 8.562: Regel 8.826:
 
|colspan="5"|Naamgegevens
 
|colspan="5"|Naamgegevens
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="6"|
+
|rowspan="7"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Initialen
+
|colspan="3"|Voornamen
−
|style="background-color: white;"|M.
+
|style="background-color: white;"|L.
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Naamgebruik
 
|colspan="3"|Naamgebruik
−
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
+
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Geslachtsnaam
 
|colspan="4"|Geslachtsnaam
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="2"|
+
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Voorvoegsels
 +
|style="background-color: white;"|van
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Achternaam
 
|colspan="2"|Achternaam
−
|style="background-color: white;"|XXX_Pherai
+
|style="background-color: white;"|XXX_Meijs
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Identificatienummer
 
|colspan="4"|Identificatienummer
−
|style="background-color: white;"|999900870 [BSN]
+
|style="background-color: white;"|999900808 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geboortedatum
 
|colspan="4"|Geboortedatum
−
|style="background-color: white;"|1 nov 1985
+
|style="background-color: white;"|26 okt 1985
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="4"|Geslacht
 
|colspan="4"|Geslacht
−
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
+
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
−
|}<section end=patient-av-mp-va-tst-11-1-externdoseerschema-v20 /><section begin=mbhs-av-mp-va-tst-11-1-externdoseerschema-v20 />
+
|}<section end=patient-av-mp-va-tst-8-3-onderbreken-andermans-MA-v30 /><section begin=mbhs-av-mp-va-tst-8-3-onderbreken-andermans-MA-v30 />
−
==== Scenario 11.1 - MBH_200_wdsmtd1====
+
==== Scenario 8.3 - MBH_300_onderbrekenandermansMA-tav====
  
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_200_wdsmtd1_TA
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_onderbrekenandermansTA_TA2-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 8.596: Regel 8.863:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_wdsmtd1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
+
|style="background-color: white;"|MBH_300_onderbrekenandermansTA_TA2-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Toedieningsafspraak datum tijd
+
|colspan="3"|RegistratieDatumTijd
−
|style="background-color: white;"|T om 09:00 uur
+
|style="background-color: white;"|T om 10:07 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="3"|Gebruiksperiode
 
|colspan="3"|Gebruiksperiode
−
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen''
+
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T''
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="2"|
+
|rowspan="3"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Ingangsdatum
 
|colspan="2"|Ingangsdatum
−
|style="background-color: white;"|T - 20 dagen
+
|style="background-color: white;"|T - 60 dagen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|ToedieningsafspraakStopType
 +
|style="background-color: white;"|onderbroken (code = '385655000' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 8.614: Regel 8.887:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Gebruiksinstructie
 
|colspan="4"|Gebruiksinstructie
Regel 8.630: Regel 8.903:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Omschrijving
 
|colspan="2"|Omschrijving
−
|style="background-color: white;"|Vanaf T - 20 dagen, Volgens schema trombosedienst, Oraal
+
|style="background-color: white;"|1 maal per dag 1 stuk, oraal
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Toedieningsweg
 
|colspan="2"|Toedieningsweg
−
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
+
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Aanvullende instructie
+
|colspan="2"|Doseerinstructie
−
|style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst
+
|style="background-color: white;"|1 maal per dag 1 stuk
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|Relatie medicatieafspraak
+
|colspan="4"|RelatieMedicatieafspraak
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|rowspan="2"|
 
|rowspan="2"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Identificatie
 
|colspan="2"|Identificatie
−
|style="background-color: white;"|MBH_200_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
+
|style="background-color: white;"|MBH_300_onderbrekenandermansMA_MA2-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_onderbrekenandermansMA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
{| class="wikitable" width="85%"
 
{| class="wikitable" width="85%"
−
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_200_wdsmtd1_MVE
+
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_onderbrekenandermansTA_andermansMVE-tav
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|-style="background-color: #1F497D;; color: white; text-align:left;"  
 
|colspan="3" width="25%"| Gegevenselement
 
|colspan="3" width="25%"| Gegevenselement
Regel 8.656: Regel 8.929:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Identificatie
 
|colspan="3"|Identificatie
−
|style="background-color: white;"|MBH_200_wdsmtd1_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
+
|style="background-color: white;"|MBH_300_onderbrekenandermansTA_andermansMVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Medicatieverstrekkings datum tijd
+
|colspan="3"|MedicatieverstrekkingsDatumTijd
−
|style="background-color: white;"|T om 09:00 uur
+
|style="background-color: white;"|T - 60 dagen om 10:00 uur
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|colspan="4"|Verstrekker
 
|colspan="4"|Verstrekker
Regel 8.666: Regel 8.939:
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="2"|Zorgaanbieder
 
|colspan="2"|Zorgaanbieder
−
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
+
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Verstrekte hoeveelheid
+
|colspan="3"|VerstrekteHoeveelheid
−
|style="background-color: white;"|60 stuks
+
|style="background-color: white;"|90 stuks
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - primaire code
 
|colspan="3"|Geneesmiddel - primaire code
−
|style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK')
+
|style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
+
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|Geneesmiddel - generiekere code
 
|colspan="3"|Geneesmiddel - generiekere code
−
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
+
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="3"|Relatie verstrekkingsverzoek
+
|colspan="3"|RelatieVerstrekkingsverzoek
−
|style="background-color: white;"|MBH_200_wdsmtd1_VV
+
|style="background-color: white;"|MBH_300_onderbrekenandermansMA_andermansVV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|colspan="3"|MBH identificatie
 
|colspan="3"|MBH identificatie
−
|style="background-color: white;"|MBH_200_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
+
|style="background-color: white;"|MBH_300_onderbrekenandermansMA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 
|}
 
|}
 
==== Bouwstenen ====
 
==== Bouwstenen ====
Regel 8.694: Regel 8.967:
  
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
−
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
+
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|rowspan="3"|
+
|rowspan="4"|
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Zorgaanbieder identificatienummer
+
|colspan="2"|ZorgaanbiederIdentificatienummer
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
−
|colspan="2"|Organisatie naam
+
|colspan="2"|OrganisatieNaam
 
|style="background-color: white;"|Apotheek De Gulle Gaper
 
|style="background-color: white;"|Apotheek De Gulle Gaper
−
|}<section end=mbhs-av-mp-va-tst-11-1-externdoseerschema-v20 /><section end=av-mp-va-tst-11-1-externdoseerschema-v20 />
+
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-8-3-onderbreken-andermans-MA-v30 /><section end=av-mp-va-tst-8-3-onderbreken-andermans-MA-v30 />
 +
== TEST Scenarioset 8 Wijzigen andermans MA==
 +
<section begin=av-mp-va-tst-8-4-wijzigen-andermans-MA-v30 /><section begin=patient-av-mp-va-tst-8-4-wijzigen-andermans-MA-v30 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="4" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Naamgegevens
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="7"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Voornamen
 +
|style="background-color: white;"|L.
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Naamgebruik
 +
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Geslachtsnaam
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Voorvoegsels
 +
|style="background-color: white;"|van
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Achternaam
 +
|style="background-color: white;"|XXX_Meijs
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Identificatienummer
 +
|style="background-color: white;"|999900808 [BSN]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geboortedatum
 +
|style="background-color: white;"|26 okt 1985
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geslacht
 +
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
 +
|}<section end=patient-av-mp-va-tst-8-4-wijzigen-andermans-MA-v30 /><section begin=mbhs-av-mp-va-tst-8-4-wijzigen-andermans-MA-v30 />
 +
==== Scenario 8.4 - MBH_300_wijzigenandermansMA-tav====
 +
 
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_wijzigenandermansTA_TA1-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_wijzigenandermansTA_TA1-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RegistratieDatumTijd
 +
|style="background-color: white;"|T - 7 dagen om 08:50 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="3"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T - 7 dagen, tot en met T + 13 dagen''
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T - 7 dagen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T + 13 dagen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Gebruiksinstructie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Omschrijving
 +
|style="background-color: white;"|1 maal per dag 2 stuks, oraal
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Toedieningsweg
 +
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Doseerinstructie
 +
|style="background-color: white;"|1 maal per dag 2 stuks
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieMedicatieafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_wijzigenandermansMA_MA1-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_wijzigenandermansMA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_wijzigenandermansTA_andermansMVE-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_wijzigenandermansTA_andermansMVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MedicatieverstrekkingsDatumTijd
 +
|style="background-color: white;"|T - 7 dagen om 08:50 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|VerstrekteHoeveelheid
 +
|style="background-color: white;"|42 stuks
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RelatieVerstrekkingsverzoek
 +
|style="background-color: white;"|MBH_300_wijzigenandermansMA_andermansVV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_wijzigenandermansMA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
==== Bouwstenen ====
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|ZorgaanbiederIdentificatienummer
 +
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|OrganisatieNaam
 +
|style="background-color: white;"|Apotheek De Gulle Gaper
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-8-4-wijzigen-andermans-MA-v30 /><section end=av-mp-va-tst-8-4-wijzigen-andermans-MA-v30 />
 +
== TEST Scenarioset 9 Verbruiksperiode ==
 +
<section begin=av-mp-va-tst-9-1a-verbruiksperiode-start-eind-v30 /><section begin=patient-av-mp-va-tst-9-1a-verbruiksperiode-start-eind-v30 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="4" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Naamgegevens
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="6"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Initialen
 +
|style="background-color: white;"|M.
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Naamgebruik
 +
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Geslachtsnaam
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Achternaam
 +
|style="background-color: white;"|XXX_Nederveen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Identificatienummer
 +
|style="background-color: white;"|999900833 [BSN]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geboortedatum
 +
|style="background-color: white;"|28 okt 1985
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geslacht
 +
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
 +
|}<section end=patient-av-mp-va-tst-9-1a-verbruiksperiode-start-eind-v30 /><section begin=mbhs-av-mp-va-tst-9-1a-verbruiksperiode-start-eind-v30 />
 +
==== Scenario 9.1a - MBH_300_logistiekeverbruiksperiode_start_eind-tav====
 +
 
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_logistiekeverbruiksperiode_start_eind_TA-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_start_eind_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RegistratieDatumTijd
 +
|style="background-color: white;"|T om 12:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="3"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 12 maanden''
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T + 12 maanden
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Gebruiksinstructie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Omschrijving
 +
|style="background-color: white;"|1 maal per dag 1 stuk, Oraal
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Toedieningsweg
 +
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Doseerinstructie
 +
|style="background-color: white;"|1 maal per dag 1 stuk
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieMedicatieafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_start_eind_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_start_eind-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MedicatieverstrekkingsDatumTijd
 +
|style="background-color: white;"|T om 12:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|VerstrekteHoeveelheid
 +
|style="background-color: white;"|100 stuks
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Verbruiksduur
 +
|style="background-color: white;"|100 dagen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RelatieVerstrekkingsverzoek
 +
|style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_start_eind_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_start_eind-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
==== Bouwstenen ====
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|ZorgaanbiederIdentificatienummer
 +
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|OrganisatieNaam
 +
|style="background-color: white;"|Apotheek De Gulle Gaper
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-9-1a-verbruiksperiode-start-eind-v30 /><section end=av-mp-va-tst-9-1a-verbruiksperiode-start-eind-v30 />
 +
== TEST Scenarioset 9 GDS==
 +
<section begin=av-mp-va-tst-9-1b-verbruiksperiode-einddatum-v30 /><section begin=patient-av-mp-va-tst-9-1b-verbruiksperiode-einddatum-v30 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="4" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Naamgegevens
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="6"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Initialen
 +
|style="background-color: white;"|M.
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Naamgebruik
 +
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Geslachtsnaam
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Achternaam
 +
|style="background-color: white;"|XXX_Nederveen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Identificatienummer
 +
|style="background-color: white;"|999900833 [BSN]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geboortedatum
 +
|style="background-color: white;"|28 okt 1985
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geslacht
 +
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
 +
|}<section end=patient-av-mp-va-tst-9-1b-verbruiksperiode-einddatum-v30 /><section begin=mbhs-av-mp-va-tst-9-1b-verbruiksperiode-einddatum-v30 />
 +
==== Scenario 9.1b - MBH_300_distributievorm_GDS-tav====
 +
 
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_distributievorm_GDS_TA-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_distributievorm_GDS_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RegistratieDatumTijd
 +
|style="background-color: white;"|T om 12:01 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="3"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 200 dagen''
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T + 200 dagen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Gebruiksinstructie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Omschrijving
 +
|style="background-color: white;"|1 maal per dag 1 stuk, Oraal
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Toedieningsweg
 +
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Doseerinstructie
 +
|style="background-color: white;"|1 maal per dag 1 stuk
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Distributievorm
 +
|style="background-color: white;"|GDS (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.3.8')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieMedicatieafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_distributievorm_GDS_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_distributievorm_GDS-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_distributievorm_GDS_MVE-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_distributievorm_GDS_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MedicatieverstrekkingsDatumTijd
 +
|style="background-color: white;"|T om 12:01 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|VerstrekteHoeveelheid
 +
|style="background-color: white;"|14 stuks
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Verbruiksduur
 +
|style="background-color: white;"|14 dagen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Distributievorm
 +
|style="background-color: white;"|GDS (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.3.8')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RelatieVerstrekkingsverzoek
 +
|style="background-color: white;"|MBH_300_distributievorm_GDS_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_distributievorm_GDS-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
==== Bouwstenen ====
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|ZorgaanbiederIdentificatienummer
 +
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|OrganisatieNaam
 +
|style="background-color: white;"|Apotheek De Gulle Gaper
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-9-1b-verbruiksperiode-einddatum-v30 /><section end=av-mp-va-tst-9-1b-verbruiksperiode-einddatum-v30 />
 +
== TEST Scenarioset 9 verbruiksduur (dagen)==
 +
<section begin=av-mp-va-tst-9-1c-verbruiksperiode-duur-v30 /><section begin=patient-av-mp-va-tst-9-1c-verbruiksperiode-duur-v30 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="4" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Naamgegevens
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="6"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Initialen
 +
|style="background-color: white;"|M.
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Naamgebruik
 +
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Geslachtsnaam
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Achternaam
 +
|style="background-color: white;"|XXX_Nederveen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Identificatienummer
 +
|style="background-color: white;"|999900833 [BSN]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geboortedatum
 +
|style="background-color: white;"|28 okt 1985
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geslacht
 +
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
 +
|}<section end=patient-av-mp-va-tst-9-1c-verbruiksperiode-duur-v30 /><section begin=mbhs-av-mp-va-tst-9-1c-verbruiksperiode-duur-v30 />
 +
==== Scenario 9.1c - MBH_300_logistiekeverbruiksperiode_duur_dagen-tav====
 +
 
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_logistiekeverbruiksperiode_duur_dagen_TA-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_duur_dagen_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RegistratieDatumTijd
 +
|style="background-color: white;"|T om 12:02 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="3"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 150 dagen''
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T + 150 dagen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|PARACETAMOL PCH TABLET 500MG (code = '768901' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Gebruiksinstructie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Omschrijving
 +
|style="background-color: white;"|1 maal per dag 1 stuk, Oraal
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Toedieningsweg
 +
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Doseerinstructie
 +
|style="background-color: white;"|1 maal per dag 1 stuk
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieMedicatieafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_duur_dagen_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_duur_dagen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MedicatieverstrekkingsDatumTijd
 +
|style="background-color: white;"|T om 12:02 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|VerstrekteHoeveelheid
 +
|style="background-color: white;"|50 stuks
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Verbruiksduur
 +
|style="background-color: white;"|50 dagen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|PARACETAMOL PCH TABLET 500MG (code = '768901' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RelatieVerstrekkingsverzoek
 +
|style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_duur_dagen_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_duur_dagen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
==== Bouwstenen ====
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|ZorgaanbiederIdentificatienummer
 +
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|OrganisatieNaam
 +
|style="background-color: white;"|Apotheek De Gulle Gaper
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-9-1c-verbruiksperiode-duur-v30 /><section end=av-mp-va-tst-9-1c-verbruiksperiode-duur-v30 />
 +
== TEST Scenarioset 9 Herhalingen a==
 +
<section begin=av-mp-va-tst-9-2a-herhalingen-v30 /><section begin=patient-av-mp-va-tst-9-2a-herhalingen-v30 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="4" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Naamgegevens
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="6"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Initialen
 +
|style="background-color: white;"|M.
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Naamgebruik
 +
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Geslachtsnaam
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Achternaam
 +
|style="background-color: white;"|XXX_Nederveen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Identificatienummer
 +
|style="background-color: white;"|999900833 [BSN]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geboortedatum
 +
|style="background-color: white;"|28 okt 1985
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geslacht
 +
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
 +
|}<section end=patient-av-mp-va-tst-9-2a-herhalingen-v30 /><section begin=mbhs-av-mp-va-tst-9-2a-herhalingen-v30 />
 +
==== Scenario 9.2a - MBH_300_herhalingen-tav====
 +
 
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_herhalingen_TA-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_herhalingen_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RegistratieDatumTijd
 +
|style="background-color: white;"|T om 12:05 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="3"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T''
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Gebruiksinstructie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Omschrijving
 +
|style="background-color: white;"|1 maal per dag 1 stuk, Oraal
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Toedieningsweg
 +
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Doseerinstructie
 +
|style="background-color: white;"|1 maal per dag 1 stuk
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieMedicatieafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_herhalingen_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_herhalingen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_herhalingen_MVE1-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_herhalingen_MVE1-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MedicatieverstrekkingsDatumTijd
 +
|style="background-color: white;"|T om 12:05 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|VerstrekteHoeveelheid
 +
|style="background-color: white;"|30 stuks
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RelatieVerstrekkingsverzoek
 +
|style="background-color: white;"|MBH_300_herhalingen_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_herhalingen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
==== Bouwstenen ====
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|ZorgaanbiederIdentificatienummer
 +
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|OrganisatieNaam
 +
|style="background-color: white;"|Apotheek De Gulle Gaper
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-9-2a-herhalingen-v30 /><section end=av-mp-va-tst-9-2a-herhalingen-v30 />
 +
== TEST Scenarioset 9 Herhalingen b==
 +
<section begin=av-mp-va-tst-9-2b-herhalingen-v30 /><section begin=patient-av-mp-va-tst-9-2b-herhalingen-v30 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="4" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Naamgegevens
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="6"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Initialen
 +
|style="background-color: white;"|M.
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Naamgebruik
 +
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Geslachtsnaam
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Achternaam
 +
|style="background-color: white;"|XXX_Nederveen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Identificatienummer
 +
|style="background-color: white;"|999900833 [BSN]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geboortedatum
 +
|style="background-color: white;"|28 okt 1985
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geslacht
 +
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
 +
|}<section end=patient-av-mp-va-tst-9-2b-herhalingen-v30 /><section begin=mbhs-av-mp-va-tst-9-2b-herhalingen-v30 />
 +
==== Scenario 9.2b - MBH_300_herhalingen-tav====
 +
 
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_herhalingen_TA-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_herhalingen_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RegistratieDatumTijd
 +
|style="background-color: white;"|T - 30 dagen om 12:05 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="3"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen''
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T - 30 dagen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Gebruiksinstructie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Omschrijving
 +
|style="background-color: white;"|1 maal per dag 1 stuk, Oraal
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Toedieningsweg
 +
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Doseerinstructie
 +
|style="background-color: white;"|1 maal per dag 1 stuk
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieMedicatieafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_herhalingen_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_herhalingen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_herhalingen_MVE2-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_herhalingen_MVE2-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MedicatieverstrekkingsDatumTijd
 +
|style="background-color: white;"|T om 10:24:05 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|VerstrekteHoeveelheid
 +
|style="background-color: white;"|30 stuks
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RelatieVerstrekkingsverzoek
 +
|style="background-color: white;"|MBH_300_herhalingen_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_herhalingen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
==== Bouwstenen ====
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|ZorgaanbiederIdentificatienummer
 +
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|OrganisatieNaam
 +
|style="background-color: white;"|Apotheek De Gulle Gaper
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-9-2b-herhalingen-v30 /><section end=av-mp-va-tst-9-2b-herhalingen-v30 />
 +
== TEST Scenarioset 9 Herhalingen c==
 +
<section begin=av-mp-va-tst-9-2c-herhalingen-v30 /><section begin=patient-av-mp-va-tst-9-2c-herhalingen-v30 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="4" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Naamgegevens
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="6"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Initialen
 +
|style="background-color: white;"|M.
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Naamgebruik
 +
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Geslachtsnaam
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Achternaam
 +
|style="background-color: white;"|XXX_Nederveen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Identificatienummer
 +
|style="background-color: white;"|999900833 [BSN]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geboortedatum
 +
|style="background-color: white;"|28 okt 1985
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geslacht
 +
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
 +
|}<section end=patient-av-mp-va-tst-9-2c-herhalingen-v30 /><section begin=mbhs-av-mp-va-tst-9-2c-herhalingen-v30 />
 +
==== Scenario 9.2c - MBH_300_herhalingen-tav====
 +
 
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_herhalingen_TA-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_herhalingen_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RegistratieDatumTijd
 +
|style="background-color: white;"|T - 60 dagen om 12:05 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="3"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen''
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T - 60 dagen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Gebruiksinstructie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Omschrijving
 +
|style="background-color: white;"|1 maal per dag 1 stuk, Oraal
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Toedieningsweg
 +
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Doseerinstructie
 +
|style="background-color: white;"|1 maal per dag 1 stuk
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieMedicatieafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_herhalingen_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_herhalingen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_herhalingen_MVE3-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_herhalingen_MVE3-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MedicatieverstrekkingsDatumTijd
 +
|style="background-color: white;"|T om 09:46:48 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|VerstrekteHoeveelheid
 +
|style="background-color: white;"|30 stuks
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RelatieVerstrekkingsverzoek
 +
|style="background-color: white;"|MBH_300_herhalingen_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_herhalingen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
==== Bouwstenen ====
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|ZorgaanbiederIdentificatienummer
 +
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|OrganisatieNaam
 +
|style="background-color: white;"|Apotheek De Gulle Gaper
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-9-2c-herhalingen-v30 /><section end=av-mp-va-tst-9-2c-herhalingen-v30 />
 +
== TEST Scenarioset 9 Afleverlocatie / Aanschrijfdatum==
 +
<section begin=av-mp-va-tst-9-3-afleverlocatie-v30 /><section begin=patient-av-mp-va-tst-9-3-afleverlocatie-v30 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="4" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Naamgegevens
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="6"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Initialen
 +
|style="background-color: white;"|M.
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Naamgebruik
 +
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Geslachtsnaam
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Achternaam
 +
|style="background-color: white;"|XXX_Nederveen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Identificatienummer
 +
|style="background-color: white;"|999900833 [BSN]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geboortedatum
 +
|style="background-color: white;"|28 okt 1985
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geslacht
 +
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
 +
|}<section end=patient-av-mp-va-tst-9-3-afleverlocatie-v30 /><section begin=mbhs-av-mp-va-tst-9-3-afleverlocatie-v30 />
 +
==== Scenario 9.3 - MBH_300_afleverlocatie-tav====
 +
 
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_afleverlocatie_TA-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_afleverlocatie_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RegistratieDatumTijd
 +
|style="background-color: white;"|T om 12:07 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="3"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, tot en met T + 10 dagen''
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T + 1 dag
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T + 10 dagen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|MODAFINIL FOCUS TABLET 200MG (code = '2842246' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|MODAFINIL TABLET 200MG (code = '199311' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|MODAFINIL TABLET 200MG (code = '179051' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Gebruiksinstructie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Omschrijving
 +
|style="background-color: white;"|3 maal per dag 1 stuk, Oraal
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Toedieningsweg
 +
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Doseerinstructie
 +
|style="background-color: white;"|3 maal per dag 1 stuk
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieMedicatieafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_afleverlocatie_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_afleverlocatie-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_afleverlocatie_MVE-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_afleverlocatie_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MedicatieverstrekkingsDatumTijd
 +
|style="background-color: white;"|T om 12:07 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|AanschrijfDatum
 +
|style="background-color: white;"|T om 11:07 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|VerstrekteHoeveelheid
 +
|style="background-color: white;"|30 stuks
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|MODAFINIL FOCUS TABLET 200MG (code = '2842246' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|MODAFINIL TABLET 200MG (code = '199311' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|MODAFINIL TABLET 200MG (code = '179051' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Afleverlocatie
 +
|style="background-color: white;"|Dorpsrand 200,1256ZZ Ons Dorp
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RelatieVerstrekkingsverzoek
 +
|style="background-color: white;"|MBH_300_afleverlocatie_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_afleverlocatie-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
==== Bouwstenen ====
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|ZorgaanbiederIdentificatienummer
 +
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|OrganisatieNaam
 +
|style="background-color: white;"|Apotheek De Gulle Gaper
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-9-3-afleverlocatie-v30 /><section end=av-mp-va-tst-9-3-afleverlocatie-v30 />
 +
== TEST Scenarioset 10 HPK geneesmiddel==
 +
<section begin=av-mp-va-tst-10-1-hpk-geneesmiddel-v30 /><section begin=patient-av-mp-va-tst-10-1-hpk-geneesmiddel-v30 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="4" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Naamgegevens
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="6"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Initialen
 +
|style="background-color: white;"|M.
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Naamgebruik
 +
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Geslachtsnaam
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Achternaam
 +
|style="background-color: white;"|XXX_Niesing
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Identificatienummer
 +
|style="background-color: white;"|999900845 [BSN]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geboortedatum
 +
|style="background-color: white;"|29 okt 1985
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geslacht
 +
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
 +
|}<section end=patient-av-mp-va-tst-10-1-hpk-geneesmiddel-v30 /><section begin=mbhs-av-mp-va-tst-10-1-hpk-geneesmiddel-v30 />
 +
==== Scenario 10.1 - MBH_300_HPKvoorschrijven-tav====
 +
 
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_HPKvoorschrijven_TA-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_HPKvoorschrijven_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RegistratieDatumTijd
 +
|style="background-color: white;"|T om 14:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="3"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 150 dagen''
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T + 150 dagen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Gebruiksinstructie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Omschrijving
 +
|style="background-color: white;"|1 maal per dag 1 stuk, Oraal
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Toedieningsweg
 +
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Doseerinstructie
 +
|style="background-color: white;"|1 maal per dag 1 stuk
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieMedicatieafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_HPKvoorschrijven_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_HPKvoorschrijven-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_HPKvoorschrijven_MVE-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_HPKvoorschrijven_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MedicatieverstrekkingsDatumTijd
 +
|style="background-color: white;"|T om 14:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|VerstrekteHoeveelheid
 +
|style="background-color: white;"|150 stuks
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RelatieVerstrekkingsverzoek
 +
|style="background-color: white;"|MBH_300_HPKvoorschrijven_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_HPKvoorschrijven-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
==== Bouwstenen ====
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|ZorgaanbiederIdentificatienummer
 +
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|OrganisatieNaam
 +
|style="background-color: white;"|Apotheek De Gulle Gaper
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-10-1-hpk-geneesmiddel-v30 /><section end=av-mp-va-tst-10-1-hpk-geneesmiddel-v30 />
 +
== TEST Scenarioset 10 ZI-nummer geneesmiddel==
 +
<section begin=av-mp-va-tst-10-2-zi-nummer-geneesmiddel-v30 /><section begin=patient-av-mp-va-tst-10-2-zi-nummer-geneesmiddel-v30 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="4" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Naamgegevens
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="6"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Initialen
 +
|style="background-color: white;"|M.
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Naamgebruik
 +
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Geslachtsnaam
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Achternaam
 +
|style="background-color: white;"|XXX_Niesing
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Identificatienummer
 +
|style="background-color: white;"|999900845 [BSN]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geboortedatum
 +
|style="background-color: white;"|29 okt 1985
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geslacht
 +
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
 +
|}<section end=patient-av-mp-va-tst-10-2-zi-nummer-geneesmiddel-v30 /><section begin=mbhs-av-mp-va-tst-10-2-zi-nummer-geneesmiddel-v30 />
 +
==== Scenario 10.2 - MBH_300_ZINRvoorschrijven-tav====
 +
 
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_ZINRvoorschrijven_TA-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RegistratieDatumTijd
 +
|style="background-color: white;"|T om 14:05 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="3"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 150 dagen''
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T + 150 dagen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '16255429' in codeSystem 'G-Standaard ZI-nr')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '2593866' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Gebruiksinstructie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Omschrijving
 +
|style="background-color: white;"|1 maal per dag 1 stuk, Oraal
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Toedieningsweg
 +
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Doseerinstructie
 +
|style="background-color: white;"|1 maal per dag 1 stuk
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieMedicatieafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_ZINRvoorschrijven-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_ZINRvoorschrijven_MVE-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MedicatieverstrekkingsDatumTijd
 +
|style="background-color: white;"|T om 14:05 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|VerstrekteHoeveelheid
 +
|style="background-color: white;"|150 stuks
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '16255429' in codeSystem 'G-Standaard ZI-nr')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '2593866' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RelatieVerstrekkingsverzoek
 +
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_ZINRvoorschrijven-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
==== Bouwstenen ====
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|ZorgaanbiederIdentificatienummer
 +
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|OrganisatieNaam
 +
|style="background-color: white;"|Apotheek De Gulle Gaper
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-10-2-zi-nummer-geneesmiddel-v30 /><section end=av-mp-va-tst-10-2-zi-nummer-geneesmiddel-v30 />
 +
== TEST Scenarioset 11 extern doseerschema==
 +
<section begin=av-mp-va-tst-11-1-externdoseerschema-v30 /><section begin=patient-av-mp-va-tst-11-1-externdoseerschema-v30 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="4" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Naamgegevens
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="6"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Initialen
 +
|style="background-color: white;"|M.
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Naamgebruik
 +
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Geslachtsnaam
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Achternaam
 +
|style="background-color: white;"|XXX_Pherai
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Identificatienummer
 +
|style="background-color: white;"|999900870 [BSN]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geboortedatum
 +
|style="background-color: white;"|1 nov 1985
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geslacht
 +
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
 +
|}<section end=patient-av-mp-va-tst-11-1-externdoseerschema-v30 /><section begin=mbhs-av-mp-va-tst-11-1-externdoseerschema-v30 />
 +
==== Scenario 11.1 - MBH_300_wdsmtd1-tav====
 +
 
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_wdsmtd1_TA-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_wdsmtd1_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RegistratieDatumTijd
 +
|style="background-color: white;"|T om 09:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="3"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen''
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T - 20 dagen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Gebruiksinstructie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Omschrijving
 +
|style="background-color: white;"|Volgens schema trombosedienst, Oraal
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Toedieningsweg
 +
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|AanvullendeInstructie
 +
|style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieMedicatieafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_wdsmtd1_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_wdsmtd1-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_wdsmtd1_MVE-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_wdsmtd1_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MedicatieverstrekkingsDatumTijd
 +
|style="background-color: white;"|T om 09:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|VerstrekteHoeveelheid
 +
|style="background-color: white;"|60 stuks
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RelatieVerstrekkingsverzoek
 +
|style="background-color: white;"|MBH_300_wdsmtd1_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_wdsmtd1-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
==== Bouwstenen ====
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|ZorgaanbiederIdentificatienummer
 +
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|OrganisatieNaam
 +
|style="background-color: white;"|Apotheek De Gulle Gaper
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-tst-11-1-externdoseerschema-v30 /><section end=av-mp-va-tst-11-1-externdoseerschema-v30 />
 +
== TEST Scenarioset 23.1a afhandelen voorschrift t.b.v. VMA==
 +
<section begin=av-mp-va-vsg-tst-23-1a-vma-geaccepteerd-v30 /><section begin=patient-av-mp-va-vsg-tst-23-1a-vma-geaccepteerd-v30 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="4" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Naamgegevens
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="6"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Voornamen
 +
|style="background-color: white;"|K.
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Naamgebruik
 +
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Geslachtsnaam
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Achternaam
 +
|style="background-color: white;"|XXX_Verbeekz
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Identificatienummer
 +
|style="background-color: white;"|999908522 [BSN]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geboortedatum
 +
|style="background-color: white;"|19 feb 1912
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geslacht
 +
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
 +
|}<section end=patient-av-mp-va-vsg-tst-23-1a-vma-geaccepteerd-v30 /><section begin=mbhs-av-mp-va-vsg-tst-23-1a-vma-geaccepteerd-v30 />
 +
==== Scenario 23.1a - MBH_300_VMA_geaccepteerd-tav====
 +
 
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_VMA_geaccepteerd_TA_start-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_VMA_geaccepteerd_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RegistratieDatumTijd
 +
|style="background-color: white;"|T om 15:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="3"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 29 dagen''
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T + 29 dagen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|OMEPRAZOL TEVA CAPSULE MSR 20MG (code = '2239671' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 20MG (code = '60062' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 20MG (code = '114529' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Gebruiksinstructie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Omschrijving
 +
|style="background-color: white;"|1 maal per dag 1 stuk, oraal
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Toedieningsweg
 +
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Doseerinstructie
 +
|style="background-color: white;"|1 maal per dag 1 stuk
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_VMA_geaccepteerd-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_VMA_geaccepteerd_MVE-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_VMA_geaccepteerd_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MedicatieverstrekkingsDatumTijd
 +
|style="background-color: white;"|T om 15:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|VerstrekteHoeveelheid
 +
|style="background-color: white;"|28 stuks
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|OMEPRAZOL TEVA CAPSULE MSR 20MG (code = '2239671' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 20MG (code = '60062' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 20MG (code = '114529' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_VMA_geaccepteerd-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
==== Bouwstenen ====
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|ZorgaanbiederIdentificatienummer
 +
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|OrganisatieNaam
 +
|style="background-color: white;"|Apotheek De Gulle Gaper
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-vsg-tst-23-1a-vma-geaccepteerd-v30 /><section end=av-mp-va-vsg-tst-23-1a-vma-geaccepteerd-v30 />
 +
== TEST Scenarioset 23.1b afhandelen voorschrift t.b.v. VMA==
 +
<section begin=av-mp-va-vsg-tst-23-1b-vma-geaccepteerd-v30 /><section begin=patient-av-mp-va-vsg-tst-23-1b-vma-geaccepteerd-v30 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="4" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Naamgegevens
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="6"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Voornamen
 +
|style="background-color: white;"|K.
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Naamgebruik
 +
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Geslachtsnaam
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Achternaam
 +
|style="background-color: white;"|XXX_Verbeekz
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Identificatienummer
 +
|style="background-color: white;"|999908522 [BSN]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geboortedatum
 +
|style="background-color: white;"|19 feb 1912
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geslacht
 +
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
 +
|}<section end=patient-av-mp-va-vsg-tst-23-1b-vma-geaccepteerd-v30 /><section begin=mbhs-av-mp-va-vsg-tst-23-1b-vma-geaccepteerd-v30 />
 +
==== Scenario 23.1b - MBH_300_VMA_geaccepteerd-tav====
 +
 
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_VMA_geaccepteerd_TA_techstop-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_VMA_geaccepteerd_TA_techstop-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RegistratieDatumTijd
 +
|style="background-color: white;"|T + 1 dag om 13:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="3"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 1 dag om 13:00 uur''
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T + 1 dag om 13:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|ToedieningsafspraakStopType
 +
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|OMEPRAZOL TEVA CAPSULE MSR 20MG (code = '2239671' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 20MG (code = '60062' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 20MG (code = '114529' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Gebruiksinstructie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Omschrijving
 +
|style="background-color: white;"|1 maal per dag 1 stuk, Oraal
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Toedieningsweg
 +
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Doseerinstructie
 +
|style="background-color: white;"|1 maal per dag 1 stuk
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieToedieningsafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_VMA_geaccepteerd_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_VMA_geaccepteerd-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_VMA_geaccepteerd_TA_naVMA-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_VMA_geaccepteerd_TA_naVMA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RegistratieDatumTijd
 +
|style="background-color: white;"|T + 1 dag om 13:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="3"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag om 13:00 uur, tot en met T + 29 dagen''
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T + 1 dag om 13:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T + 29 dagen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|OMEPRAZOL TEVA CAPSULE MSR 20MG (code = '2239671' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 20MG (code = '60062' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 20MG (code = '114529' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Gebruiksinstructie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Omschrijving
 +
|style="background-color: white;"|1 maal per dag 1 stuk, Oraal
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Toedieningsweg
 +
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Doseerinstructie
 +
|style="background-color: white;"|1 maal per dag 1 stuk
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieMedicatieafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_VMA_geaccepteerd_MA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_VMA_geaccepteerd-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
==== Bouwstenen ====
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|ZorgaanbiederIdentificatienummer
 +
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|OrganisatieNaam
 +
|style="background-color: white;"|Apotheek De Gulle Gaper
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-vsg-tst-23-1b-vma-geaccepteerd-v30 /><section end=av-mp-va-vsg-tst-23-1b-vma-geaccepteerd-v30 />
 +
== TEST Scenarioset 23.2 afhandelen voorschrift t.b.v. VMA==
 +
<section begin=av-mp-va-vsg-tst-23-2-vma-afgewezen-PRK-v30 /><section begin=patient-av-mp-va-vsg-tst-23-2-vma-afgewezen-PRK-v30 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="4" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Naamgegevens
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="6"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Voornamen
 +
|style="background-color: white;"|K.
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Naamgebruik
 +
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Geslachtsnaam
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Achternaam
 +
|style="background-color: white;"|XXX_Wieling
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Identificatienummer
 +
|style="background-color: white;"|999908510 [BSN]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geboortedatum
 +
|style="background-color: white;"|18 feb 1912
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geslacht
 +
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
 +
|}<section end=patient-av-mp-va-vsg-tst-23-2-vma-afgewezen-PRK-v30 /><section begin=mbhs-av-mp-va-vsg-tst-23-2-vma-afgewezen-PRK-v30 />
 +
==== Scenario 23.2 - MBH_300_VMAafgewezen_PRK-tav====
 +
 
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_VMAafgewezen_PRK_TA-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_VMAafgewezen_PRK_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RegistratieDatumTijd
 +
|style="background-color: white;"|T om 16:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="3"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 13 dagen''
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T + 13 dagen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|PLEINVUE POEDER VOOR DRANK IN SACHET (code = '2748088' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|MACROGOL/ZOUTEN PDR V DRANK (PLEINVUE) (code = '150002' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|MACROGOL/ZOUTEN PDR V DRANK (PLEINVUE) (code = '174076' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Gebruiksinstructie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Omschrijving
 +
|style="background-color: white;"|1 à 2 maal per dag 1 stuk, Oraal
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Toedieningsweg
 +
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Doseerinstructie
 +
|style="background-color: white;"|1 à 2 maal per dag 1 stuk
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieMedicatieafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_VMAafgewezen_PRK_MA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_VMAafgewezen_PRK-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_VMAafgewezen_PRK_MVE-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_VMAafgewezen_PRK_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MedicatieverstrekkingsDatumTijd
 +
|style="background-color: white;"|T om 16:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|VerstrekteHoeveelheid
 +
|style="background-color: white;"|28 stuks
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|PLEINVUE POEDER VOOR DRANK IN SACHET (code = '2748088' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|MACROGOL/ZOUTEN PDR V DRANK (PLEINVUE) (code = '150002' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|MACROGOL/ZOUTEN PDR V DRANK (PLEINVUE) (code = '174076' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RelatieVerstrekkingsverzoek
 +
|style="background-color: white;"|MBH_300_VMAafgewezen_PRK_VV_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_VMAafgewezen_PRK-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
==== Bouwstenen ====
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|ZorgaanbiederIdentificatienummer
 +
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|OrganisatieNaam
 +
|style="background-color: white;"|Apotheek De Gulle Gaper
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-vsg-tst-23-2-vma-afgewezen-PRK-v30 /><section end=av-mp-va-vsg-tst-23-2-vma-afgewezen-PRK-v30 />
 +
== TEST Scenarioset 23.3a afhandelen voorschrift t.b.v. VMA==
 +
<section begin=av-mp-va-vsg-tst-23-3a-vma-aanvullend-middel-v30 /><section begin=patient-av-mp-va-vsg-tst-23-3a-vma-aanvullend-middel-v30 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="4" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Naamgegevens
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="6"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Voornamen
 +
|style="background-color: white;"|J.
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Naamgebruik
 +
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Geslachtsnaam
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Achternaam
 +
|style="background-color: white;"|XXX_Willemsz
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Identificatienummer
 +
|style="background-color: white;"|999908492 [BSN]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geboortedatum
 +
|style="background-color: white;"|16 feb 1912
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geslacht
 +
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
 +
|}<section end=patient-av-mp-va-vsg-tst-23-3a-vma-aanvullend-middel-v30 /><section begin=mbhs-av-mp-va-vsg-tst-23-3a-vma-aanvullend-middel-v30 />
 +
==== Scenario 23.3a - MBH_300_VMAaanvullendmiddel-tav====
 +
 
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_VMAaanvullendmiddel_TA_start-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_VMAaanvullendmiddel_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RegistratieDatumTijd
 +
|style="background-color: white;"|T om 11:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="3"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 13 dagen''
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T + 13 dagen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|PLEINVUE POEDER VOOR DRANK IN SACHET (code = '2748088' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|MACROGOL/ZOUTEN PDR V DRANK (PLEINVUE) (code = '150002' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|MACROGOL/ZOUTEN PDR V DRANK (PLEINVUE) (code = '174076' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Gebruiksinstructie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Omschrijving
 +
|style="background-color: white;"|1 à 2 maal per dag 1 stuk, Oraal
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Toedieningsweg
 +
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Doseerinstructie
 +
|style="background-color: white;"|1 à 2 maal per dag 1 stuk
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_VMAaanvullendmiddel-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_VMAaanvullendmiddel_MVE-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_VMAaanvullendmiddel_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MedicatieverstrekkingsDatumTijd
 +
|style="background-color: white;"|T om 11:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|VerstrekteHoeveelheid
 +
|style="background-color: white;"|28 stuks
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|PLEINVUE POEDER VOOR DRANK IN SACHET (code = '2748088' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|MACROGOL/ZOUTEN PDR V DRANK (PLEINVUE) (code = '150002' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|MACROGOL/ZOUTEN PDR V DRANK (PLEINVUE) (code = '174076' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_VMAaanvullendmiddel-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
==== Bouwstenen ====
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|ZorgaanbiederIdentificatienummer
 +
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|OrganisatieNaam
 +
|style="background-color: white;"|Apotheek De Gulle Gaper
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-vsg-tst-23-3a-vma-aanvullend-middel-v30 /><section end=av-mp-va-vsg-tst-23-3a-vma-aanvullend-middel-v30 />
 +
== TEST Scenarioset 23.3b afhandelen voorschrift t.b.v. VMA==
 +
<section begin=av-mp-va-vsg-tst-23-3b-vma-aanvullend-middel-v30 /><section begin=patient-av-mp-va-vsg-tst-23-3b-vma-aanvullend-middel-v30 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="4" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Naamgegevens
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="6"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Voornamen
 +
|style="background-color: white;"|J.
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Naamgebruik
 +
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Geslachtsnaam
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Achternaam
 +
|style="background-color: white;"|XXX_Willemsz
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Identificatienummer
 +
|style="background-color: white;"|999908492 [BSN]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geboortedatum
 +
|style="background-color: white;"|16 feb 1912
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geslacht
 +
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
 +
|}<section end=patient-av-mp-va-vsg-tst-23-3b-vma-aanvullend-middel-v30 /><section begin=mbhs-av-mp-va-vsg-tst-23-3b-vma-aanvullend-middel-v30 />
 +
==== Scenario 23.3b - MBH_300_VMAaanvullendmiddel-tav====
 +
 
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_VMAaanvullendmiddel_techstopTA-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_VMAaanvullendmiddel_techstopTA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RegistratieDatumTijd
 +
|style="background-color: white;"|T om 16:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="3"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T om 16:00 uur''
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T om 16:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|ToedieningsafspraakStopType
 +
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|PLEINVUE POEDER VOOR DRANK IN SACHET (code = '2748088' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|MACROGOL/ZOUTEN PDR V DRANK (PLEINVUE) (code = '150002' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|MACROGOL/ZOUTEN PDR V DRANK (PLEINVUE) (code = '174076' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Gebruiksinstructie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Omschrijving
 +
|style="background-color: white;"|1 à 2 maal per dag 1 stuk, Oraal
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Toedieningsweg
 +
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Doseerinstructie
 +
|style="background-color: white;"|1 à 2 maal per dag 1 stuk
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieToedieningsafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_VMAaanvullendmiddel_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_VMAaanvullendmiddel-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_VMAaanvullendmiddel_TA_naVMA-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_VMAaanvullendmiddel_TA_naVMA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RegistratieDatumTijd
 +
|style="background-color: white;"|T om 16:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="3"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T om 16:00 uur, tot en met T + 13 dagen''
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T om 16:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T + 13 dagen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|PLEINVUE POEDER VOOR DRANK IN SACHET (code = '2748088' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|MACROGOL/ZOUTEN PDR V DRANK (PLEINVUE) (code = '150002' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|MACROGOL/ZOUTEN PDR V DRANK (PLEINVUE) (code = '174076' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Gebruiksinstructie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Omschrijving
 +
|style="background-color: white;"|1 à 2 maal per dag 1 stuk, Oraal
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Toedieningsweg
 +
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Doseerinstructie
 +
|style="background-color: white;"|1 à 2 maal per dag 1 stuk
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieMedicatieafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_VMAaanvullendmiddel_MA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_VMAaanvullendmiddel-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
==== Bouwstenen ====
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|ZorgaanbiederIdentificatienummer
 +
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|OrganisatieNaam
 +
|style="background-color: white;"|Apotheek De Gulle Gaper
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-vsg-tst-23-3b-vma-aanvullend-middel-v30 /><section end=av-mp-va-vsg-tst-23-3b-vma-aanvullend-middel-v30 />
 +
== TEST Scenarioset 23.4a afhandelen voorschrift t.b.v. VMA==
 +
<section begin=av-mp-va-vsg-tst-23-4a-vma-vervangend-middel-v30 /><section begin=patient-av-mp-va-vsg-tst-23-4a-vma-vervangend-middel-v30 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="4" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Naamgegevens
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="7"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Voornamen
 +
|style="background-color: white;"|J.
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Naamgebruik
 +
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Geslachtsnaam
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Voorvoegsels
 +
|style="background-color: white;"|van de
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Achternaam
 +
|style="background-color: white;"|XXX_Knaap
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Identificatienummer
 +
|style="background-color: white;"|999908480 [BSN]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geboortedatum
 +
|style="background-color: white;"|15 feb 1912
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geslacht
 +
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
 +
|}<section end=patient-av-mp-va-vsg-tst-23-4a-vma-vervangend-middel-v30 /><section begin=mbhs-av-mp-va-vsg-tst-23-4a-vma-vervangend-middel-v30 />
 +
==== Scenario 23.4a - MBH_300_VMAvervangend_voorschr-tav====
 +
 
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_VMAvervangend_voorschr_TA_start-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_VMAvervangend_voorschr_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RegistratieDatumTijd
 +
|style="background-color: white;"|T om 15:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="3"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T''
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|ToedieningsafspraakRedenWijzigenOfStaken
 +
|style="background-color: white;"|geneesmiddel niet voorradig (code = '182856006' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|KETOZOLIN SHAMPOO 20MG/ML (code = '2854368' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|KETOCONAZOL SHAMPOO 20MG/G (code = '80349' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|KETOCONAZOL SHAMPOO 20MG/G (code = '125156' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Gebruiksinstructie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="5"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Omschrijving
 +
|style="background-color: white;"|2 maal per week, een kleine hoeveelheid over het nog natte haar verdelen en voorzichtig inmasseren, na 3–5 min uitspoelen. De behandeling voortzetten tot de symptomen zijn verdwenen, Cutaan
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Toedieningsweg
 +
|style="background-color: white;"|Cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|AanvullendeInstructie
 +
|style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): een kleine hoeveelheid over het nog natte haar verdelen en voorzichtig inmasseren, na 3–5 min uitspoelen. De behandeling voortzetten tot de symptomen zijn verdwenen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Doseerinstructie
 +
|style="background-color: white;"|2 maal per week
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieMedicatieafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_VMAvervangend_voorschr_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_VMAvervangend_voorschr-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_VMAvervangend_voorschr_MVE_start-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_VMAvervangend_voorschr_MVE_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MedicatieverstrekkingsDatumTijd
 +
|style="background-color: white;"|T om 15:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|VerstrekteHoeveelheid
 +
|style="background-color: white;"|100 ml
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|KETOZOLIN SHAMPOO 20MG/ML (code = '2854368' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|KETOCONAZOL SHAMPOO 20MG/G (code = '80349' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|KETOCONAZOL SHAMPOO 20MG/G (code = '125156' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_VMAvervangend_voorschr-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
==== Bouwstenen ====
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|ZorgaanbiederIdentificatienummer
 +
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|OrganisatieNaam
 +
|style="background-color: white;"|Apotheek De Gulle Gaper
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-vsg-tst-23-4a-vma-vervangend-middel-v30 /><section end=av-mp-va-vsg-tst-23-4a-vma-vervangend-middel-v30 />
 +
== TEST Scenarioset 23.4b afhandelen voorschrift t.b.v. VMA==
 +
<section begin=av-mp-va-vsg-tst-23-4b-vma-vervangend-middel-v30 /><section begin=patient-av-mp-va-vsg-tst-23-4b-vma-vervangend-middel-v30 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="4" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Naamgegevens
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="7"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Voornamen
 +
|style="background-color: white;"|J.
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Naamgebruik
 +
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Geslachtsnaam
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Voorvoegsels
 +
|style="background-color: white;"|van de
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Achternaam
 +
|style="background-color: white;"|XXX_Knaap
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Identificatienummer
 +
|style="background-color: white;"|999908480 [BSN]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geboortedatum
 +
|style="background-color: white;"|15 feb 1912
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geslacht
 +
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
 +
|}<section end=patient-av-mp-va-vsg-tst-23-4b-vma-vervangend-middel-v30 /><section begin=mbhs-av-mp-va-vsg-tst-23-4b-vma-vervangend-middel-v30 />
 +
==== Scenario 23.4b - MBH_300_VMAvervangend_voorschr-tav====
 +
 
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_VMAvervangend_voorschr_stopTA-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_VMAvervangend_voorschr_stopTA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RegistratieDatumTijd
 +
|style="background-color: white;"|T om 17:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="3"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T om 17:00 uur''
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T om 17:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|ToedieningsafspraakStopType
 +
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|KETOZOLIN SHAMPOO 20MG/ML (code = '2854368' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|KETOCONAZOL SHAMPOO 20MG/G (code = '80349' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|KETOCONAZOL SHAMPOO 20MG/G (code = '125156' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Gebruiksinstructie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="5"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Omschrijving
 +
|style="background-color: white;"|2 maal per week, een kleine hoeveelheid over het nog natte haar verdelen en voorzichtig inmasseren, na 3–5 min uitspoelen. De behandeling voortzetten tot de symptomen zijn verdwenen, Cutaan
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Toedieningsweg
 +
|style="background-color: white;"|Cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|AanvullendeInstructie
 +
|style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): een kleine hoeveelheid over het nog natte haar verdelen en voorzichtig inmasseren, na 3–5 min uitspoelen. De behandeling voortzetten tot de symptomen zijn verdwenen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Doseerinstructie
 +
|style="background-color: white;"|2 maal per week
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieMedicatieafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_VMAvervangend_voorschr_stopMA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieToedieningsafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_VMAvervangend_voorschr_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_VMAvervangend_voorschr-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
==== Bouwstenen ====
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|ZorgaanbiederIdentificatienummer
 +
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|OrganisatieNaam
 +
|style="background-color: white;"|Apotheek De Gulle Gaper
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-vsg-tst-23-4b-vma-vervangend-middel-v30 /><section end=av-mp-va-vsg-tst-23-4b-vma-vervangend-middel-v30 />
 +
== TEST Scenarioset 23.4c afhandelen voorschrift t.b.v. VMA==
 +
<section begin=av-mp-va-vsg-tst-23-4c-vma-vervangend-middel-v30 /><section begin=patient-av-mp-va-vsg-tst-23-4c-vma-vervangend-middel-v30 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="4" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Naamgegevens
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="7"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Voornamen
 +
|style="background-color: white;"|J.
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Naamgebruik
 +
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Geslachtsnaam
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Voorvoegsels
 +
|style="background-color: white;"|van de
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Achternaam
 +
|style="background-color: white;"|XXX_Knaap
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Identificatienummer
 +
|style="background-color: white;"|999908480 [BSN]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geboortedatum
 +
|style="background-color: white;"|15 feb 1912
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geslacht
 +
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
 +
|}<section end=patient-av-mp-va-vsg-tst-23-4c-vma-vervangend-middel-v30 /><section begin=mbhs-av-mp-va-vsg-tst-23-4c-vma-vervangend-middel-v30 />
 +
==== Scenario 23.4c - MBH_300_VMAvervangendmiddel-tav====
 +
 
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_VMAvervangendmiddel_TA_naVMA-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_VMAvervangendmiddel_TA_naVMA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RegistratieDatumTijd
 +
|style="background-color: white;"|T om 17:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="3"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T om 17:00 uur''
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T om 17:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|KETOZOLIN SHAMPOO 20MG/ML (code = '2854368' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|KETOCONAZOL SHAMPOO 20MG/G (code = '80349' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|KETOCONAZOL SHAMPOO 20MG/G (code = '125156' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Gebruiksinstructie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="5"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Omschrijving
 +
|style="background-color: white;"|2 maal per week, een kleine hoeveelheid over het nog natte haar verdelen en voorzichtig inmasseren, na 3–5 min uitspoelen. De behandeling voortzetten tot de symptomen zijn verdwenen, Cutaan
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Toedieningsweg
 +
|style="background-color: white;"|Cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|AanvullendeInstructie
 +
|style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): een kleine hoeveelheid over het nog natte haar verdelen en voorzichtig inmasseren, na 3–5 min uitspoelen. De behandeling voortzetten tot de symptomen zijn verdwenen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Doseerinstructie
 +
|style="background-color: white;"|2 maal per week
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieMedicatieafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_VMAvervangendmiddel_MA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieToedieningsafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_VMAvervangend_voorschr_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_VMAvervangendmiddel-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
==== Bouwstenen ====
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|ZorgaanbiederIdentificatienummer
 +
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|OrganisatieNaam
 +
|style="background-color: white;"|Apotheek De Gulle Gaper
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-vsg-tst-23-4c-vma-vervangend-middel-v30 /><section end=av-mp-va-vsg-tst-23-4c-vma-vervangend-middel-v30 />
 +
== TEST Scenarioset 23.5a afhandelen voorschrift t.b.v. VVV==
 +
<section begin=av-mp-va-vsg-tst-23-5a-vvv-geaccepteerd-v30 /><section begin=patient-av-mp-va-vsg-tst-23-5a-vvv-geaccepteerd-v30 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="4" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Naamgegevens
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="7"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Voornamen
 +
|style="background-color: white;"|J.
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Naamgebruik
 +
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Geslachtsnaam
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Voorvoegsels
 +
|style="background-color: white;"|de
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Achternaam
 +
|style="background-color: white;"|XXX_Wit
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Identificatienummer
 +
|style="background-color: white;"|999908509 [BSN]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geboortedatum
 +
|style="background-color: white;"|17 feb 1912
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geslacht
 +
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
 +
|}<section end=patient-av-mp-va-vsg-tst-23-5a-vvv-geaccepteerd-v30 /><section begin=mbhs-av-mp-va-vsg-tst-23-5a-vvv-geaccepteerd-v30 />
 +
==== Scenario 23.5a - MBH_300_VVV_geaccepteerd-tav====
 +
 
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_VVV_geaccepteerd_TA_start-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_VVV_geaccepteerd_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RegistratieDatumTijd
 +
|style="background-color: white;"|T - 2 dagen om 14:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="3"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T - 2 dagen, tot en met T''
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T - 2 dagen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|METOCLOPRAMIDE HCL ACCORD TABLET 10MG (code = '2115468' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Gebruiksinstructie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Omschrijving
 +
|style="background-color: white;"|1 maal per 2 dagen 2 stuks, Oraal
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Toedieningsweg
 +
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Doseerinstructie
 +
|style="background-color: white;"|1 maal per 2 dagen 2 stuks
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieMedicatieafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_VVV_geaccepteerd_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_VVV_geaccepteerd-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_VVV_geaccepteerd_MVE_start-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_VVV_geaccepteerd_MVE_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MedicatieverstrekkingsDatumTijd
 +
|style="background-color: white;"|T - 2 dagen om 14:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|VerstrekteHoeveelheid
 +
|style="background-color: white;"|6 stuks
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|METOCLOPRAMIDE HCL ACCORD TABLET 10MG (code = '2115468' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RelatieVerstrekkingsverzoek
 +
|style="background-color: white;"|MBH_300_VVV_geaccepteerd_VV_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_VVV_geaccepteerd-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
==== Bouwstenen ====
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|ZorgaanbiederIdentificatienummer
 +
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|OrganisatieNaam
 +
|style="background-color: white;"|Apotheek De Gulle Gaper
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-vsg-tst-23-5a-vvv-geaccepteerd-v30 /><section end=av-mp-va-vsg-tst-23-5a-vvv-geaccepteerd-v30 />
 +
== TEST Scenarioset 23.5b afhandelen voorschrift t.b.v. VVV==
 +
<section begin=av-mp-va-vsg-tst-23-5b-vvv-geaccepteerd-v30 /><section begin=patient-av-mp-va-vsg-tst-23-5b-vvv-geaccepteerd-v30 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="4" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Naamgegevens
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="7"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Voornamen
 +
|style="background-color: white;"|J.
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Naamgebruik
 +
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Geslachtsnaam
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Voorvoegsels
 +
|style="background-color: white;"|de
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Achternaam
 +
|style="background-color: white;"|XXX_Wit
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Identificatienummer
 +
|style="background-color: white;"|999908509 [BSN]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geboortedatum
 +
|style="background-color: white;"|17 feb 1912
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geslacht
 +
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
 +
|}<section end=patient-av-mp-va-vsg-tst-23-5b-vvv-geaccepteerd-v30 /><section begin=mbhs-av-mp-va-vsg-tst-23-5b-vvv-geaccepteerd-v30 />
 +
==== Scenario 23.5b - MBH_300_VVV_geaccepteerd-tav====
 +
 
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_VVV_geaccepteerd_TA_start-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_VVV_geaccepteerd_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RegistratieDatumTijd
 +
|style="background-color: white;"|T - 2 dagen om 14:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="3"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T - 2 dagen, tot en met T''
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T - 2 dagen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|METOCLOPRAMIDE HCL ACCORD TABLET 10MG (code = '2115468' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Gebruiksinstructie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Omschrijving
 +
|style="background-color: white;"|1 maal per 2 dagen 2 stuks, Oraal
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Toedieningsweg
 +
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Doseerinstructie
 +
|style="background-color: white;"|1 maal per 2 dagen 2 stuks
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieMedicatieafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_VVV_geaccepteerd_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_VVV_geaccepteerd-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_VVV_geaccepteerd_MVE_naVVV-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_VVV_geaccepteerd_MVE_naVVV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MedicatieverstrekkingsDatumTijd
 +
|style="background-color: white;"|T om 15:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|VerstrekteHoeveelheid
 +
|style="background-color: white;"|5 stuks
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|METOCLOPRAMIDE HCL ACCORD TABLET 10MG (code = '2115468' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RelatieVerstrekkingsverzoek
 +
|style="background-color: white;"|MBH_300_VVV_geaccepteerd_VV__naVVV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_VVV_geaccepteerd-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
==== Bouwstenen ====
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|ZorgaanbiederIdentificatienummer
 +
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|OrganisatieNaam
 +
|style="background-color: white;"|Apotheek De Gulle Gaper
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-vsg-tst-23-5b-vvv-geaccepteerd-v30 /><section end=av-mp-va-vsg-tst-23-5b-vvv-geaccepteerd-v30 />
 +
== TEST Scenarioset 23.6 afhandelen voorschrift t.b.v. VVV==
 +
<section begin=av-mp-va-vsg-tst-23-6-vvv-geaccepteerdmetwijziging-v30 /><section begin=patient-av-mp-va-vsg-tst-23-6-vvv-geaccepteerdmetwijziging-v30 />
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="4" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="5"|Naamgegevens
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="7"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Voornamen
 +
|style="background-color: white;"|J.
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Naamgebruik
 +
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Geslachtsnaam
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Voorvoegsels
 +
|style="background-color: white;"|van
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Achternaam
 +
|style="background-color: white;"|XXX_Reenen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Identificatienummer
 +
|style="background-color: white;"|999908479 [BSN]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geboortedatum
 +
|style="background-color: white;"|14 feb 1912
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="4"|Geslacht
 +
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>')
 +
|}<section end=patient-av-mp-va-vsg-tst-23-6-vvv-geaccepteerdmetwijziging-v30 /><section begin=mbhs-av-mp-va-vsg-tst-23-6-vvv-geaccepteerdmetwijziging-v30 />
 +
==== Scenario 23.6 - MBH_300_VVV_wijziging-tav====
 +
 
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Toedieningsafspraak MBH_300_VVV_wijziging_TA-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_VVV_wijziging_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RegistratieDatumTijd
 +
|style="background-color: white;"|T om 16:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="3"|Gebruiksperiode
 +
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 4 dagen''
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="3"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Ingangsdatum
 +
|style="background-color: white;"|T
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Einddatum
 +
|style="background-color: white;"|T + 4 dagen
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|OMEPRAZOL TEVA CAPSULE MSR 20MG (code = '2239671' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 20MG (code = '60062' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 20MG (code = '114529' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Gebruiksinstructie
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Omschrijving
 +
|style="background-color: white;"|1 maal per dag 1 stuk, Oraal
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Toedieningsweg
 +
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Doseerinstructie
 +
|style="background-color: white;"|1 maal per dag 1 stuk
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|RelatieMedicatieafspraak
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Identificatie
 +
|style="background-color: white;"|MBH_300_VVV_wijziging_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_VVV_wijziging-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieverstrekking MBH_300_VVV_wijziging_MVE-tav
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Identificatie
 +
|style="background-color: white;"|MBH_300_VVV_wijziging_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MedicatieverstrekkingsDatumTijd
 +
|style="background-color: white;"|T om 16:00 uur
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|Verstrekker
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="2"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Zorgaanbieder
 +
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]]
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|VerstrekteHoeveelheid
 +
|style="background-color: white;"|5 stuks
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - primaire code
 +
|style="background-color: white;"|OMEPRAZOL TEVA CAPSULE MSR 20MG (code = '2239671' in codeSystem 'G-Standaard HPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 20MG (code = '60062' in codeSystem 'G-Standaard PRK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|Geneesmiddel - generiekere code
 +
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 20MG (code = '114529' in codeSystem 'G-Standaard GPK')
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|RelatieVerstrekkingsverzoek
 +
|style="background-color: white;"|MBH_300_VVV_wijziging_VV_naVVV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="3"|MBH identificatie
 +
|style="background-color: white;"|MBH_300_VVV_wijziging-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
 +
|}
 +
==== Bouwstenen ====
 +
{| class="wikitable" width="85%"
 +
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Bouwstenen
 +
|-style="background-color: #1F497D;; color: white; text-align:left;"
 +
|colspan="3" width="25%"| Gegevenselement
 +
|| Waarde
 +
 
 +
|-style="vertical-align:top; background-color: #E3E3E3;;" 
 +
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span>
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|rowspan="4"|
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|ZorgaanbiederIdentificatienummer
 +
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|OrganisatieNaam
 +
|style="background-color: white;"|Apotheek De Gulle Gaper
 +
|-style="vertical-align:top; background-color: #E3E3E3;;"
 +
|colspan="2"|Adresgegevens
 +
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
 +
|}<section end=mbhs-av-mp-va-vsg-tst-23-6-vvv-geaccepteerdmetwijziging-v30 /><section end=av-mp-va-vsg-tst-23-6-vvv-geaccepteerdmetwijziging-v30 />
  
 
[[Categorie:Kwalificatie]]
 
[[Categorie:Kwalificatie]]

Huidige versie van 24 jun 2026 om 16:39



Inhoud

1 Addenda voor inhoudelijke gegevens

1.1 Overzicht van scenario's voor sturend/beschikbaarstellend systeem

1.1.1 Scenarioset 1

Scenario Beschrijving MBH id TA id MVE id
1.1 Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum en einddatum MBH_300_start_eind-tav MBH_300_start_eind_TA-tav MBH_300_start_eind_MVE-tav
1.2a Afhandelen medicatievoorschrift met een toediedingsafspraak gebruiksperiode ingangsdatum en duur (weken) MBH_300_start_duur-tav MBH_300_start_duur_TA-tav MBH_300_start_duur_MVE-tav
1.2b Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum en duur (dagen) MBH_300_start_duur2-tav MBH_300_start_duur2_TA-tav MBH_300_start_duur2_MVE-tav
1.3 Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum (chronische medicatie) MBH_300_chronisch-tav MBH_300_chronisch_TA-tav MBH_300_chronisch_MVE-tav
1.4
Extra MVE 
LET OP: MVE met TA uit scenario 1.3 (20 dagen later)
 MBH_300_chronisch-tav MBH_300_chronisch_TA-tav MBH_300_chronisch_MVE_extraMVEbestaandeTA-tav
1.5 Afhandeling medicatievoorschrift met eenheid 'dosis/stuks' MBH_300_dosis_stuks-tav MBH_300_dosis_stuks_TA-tav MBH_300_dosis_stuks_MVE-tav
1.6
Afhandeling medicatievoorschrift met onzekerheidscriterium
 MBH_300_start_criterium-tav MBH_300_start_criterium_TA-tav MBH_300_start_criterium_MVE-tav

1.1.2 Scenarioset 2

Scenario Beschrijving MBH id TA id MVE id
2.1 Aanvullende instructie (TA) MBH_300_aanvullendeinstructie-tav MBH_300_aanvullendeinstructie_TA-tav MBH_300_aanvullendeinstructie_MVE-tav
2.2 Toelichting (TA), toelichting (MVE) MBH_300_toelichting-tav MBH_300_toelichting_TA-tav MBH_300_toelichting_MVE-tav
2.3 Reden van voorschrijven (TA) MBH_300_redenvanvoorschrijven-tav MBH_300_redenvanvoorschrijven_TA-tav MBH_300_redenvanvoorschrijven_MVE-tav
2.4 Aanvullende informatie (MA), aanvullende wensen (VV) MBH_300_aanvullendeinformatiewensen-tav MBH_300_aanvullendeinformatiewensen_TA-tav MBH_300_aanvullendeinformatiewensen_MVE-tav
2.5 Toedieningsweg (TA) MBH_300_Toedieningsweg-tav MBH_300_Toedieningsweg_TA-tav MBH_300_Toedieningsweg_MVE-tav

1.1.3 Scenarioset 3

Scenario Beschrijving MBH id TA id MVE id
3.1a
Benodigd voor scenario 3.1b
 
 MBH_300_stoppen-tav MBH_300_stoppen_TA_start-tav MBH_300_stoppen_MVE-tav
3.1b
Stop-toedieningsafspraak, met reden staken
LET OP: stoppen toedieningsafspraak van scenario 3.1a
 MBH_300_stoppen-tav MBH_300_stoppen_TA_staken-tav
3.2a
Benodigd voor scenario 3.2b
 MBH_300_wijzigen_verhoging-tav MBH_300_wijzigen_verhoging_TA_start-tav MBH_300_wijzigen_verhoging_MVE-tav
3.2b
Wijziging toedieningsafspraak, verhoging wijziging (stop-ta + nieuwe ta) met MVE
LET OP: wijziging toedieningsafspraak van scenario 3.2a
 MBH_300_wijzigen_verhoging-tav MBH_300_wijzigen_verhoging_TA_wijzigingmetMVE-tav
MBH_300_wijzigen_verhoging_TA_techstaken-tav		 MBH_300_wijzigen_verhoging_MVE_extra-tav
3.3a
Benodigd voor scenario 3.3b
 MBH_300_wijzigen_verlaging-tav MBH_300_wijzigen_verlaging_TA_start-tav MBH_300_wijzigen_verlaging_MVE-tav
3.3b
Wijziging toedieningsafspraak, met verlaging wijziging (stop-ta + nieuwe ta) zonder MVE
LET OP: wijziging toedieningsafspraak van scenario 3.3a
 MBH_300_wijzigen_verlaging-tav MBH_300_wijzigen_verlaging_TA_wijzigingzonderMVE-tav
MBH_300_wijzigen_verlaging_TA_techstaken-tav
3.4a
Benodigd voor scenario 3.4b
 MBH_300_onderbreken-tav MBH_300_onderbreken_TA_start-tav MBH_300_onderbreken_MVE-tav
3.4b
Onderbreken toedieningsafspraak
LET OP: onderbreking toedieningsafspraak van scenario 3.4a
 MBH_300_onderbreken-tav MBH_300_onderbreken_TA_onderbreken-tav
3.5a
Benodigd voor scenario 3.5b
 MBH_300_TAwijzigen-tav MBH_300_TAwijzigen_TA_start-tav MBH_300_TAwijzigen_MVE-tav
3.5b
Wijziging toedieningsafspraak, met reden wijziging (stop-ta + nieuwe ta) en MVE
LET OP: wijziging toedieningsafspraak van scenario 3.5a
 MBH_300_TAwijzigen-tav MBH_300_TAwijzigen_TA_anderePRK-tav
MBH_300_TAwijzigen_TA_techstaken-tav		 MBH_300_TAwijzigen_MVE_anderePRK-tav
3.6a
Benodigd voor scenarioset 3.6b
 MBH_300_annuleren-tav MBH_300_annuleren_TA_starten-tav MBH_300_annuleren_MVE_starten-tav
3.6b

annuleer-toedieningsafspraak

LET OP: annuleren medicatieafspraak van scenario 3.6a

 MBH_300_annuleren-tav MBH_300_annuleren_TA_geannuleerd-tav
3.8a
Starten van parallelle TA voor GDS
 MBH_300_stoppen_parallele_TA-tav MBH_300_stoppen_parallele_TA_TA_start_GDS-tav MBH_300_stoppen_parallele_TA_MVE_start_GDS-tav
3.8b
Starten van parallelle TA voor zo nodig medicaties
 MBH_300_stoppen_parallele_TA-tav MBH_300_stoppen_parallele_TA_TA_start_zonodig-tav MBH_300_stoppen_parallele_TA_MVE_start_zonodig-tav
3.8c
Stoppen van zonodig TA
Let op: de stop-TA stopt de toedieningsafspraak van scenario 3.8b
 MBH_300_stoppen_parallele_TA-tav MBH_300_stoppen_parallele_TA_TA_stop_zonodig-tav
3.8d
starten van een nieuwe zonodig TA
 
 MBH_300_stoppen_parallele_TA-tav MBH_300_stoppen_parallele_TA_TA_start2_zonodig-tav MBH_300_stoppen_parallele_TA_MVE_start2_zonodig-tav

1.1.4 Scenarioset 6

Scenario Beschrijving MBH id TA id MVE id
6.1 Variabele frequentie
 MBH_300_variabelefrequentie-tav MBH_300_variabelefrequentie_TA-tav MBH_300_variabelefrequentie_MVE-tav
6.2 Interval MBH_300_interval-tav MBH_300_interval_TA-tav MBH_300_interval_MVE-tav
6.3 Variabele hoeveelheid (1) MBH_300_variabelehoeveelheid-tav MBH_300_variabelehoeveelheid_TA-tav MBH_300_variabelehoeveelheid_MVE-tav
6.4 Zonder keerdosis MBH_300_zonderkeerdosis-tav MBH_300_zonderkeerdosis_TA-tav MBH_300_zonderkeerdosis_MVE-tav
6.5 Bijzondere keerdosis MBH_300_bijzonderekeerdosis-tav MBH_300_bijzonderekeerdosis_TA-tav MBH_300_bijzonderekeerdosis_MVE-tav
6.6 Variabele hoeveelheid (2)
 MBH_300_variabelehoeveelheid2-tav MBH_300_variabelehoeveelheid2_TA-tav MBH_300_variabelehoeveelheid2_MVE-tav
6.7a Tijdstippen MBH_300_tijdstippen_flexibel-tav MBH_300_tijdstippen_flexibel_TA-tav MBH_300_tijdstippen_flexibel_MVE-tav
6.7b Tijdstippen MBH_300_tijdstippen_niet_flexibel-tav MBH_300_tijdstippen_niet_flexibel_TA-tav MBH_300_tijdstippen_niet_flexibel_MVE-tav
6.8 Weekdagen MBH_300_weekdagen-tav MBH_300_weekdagen_TA-tav MBH_300_weekdagen_MVE-tav
6.9 Dagdeel MBH_300_dagdeel-tav MBH_300_dagdeel_TA-tav MBH_300_dagdeel_MVE-tav
6.10 Cyclisch schema MBH_300_cyclischschema-tav MBH_300_cyclischschema_TA-tav MBH_300_cyclischschema_MVE-tav
6.11 Afbouw schema en doseerduur MBH_300_afbouwschema-tav MBH_300_afbouwschema_TA-tav MBH_300_afbouwschema_MVE-tav
6.12 Variabele hoeveelheid en maximum MBH_300_variabelehoeveelheidenmaximum-tav MBH_300_variabelehoeveelheidenmaximum_TA-tav MBH_300_variabelehoeveelheidenmaximum_MVE-tav
6.13 Toedieningssnelheid MBH_300_toedieningssnelheid-tav MBH_300_toedieningssnelheid_TA-tav MBH_300_toedieningssnelheid_MVE-tav
6.14 Toedieningsduur MBH_300_toedieningsduur-tav MBH_300_toedieningsduur_TA-tav MBH_300_toedieningsduur_MVE-tav
6.15 Zo nodig
 MBH_300_zonodig-tav MBH_300_zonodig_TA-tav MBH_300_zonodig_MVE-tav
6.17 Dagdeel MBH_300_redundantefrequentie-tav MBH_300_redundantefrequentie_TA-tav MBH_300_redundantefrequentie_MVE-tav

1.1.5 Scenarioset 7

Scenario Beschrijving MBH id TA id MVE id
7.1 Alle ingrediënten MBH_300_magistraalalleingredienten-tav MBH_300_magistraalalleingredienten_TA-tav MBH_300_magistraalalleingredienten_MVE-tav
7.2 Actief ingrediënt MBH_300_magistraalactieveingredient-tav MBH_300_magistraalactieveingredient_TA-tav MBH_300_magistraalactieveingredient_MVE-tav
7.3 90 miljoen nummer MBH_300_magistraal90miljoennr-tav MBH_300_magistraal90miljoennr_TA-tav MBH_300_magistraal90miljoennr_MVE-tav
7.4
Vrije tekst product
 MBH_300_vrijetekstproduct-tav MBH_300_vrijetekstproduct_TA-tav MBH_300_vrijetekstproduct_MVE-tav

1.1.6 Scenarioset 8

Scenario Beschrijving MBH id TA id MVE id
8.1
Verstrekking onder andermans toedieningsafspraak
 MBH_300_VVandermansMA-tav MBH_300_MVEandermansTA_TA-tav MBH_300_MVEandermansTA_MVE-tav
8.2
Stoppen andermans toedieningsafspraak
 MBH_300_stakenandermansMA-tav MBH_300_stakenandermansTA_TA2-tav MBH_300_stakenandermansTA_andermansMVE-tav
8.3
Onderbreken andermans toedieningsafspraak
 MBH_300_onderbrekenandermansMA-tav MBH_300_onderbrekenandermansTA_TA2-tav MBH_300_onderbrekenandermansTA_andermansMVE-tav
8.4
Verstrekking onder andermans toedieningsafspraak
 MBH_300_wijzigenandermansMA-tav MBH_300_wijzigenandermansTA_TA1-tav MBH_300_wijzigenandermansTA_andermansMVE-tav

1.1.7 Scenarioset 9

Scenario Beschrijving MBH id TA id MVE id
9.1a Logistieke verbruiksperiode MBH_300_logistiekeverbruiksperiode_start_eind-tav MBH_300_logistiekeverbruiksperiode_start_eind_TA-tav MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tav
9.1b
GDS
 MBH_300_distributievorm_GDS-tav MBH_300_distributievorm_GDS_TA-tav MBH_300_distributievorm_GDS_MVE-tav
9.1c
Logistieke verbruiksduur
 MBH_300_logistiekeverbruiksperiode_duur_dagen-tav MBH_300_logistiekeverbruiksperiode_duur_dagen_TA-tav MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tav
9.2a Herhalingen MBH_300_herhalingen-tav MBH_300_herhalingen_TA-tav MBH_300_herhalingen_MVE1-tav
9.2b Herhalingen MBH_300_herhalingen-tav MBH_300_herhalingen_TA-tav MBH_300_herhalingen_MVE2-tav
9.2c Herhalingen MBH_300_herhalingen-tav MBH_300_herhalingen_TA-tav MBH_300_herhalingen_MVE3-tav
9.3
Afleverlocatie en Aanschrijfdatum
 MBH_300_afleverlocatie-tav MBH_300_afleverlocatie_TA-tav MBH_300_afleverlocatie_MVE-tav

1.1.8 Scenarioset 10

Scenario Beschrijving MBH id TA id MVE id
10.1 HPK geneesmiddel MBH_300_HPKvoorschrijven-tav MBH_300_HPKvoorschrijven_TA-tav MBH_300_HPKvoorschrijven_MVE-tav
10.2 ZI-nr geneesmiddel
 MBH_300_ZINRvoorschrijven-tav MBH_300_ZINRvoorschrijven_TA-tav MBH_300_ZINRvoorschrijven_MVE-tav

1.1.9 Scenarioset 11

Scenario Beschrijving MBH id TA id MVE id
11.1
Afhandelen medicatievoorschrift met verwijzing naar extern doseerschema
 MBH_300_wdsmtd1-tav MBH_300_wdsmtd1_TA-tav MBH_300_wdsmtd1_MVE-tav

1.1.10 Scenarioset 23

Scenario Beschrijving MBH id TA id MVE id
23.1a
TEST Scenarioset 23.1a afhandelen voorschrift voor afhandeling VMA t.b.v. 100% akkoord VMA met eerdere verstrekking​
 MBH_300_VMA_geaccepteerd-tav MBH_300_VMA_geaccepteerd_TA_start-tav MBH_300_VMA_geaccepteerd_MVE-tav
23.1b
TEST Scenarioset 23.1b afhandelen voorschrift na afhandeling VMA t.b.v. 100% akkoord VMA met eerdere verstrekking​
 MBH_300_VMA_geaccepteerd-tav MBH_300_VMA_geaccepteerd_TA_techstop-tav
MBH_300_VMA_geaccepteerd_TA_naVMA-tav
23.2
TEST Scenarioset 23.2 afhandelen voorschrift t.b.v. Afwijzen VMA o.b.v. voorstel PRK
 MBH_300_VMAafgewezen_PRK-tav MBH_300_VMAafgewezen_PRK_TA-tav MBH_300_VMAafgewezen_PRK_MVE-tav
23.3a
TEST Scenarioset 23.3a afhandelen voorschrift voor afhandeling VMA t.b.v. Aanvullend middel VMA
 MBH_300_VMAaanvullendmiddel-tav MBH_300_VMAaanvullendmiddel_TA_start-tav MBH_300_VMAaanvullendmiddel_MVE-tav
23.3b
TEST Scenarioset 23.3b afhandelen voorschrift na afhandeling VMA t.b.v. Aanvullend middel VMA
 MBH_300_VMAaanvullendmiddel-tav MBH_300_VMAaanvullendmiddel_techstopTA-tav
MBH_300_VMAaanvullendmiddel_TA_naVMA-tav
23.4a
TEST Scenarioset 23.4a afhandelen voorschrift voor akkoord VMA t.b.v. Vervangend middel VMA
 MBH_300_VMAvervangend_voorschr-tav MBH_300_VMAvervangend_voorschr_TA_start-tav MBH_300_VMAvervangend_voorschr_MVE_start-tav
23.4b
TEST Scenarioset 23.4b afhandelen voorschrift na akkoord VMA t.b.v. Vervangend middel VMA
 MBH_300_VMAvervangend_voorschr-tav MBH_300_VMAvervangend_voorschr_stopTA-tav
23.4c
TEST Scenarioset 23.4c afhandelen voorschrift na akkoord VMA t.b.v. Vervangend middel VMA
 MBH_300_VMAvervangendmiddel-tav MBH_300_VMAvervangendmiddel_TA_naVMA-tav
23.5a
TEST Scenarioset 23.5a afhandelen voorschrift t.b.v. 100% akkoord VVV met eerdere verstrekking
 MBH_300_VVV_geaccepteerd-tav MBH_300_VVV_geaccepteerd_TA_start-tav MBH_300_VVV_geaccepteerd_MVE_start-tav
23.5b
TEST Scenarioset 23.5b afhandelen voorschrift t.b.v. 100% akkoord VVV met eerdere verstrekking
 MBH_300_VVV_geaccepteerd-tav MBH_300_VVV_geaccepteerd_TA_start-tav MBH_300_VVV_geaccepteerd_MVE_naVVV-tav
23.6
TEST Scenarioset 23.6 afhandelen voorschrift t.b.v. gedeeltelijke overname VVV
 MBH_300_VVV_wijziging-tav MBH_300_VVV_wijziging_TA-tav MBH_300_VVV_wijziging_MVE-tav

1.2 Overzicht van scenario's voor ontvangend systeem

1.2.1 Scenarioset 1

Scenario Beschrijving MBH id TA id MVE id
1.1 Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum en einddatum MBH_300_start_eind-tav MBH_300_start_eind_TA-tav MBH_300_start_eind_MVE-tav
1.2a Afhandelen medicatievoorschrift met een toediedingsafspraak gebruiksperiode ingangsdatum en duur (weken) MBH_300_start_duur-tav MBH_300_start_duur_TA-tav MBH_300_start_duur_MVE-tav
1.2b Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum en duur (dagen) MBH_300_start_duur2-tav MBH_300_start_duur2_TA-tav MBH_300_start_duur2_MVE-tav
1.3 Afhandelen medicatievoorschrift met een toedieningsafspraak gebruiksperiode ingangsdatum (chronische medicatie) MBH_300_chronisch-tav MBH_300_chronisch_TA-tav MBH_300_chronisch_MVE-tav
1.4
Extra MVE 
LET OP: MVE met TA uit scenario 1.3 (20 dagen later)
 MBH_300_chronisch-tav MBH_300_chronisch_TA-tav MBH_300_chronisch_MVE_extraMVEbestaandeTA-tav
1.5 Afhandeling medicatievoorschrift met eenheid 'dosis/stuks' MBH_300_dosis_stuks-tav MBH_300_dosis_stuks_TA-tav MBH_300_dosis_stuks_MVE-tav
1.6
Afhandeling medicatievoorschrift met onzekerheidscriterium
 MBH_300_start_criterium-tav MBH_300_start_criterium_TA-tav MBH_300_start_criterium_MVE-tav

1.2.2 Scenarioset 2

Scenario Beschrijving MBH id TA id MVE id
2.1 Aanvullende instructie (TA) MBH_300_aanvullendeinstructie-tav MBH_300_aanvullendeinstructie_TA-tav MBH_300_aanvullendeinstructie_MVE-tav
2.2 Toelichting (TA), toelichting (MVE) MBH_300_toelichting-tav MBH_300_toelichting_TA-tav MBH_300_toelichting_MVE-tav
2.3 Reden van voorschrijven (TA) MBH_300_redenvanvoorschrijven-tav MBH_300_redenvanvoorschrijven_TA-tav MBH_300_redenvanvoorschrijven_MVE-tav
2.4 Aanvullende informatie (MA), aanvullende wensen (VV) MBH_300_aanvullendeinformatiewensen-tav MBH_300_aanvullendeinformatiewensen_TA-tav MBH_300_aanvullendeinformatiewensen_MVE-tav
2.5 Toedieningsweg (TA) MBH_300_Toedieningsweg-tav MBH_300_Toedieningsweg_TA-tav MBH_300_Toedieningsweg_MVE-tav

1.2.3 Scenarioset 3

Scenario Beschrijving MBH id TA id MVE id
3.1a
Benodigd voor scenario 3.1b
 
 MBH_300_stoppen-tav MBH_300_stoppen_TA_start-tav MBH_300_stoppen_MVE-tav
3.1b
Stop-toedieningsafspraak, met reden staken
LET OP: stoppen toedieningsafspraak van scenario 3.1a
 MBH_300_stoppen-tav MBH_300_stoppen_TA_staken-tav
3.2a
Benodigd voor scenario 3.2b
 MBH_300_wijzigen_verhoging-tav MBH_300_wijzigen_verhoging_TA_start-tav MBH_300_wijzigen_verhoging_MVE-tav
3.2b
Wijziging toedieningsafspraak, verhoging wijziging (stop-ta + nieuwe ta) met MVE
LET OP: wijziging toedieningsafspraak van scenario 3.2a
 MBH_300_wijzigen_verhoging-tav MBH_300_wijzigen_verhoging_TA_wijzigingmetMVE-tav
MBH_300_wijzigen_verhoging_TA_techstaken-tav		 MBH_300_wijzigen_verhoging_MVE_extra-tav
3.3a
Benodigd voor scenario 3.3b
 MBH_300_wijzigen_verlaging-tav MBH_300_wijzigen_verlaging_TA_start-tav MBH_300_wijzigen_verlaging_MVE-tav
3.3b
Wijziging toedieningsafspraak, met verlaging wijziging (stop-ta + nieuwe ta) zonder MVE
LET OP: wijziging toedieningsafspraak van scenario 3.3a
 MBH_300_wijzigen_verlaging-tav MBH_300_wijzigen_verlaging_TA_wijzigingzonderMVE-tav
MBH_300_wijzigen_verlaging_TA_techstaken-tav
3.4a
Benodigd voor scenario 3.4b
 MBH_300_onderbreken-tav MBH_300_onderbreken_TA_start-tav MBH_300_onderbreken_MVE-tav
3.4b
Onderbreken toedieningsafspraak
LET OP: onderbreking toedieningsafspraak van scenario 3.4a
 MBH_300_onderbreken-tav MBH_300_onderbreken_TA_onderbreken-tav
3.5a
Benodigd voor scenario 3.5b
 MBH_300_TAwijzigen-tav MBH_300_TAwijzigen_TA_start-tav MBH_300_TAwijzigen_MVE-tav
3.5b
Wijziging toedieningsafspraak, met reden wijziging (stop-ta + nieuwe ta) en MVE
LET OP: wijziging toedieningsafspraak van scenario 3.5a
 MBH_300_TAwijzigen-tav MBH_300_TAwijzigen_TA_anderePRK-tav
MBH_300_TAwijzigen_TA_techstaken-tav		 MBH_300_TAwijzigen_MVE_anderePRK-tav
3.6a
Benodigd voor scenarioset 3.6b
 MBH_300_annuleren-tav MBH_300_annuleren_TA_starten-tav MBH_300_annuleren_MVE_starten-tav
3.6b

annuleer-toedieningsafspraak

LET OP: annuleren medicatieafspraak van scenario 3.6a

 MBH_300_annuleren-tav MBH_300_annuleren_TA_geannuleerd-tav
3.8a
Starten van parallelle TA voor GDS
 MBH_300_stoppen_parallele_TA-tav MBH_300_stoppen_parallele_TA_TA_start_GDS-tav MBH_300_stoppen_parallele_TA_MVE_start_GDS-tav
3.8b
Starten van parallelle TA voor zo nodig medicaties
 MBH_300_stoppen_parallele_TA-tav MBH_300_stoppen_parallele_TA_TA_start_zonodig-tav MBH_300_stoppen_parallele_TA_MVE_start_zonodig-tav
3.8c
Stoppen van zonodig TA
Let op: de stop-TA stopt de toedieningsafspraak van scenario 3.8b
 MBH_300_stoppen_parallele_TA-tav MBH_300_stoppen_parallele_TA_TA_stop_zonodig-tav
3.8d
starten van een nieuwe zonodig TA
 
 MBH_300_stoppen_parallele_TA-tav MBH_300_stoppen_parallele_TA_TA_start2_zonodig-tav MBH_300_stoppen_parallele_TA_MVE_start2_zonodig-tav

1.2.4 Scenarioset 6

Scenario Beschrijving MBH id TA id MVE id
6.1 Variabele frequentie
 MBH_300_variabelefrequentie-tav MBH_300_variabelefrequentie_TA-tav MBH_300_variabelefrequentie_MVE-tav
6.2 Interval MBH_300_interval-tav MBH_300_interval_TA-tav MBH_300_interval_MVE-tav
6.3 Variabele hoeveelheid (1) MBH_300_variabelehoeveelheid-tav MBH_300_variabelehoeveelheid_TA-tav MBH_300_variabelehoeveelheid_MVE-tav
6.4 Zonder keerdosis MBH_300_zonderkeerdosis-tav MBH_300_zonderkeerdosis_TA-tav MBH_300_zonderkeerdosis_MVE-tav
6.5 Bijzondere keerdosis MBH_300_bijzonderekeerdosis-tav MBH_300_bijzonderekeerdosis_TA-tav MBH_300_bijzonderekeerdosis_MVE-tav
6.6 Variabele hoeveelheid (2)
 MBH_300_variabelehoeveelheid2-tav MBH_300_variabelehoeveelheid2_TA-tav MBH_300_variabelehoeveelheid2_MVE-tav
6.7a Tijdstippen MBH_300_tijdstippen_flexibel-tav MBH_300_tijdstippen_flexibel_TA-tav MBH_300_tijdstippen_flexibel_MVE-tav
6.7b Tijdstippen MBH_300_tijdstippen_niet_flexibel-tav MBH_300_tijdstippen_niet_flexibel_TA-tav MBH_300_tijdstippen_niet_flexibel_MVE-tav
6.8 Weekdagen MBH_300_weekdagen-tav MBH_300_weekdagen_TA-tav MBH_300_weekdagen_MVE-tav
6.9 Dagdeel MBH_300_dagdeel-tav MBH_300_dagdeel_TA-tav MBH_300_dagdeel_MVE-tav
6.10 Cyclisch schema MBH_300_cyclischschema-tav MBH_300_cyclischschema_TA-tav MBH_300_cyclischschema_MVE-tav
6.11 Afbouw schema en doseerduur MBH_300_afbouwschema-tav MBH_300_afbouwschema_TA-tav MBH_300_afbouwschema_MVE-tav
6.12 Variabele hoeveelheid en maximum MBH_300_variabelehoeveelheidenmaximum-tav MBH_300_variabelehoeveelheidenmaximum_TA-tav MBH_300_variabelehoeveelheidenmaximum_MVE-tav
6.13 Toedieningssnelheid MBH_300_toedieningssnelheid-tav MBH_300_toedieningssnelheid_TA-tav MBH_300_toedieningssnelheid_MVE-tav
6.14 Toedieningsduur MBH_300_toedieningsduur-tav MBH_300_toedieningsduur_TA-tav MBH_300_toedieningsduur_MVE-tav
6.15 Zo nodig
 MBH_300_zonodig-tav MBH_300_zonodig_TA-tav MBH_300_zonodig_MVE-tav
6.17 Dagdeel MBH_300_redundantefrequentie-tav MBH_300_redundantefrequentie_TA-tav MBH_300_redundantefrequentie_MVE-tav

1.2.5 Scenarioset 7

Scenario Beschrijving MBH id TA id MVE id
7.1 Alle ingrediënten MBH_300_magistraalalleingredienten-tav MBH_300_magistraalalleingredienten_TA-tav MBH_300_magistraalalleingredienten_MVE-tav
7.2 Actief ingrediënt MBH_300_magistraalactieveingredient-tav MBH_300_magistraalactieveingredient_TA-tav MBH_300_magistraalactieveingredient_MVE-tav
7.3 90 miljoen nummer MBH_300_magistraal90miljoennr-tav MBH_300_magistraal90miljoennr_TA-tav MBH_300_magistraal90miljoennr_MVE-tav
7.4
Vrije tekst product
 MBH_300_vrijetekstproduct-tav MBH_300_vrijetekstproduct_TA-tav MBH_300_vrijetekstproduct_MVE-tav

1.2.6 Scenarioset 8

Scenario Beschrijving MBH id TA id MVE id
8.1
Verstrekking onder andermans toedieningsafspraak
 MBH_300_VVandermansMA-tav MBH_300_MVEandermansTA_TA-tav MBH_300_MVEandermansTA_MVE-tav
8.2
Stoppen andermans toedieningsafspraak
 MBH_300_stakenandermansMA-tav MBH_300_stakenandermansTA_TA2-tav MBH_300_stakenandermansTA_andermansMVE-tav
8.3
Onderbreken andermans toedieningsafspraak
 MBH_300_onderbrekenandermansMA-tav MBH_300_onderbrekenandermansTA_TA2-tav MBH_300_onderbrekenandermansTA_andermansMVE-tav
8.4
Verstrekking onder andermans toedieningsafspraak
 MBH_300_wijzigenandermansMA-tav MBH_300_wijzigenandermansTA_TA1-tav MBH_300_wijzigenandermansTA_andermansMVE-tav

1.2.7 Scenarioset 9

Scenario Beschrijving MBH id TA id MVE id
9.1a Logistieke verbruiksperiode MBH_300_logistiekeverbruiksperiode_start_eind-tav MBH_300_logistiekeverbruiksperiode_start_eind_TA-tav MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tav
9.1b
GDS
 MBH_300_distributievorm_GDS-tav MBH_300_distributievorm_GDS_TA-tav MBH_300_distributievorm_GDS_MVE-tav
9.1c
Logistieke verbruiksduur
 MBH_300_logistiekeverbruiksperiode_duur_dagen-tav MBH_300_logistiekeverbruiksperiode_duur_dagen_TA-tav MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tav
9.2a Herhalingen MBH_300_herhalingen-tav MBH_300_herhalingen_TA-tav MBH_300_herhalingen_MVE1-tav
9.2b Herhalingen MBH_300_herhalingen-tav MBH_300_herhalingen_TA-tav MBH_300_herhalingen_MVE2-tav
9.2c Herhalingen MBH_300_herhalingen-tav MBH_300_herhalingen_TA-tav MBH_300_herhalingen_MVE3-tav
9.3
Afleverlocatie en Aanschrijfdatum
 MBH_300_afleverlocatie-tav MBH_300_afleverlocatie_TA-tav MBH_300_afleverlocatie_MVE-tav

1.2.8 Scenarioset 10

Scenario Beschrijving MBH id TA id MVE id
10.1 HPK geneesmiddel MBH_300_HPKvoorschrijven-tav MBH_300_HPKvoorschrijven_TA-tav MBH_300_HPKvoorschrijven_MVE-tav
10.2 ZI-nr geneesmiddel
 MBH_300_ZINRvoorschrijven-tav MBH_300_ZINRvoorschrijven_TA-tav MBH_300_ZINRvoorschrijven_MVE-tav

1.2.9 Scenarioset 11

Scenario Beschrijving MBH id TA id MVE id
11.1
Afhandelen medicatievoorschrift met verwijzing naar extern doseerschema
 MBH_300_wdsmtd1-tav MBH_300_wdsmtd1_TA-tav MBH_300_wdsmtd1_MVE-tav

1.2.10 Scenarioset 23

Scenario Beschrijving MBH id TA id MVE id
23.1a
TEST Scenarioset 23.1a afhandelen voorschrift voor afhandeling VMA t.b.v. 100% akkoord VMA met eerdere verstrekking​
 MBH_300_VMA_geaccepteerd-tav MBH_300_VMA_geaccepteerd_TA_start-tav MBH_300_VMA_geaccepteerd_MVE-tav
23.1b
TEST Scenarioset 23.1b afhandelen voorschrift na afhandeling VMA t.b.v. 100% akkoord VMA met eerdere verstrekking​
 MBH_300_VMA_geaccepteerd-tav MBH_300_VMA_geaccepteerd_TA_techstop-tav
MBH_300_VMA_geaccepteerd_TA_naVMA-tav
23.2
TEST Scenarioset 23.2 afhandelen voorschrift t.b.v. Afwijzen VMA o.b.v. voorstel PRK
 MBH_300_VMAafgewezen_PRK-tav MBH_300_VMAafgewezen_PRK_TA-tav MBH_300_VMAafgewezen_PRK_MVE-tav
23.3a
TEST Scenarioset 23.3a afhandelen voorschrift voor afhandeling VMA t.b.v. Aanvullend middel VMA
 MBH_300_VMAaanvullendmiddel-tav MBH_300_VMAaanvullendmiddel_TA_start-tav MBH_300_VMAaanvullendmiddel_MVE-tav
23.3b
TEST Scenarioset 23.3b afhandelen voorschrift na afhandeling VMA t.b.v. Aanvullend middel VMA
 MBH_300_VMAaanvullendmiddel-tav MBH_300_VMAaanvullendmiddel_techstopTA-tav
MBH_300_VMAaanvullendmiddel_TA_naVMA-tav
23.4a
TEST Scenarioset 23.4a afhandelen voorschrift voor akkoord VMA t.b.v. Vervangend middel VMA
 MBH_300_VMAvervangend_voorschr-tav MBH_300_VMAvervangend_voorschr_TA_start-tav MBH_300_VMAvervangend_voorschr_MVE_start-tav
23.4b
TEST Scenarioset 23.4b afhandelen voorschrift na akkoord VMA t.b.v. Vervangend middel VMA
 MBH_300_VMAvervangend_voorschr-tav MBH_300_VMAvervangend_voorschr_stopTA-tav
23.4c
TEST Scenarioset 23.4c afhandelen voorschrift na akkoord VMA t.b.v. Vervangend middel VMA
 MBH_300_VMAvervangendmiddel-tav MBH_300_VMAvervangendmiddel_TA_naVMA-tav
23.5a
TEST Scenarioset 23.5a afhandelen voorschrift t.b.v. 100% akkoord VVV met eerdere verstrekking
 MBH_300_VVV_geaccepteerd-tav MBH_300_VVV_geaccepteerd_TA_start-tav MBH_300_VVV_geaccepteerd_MVE_start-tav
23.5b
TEST Scenarioset 23.5b afhandelen voorschrift t.b.v. 100% akkoord VVV met eerdere verstrekking
 MBH_300_VVV_geaccepteerd-tav MBH_300_VVV_geaccepteerd_TA_start-tav MBH_300_VVV_geaccepteerd_MVE_naVVV-tav
23.6
TEST Scenarioset 23.6 afhandelen voorschrift t.b.v. gedeeltelijke overname VVV
 MBH_300_VVV_wijziging-tav MBH_300_VVV_wijziging_TA-tav MBH_300_VVV_wijziging_MVE-tav

1.3 TEST Scenarioset 1 ingangsdatum einddatum

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen C.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Brugge
Identificatienummer 999900419 [BSN]
Geboortedatum 16 okt 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.3.1 Scenario 1.1 - MBH_300_start_eind-tav

Toedieningsafspraak MBH_300_start_eind_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_start_eind_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 12:20 uur
Gebruiksperiode Vanaf T, tot en met T + 5 dagen
Ingangsdatum T
Einddatum T + 5 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code METOCLOPRAMIDE HCL ACCORD TABLET 10MG (code = '2115468' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_start_eind_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_start_eind-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_start_eind_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_start_eind_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 12:20 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 5 stuks
Geneesmiddel - primaire code METOCLOPRAMIDE HCL ACCORD TABLET 10MG (code = '2115468' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_start_eind_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_start_eind-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.3.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.4 TEST Scenarioset 1 ingangsdatum en duur (weken)

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen C.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Brugge
Identificatienummer 999900419 [BSN]
Geboortedatum 16 okt 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.4.1 Scenario 1.2a - MBH_300_start_duur-tav

Toedieningsafspraak MBH_300_start_duur_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_start_duur_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 12:30 uur
Gebruiksperiode Vanaf T, gedurende 3 weken
Ingangsdatum T
Gebruiksduur 3 weken
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK')
Geneesmiddel - generiekere code LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_start_duur_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_start_duur-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_start_duur_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_start_duur_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 12:30 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 21 stuks
Geneesmiddel - primaire code LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK')
Geneesmiddel - generiekere code LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_start_duur_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_start_duur-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.4.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.5 TEST Scenarioset 1 ingangsdatum duur (dagen)

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen C.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Brugge
Identificatienummer 999900419 [BSN]
Geboortedatum 16 okt 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.5.1 Scenario 1.2b - MBH_300_start_duur2-tav

Toedieningsafspraak MBH_300_start_duur2_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_start_duur2_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 12:30 uur
Gebruiksperiode Vanaf T, gedurende 28 dagen
Ingangsdatum T
Gebruiksduur 28 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_start_duur2_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_start_duur2-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_start_duur2_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_start_duur2_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 12:30 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 28 stuks
Geneesmiddel - primaire code PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_start_duur2_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_start_duur2-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.5.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.6 TEST Scenarioset 1 chronische medicatie

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen C.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Brugge
Identificatienummer 999900419 [BSN]
Geboortedatum 16 okt 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.6.1 Scenario 1.3 - MBH_300_chronisch-tav

Toedieningsafspraak MBH_300_chronisch_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_chronisch_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 12:32 uur
Gebruiksperiode Vanaf T
Ingangsdatum T
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_chronisch_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_chronisch-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_chronisch_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_chronisch_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 12:32 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 21 stuks
Geneesmiddel - primaire code ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_chronisch_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_chronisch-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.6.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.7 TEST Scenarioset 1 extra VV onder bestaande MA

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen C.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Brugge
Identificatienummer 999900419 [BSN]
Geboortedatum 16 okt 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.7.1 Scenario 1.4 - MBH_300_chronisch-tav

Toedieningsafspraak MBH_300_chronisch_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_chronisch_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T - 20 dagen om 12:32 uur
Gebruiksperiode Vanaf T - 20 dagen
Ingangsdatum T - 20 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_chronisch_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_chronisch-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_chronisch_MVE_extraMVEbestaandeTA-tav
Gegevenselement Waarde
Identificatie MBH_300_chronisch_MVE_extraMVEbestaandeTA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 12:35 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 90 stuks
Geneesmiddel - primaire code ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_chronisch_VV_extraVVbestaandeMA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_chronisch-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.7.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.8 TEST Scenarioset 1 met eenheid 'dosis/stuks'

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen C.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Brugge
Identificatienummer 999900419 [BSN]
Geboortedatum 16 okt 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.8.1 Scenario 1.5 - MBH_300_dosis_stuks-tav

Toedieningsafspraak MBH_300_dosis_stuks_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_dosis_stuks_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 12:35 uur
Gebruiksperiode Vanaf T, tot en met T + 29 dagen
Ingangsdatum T
Einddatum T + 29 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code FLIXOTIDE DISKUS INHPDR 100MCG 60DO (code = '1029754' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 2 maal per dag 1 dosis, inhalatie
Toedieningsweg inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 2 maal per dag 1 dosis
RelatieMedicatieafspraak
Identificatie MBH_300_dosis_stuks_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_dosis_stuks-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_dosis_stuks_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_dosis_stuks_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 12:35 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 1 stuk
Geneesmiddel - primaire code FLIXOTIDE DISKUS INHPDR 100MCG 60DO (code = '1029754' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_dosis_stuks_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_dosis_stuks-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.8.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.9 TEST Scenarioset 1 met onzekerheidscriterium

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen C.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Brugge
Identificatienummer 999900419 [BSN]
Geboortedatum 16 okt 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.9.1 Scenario 1.6 - MBH_300_start_criterium-tav

Toedieningsafspraak MBH_300_start_criterium_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_start_criterium_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 12:20 uur
Gebruiksperiode Vanaf T + 1 dag, gedurende 3 dagen (3 dagen voor operatie starten)
Ingangsdatum T + 1 dag
Gebruiksduur 3 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code CHLOORHEXIDINE DIGLUCONAAT CREME 1% (code = '1189921' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code CHLOORHEXIDINE CREME 10MG/G (code = '10138' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code CHLOORHEXIDINE CREME 10MG/G (code = '26603' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag, cutaan
Toedieningsweg cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag
RelatieMedicatieafspraak
Identificatie MBH_300_start_criterium_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_start_criterium-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_start_criterium_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_start_criterium_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 12:20 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 30 gram
Geneesmiddel - primaire code CHLOORHEXIDINE DIGLUCONAAT CREME 1% (code = '1189921' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code CHLOORHEXIDINE CREME 10MG/G (code = '10138' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code CHLOORHEXIDINE CREME 10MG/G (code = '26603' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_start_criterium_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_start_criterium-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.9.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.10 TEST Scenarioset 2 Aanvullende instructie

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen C.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Coenen
Identificatienummer 999900420 [BSN]
Geboortedatum 17 okt 1963
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.10.1 Scenario 2.1 - MBH_300_aanvullendeinstructie-tav

Toedieningsafspraak MBH_300_aanvullendeinstructie_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_aanvullendeinstructie_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:00 uur
Gebruiksperiode Vanaf T, tot en met T + 12 maanden
Ingangsdatum T
Einddatum T + 12 maanden
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk, Bij het eten innemen, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
AanvullendeInstructie overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Bij het eten innemen
Doseerinstructie 1 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_aanvullendeinstructie_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_aanvullendeinstructie-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_aanvullendeinstructie_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_aanvullendeinstructie_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 09:00 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 180 stuks
Geneesmiddel - primaire code ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_aanvullendeinstructie_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_aanvullendeinstructie-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.10.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.11 TEST Scenarioset 2 Toelichting

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen C.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Coenen
Identificatienummer 999900420 [BSN]
Geboortedatum 17 okt 1963
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.11.1 Scenario 2.2 - MBH_300_toelichting-tav

Toedieningsafspraak MBH_300_toelichting_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_toelichting_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:02 uur
Gebruiksperiode Vanaf T
Ingangsdatum T
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
Toelichting In overleg met specialist
RelatieMedicatieafspraak
Identificatie MBH_300_toelichting_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_toelichting-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_toelichting_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_toelichting_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 09:02 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 30 stuks
Geneesmiddel - primaire code FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
Toelichting Extra verstrekkingsverzoek omdat patient medicatie is kwijtgeraakt
RelatieVerstrekkingsverzoek MBH_300_toelichting_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_toelichting-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.11.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.12 TEST Scenarioset 2 Reden van voorschrijven

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen C.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Coenen
Identificatienummer 999900420 [BSN]
Geboortedatum 17 okt 1963
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.12.1 Scenario 2.3 - MBH_300_redenvanvoorschrijven-tav

Toedieningsafspraak MBH_300_redenvanvoorschrijven_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_redenvanvoorschrijven_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:05 uur
Gebruiksperiode Vanaf T, tot en met T + 27 dagen
Ingangsdatum T
Einddatum T + 27 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code METHOTREXAAT PCH TABLET 2,5MG (code = '1421778' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per week 5 stuks, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per week 5 stuks
RelatieMedicatieafspraak
Identificatie MBH_300_redenvanvoorschrijven_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_redenvanvoorschrijven-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_redenvanvoorschrijven_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_redenvanvoorschrijven_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 09:05 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 20 stuks
Geneesmiddel - primaire code METHOTREXAAT PCH TABLET 2,5MG (code = '1421778' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_redenvanvoorschrijven_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_redenvanvoorschrijven-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.12.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.13 TEST Scenarioset 2 Aanvullende informatie

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen C.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Coenen
Identificatienummer 999900420 [BSN]
Geboortedatum 17 okt 1963
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.13.1 Scenario 2.4 - MBH_300_aanvullendeinformatiewensen-tav

Toedieningsafspraak MBH_300_aanvullendeinformatiewensen_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_aanvullendeinformatiewensen_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T - 5 dagen om 09:06 uur
Gebruiksperiode Vanaf T - 4 dagen, tot en met T + 5 dagen
Ingangsdatum T - 4 dagen
Einddatum T + 5 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving elke dag om 19:00 1 stuk - let op, exacte toedientijd(en), Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie elke dag om 19:00 1 stuk - let op, exacte toedientijd(en)
Toelichting Bijwerking besproken
RelatieMedicatieafspraak
Identificatie MBH_300_aanvullendeinformatiewensen_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_aanvullendeinformatiewensen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_aanvullendeinformatiewensen_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_aanvullendeinformatiewensen_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T - 5 dagen om 09:06 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 40 stuks
Geneesmiddel - primaire code BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK')
MedicatieverstrekkingAanvullendeInformatie Aantal bewust gewijzigd (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2052')
RelatieVerstrekkingsverzoek MBH_300_aanvullendeinformatiewensen_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_aanvullendeinformatiewensen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.13.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.14 TEST Scenarioset 2 Toedieningsweg los

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen C.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Coenen
Identificatienummer 999900420 [BSN]
Geboortedatum 17 okt 1963
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.14.1 Scenario 2.5 - MBH_300_Toedieningsweg-tav

Toedieningsafspraak MBH_300_Toedieningsweg_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_Toedieningsweg_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:15 uur
Gebruiksperiode Vanaf T, tot en met T + 7 dagen
Ingangsdatum T
Einddatum T + 7 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code SOFRADEX OORDRUPPELS (code = '644781' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 2 maal per dag 1 druppel, In het rechter oog, oculair
Toedieningsweg oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
AanvullendeInstructie overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): In het rechter oog
Doseerinstructie 2 maal per dag 1 druppel
Toelichting Gebruiksinstructie gegeven
RelatieMedicatieafspraak
Identificatie MBH_300_Toedieningsweg_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_Toedieningsweg-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_Toedieningsweg_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_Toedieningsweg_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 09:15 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 1 stuk
Geneesmiddel - primaire code SOFRADEX OORDRUPPELS (code = '644781' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_Toedieningsweg_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_Toedieningsweg-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.14.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.15 TEST Scenarioset 3 (initieren scenario) Stoppen

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen C
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Voorvoegsels van de
Achternaam XXX_Voortman
Identificatienummer 999908881 [BSN]
Geboortedatum 18 sep 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.15.1 Scenario 3.1a - MBH_300_stoppen-tav

Toedieningsafspraak MBH_300_stoppen_TA_start-tav
Gegevenselement Waarde
Identificatie MBH_300_stoppen_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:00 uur
Gebruiksperiode Vanaf T, tot en met T + 280 dagen
Ingangsdatum T
Einddatum T + 280 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_stoppen_MA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_stoppen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_stoppen_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_stoppen_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 09:00 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 180 stuks
Geneesmiddel - primaire code ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_stoppen_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_stoppen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.15.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.16 TEST Scenarioset 3 Stoppen

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen C
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Voorvoegsels van de
Achternaam XXX_Voortman
Identificatienummer 999908881 [BSN]
Geboortedatum 18 sep 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.16.1 Scenario 3.1b - MBH_300_stoppen-tav

Toedieningsafspraak MBH_300_stoppen_TA_staken-tav
Gegevenselement Waarde
Identificatie MBH_300_stoppen_TA_staken-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 19:00 uur
Gebruiksperiode Vanaf T, tot en met T + 1 dag
Ingangsdatum T
Einddatum T + 1 dag
ToedieningsafspraakStopType stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_JANSEN_EN_CO
Geneesmiddel - primaire code ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_stoppen_MA_staken-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
RelatieToedieningsafspraak
Identificatie MBH_300_stoppen_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_stoppen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.16.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_JANSEN_EN_CO
ZorgaanbiederIdentificatienummer 99901111 (in identificerend systeem: URA)
OrganisatieNaam Apotheek Jansen en Co

1.17 TEST Scenarioset 3 (initieren scenario) Wijzigen (verhoging)

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen C
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Voorvoegsels van de
Achternaam XXX_Voortman
Identificatienummer 999908881 [BSN]
Geboortedatum 18 sep 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.17.1 Scenario 3.2a - MBH_300_wijzigen_verhoging-tav

Toedieningsafspraak MBH_300_wijzigen_verhoging_TA_start-tav
Gegevenselement Waarde
Identificatie MBH_300_wijzigen_verhoging_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:02 uur
Gebruiksperiode Vanaf T om 09:00 uur
Ingangsdatum T om 09:00 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_wijzigen_verhoging_MA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_wijzigen_verhoging-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_wijzigen_verhoging_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_wijzigen_verhoging_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 09:02 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 30 stuks
Geneesmiddel - primaire code FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_wijzigen_verhoging_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_wijzigen_verhoging-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.17.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.18 TEST Scenarioset 3 Wijzigen (verhoging)

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen C
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Voorvoegsels van de
Achternaam XXX_Voortman
Identificatienummer 999908881 [BSN]
Geboortedatum 18 sep 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.18.1 Scenario 3.2b - MBH_300_wijzigen_verhoging-tav

Toedieningsafspraak MBH_300_wijzigen_verhoging_TA_wijzigingmetMVE-tav
Gegevenselement Waarde
Identificatie MBH_300_wijzigen_verhoging_TA_wijzigingmetMVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:02 uur
Gebruiksperiode Vanaf T om 09:00 uur
Ingangsdatum T om 09:00 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 2 stuks, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 2 stuks
RelatieMedicatieafspraak
Identificatie MBH_300_wijzigen_verhoging_MA_wijzigingmetVV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_wijzigen_verhoging-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_wijzigen_verhoging_TA_techstaken-tav
Gegevenselement Waarde
Identificatie MBH_300_wijzigen_verhoging_TA_techstaken-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:02 uur
Gebruiksperiode Vanaf T, tot en met T om 09:00 uur
Ingangsdatum T
Einddatum T om 09:00 uur
ToedieningsafspraakStopType stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_JANSEN_EN_CO
Geneesmiddel - primaire code FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_wijzigen_verhoging_MA_techstaken-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
RelatieToedieningsafspraak
Identificatie MBH_300_wijzigen_verhoging_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_wijzigen_verhoging-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_wijzigen_verhoging_MVE_extra-tav
Gegevenselement Waarde
Identificatie MBH_300_wijzigen_verhoging_MVE_extra-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 09:02 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 60 stuks
Geneesmiddel - primaire code FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_wijzigen_verhoging_VV_extra-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_wijzigen_verhoging-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.18.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
Zorgaanbieder APOTHEEK_JANSEN_EN_CO
ZorgaanbiederIdentificatienummer 99901111 (in identificerend systeem: URA)
OrganisatieNaam Apotheek Jansen en Co

1.19 TEST Scenarioset 3 (initieren scenario) Wijzigen (verlaging)

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen C
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Voorvoegsels van de
Achternaam XXX_Voortman
Identificatienummer 999908881 [BSN]
Geboortedatum 18 sep 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.19.1 Scenario 3.3a - MBH_300_wijzigen_verlaging-tav

Toedieningsafspraak MBH_300_wijzigen_verlaging_TA_start-tav
Gegevenselement Waarde
Identificatie MBH_300_wijzigen_verlaging_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:05 uur
Gebruiksperiode Vanaf T, tot en met T + 27 dagen
Ingangsdatum T
Einddatum T + 27 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per week 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per week 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_wijzigen_verlaging_MA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_wijzigen_verlaging-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_wijzigen_verlaging_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_wijzigen_verlaging_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 09:05 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 20 stuks
Geneesmiddel - primaire code FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_wijzigen_verlaging_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_wijzigen_verlaging-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.19.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.20 TEST Scenarioset 3 Wijzigen (verlaging)

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen C
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Voorvoegsels van de
Achternaam XXX_Voortman
Identificatienummer 999908881 [BSN]
Geboortedatum 18 sep 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.20.1 Scenario 3.3b - MBH_300_wijzigen_verlaging-tav

Toedieningsafspraak MBH_300_wijzigen_verlaging_TA_wijzigingzonderMVE-tav
Gegevenselement Waarde
Identificatie MBH_300_wijzigen_verlaging_TA_wijzigingzonderMVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:10 uur
Gebruiksperiode Vanaf T + 6 dagen, tot en met T + 14 dagen
Ingangsdatum T + 6 dagen
Einddatum T + 14 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_JANSEN_EN_CO
Geneesmiddel - primaire code FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per week 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per week 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_wijzigen_verlaging_MA_wijzigingzonderVV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_wijzigen_verlaging-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_wijzigen_verlaging_TA_techstaken-tav
Gegevenselement Waarde
Identificatie MBH_300_wijzigen_verlaging_TA_techstaken-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:10 uur
Gebruiksperiode Vanaf T, tot en met T + 6 dagen
Ingangsdatum T
Einddatum T + 6 dagen
ToedieningsafspraakStopType stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_JANSEN_EN_CO
Geneesmiddel - primaire code FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 2 maal per week 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 2 maal per week 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_wijzigen_verlaging_MA_techstaken-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
RelatieToedieningsafspraak
Identificatie MBH_300_wijzigen_verlaging_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_wijzigen_verlaging-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.20.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_JANSEN_EN_CO
ZorgaanbiederIdentificatienummer 99901111 (in identificerend systeem: URA)
OrganisatieNaam Apotheek Jansen en Co

1.21 TEST Scenarioset 3 (initieren scenario) Onderbreken

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen C
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Voorvoegsels van de
Achternaam XXX_Voortman
Identificatienummer 999908881 [BSN]
Geboortedatum 18 sep 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.21.1 Scenario 3.4a - MBH_300_onderbreken-tav

Toedieningsafspraak MBH_300_onderbreken_TA_start-tav
Gegevenselement Waarde
Identificatie MBH_300_onderbreken_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:06 uur
Gebruiksperiode Vanaf T, tot en met T + 10 dagen om 15:00 uur
Ingangsdatum T
Einddatum T + 10 dagen om 15:00 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 3 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 3 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_onderbreken_MA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_onderbreken-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_onderbreken_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_onderbreken_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 09:06 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 30 stuks
Geneesmiddel - primaire code BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_onderbreken_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_onderbreken-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.21.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.22 TEST Scenarioset 3 Onderbreken

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen C
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Voorvoegsels van de
Achternaam XXX_Voortman
Identificatienummer 999908881 [BSN]
Geboortedatum 18 sep 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.22.1 Scenario 3.4b - MBH_300_onderbreken-tav

Toedieningsafspraak MBH_300_onderbreken_TA_onderbreken-tav
Gegevenselement Waarde
Identificatie MBH_300_onderbreken_TA_onderbreken-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 19:12 uur
Gebruiksperiode Vanaf T, tot en met T om 15:00 uur
Ingangsdatum T
Einddatum T om 15:00 uur
ToedieningsafspraakStopType onderbroken (code = '385655000' in codeSystem 'SNOMED CT')
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_JANSEN_EN_CO
Geneesmiddel - primaire code BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 3 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 3 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_onderbreken_MA_onderbreken-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
RelatieToedieningsafspraak
Identificatie MBH_300_onderbreken_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_onderbreken-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.22.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_JANSEN_EN_CO
ZorgaanbiederIdentificatienummer 99901111 (in identificerend systeem: URA)
OrganisatieNaam Apotheek Jansen en Co

1.23 TEST Scenarioset 3 (initieren scenario) wijziging TA

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen C
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Voorvoegsels van de
Achternaam XXX_Voortman
Identificatienummer 999908881 [BSN]
Geboortedatum 18 sep 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.23.1 Scenario 3.5a - MBH_300_TAwijzigen-tav

Toedieningsafspraak MBH_300_TAwijzigen_TA_start-tav
Gegevenselement Waarde
Identificatie MBH_300_TAwijzigen_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 12:30 uur
Gebruiksperiode Vanaf T, gedurende 28 dagen
Ingangsdatum T
Gebruiksduur 28 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_TAwijzigen_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_TAwijzigen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_TAwijzigen_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_TAwijzigen_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 12:30 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 28 stuks
Geneesmiddel - primaire code PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_TAwijzigen_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_TAwijzigen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.23.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.24 TEST Scenarioset 3 wijziging TA

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen C
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Voorvoegsels van de
Achternaam XXX_Voortman
Identificatienummer 999908881 [BSN]
Geboortedatum 18 sep 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.24.1 Scenario 3.5b - MBH_300_TAwijzigen-tav

Toedieningsafspraak MBH_300_TAwijzigen_TA_anderePRK-tav
Gegevenselement Waarde
Identificatie MBH_300_TAwijzigen_TA_anderePRK-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 12:35 uur
Gebruiksperiode Vanaf T, gedurende 18 dagen
Ingangsdatum T
Gebruiksduur 18 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
ToedieningsafspraakRedenWijzigenOfStaken geneesmiddel niet voorradig (code = '182856006' in codeSystem 'SNOMED CT')
Geneesmiddel - primaire code PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 2 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 2 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_TAwijzigen_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
RelatieToedieningsafspraak
Identificatie MBH_300_TAwijzigen_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_TAwijzigen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_TAwijzigen_TA_techstaken-tav
Gegevenselement Waarde
Identificatie MBH_300_TAwijzigen_TA_techstaken-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 12:30 uur
Gebruiksperiode Vanaf T, tot en met T
Ingangsdatum T
Einddatum T
ToedieningsafspraakStopType stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_TAwijzigen_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
RelatieToedieningsafspraak
Identificatie MBH_300_TAwijzigen_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_TAwijzigen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_TAwijzigen_MVE_anderePRK-tav
Gegevenselement Waarde
Identificatie MBH_300_TAwijzigen_MVE_anderePRK-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 12:36 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 28 stuks
Geneesmiddel - primaire code PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_TAwijzigen_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_TAwijzigen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.24.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.25 TEST Scenarioset 3 (initieren scenario) annuleren

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen C
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Voorvoegsels van de
Achternaam XXX_Voortman
Identificatienummer 999908881 [BSN]
Geboortedatum 18 sep 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.25.1 Scenario 3.6a - MBH_300_annuleren-tav

Toedieningsafspraak MBH_300_annuleren_TA_starten-tav
Gegevenselement Waarde
Identificatie MBH_300_annuleren_TA_starten-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 14:10 uur
Gebruiksperiode Vanaf T + 7 dagen, tot en met T + 49 dagen om 00:00 uur
Ingangsdatum T + 7 dagen
Einddatum T + 49 dagen om 00:00 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code LARIAM TABLET 250MG (code = '602574' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code MEFLOQUINE TABLET 250MG (code = '25410' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code MEFLOQUINE TABLET 250MG (code = '66478' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per week 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per week 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_annuleren_MA_starten-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_annuleren-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_annuleren_MVE_starten-tav
Gegevenselement Waarde
Identificatie MBH_300_annuleren_MVE_starten-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 14:10 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 42 stuks
Geneesmiddel - primaire code LARIAM TABLET 250MG (code = '602574' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code MEFLOQUINE TABLET 250MG (code = '25410' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code MEFLOQUINE TABLET 250MG (code = '66478' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_annuleren_VV_starten-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_annuleren-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.25.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.26 TEST Scenarioset 3 annuleren

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen C
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Voorvoegsels van de
Achternaam XXX_Voortman
Identificatienummer 999908881 [BSN]
Geboortedatum 18 sep 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.26.1 Scenario 3.6b - MBH_300_annuleren-tav

Toedieningsafspraak MBH_300_annuleren_TA_geannuleerd-tav
Gegevenselement Waarde
Identificatie MBH_300_annuleren_TA_geannuleerd-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 14:10 uur
Gebruiksperiode Vanaf T + 6 dagen, tot en met T + 6 dagen om 00:00 uur
Ingangsdatum T + 6 dagen
Einddatum T + 6 dagen om 00:00 uur
ToedieningsafspraakStopType geannuleerd (code = '89925002' in codeSystem 'SNOMED CT')
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code LARIAM TABLET 250MG (code = '602574' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code MEFLOQUINE TABLET 250MG (code = '25410' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code MEFLOQUINE TABLET 250MG (code = '66478' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per week 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per week 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_annuleren_MA_geannuleerd-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
RelatieToedieningsafspraak
Identificatie MBH_300_annuleren_TA_starten-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_annuleren-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.26.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.27 TEST Scenarioset 3 (initieren GDS scenario) Stoppen parallelle TA

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen C
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Voorvoegsels van de
Achternaam XXX_Voortman
Identificatienummer 999908881 [BSN]
Geboortedatum 18 sep 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.27.1 Scenario 3.8a - MBH_300_stoppen_parallele_TA-tav

Toedieningsafspraak MBH_300_stoppen_parallele_TA_TA_start_GDS-tav
Gegevenselement Waarde
Identificatie MBH_300_stoppen_parallele_TA_TA_start_GDS-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 10:15 uur
Gebruiksperiode Vanaf T, gedurende 28 dagen
Ingangsdatum T
Gebruiksduur 28 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 stuk 's ochtends, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 stuk 's ochtends
Distributievorm GDS (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.3.8')
RelatieMedicatieafspraak
Identificatie MBH_300_stoppen_parallele_TA_MA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_stoppen_parallele_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_stoppen_parallele_TA_MVE_start_GDS-tav
Gegevenselement Waarde
Identificatie MBH_300_stoppen_parallele_TA_MVE_start_GDS-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 10:05 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 28 stuks
Geneesmiddel - primaire code PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK')
Distributievorm GDS (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.3.8')
RelatieVerstrekkingsverzoek MBH_300_stoppen_parallele_TA_TA_start_GDS-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_stoppen_parallele_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.27.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.28 TEST Scenarioset 3 (initieren zonodig scenario) Stoppen parallelle TA

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen C
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Voorvoegsels van de
Achternaam XXX_Voortman
Identificatienummer 999908881 [BSN]
Geboortedatum 18 sep 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.28.1 Scenario 3.8b - MBH_300_stoppen_parallele_TA-tav

Toedieningsafspraak MBH_300_stoppen_parallele_TA_TA_start_zonodig-tav
Gegevenselement Waarde
Identificatie MBH_300_stoppen_parallele_TA_TA_start_zonodig-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 10:15 uur
Gebruiksperiode Vanaf T, gedurende 28 dagen
Ingangsdatum T
Gebruiksduur 28 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Bij pijn 1 stuk 's avonds, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie Bij pijn 1 stuk 's avonds
RelatieMedicatieafspraak
Identificatie MBH_300_stoppen_parallele_TA_MA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_stoppen_parallele_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_stoppen_parallele_TA_MVE_start_zonodig-tav
Gegevenselement Waarde
Identificatie MBH_300_stoppen_parallele_TA_MVE_start_zonodig-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 10:15 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 28 stuks
Geneesmiddel - primaire code PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_stoppen_parallele_TA_TA_start_zonodig-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_stoppen_parallele_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.28.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.29 TEST Scenarioset 3 (stoppen zonodig scenario) Stoppen parallelle TA

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen C
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Voorvoegsels van de
Achternaam XXX_Voortman
Identificatienummer 999908881 [BSN]
Geboortedatum 18 sep 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.29.1 Scenario 3.8c - MBH_300_stoppen_parallele_TA-tav

Toedieningsafspraak MBH_300_stoppen_parallele_TA_TA_stop_zonodig-tav
Gegevenselement Waarde
Identificatie MBH_300_stoppen_parallele_TA_TA_stop_zonodig-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 10:05 uur
Gebruiksperiode Vanaf T - 4 dagen, tot en met T
Ingangsdatum T - 4 dagen
Einddatum T
ToedieningsafspraakStopType stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
ToedieningsafspraakRedenWijzigenOfStaken medicatiebeleid veranderd (code = '112751000146109' in codeSystem 'SNOMED CT')
Geneesmiddel - primaire code PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Bij pijn 1 stuk 's avonds, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie Bij pijn 1 stuk 's avonds
RelatieMedicatieafspraak
Identificatie MBH_300_stoppen_parallele_TA_MA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
RelatieToedieningsafspraak
Identificatie MBH_300_stoppen_parallele_TA_TA_start_zonodig-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_stoppen_parallele_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.29.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.30 TEST Scenarioset 3 (starten nieuw zonodig scenario) Stoppen parallelle TA

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen C
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Voorvoegsels van de
Achternaam XXX_Voortman
Identificatienummer 999908881 [BSN]
Geboortedatum 18 sep 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.30.1 Scenario 3.8d - MBH_300_stoppen_parallele_TA-tav

Toedieningsafspraak MBH_300_stoppen_parallele_TA_TA_start2_zonodig-tav
Gegevenselement Waarde
Identificatie MBH_300_stoppen_parallele_TA_TA_start2_zonodig-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 10:05 uur
Gebruiksperiode Vanaf T, gedurende 23 dagen
Ingangsdatum T
Gebruiksduur 23 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
ToedieningsafspraakRedenWijzigenOfStaken geneesmiddel niet voorradig (code = '182856006' in codeSystem 'SNOMED CT')
Geneesmiddel - primaire code PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Bij pijn 2 stuks 's avonds, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie Bij pijn 2 stuks 's avonds
RelatieMedicatieafspraak
Identificatie MBH_300_stoppen_parallele_TA_MA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
RelatieToedieningsafspraak
Identificatie MBH_300_stoppen_parallele_TA_TA_start_zonodig-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999)
MBH identificatie MBH_300_stoppen_parallele_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_stoppen_parallele_TA_MVE_start2_zonodig-tav
Gegevenselement Waarde
Identificatie MBH_300_stoppen_parallele_TA_MVE_start2_zonodig-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 10:05 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 23 stuks
Geneesmiddel - primaire code PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_stoppen_parallele_TA_TA_start2_zonodig-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_stoppen_parallele_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.30.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.31 TEST Scenarioset 6 Variabele frequentie

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen G.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Hemsbergen
Identificatienummer 999900602 [BSN]
Geboortedatum 2 nov 1963
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.31.1 Scenario 6.1 - MBH_300_variabelefrequentie-tav

Toedieningsafspraak MBH_300_variabelefrequentie_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_variabelefrequentie_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:00 uur
Gebruiksperiode Vanaf T, tot en met T + 16 dagen
Ingangsdatum T
Einddatum T + 16 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 à 2 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 à 2 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_variabelefrequentie_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_variabelefrequentie-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_variabelefrequentie_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_variabelefrequentie_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 09:00 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 90 stuks
Geneesmiddel - primaire code MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_variabelefrequentie_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_variabelefrequentie-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.31.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.32 TEST Scenarioset 6 Interval

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen G.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Hemsbergen
Identificatienummer 999900602 [BSN]
Geboortedatum 2 nov 1963
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.32.1 Scenario 6.2 - MBH_300_interval-tav

Toedieningsafspraak MBH_300_interval_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_interval_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:04 uur
Gebruiksperiode Vanaf T
Ingangsdatum T
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code AMOXICILLINE DISPER SANDOZ TABLET 500MG (code = '802891' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving iedere 8 uur 1 stuk - gelijke tussenpozen aanhouden, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie iedere 8 uur 1 stuk - gelijke tussenpozen aanhouden
RelatieMedicatieafspraak
Identificatie MBH_300_interval_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_interval-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_interval_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_interval_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 09:04 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 90 stuks
Geneesmiddel - primaire code AMOXICILLINE DISPER SANDOZ TABLET 500MG (code = '802891' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_interval_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_interval-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.32.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.33 TEST Scenarioset 6 Variabele hoeveelheid

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen G.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Hemsbergen
Identificatienummer 999900602 [BSN]
Geboortedatum 2 nov 1963
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.33.1 Scenario 6.3 - MBH_300_variabelehoeveelheid-tav

Toedieningsafspraak MBH_300_variabelehoeveelheid_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_variabelehoeveelheid_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:10 uur
Gebruiksperiode Vanaf T, tot en met T + 28 dagen
Ingangsdatum T
Einddatum T + 28 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code PARACETAMOL AURO TABLET 500MG (code = '1026291' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 3 maal per dag 1 à 2 stuks, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 3 maal per dag 1 à 2 stuks
RelatieMedicatieafspraak
Identificatie MBH_300_variabelehoeveelheid_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_variabelehoeveelheid-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_variabelehoeveelheid_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_variabelehoeveelheid_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 09:10 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 100 stuks
Geneesmiddel - primaire code PARACETAMOL AURO TABLET 500MG (code = '1026291' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_variabelehoeveelheid_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_variabelehoeveelheid-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.33.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.34 TEST Scenarioset 6 Zonder keerdosis

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen G.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Hemsbergen
Identificatienummer 999900602 [BSN]
Geboortedatum 2 nov 1963
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.34.1 Scenario 6.4 - MBH_300_zonderkeerdosis-tav

Toedieningsafspraak MBH_300_zonderkeerdosis_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_zonderkeerdosis_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:12 uur
Gebruiksperiode Vanaf T, tot en met T + 28 dagen
Ingangsdatum T
Einddatum T + 28 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code Cetomacrogolcreme met vaseline 10% (code = '226866' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code Cetomacrogolcreme met vaseline 10% (code = '195758' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 3 maal per dag, aanbrengen, cutaan
Toedieningsweg cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
AanvullendeInstructie aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst')
Doseerinstructie 3 maal per dag
RelatieMedicatieafspraak
Identificatie MBH_300_zonderkeerdosis_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_zonderkeerdosis-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_zonderkeerdosis_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_zonderkeerdosis_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 09:12 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 100 stuks
Geneesmiddel - primaire code CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code Cetomacrogolcreme met vaseline 10% (code = '226866' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code Cetomacrogolcreme met vaseline 10% (code = '195758' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_zonderkeerdosis_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_zonderkeerdosis-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.34.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.35 TEST Scenarioset 6 Bijzondere keerdosis

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen G.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Hemsbergen
Identificatienummer 999900602 [BSN]
Geboortedatum 2 nov 1963
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.35.1 Scenario 6.5 - MBH_300_bijzonderekeerdosis-tav

Toedieningsafspraak MBH_300_bijzonderekeerdosis_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_bijzonderekeerdosis_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:15 uur
Gebruiksperiode Vanaf T, tot en met T + 28 dagen
Ingangsdatum T
Einddatum T + 28 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code NAPROXEN APOTEX TABLET 500MG (code = '1137778' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 2 maal per dag 0.5 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 2 maal per dag 0.5 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_bijzonderekeerdosis_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_bijzonderekeerdosis-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_bijzonderekeerdosis_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_bijzonderekeerdosis_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 09:15 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 30 stuks
Geneesmiddel - primaire code NAPROXEN APOTEX TABLET 500MG (code = '1137778' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_bijzonderekeerdosis_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_bijzonderekeerdosis-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.35.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.36 TEST Scenarioset 6 Variabele hoeveelheid 2

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen G.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Hemsbergen
Identificatienummer 999900602 [BSN]
Geboortedatum 2 nov 1963
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.36.1 Scenario 6.6 - MBH_300_variabelehoeveelheid2-tav

Toedieningsafspraak MBH_300_variabelehoeveelheid2_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_variabelehoeveelheid2_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:18 uur
Gebruiksperiode Vanaf T, tot en met T + 28 dagen
Ingangsdatum T
Einddatum T + 28 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code WATERSTOFPEROXIDE 3% CONC VOOR MONDSP FNA MR (code = '261815' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72664' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 2 maal per dag 10 à 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen, OROMUCOSAAL
Toedieningsweg OROMUCOSAAL (code = '34' in codeSystem 'G-Standaard Toedieningswegen')
AanvullendeInstructie Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst')
AanvullendeInstructie mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst')
Doseerinstructie 2 maal per dag 10 à 15 ml
RelatieMedicatieafspraak
Identificatie MBH_300_variabelehoeveelheid2_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_variabelehoeveelheid2-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_variabelehoeveelheid2_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_variabelehoeveelheid2_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 09:18 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 450 ml
Geneesmiddel - primaire code WATERSTOFPEROXIDE 3% CONC VOOR MONDSP FNA MR (code = '261815' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72664' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_variabelehoeveelheid2_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_variabelehoeveelheid2-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.36.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.37 TEST Scenarioset 6 Tijdstippen flexibel

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen G.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Hemsbergen
Identificatienummer 999900602 [BSN]
Geboortedatum 2 nov 1963
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.37.1 Scenario 6.7a - MBH_300_tijdstippen_flexibel-tav

Toedieningsafspraak MBH_300_tijdstippen_flexibel_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_tijdstippen_flexibel_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:24 uur
Gebruiksperiode Vanaf T, tot en met T + 14 dagen
Ingangsdatum T
Einddatum T + 14 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving elke dag om 08:00, 14:00 en 20:00 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie elke dag om 08:00, 14:00 en 20:00 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_tijdstippen_flexibel_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_tijdstippen_flexibel-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_tijdstippen_flexibel_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_tijdstippen_flexibel_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 09:24 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 45 stuks
Geneesmiddel - primaire code METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_tijdstippen_flexibel_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_tijdstippen_flexibel-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.37.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.38 TEST Scenarioset 6 Tijdstippen niet flexibel

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen G.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Hemsbergen
Identificatienummer 999900602 [BSN]
Geboortedatum 2 nov 1963
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.38.1 Scenario 6.7b - MBH_300_tijdstippen_niet_flexibel-tav

Toedieningsafspraak MBH_300_tijdstippen_niet_flexibel_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_tijdstippen_niet_flexibel_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 10:15 uur
Gebruiksperiode Vanaf T, tot en met T + 7 dagen
Ingangsdatum T
Einddatum T + 7 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, exacte toedientijd(en), oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, exacte toedientijd(en)
RelatieMedicatieafspraak
Identificatie MBH_300_tijdstippen_niet_flexibel_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_tijdstippen_niet_flexibel-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_tijdstippen_niet_flexibel_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_tijdstippen_niet_flexibel_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 10:17 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 24 stuks
Geneesmiddel - primaire code METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_tijdstippen_niet_flexibel_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_tijdstippen_niet_flexibel-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.38.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.39 TEST Scenarioset 6 Weekdagen

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen G.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Hemsbergen
Identificatienummer 999900602 [BSN]
Geboortedatum 2 nov 1963
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.39.1 Scenario 6.8 - MBH_300_weekdagen-tav

Toedieningsafspraak MBH_300_weekdagen_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_weekdagen_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:25 uur
Gebruiksperiode Vanaf T, tot en met T + 70 dagen
Ingangsdatum T
Einddatum T + 70 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code ALDARA CREME 50MG/G IN SACHET (code = '1198521' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving op maandag, woensdag en vrijdag, voor de nacht, aanbrengen, cutaan
Toedieningsweg cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
AanvullendeInstructie voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst')
AanvullendeInstructie aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst')
Doseerinstructie op maandag, woensdag en vrijdag
RelatieMedicatieafspraak
Identificatie MBH_300_weekdagen_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_weekdagen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_weekdagen_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_weekdagen_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 09:25 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 30 stuks
Geneesmiddel - primaire code ALDARA CREME 50MG/G IN SACHET (code = '1198521' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_weekdagen_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_weekdagen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.39.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.40 TEST Scenarioset 6 Dagdeel

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen G.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Hemsbergen
Identificatienummer 999900602 [BSN]
Geboortedatum 2 nov 1963
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.40.1 Scenario 6.9 - MBH_300_dagdeel-tav

Toedieningsafspraak MBH_300_dagdeel_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_dagdeel_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:27 uur
Gebruiksperiode Vanaf T
Ingangsdatum T
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code INEGY TABLET 10/20MG (code = '1719785' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 stuk 's avonds, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 stuk 's avonds
RelatieMedicatieafspraak
Identificatie MBH_300_dagdeel_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_dagdeel-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_dagdeel_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_dagdeel_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 09:27 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 60 stuks
Geneesmiddel - primaire code INEGY TABLET 10/20MG (code = '1719785' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_dagdeel_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_dagdeel-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.40.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.41 TEST Scenarioset 6 Cyclisch schema

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen G.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Hemsbergen
Identificatienummer 999900602 [BSN]
Geboortedatum 2 nov 1963
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.41.1 Scenario 6.10 - MBH_300_cyclischschema-tav

Toedieningsafspraak MBH_300_cyclischschema_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_cyclischschema_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:33 uur
Gebruiksperiode Vanaf T
Ingangsdatum T
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code MARVELON TABLET (code = '416681' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving cyclus van 28 dagen: steeds gedurende 21 dagen 1 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie gedurende 21 dagen 1 maal per dag 1 stuk
HerhaalperiodeCyclischSchema 28 dagen
RelatieMedicatieafspraak
Identificatie MBH_300_cyclischschema_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_cyclischschema-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_cyclischschema_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_cyclischschema_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 09:33 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 126 stuks
Geneesmiddel - primaire code MARVELON TABLET (code = '416681' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_cyclischschema_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_cyclischschema-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.41.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.42 TEST Scenarioset 6 Afbouwschema

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen G.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Hemsbergen
Identificatienummer 999900602 [BSN]
Geboortedatum 2 nov 1963
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.42.1 Scenario 6.11 - MBH_300_afbouwschema-tav

Toedieningsafspraak MBH_300_afbouwschema_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_afbouwschema_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:40 uur
Gebruiksperiode Vanaf T, tot en met T + 41 dagen
Ingangsdatum T
Einddatum T + 41 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code AFFUSINE CREME 20MG/G (code = '2292556' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving eerst gedurende 2 weken 1 maal per dag 3 gram, dan gedurende 3 weken 1 maal per dag 2 gram, dan gedurende 6 dagen 1 maal per dag 1 gram, cutaan
Toedieningsweg cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 eerst gedurende 2 weken 1 maal per dag 3 gram
Doseerinstructie 2 dan gedurende 3 weken 1 maal per dag 2 gram
Doseerinstructie 3 dan gedurende 6 dagen 1 maal per dag 1 gram
RelatieMedicatieafspraak
Identificatie MBH_300_afbouwschema_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_afbouwschema-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_afbouwschema_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_afbouwschema_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 09:40 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 90 gram
Geneesmiddel - primaire code AFFUSINE CREME 20MG/G (code = '2292556' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_afbouwschema_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_afbouwschema-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.42.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.43 TEST Scenarioset 6 Variabele hoeveelheid en maximum

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen G.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Hemsbergen
Identificatienummer 999900602 [BSN]
Geboortedatum 2 nov 1963
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.43.1 Scenario 6.12 - MBH_300_variabelehoeveelheidenmaximum-tav

Toedieningsafspraak MBH_300_variabelehoeveelheidenmaximum_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_variabelehoeveelheidenmaximum_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:45 uur
Gebruiksperiode Vanaf T, tot en met T + 21 dagen
Ingangsdatum T
Einddatum T + 21 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code CODEINEFOSFAAT PCH TABLET 10MG (code = '874965' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag
RelatieMedicatieafspraak
Identificatie MBH_300_variabelehoeveelheidenmaximum_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_variabelehoeveelheidenmaximum-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_variabelehoeveelheidenmaximum_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_variabelehoeveelheidenmaximum_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 09:45 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 120 stuks
Geneesmiddel - primaire code CODEINEFOSFAAT PCH TABLET 10MG (code = '874965' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_variabelehoeveelheidenmaximum_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_variabelehoeveelheidenmaximum-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.43.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.44 TEST Scenarioset 6 Toedieningssnelheid

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen G.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Hemsbergen
Identificatienummer 999900602 [BSN]
Geboortedatum 2 nov 1963
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.44.1 Scenario 6.13 - MBH_300_toedieningssnelheid-tav

Toedieningsafspraak MBH_300_toedieningssnelheid_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_toedieningssnelheid_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:47 uur
Gebruiksperiode Vanaf T, tot en met T + 8 dagen
Ingangsdatum T
Einddatum T + 8 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code MORFINE HCL 3WATER INFVLST 5MG/ML CASS 100ML AHZ (code = '2554771' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving toedieningssnelheid: 0.2 à 0.5 ml/h, Intraveneus
Toedieningsweg Intraveneus (code = '5' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie toedieningssnelheid: 0.2 à 0.5 ml/h
RelatieMedicatieafspraak
Identificatie MBH_300_toedieningssnelheid_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_toedieningssnelheid-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_toedieningssnelheid_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_toedieningssnelheid_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 09:47 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 100 ml
Geneesmiddel - primaire code MORFINE HCL 3WATER INFVLST 5MG/ML CASS 100ML AHZ (code = '2554771' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_toedieningssnelheid_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_toedieningssnelheid-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.44.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.45 TEST Scenarioset 6 Toedieningsduur

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen G.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Hemsbergen
Identificatienummer 999900602 [BSN]
Geboortedatum 2 nov 1963
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.45.1 Scenario 6.14 - MBH_300_toedieningsduur-tav

Toedieningsafspraak MBH_300_toedieningsduur_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_toedieningsduur_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:49 uur
Gebruiksperiode Vanaf T
Ingangsdatum T
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG (code = '1013602' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '228427' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '196738' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk gedurende 16 uur, transdermaal
Toedieningsweg transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk gedurende 16 uur
RelatieMedicatieafspraak
Identificatie MBH_300_toedieningsduur_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_toedieningsduur-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_toedieningsduur_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_toedieningsduur_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 09:49 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 30 stuks
Geneesmiddel - primaire code DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG (code = '1013602' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '228427' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '196738' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_toedieningsduur_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_toedieningsduur-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.45.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.46 TEST Scenarioset 6 Zo nodig

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen G.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Hemsbergen
Identificatienummer 999900602 [BSN]
Geboortedatum 2 nov 1963
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.46.1 Scenario 6.15 - MBH_300_zonodig-tav

Toedieningsafspraak MBH_300_zonodig_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_zonodig_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:57 uur
Gebruiksperiode Vanaf T, tot en met T + 27 dagen
Ingangsdatum T
Einddatum T + 27 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Zo nodig 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie Zo nodig 1 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_zonodig_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_zonodig-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_zonodig_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_zonodig_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 09:57 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 14 stuks
Geneesmiddel - primaire code ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_zonodig_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_zonodig-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.46.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.47 TEST Scenarioset 6 Redundante frequentie

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen G.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Hemsbergen
Identificatienummer 999900602 [BSN]
Geboortedatum 2 nov 1963
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.47.1 Scenario 6.17 - MBH_300_redundantefrequentie-tav

Toedieningsafspraak MBH_300_redundantefrequentie_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_redundantefrequentie_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:45 uur
Gebruiksperiode Vanaf T om 09:45 uur, gedurende 14 dagen
Ingangsdatum T om 09:45 uur
Gebruiksduur 14 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code PREDNISON AURO TABLET 5MG (code = '2033682' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code PREDNISON TABLET 5MG (code = '8311' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code PREDNISON TABLET 5MG (code = '23817' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag om 10:00 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag om 10:00 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_redundantefrequentie_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_redundantefrequentie-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_redundantefrequentie_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_redundantefrequentie_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 09:45 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 14 stuks
Geneesmiddel - primaire code PREDNISON AURO TABLET 5MG (code = '2033682' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code PREDNISON TABLET 5MG (code = '8311' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code PREDNISON TABLET 5MG (code = '23817' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_redundantefrequentie_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_redundantefrequentie-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.47.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.48 TEST Scenarioset 7 alle ingrediënten

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen G.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Hess
Identificatienummer 999900614 [BSN]
Geboortedatum 3 nov 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.48.1 Scenario 7.1 - MBH_300_magistraalalleingredienten-tav

Toedieningsafspraak MBH_300_magistraalalleingredienten_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_magistraalalleingredienten_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 13:00 uur
Gebruiksperiode Vanaf T, tot en met T + 31 dagen
Ingangsdatum T
Einddatum T + 31 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - ProductSpecificatie
ProductNaam Ureum 10% in eucerine cum aqua 100gr
Omschrijving Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr
Ingredient
IngredientCode UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK')
Sterkte 10 gram per 100 gram
Ingredient
IngredientCode EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK')
Sterkte 90 gram per 100 gram
Gebruiksinstructie
Omschrijving Zo nodig, cutaan
Toedieningsweg cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie Zo nodig
RelatieMedicatieafspraak
Identificatie MBH_300_magistraalalleingredienten_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_magistraalalleingredienten-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_magistraalalleingredienten_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_magistraalalleingredienten_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 13:00 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 50 ml
Geneesmiddel - ProductSpecificatie
ProductNaam Ureum 10% in eucerine cum aqua 100gr
Omschrijving Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr
Ingredient
IngredientCode UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK')
Sterkte 10 gram per 100 gram
Ingredient
IngredientCode EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK')
Sterkte 90 gram per 100 gram
RelatieVerstrekkingsverzoek MBH_300_magistraalalleingredienten_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_magistraalalleingredienten-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.48.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.49 TEST Scenarioset 7 Actief ingrediënt

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen G.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Hess
Identificatienummer 999900614 [BSN]
Geboortedatum 3 nov 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.49.1 Scenario 7.2 - MBH_300_magistraalactieveingredient-tav

Toedieningsafspraak MBH_300_magistraalactieveingredient_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_magistraalactieveingredient_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 13:05 uur
Gebruiksperiode Vanaf T + 1 dag, tot en met T + 70 dagen
Ingangsdatum T + 1 dag
Einddatum T + 70 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - ProductSpecificatie
ProductNaam Vaseline 20% in cetomacrogolcrème FNA
Omschrijving Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr
Ingredient
IngredientCode CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK')
Sterkte 80 gram per 100 gram
Gebruiksinstructie
Omschrijving 1 maal per dag, cutaan
Toedieningsweg cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag
RelatieMedicatieafspraak
Identificatie MBH_300_magistraalactieveingredient_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_magistraalactieveingredient-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_magistraalactieveingredient_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_magistraalactieveingredient_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 13:05 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 75 gram
Geneesmiddel - ProductSpecificatie
ProductNaam Vaseline 20% in cetomacrogolcrème FNA
Omschrijving Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr
Ingredient
IngredientCode CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK')
Sterkte 80 gram per 100 gram
RelatieVerstrekkingsverzoek MBH_300_magistraalactieveingredient_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_magistraalactieveingredient-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.49.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.50 TEST Scenarioset 7 90 miljoennummer

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen G.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Hess
Identificatienummer 999900614 [BSN]
Geboortedatum 3 nov 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.50.1 Scenario 7.3 - MBH_300_magistraal90miljoennr-tav

Toedieningsafspraak MBH_300_magistraal90miljoennr_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_magistraal90miljoennr_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 13:08 uur
Gebruiksperiode Vanaf T, tot en met T + 30 dagen
Ingangsdatum T
Einddatum T + 30 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - ProductSpecificatie
ProductCode Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.999.77.90000000.1.1111')
ProductNaam Ureum 10% in eucerine cum aqua 100gr
Omschrijving Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr
Ingredient
IngredientCode UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK')
Sterkte 10 gram per 100 gram
Gebruiksinstructie
Omschrijving 1 maal per dag, cutaan
Toedieningsweg cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag
RelatieMedicatieafspraak
Identificatie MBH_300_magistraal90miljoennr_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_magistraal90miljoennr-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_magistraal90miljoennr_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_magistraal90miljoennr_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 13:08 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 100 gram
Geneesmiddel - ProductSpecificatie
ProductCode Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.999.77.90000000.1.1111')
ProductNaam Ureum 10% in eucerine cum aqua 100gr
Omschrijving Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr
Ingredient
IngredientCode UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK')
Sterkte 10 gram per 100 gram
RelatieVerstrekkingsverzoek MBH_300_magistraal90miljoennr_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_magistraal90miljoennr-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.50.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.51 TEST Scenarioset 7 vrije tekst product

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen G.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Hess
Identificatienummer 999900614 [BSN]
Geboortedatum 3 nov 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.51.1 Scenario 7.4 - MBH_300_vrijetekstproduct-tav

Toedieningsafspraak MBH_300_vrijetekstproduct_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_vrijetekstproduct_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 15:50 uur
Gebruiksperiode Vanaf T - 1 dag, gedurende 12 weken
Ingangsdatum T - 1 dag
Gebruiksduur 12 weken
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - ProductSpecificatie
ProductNaam Jemperli 500 mg/ 10 mL
Omschrijving Titel: Jemperli (Dostarlimab-gxly) 500 mg/10 mL
Gebruiksinstructie
Omschrijving 1 maal per 3 weken 1 stuk, Intraveneus
Toedieningsweg Intraveneus (code = '5' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per 3 weken 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_vrijetekstproduct_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_vrijetekstproduct-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_vrijetekstproduct_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_vrijetekstproduct_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 15:50 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 4 stuks
Geneesmiddel - ProductSpecificatie
ProductNaam Jemperli 500 mg/ 10 mL
Omschrijving Titel: Jemperli (Dostarlimab-gxly) 500 mg/10 mL
RelatieVerstrekkingsverzoek MBH_300_vrijetekstproduct_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_vrijetekstproduct-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.51.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.52 TEST Scenarioset 8 VV onder andermans MA

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen L.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Voorvoegsels van
Achternaam XXX_Meijs
Identificatienummer 999900808 [BSN]
Geboortedatum 26 okt 1985
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.52.1 Scenario 8.1 - MBH_300_VVandermansMA-tav

Toedieningsafspraak MBH_300_MVEandermansTA_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_MVEandermansTA_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T - 14 dagen om 10:00 uur
Gebruiksperiode Vanaf T - 14 dagen, tot en met T + 6 dagen
Ingangsdatum T - 14 dagen
Einddatum T + 6 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code DICLOFENAC NATRIUM AUROBINDO RET TABLET MGA 100MG (code = '630608' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_VVandermansMA_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_VVandermansMA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_MVEandermansTA_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_MVEandermansTA_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 10:00 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 6 stuks
Geneesmiddel - primaire code DICLOFENAC NATRIUM AUROBINDO RET TABLET MGA 100MG (code = '630608' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_VVandermansMA_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_VVandermansMA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.52.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.53 TEST Scenarioset 8 Staken andermans MA

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen L.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Voorvoegsels van
Achternaam XXX_Meijs
Identificatienummer 999900808 [BSN]
Geboortedatum 26 okt 1985
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.53.1 Scenario 8.2 - MBH_300_stakenandermansMA-tav

Toedieningsafspraak MBH_300_stakenandermansTA_TA2-tav
Gegevenselement Waarde
Identificatie MBH_300_stakenandermansTA_TA2-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 10:05 uur
Gebruiksperiode Vanaf T - 5 dagen, tot en met T
Ingangsdatum T - 5 dagen
Einddatum T
ToedieningsafspraakStopType stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK')
Geneesmiddel - generiekere code LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_stakenandermansMA_MA2-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_stakenandermansMA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_stakenandermansTA_andermansMVE-tav
Gegevenselement Waarde
Identificatie MBH_300_stakenandermansTA_andermansMVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T - 5 dagen om 09:45 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 21 stuks
Geneesmiddel - primaire code LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK')
Geneesmiddel - generiekere code LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_stakenandermansMA_andermansVV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_stakenandermansMA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.53.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.54 TEST Scenarioset 8 Onderbreken andermans MA

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen L.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Voorvoegsels van
Achternaam XXX_Meijs
Identificatienummer 999900808 [BSN]
Geboortedatum 26 okt 1985
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.54.1 Scenario 8.3 - MBH_300_onderbrekenandermansMA-tav

Toedieningsafspraak MBH_300_onderbrekenandermansTA_TA2-tav
Gegevenselement Waarde
Identificatie MBH_300_onderbrekenandermansTA_TA2-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 10:07 uur
Gebruiksperiode Vanaf T - 60 dagen, tot en met T
Ingangsdatum T - 60 dagen
Einddatum T
ToedieningsafspraakStopType onderbroken (code = '385655000' in codeSystem 'SNOMED CT')
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_onderbrekenandermansMA_MA2-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_onderbrekenandermansMA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_onderbrekenandermansTA_andermansMVE-tav
Gegevenselement Waarde
Identificatie MBH_300_onderbrekenandermansTA_andermansMVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T - 60 dagen om 10:00 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 90 stuks
Geneesmiddel - primaire code ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_onderbrekenandermansMA_andermansVV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_onderbrekenandermansMA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.54.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.55 TEST Scenarioset 8 Wijzigen andermans MA

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen L.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Voorvoegsels van
Achternaam XXX_Meijs
Identificatienummer 999900808 [BSN]
Geboortedatum 26 okt 1985
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.55.1 Scenario 8.4 - MBH_300_wijzigenandermansMA-tav

Toedieningsafspraak MBH_300_wijzigenandermansTA_TA1-tav
Gegevenselement Waarde
Identificatie MBH_300_wijzigenandermansTA_TA1-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T - 7 dagen om 08:50 uur
Gebruiksperiode Vanaf T - 7 dagen, tot en met T + 13 dagen
Ingangsdatum T - 7 dagen
Einddatum T + 13 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 2 stuks, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 2 stuks
RelatieMedicatieafspraak
Identificatie MBH_300_wijzigenandermansMA_MA1-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_wijzigenandermansMA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_wijzigenandermansTA_andermansMVE-tav
Gegevenselement Waarde
Identificatie MBH_300_wijzigenandermansTA_andermansMVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T - 7 dagen om 08:50 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 42 stuks
Geneesmiddel - primaire code FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_wijzigenandermansMA_andermansVV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_wijzigenandermansMA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.55.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.56 TEST Scenarioset 9 Verbruiksperiode

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen M.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Nederveen
Identificatienummer 999900833 [BSN]
Geboortedatum 28 okt 1985
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.56.1 Scenario 9.1a - MBH_300_logistiekeverbruiksperiode_start_eind-tav

Toedieningsafspraak MBH_300_logistiekeverbruiksperiode_start_eind_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_logistiekeverbruiksperiode_start_eind_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 12:00 uur
Gebruiksperiode Vanaf T, tot en met T + 12 maanden
Ingangsdatum T
Einddatum T + 12 maanden
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_logistiekeverbruiksperiode_start_eind_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_logistiekeverbruiksperiode_start_eind-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 12:00 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 100 stuks
Verbruiksduur 100 dagen
Geneesmiddel - primaire code ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_logistiekeverbruiksperiode_start_eind_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_logistiekeverbruiksperiode_start_eind-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.56.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.57 TEST Scenarioset 9 GDS

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen M.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Nederveen
Identificatienummer 999900833 [BSN]
Geboortedatum 28 okt 1985
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.57.1 Scenario 9.1b - MBH_300_distributievorm_GDS-tav

Toedieningsafspraak MBH_300_distributievorm_GDS_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_distributievorm_GDS_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 12:01 uur
Gebruiksperiode Vanaf T, tot en met T + 200 dagen
Ingangsdatum T
Einddatum T + 200 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
Distributievorm GDS (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.3.8')
RelatieMedicatieafspraak
Identificatie MBH_300_distributievorm_GDS_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_distributievorm_GDS-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_distributievorm_GDS_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_distributievorm_GDS_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 12:01 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 14 stuks
Verbruiksduur 14 dagen
Geneesmiddel - primaire code MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK')
Distributievorm GDS (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.3.8')
RelatieVerstrekkingsverzoek MBH_300_distributievorm_GDS_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_distributievorm_GDS-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.57.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.58 TEST Scenarioset 9 verbruiksduur (dagen)

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen M.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Nederveen
Identificatienummer 999900833 [BSN]
Geboortedatum 28 okt 1985
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.58.1 Scenario 9.1c - MBH_300_logistiekeverbruiksperiode_duur_dagen-tav

Toedieningsafspraak MBH_300_logistiekeverbruiksperiode_duur_dagen_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_logistiekeverbruiksperiode_duur_dagen_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 12:02 uur
Gebruiksperiode Vanaf T, tot en met T + 150 dagen
Ingangsdatum T
Einddatum T + 150 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code PARACETAMOL PCH TABLET 500MG (code = '768901' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_logistiekeverbruiksperiode_duur_dagen_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_logistiekeverbruiksperiode_duur_dagen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 12:02 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 50 stuks
Verbruiksduur 50 dagen
Geneesmiddel - primaire code PARACETAMOL PCH TABLET 500MG (code = '768901' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_logistiekeverbruiksperiode_duur_dagen_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_logistiekeverbruiksperiode_duur_dagen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.58.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.59 TEST Scenarioset 9 Herhalingen a

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen M.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Nederveen
Identificatienummer 999900833 [BSN]
Geboortedatum 28 okt 1985
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.59.1 Scenario 9.2a - MBH_300_herhalingen-tav

Toedieningsafspraak MBH_300_herhalingen_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_herhalingen_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 12:05 uur
Gebruiksperiode Vanaf T
Ingangsdatum T
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_herhalingen_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_herhalingen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_herhalingen_MVE1-tav
Gegevenselement Waarde
Identificatie MBH_300_herhalingen_MVE1-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 12:05 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 30 stuks
Geneesmiddel - primaire code FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_herhalingen_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_herhalingen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.59.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.60 TEST Scenarioset 9 Herhalingen b

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen M.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Nederveen
Identificatienummer 999900833 [BSN]
Geboortedatum 28 okt 1985
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.60.1 Scenario 9.2b - MBH_300_herhalingen-tav

Toedieningsafspraak MBH_300_herhalingen_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_herhalingen_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T - 30 dagen om 12:05 uur
Gebruiksperiode Vanaf T - 30 dagen
Ingangsdatum T - 30 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_herhalingen_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_herhalingen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_herhalingen_MVE2-tav
Gegevenselement Waarde
Identificatie MBH_300_herhalingen_MVE2-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 10:24:05 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 30 stuks
Geneesmiddel - primaire code FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_herhalingen_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_herhalingen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.60.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.61 TEST Scenarioset 9 Herhalingen c

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen M.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Nederveen
Identificatienummer 999900833 [BSN]
Geboortedatum 28 okt 1985
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.61.1 Scenario 9.2c - MBH_300_herhalingen-tav

Toedieningsafspraak MBH_300_herhalingen_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_herhalingen_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T - 60 dagen om 12:05 uur
Gebruiksperiode Vanaf T - 60 dagen
Ingangsdatum T - 60 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_herhalingen_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_herhalingen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_herhalingen_MVE3-tav
Gegevenselement Waarde
Identificatie MBH_300_herhalingen_MVE3-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 09:46:48 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 30 stuks
Geneesmiddel - primaire code FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_herhalingen_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_herhalingen-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.61.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.62 TEST Scenarioset 9 Afleverlocatie / Aanschrijfdatum

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen M.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Nederveen
Identificatienummer 999900833 [BSN]
Geboortedatum 28 okt 1985
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.62.1 Scenario 9.3 - MBH_300_afleverlocatie-tav

Toedieningsafspraak MBH_300_afleverlocatie_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_afleverlocatie_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 12:07 uur
Gebruiksperiode Vanaf T + 1 dag, tot en met T + 10 dagen
Ingangsdatum T + 1 dag
Einddatum T + 10 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code MODAFINIL FOCUS TABLET 200MG (code = '2842246' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code MODAFINIL TABLET 200MG (code = '199311' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code MODAFINIL TABLET 200MG (code = '179051' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 3 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 3 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_afleverlocatie_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_afleverlocatie-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_afleverlocatie_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_afleverlocatie_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 12:07 uur
AanschrijfDatum T om 11:07 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 30 stuks
Geneesmiddel - primaire code MODAFINIL FOCUS TABLET 200MG (code = '2842246' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code MODAFINIL TABLET 200MG (code = '199311' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code MODAFINIL TABLET 200MG (code = '179051' in codeSystem 'G-Standaard GPK')
Afleverlocatie Dorpsrand 200,1256ZZ Ons Dorp
RelatieVerstrekkingsverzoek MBH_300_afleverlocatie_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_afleverlocatie-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.62.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.63 TEST Scenarioset 10 HPK geneesmiddel

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen M.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Niesing
Identificatienummer 999900845 [BSN]
Geboortedatum 29 okt 1985
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.63.1 Scenario 10.1 - MBH_300_HPKvoorschrijven-tav

Toedieningsafspraak MBH_300_HPKvoorschrijven_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_HPKvoorschrijven_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 14:00 uur
Gebruiksperiode Vanaf T, tot en met T + 150 dagen
Ingangsdatum T
Einddatum T + 150 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_HPKvoorschrijven_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_HPKvoorschrijven-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_HPKvoorschrijven_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_HPKvoorschrijven_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 14:00 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 150 stuks
Geneesmiddel - primaire code XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_HPKvoorschrijven_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_HPKvoorschrijven-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.63.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.64 TEST Scenarioset 10 ZI-nummer geneesmiddel

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen M.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Niesing
Identificatienummer 999900845 [BSN]
Geboortedatum 29 okt 1985
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.64.1 Scenario 10.2 - MBH_300_ZINRvoorschrijven-tav

Toedieningsafspraak MBH_300_ZINRvoorschrijven_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_ZINRvoorschrijven_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 14:05 uur
Gebruiksperiode Vanaf T, tot en met T + 150 dagen
Ingangsdatum T
Einddatum T + 150 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '16255429' in codeSystem 'G-Standaard ZI-nr')
Geneesmiddel - generiekere code INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '2593866' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_ZINRvoorschrijven_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_ZINRvoorschrijven-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_ZINRvoorschrijven_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_ZINRvoorschrijven_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 14:05 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 150 stuks
Geneesmiddel - primaire code INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '16255429' in codeSystem 'G-Standaard ZI-nr')
Geneesmiddel - generiekere code INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '2593866' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_ZINRvoorschrijven_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_ZINRvoorschrijven-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.64.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.65 TEST Scenarioset 11 extern doseerschema

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen M.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Pherai
Identificatienummer 999900870 [BSN]
Geboortedatum 1 nov 1985
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.65.1 Scenario 11.1 - MBH_300_wdsmtd1-tav

Toedieningsafspraak MBH_300_wdsmtd1_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_wdsmtd1_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 09:00 uur
Gebruiksperiode Vanaf T - 20 dagen
Ingangsdatum T - 20 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Volgens schema trombosedienst, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
AanvullendeInstructie overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst
RelatieMedicatieafspraak
Identificatie MBH_300_wdsmtd1_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_wdsmtd1-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_wdsmtd1_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_wdsmtd1_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 09:00 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 60 stuks
Geneesmiddel - primaire code ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_wdsmtd1_VV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_wdsmtd1-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.65.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.66 TEST Scenarioset 23.1a afhandelen voorschrift t.b.v. VMA

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen K.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Verbeekz
Identificatienummer 999908522 [BSN]
Geboortedatum 19 feb 1912
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.66.1 Scenario 23.1a - MBH_300_VMA_geaccepteerd-tav

Toedieningsafspraak MBH_300_VMA_geaccepteerd_TA_start-tav
Gegevenselement Waarde
Identificatie MBH_300_VMA_geaccepteerd_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 15:00 uur
Gebruiksperiode Vanaf T, tot en met T + 29 dagen
Ingangsdatum T
Einddatum T + 29 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code OMEPRAZOL TEVA CAPSULE MSR 20MG (code = '2239671' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code OMEPRAZOL CAPSULE MSR 20MG (code = '60062' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code OMEPRAZOL CAPSULE MSR 20MG (code = '114529' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
MBH identificatie MBH_300_VMA_geaccepteerd-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_VMA_geaccepteerd_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_VMA_geaccepteerd_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 15:00 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 28 stuks
Geneesmiddel - primaire code OMEPRAZOL TEVA CAPSULE MSR 20MG (code = '2239671' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code OMEPRAZOL CAPSULE MSR 20MG (code = '60062' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code OMEPRAZOL CAPSULE MSR 20MG (code = '114529' in codeSystem 'G-Standaard GPK')
MBH identificatie MBH_300_VMA_geaccepteerd-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.66.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.67 TEST Scenarioset 23.1b afhandelen voorschrift t.b.v. VMA

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen K.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Verbeekz
Identificatienummer 999908522 [BSN]
Geboortedatum 19 feb 1912
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.67.1 Scenario 23.1b - MBH_300_VMA_geaccepteerd-tav

Toedieningsafspraak MBH_300_VMA_geaccepteerd_TA_techstop-tav
Gegevenselement Waarde
Identificatie MBH_300_VMA_geaccepteerd_TA_techstop-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T + 1 dag om 13:00 uur
Gebruiksperiode Vanaf T, tot en met T + 1 dag om 13:00 uur
Ingangsdatum T
Einddatum T + 1 dag om 13:00 uur
ToedieningsafspraakStopType stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code OMEPRAZOL TEVA CAPSULE MSR 20MG (code = '2239671' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code OMEPRAZOL CAPSULE MSR 20MG (code = '60062' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code OMEPRAZOL CAPSULE MSR 20MG (code = '114529' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
RelatieToedieningsafspraak
Identificatie MBH_300_VMA_geaccepteerd_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_VMA_geaccepteerd-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_VMA_geaccepteerd_TA_naVMA-tav
Gegevenselement Waarde
Identificatie MBH_300_VMA_geaccepteerd_TA_naVMA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T + 1 dag om 13:00 uur
Gebruiksperiode Vanaf T + 1 dag om 13:00 uur, tot en met T + 29 dagen
Ingangsdatum T + 1 dag om 13:00 uur
Einddatum T + 29 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code OMEPRAZOL TEVA CAPSULE MSR 20MG (code = '2239671' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code OMEPRAZOL CAPSULE MSR 20MG (code = '60062' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code OMEPRAZOL CAPSULE MSR 20MG (code = '114529' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_VMA_geaccepteerd_MA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_VMA_geaccepteerd-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.67.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.68 TEST Scenarioset 23.2 afhandelen voorschrift t.b.v. VMA

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen K.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Wieling
Identificatienummer 999908510 [BSN]
Geboortedatum 18 feb 1912
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.68.1 Scenario 23.2 - MBH_300_VMAafgewezen_PRK-tav

Toedieningsafspraak MBH_300_VMAafgewezen_PRK_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_VMAafgewezen_PRK_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 16:00 uur
Gebruiksperiode Vanaf T, tot en met T + 13 dagen
Ingangsdatum T
Einddatum T + 13 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code PLEINVUE POEDER VOOR DRANK IN SACHET (code = '2748088' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code MACROGOL/ZOUTEN PDR V DRANK (PLEINVUE) (code = '150002' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code MACROGOL/ZOUTEN PDR V DRANK (PLEINVUE) (code = '174076' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 à 2 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 à 2 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_VMAafgewezen_PRK_MA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_VMAafgewezen_PRK-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_VMAafgewezen_PRK_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_VMAafgewezen_PRK_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 16:00 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 28 stuks
Geneesmiddel - primaire code PLEINVUE POEDER VOOR DRANK IN SACHET (code = '2748088' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code MACROGOL/ZOUTEN PDR V DRANK (PLEINVUE) (code = '150002' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code MACROGOL/ZOUTEN PDR V DRANK (PLEINVUE) (code = '174076' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_VMAafgewezen_PRK_VV_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_VMAafgewezen_PRK-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.68.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.69 TEST Scenarioset 23.3a afhandelen voorschrift t.b.v. VMA

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen J.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Willemsz
Identificatienummer 999908492 [BSN]
Geboortedatum 16 feb 1912
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.69.1 Scenario 23.3a - MBH_300_VMAaanvullendmiddel-tav

Toedieningsafspraak MBH_300_VMAaanvullendmiddel_TA_start-tav
Gegevenselement Waarde
Identificatie MBH_300_VMAaanvullendmiddel_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 11:00 uur
Gebruiksperiode Vanaf T, tot en met T + 13 dagen
Ingangsdatum T
Einddatum T + 13 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code PLEINVUE POEDER VOOR DRANK IN SACHET (code = '2748088' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code MACROGOL/ZOUTEN PDR V DRANK (PLEINVUE) (code = '150002' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code MACROGOL/ZOUTEN PDR V DRANK (PLEINVUE) (code = '174076' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 à 2 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 à 2 maal per dag 1 stuk
MBH identificatie MBH_300_VMAaanvullendmiddel-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_VMAaanvullendmiddel_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_VMAaanvullendmiddel_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 11:00 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 28 stuks
Geneesmiddel - primaire code PLEINVUE POEDER VOOR DRANK IN SACHET (code = '2748088' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code MACROGOL/ZOUTEN PDR V DRANK (PLEINVUE) (code = '150002' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code MACROGOL/ZOUTEN PDR V DRANK (PLEINVUE) (code = '174076' in codeSystem 'G-Standaard GPK')
MBH identificatie MBH_300_VMAaanvullendmiddel-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.69.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.70 TEST Scenarioset 23.3b afhandelen voorschrift t.b.v. VMA

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen J.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Achternaam XXX_Willemsz
Identificatienummer 999908492 [BSN]
Geboortedatum 16 feb 1912
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.70.1 Scenario 23.3b - MBH_300_VMAaanvullendmiddel-tav

Toedieningsafspraak MBH_300_VMAaanvullendmiddel_techstopTA-tav
Gegevenselement Waarde
Identificatie MBH_300_VMAaanvullendmiddel_techstopTA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 16:00 uur
Gebruiksperiode Vanaf T, tot en met T om 16:00 uur
Ingangsdatum T
Einddatum T om 16:00 uur
ToedieningsafspraakStopType stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code PLEINVUE POEDER VOOR DRANK IN SACHET (code = '2748088' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code MACROGOL/ZOUTEN PDR V DRANK (PLEINVUE) (code = '150002' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code MACROGOL/ZOUTEN PDR V DRANK (PLEINVUE) (code = '174076' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 à 2 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 à 2 maal per dag 1 stuk
RelatieToedieningsafspraak
Identificatie MBH_300_VMAaanvullendmiddel_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_VMAaanvullendmiddel-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_VMAaanvullendmiddel_TA_naVMA-tav
Gegevenselement Waarde
Identificatie MBH_300_VMAaanvullendmiddel_TA_naVMA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 16:00 uur
Gebruiksperiode Vanaf T om 16:00 uur, tot en met T + 13 dagen
Ingangsdatum T om 16:00 uur
Einddatum T + 13 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code PLEINVUE POEDER VOOR DRANK IN SACHET (code = '2748088' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code MACROGOL/ZOUTEN PDR V DRANK (PLEINVUE) (code = '150002' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code MACROGOL/ZOUTEN PDR V DRANK (PLEINVUE) (code = '174076' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 à 2 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 à 2 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_VMAaanvullendmiddel_MA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_VMAaanvullendmiddel-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.70.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.71 TEST Scenarioset 23.4a afhandelen voorschrift t.b.v. VMA

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen J.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Voorvoegsels van de
Achternaam XXX_Knaap
Identificatienummer 999908480 [BSN]
Geboortedatum 15 feb 1912
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.71.1 Scenario 23.4a - MBH_300_VMAvervangend_voorschr-tav

Toedieningsafspraak MBH_300_VMAvervangend_voorschr_TA_start-tav
Gegevenselement Waarde
Identificatie MBH_300_VMAvervangend_voorschr_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 15:00 uur
Gebruiksperiode Vanaf T
Ingangsdatum T
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
ToedieningsafspraakRedenWijzigenOfStaken geneesmiddel niet voorradig (code = '182856006' in codeSystem 'SNOMED CT')
Geneesmiddel - primaire code KETOZOLIN SHAMPOO 20MG/ML (code = '2854368' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code KETOCONAZOL SHAMPOO 20MG/G (code = '80349' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code KETOCONAZOL SHAMPOO 20MG/G (code = '125156' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 2 maal per week, een kleine hoeveelheid over het nog natte haar verdelen en voorzichtig inmasseren, na 3–5 min uitspoelen. De behandeling voortzetten tot de symptomen zijn verdwenen, Cutaan
Toedieningsweg Cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
AanvullendeInstructie overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): een kleine hoeveelheid over het nog natte haar verdelen en voorzichtig inmasseren, na 3–5 min uitspoelen. De behandeling voortzetten tot de symptomen zijn verdwenen
Doseerinstructie 2 maal per week
RelatieMedicatieafspraak
Identificatie MBH_300_VMAvervangend_voorschr_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_VMAvervangend_voorschr-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_VMAvervangend_voorschr_MVE_start-tav
Gegevenselement Waarde
Identificatie MBH_300_VMAvervangend_voorschr_MVE_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 15:00 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 100 ml
Geneesmiddel - primaire code KETOZOLIN SHAMPOO 20MG/ML (code = '2854368' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code KETOCONAZOL SHAMPOO 20MG/G (code = '80349' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code KETOCONAZOL SHAMPOO 20MG/G (code = '125156' in codeSystem 'G-Standaard GPK')
MBH identificatie MBH_300_VMAvervangend_voorschr-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.71.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.72 TEST Scenarioset 23.4b afhandelen voorschrift t.b.v. VMA

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen J.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Voorvoegsels van de
Achternaam XXX_Knaap
Identificatienummer 999908480 [BSN]
Geboortedatum 15 feb 1912
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.72.1 Scenario 23.4b - MBH_300_VMAvervangend_voorschr-tav

Toedieningsafspraak MBH_300_VMAvervangend_voorschr_stopTA-tav
Gegevenselement Waarde
Identificatie MBH_300_VMAvervangend_voorschr_stopTA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 17:00 uur
Gebruiksperiode Vanaf T, tot en met T om 17:00 uur
Ingangsdatum T
Einddatum T om 17:00 uur
ToedieningsafspraakStopType stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code KETOZOLIN SHAMPOO 20MG/ML (code = '2854368' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code KETOCONAZOL SHAMPOO 20MG/G (code = '80349' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code KETOCONAZOL SHAMPOO 20MG/G (code = '125156' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 2 maal per week, een kleine hoeveelheid over het nog natte haar verdelen en voorzichtig inmasseren, na 3–5 min uitspoelen. De behandeling voortzetten tot de symptomen zijn verdwenen, Cutaan
Toedieningsweg Cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
AanvullendeInstructie overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): een kleine hoeveelheid over het nog natte haar verdelen en voorzichtig inmasseren, na 3–5 min uitspoelen. De behandeling voortzetten tot de symptomen zijn verdwenen
Doseerinstructie 2 maal per week
RelatieMedicatieafspraak
Identificatie MBH_300_VMAvervangend_voorschr_stopMA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
RelatieToedieningsafspraak
Identificatie MBH_300_VMAvervangend_voorschr_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_VMAvervangend_voorschr-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.72.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.73 TEST Scenarioset 23.4c afhandelen voorschrift t.b.v. VMA

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen J.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Voorvoegsels van de
Achternaam XXX_Knaap
Identificatienummer 999908480 [BSN]
Geboortedatum 15 feb 1912
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.73.1 Scenario 23.4c - MBH_300_VMAvervangendmiddel-tav

Toedieningsafspraak MBH_300_VMAvervangendmiddel_TA_naVMA-tav
Gegevenselement Waarde
Identificatie MBH_300_VMAvervangendmiddel_TA_naVMA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 17:00 uur
Gebruiksperiode Vanaf T om 17:00 uur
Ingangsdatum T om 17:00 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code KETOZOLIN SHAMPOO 20MG/ML (code = '2854368' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code KETOCONAZOL SHAMPOO 20MG/G (code = '80349' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code KETOCONAZOL SHAMPOO 20MG/G (code = '125156' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 2 maal per week, een kleine hoeveelheid over het nog natte haar verdelen en voorzichtig inmasseren, na 3–5 min uitspoelen. De behandeling voortzetten tot de symptomen zijn verdwenen, Cutaan
Toedieningsweg Cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
AanvullendeInstructie overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): een kleine hoeveelheid over het nog natte haar verdelen en voorzichtig inmasseren, na 3–5 min uitspoelen. De behandeling voortzetten tot de symptomen zijn verdwenen
Doseerinstructie 2 maal per week
RelatieMedicatieafspraak
Identificatie MBH_300_VMAvervangendmiddel_MA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
RelatieToedieningsafspraak
Identificatie MBH_300_VMAvervangend_voorschr_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_VMAvervangendmiddel-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.73.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.74 TEST Scenarioset 23.5a afhandelen voorschrift t.b.v. VVV

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen J.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Voorvoegsels de
Achternaam XXX_Wit
Identificatienummer 999908509 [BSN]
Geboortedatum 17 feb 1912
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.74.1 Scenario 23.5a - MBH_300_VVV_geaccepteerd-tav

Toedieningsafspraak MBH_300_VVV_geaccepteerd_TA_start-tav
Gegevenselement Waarde
Identificatie MBH_300_VVV_geaccepteerd_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T - 2 dagen om 14:00 uur
Gebruiksperiode Vanaf T - 2 dagen, tot en met T
Ingangsdatum T - 2 dagen
Einddatum T
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code METOCLOPRAMIDE HCL ACCORD TABLET 10MG (code = '2115468' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per 2 dagen 2 stuks, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per 2 dagen 2 stuks
RelatieMedicatieafspraak
Identificatie MBH_300_VVV_geaccepteerd_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_VVV_geaccepteerd-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_VVV_geaccepteerd_MVE_start-tav
Gegevenselement Waarde
Identificatie MBH_300_VVV_geaccepteerd_MVE_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T - 2 dagen om 14:00 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 6 stuks
Geneesmiddel - primaire code METOCLOPRAMIDE HCL ACCORD TABLET 10MG (code = '2115468' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_VVV_geaccepteerd_VV_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_VVV_geaccepteerd-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.74.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.75 TEST Scenarioset 23.5b afhandelen voorschrift t.b.v. VVV

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen J.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Voorvoegsels de
Achternaam XXX_Wit
Identificatienummer 999908509 [BSN]
Geboortedatum 17 feb 1912
Geslacht Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')

1.75.1 Scenario 23.5b - MBH_300_VVV_geaccepteerd-tav

Toedieningsafspraak MBH_300_VVV_geaccepteerd_TA_start-tav
Gegevenselement Waarde
Identificatie MBH_300_VVV_geaccepteerd_TA_start-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T - 2 dagen om 14:00 uur
Gebruiksperiode Vanaf T - 2 dagen, tot en met T
Ingangsdatum T - 2 dagen
Einddatum T
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code METOCLOPRAMIDE HCL ACCORD TABLET 10MG (code = '2115468' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per 2 dagen 2 stuks, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per 2 dagen 2 stuks
RelatieMedicatieafspraak
Identificatie MBH_300_VVV_geaccepteerd_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_VVV_geaccepteerd-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_VVV_geaccepteerd_MVE_naVVV-tav
Gegevenselement Waarde
Identificatie MBH_300_VVV_geaccepteerd_MVE_naVVV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 15:00 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 5 stuks
Geneesmiddel - primaire code METOCLOPRAMIDE HCL ACCORD TABLET 10MG (code = '2115468' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_VVV_geaccepteerd_VV__naVVV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_VVV_geaccepteerd-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.75.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp

1.76 TEST Scenarioset 23.6 afhandelen voorschrift t.b.v. VVV

Patiënt
Gegevenselement Waarde
Naamgegevens
Voornamen J.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik')
Geslachtsnaam
Voorvoegsels van
Achternaam XXX_Reenen
Identificatienummer 999908479 [BSN]
Geboortedatum 14 feb 1912
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.76.1 Scenario 23.6 - MBH_300_VVV_wijziging-tav

Toedieningsafspraak MBH_300_VVV_wijziging_TA-tav
Gegevenselement Waarde
Identificatie MBH_300_VVV_wijziging_TA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
RegistratieDatumTijd T om 16:00 uur
Gebruiksperiode Vanaf T, tot en met T + 4 dagen
Ingangsdatum T
Einddatum T + 4 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
Geneesmiddel - primaire code OMEPRAZOL TEVA CAPSULE MSR 20MG (code = '2239671' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code OMEPRAZOL CAPSULE MSR 20MG (code = '60062' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code OMEPRAZOL CAPSULE MSR 20MG (code = '114529' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
RelatieMedicatieafspraak
Identificatie MBH_300_VVV_wijziging_MA-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_VVV_wijziging-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieverstrekking MBH_300_VVV_wijziging_MVE-tav
Gegevenselement Waarde
Identificatie MBH_300_VVV_wijziging_MVE-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
MedicatieverstrekkingsDatumTijd T om 16:00 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER
VerstrekteHoeveelheid 5 stuks
Geneesmiddel - primaire code OMEPRAZOL TEVA CAPSULE MSR 20MG (code = '2239671' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code OMEPRAZOL CAPSULE MSR 20MG (code = '60062' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code OMEPRAZOL CAPSULE MSR 20MG (code = '114529' in codeSystem 'G-Standaard GPK')
RelatieVerstrekkingsverzoek MBH_300_VVV_wijziging_VV_naVVV-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
MBH identificatie MBH_300_VVV_wijziging-tav (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.76.2 Bouwstenen

Bouwstenen
Gegevenselement Waarde
Zorgaanbieder APOTHEEK_DE_GULLE_GAPER
ZorgaanbiederIdentificatienummer 01236578 (in identificerend systeem: URA)
OrganisatieNaam Apotheek De Gulle Gaper
Adresgegevens Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
Overgenomen van "https://informatiestandaarden.nictiz.nl/index.php?title=mp:V3.0.0_testgegevens_afhandelen_voorschrift_addendum&oldid=317755"